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Executive Summary 
Introduction 
This study has examined the participation of UK researchers in the EU’s Seventh 
Framework Programme for Research and Innovation (FP7). The study also reviewed 
the UK’s participation in Horizon 2020 up to February 2016 and UK involvement with 
EUREKA and COST (European Cooperation in Science and Technology). The study 
was commissioned in order to inform the UK’s response to the European 
Commission’s interim evaluation of Horizon 2020 and preparation in due course for 
the ninth Framework Programme. 
The study aimed to provide evidence on the levels of participation and funding 
achieved and the associated results and added value of FP7 for the UK’s university 
and business research base. Complementarity with other EU collaborative/non-
collaborative activities (COST and EUREKA) and national initiatives was also 
examined. 
The research sought to: 
• Assess and analyse UK participation patterns across Framework Programmes
(FP6, FP7 and the first two years of Horizon 2020).
• Identify and assess motivations, barriers and enablers to access and
participation in FP7 and other European collaborative/non-collaborative
activities.
The fieldwork for the study consisted of an interview programme with stakeholders in 
the UK’s research base, online surveys of successful and unsuccessful applicants 
and five in depth case studies of purposely selected FP7 projects. 
The research was commissioned before the UK referendum on 23rd June 2016. In 
this referendum, the UK voted to leave the European Union. The Government has 
made clear it would welcome agreement to continue to collaborate with European 
partners on major science, research and technology initiatives. As set out in the 
future partnership paper, “Collaboration on Science and Innovation”, published on 
6th September 2017, the UK will seek an ambitious Science and Innovation 
Agreement with the EU.
ICF would like to thank the COST Association, the EUREKA secretariat and Innovate 
UK for their contributions to the study. 
Context for the evaluation 
Overall, the UK’s research and innovation system is characterised by a relatively low 
investment in research and development (R&D), compared to other EU member 
states, and very strong human capital and scientific output. In the period 2007-2013, 
the UK invested on average 1.69% of its Gross Domestic Product (GDP) in R&D - the 
UK ranked 11th out of all EU member states and below the EU average, behind 
countries such as Germany (2.71% on average) and France (2.16% on average). In 
terms of the total value of R&D investments, the UK came 3rd behind Germany and 
France, with a total investment of €227 billion in the period 2007-2013. 
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The largest performers of research in the UK are the business sector and the higher 
education sector – the UK does not have a large number of research organisations, 
which account for a large share of the basic and applied research undertaken in 
other countries such as Germany or France. The UK overall performs well in terms of 
developing human capital and scientific output, through an internationally renowned, 
efficient and high-performing higher education sector. However, UK business 
investment in R&D is below the EU average, as a percentage of GDP. 
UK performance in FP7 
Participation and funding success in FP7 
In FP7, the UK’s performance has been strong, both in terms of overall participation 
levels and the value of EU funding won. In absolute terms, the UK ranked second for 
participation and funding attracted, compared to all other countries in FP7. Taking 
into account the relatively lower investment by the UK in R&D, the UK performed very 
strongly in FP7 winning a total of €7 billion in EU funding from FP7 (or 15.4% of 
overall EU funding awarded in FP7), the second highest of all participating countries 
behind Germany. 
In comparison with the other EU27 member states, the amount of EU funding 
secured was also high when adjusted for relative GDP, levels of government and 
business investment in R&D (GERD), and the number of researchers: 
• Funding to the UK was 16% above what might have been expected based on
GDP (ranking 11th out of the EU27 on funding relative to GDP).
• Funding to the UK was 34% above what might have been expected based on
the level of UK GERD (ranking 14th out of the EU27 on funding relative to
GERD).
• The UK’s funding was 24% above what might have been expected based on
the number of FTE researchers (7th out of the EU27 on funding relative to
number of FTE researchers).
On all of the above metrics, the UK outperformed other large EU economies such as 
Germany and France. 
Consequently, FP7 was a relatively more important funding source in the UK 
compared to other EU member states. From 2007-2013, FP7 funding constituted 
3.1% of the UK’s overall R&D investment, significantly more than in France (1.7%) 
and Germany (1.4%). FP7 was particularly significant for the UK’s higher education 
sector (HE), where it represented 7.2% of total investments in HE R&D in the period 
2007-2013. 
The UK’s proposal success rate was particularly high in the Health theme (24% of 
submitted proposals with UK participation were funded, compared to an average 
success rate of 14% of all proposals submitted). Higher than average success rates 
were also achieved in the areas of Nanosciences, Nanotechnologies, New Materials 
and New Production Technologies (23% compared to an average success rate of 
12%), the Environment theme (22% compared to an average success rate of 12%) 
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and the European Research Council (13% compared to an average success rate of 
10%). 
UK participation in FP7 was dominated by universities 
Universities represented 60% of all UK participations and received 70% of all funding 
allocated to the UK, a much larger presence than in other EU member states. This 
reflects the dominant presence of the higher education sector in the UK’s research 
and innovation system, in contrast to the strong presence of other research 
organisations in other large countries such as Germany and France. In terms of 
participation, the top 25 UK organisations that participated include 22 universities, the 
Medical Research Council, the Natural Environment Research Council and TWI Ltd. 
The UK industry share of UK participation in FP7 ranked 23th out of all EU27 
member states during FP7 (26% compared to an average of 31%). Within FP7, UK 
had the second lowest proportion of EU funding allocated to industry (18% compared 
to an average of 25%). However, whilst the overall degree of industry participation 
was relatively low, all of UK’s R&D performing sectors were represented in FP7.  
In absolute terms, UK industry participants represented 11% of all industry 
participants in FP7, topped only by industry participation from Germany (15% of 
total). 
FP7 was dominated by a relatively small group of key organisations – the top 100 UK 
participants in terms of the number of projects won (just 3% of UK participants) 
accounted for 76% of all EU funding awarded to the UK (or €5.3 billion) and 70% (or 
12,397) of all UK participations in projects. This group of 100 organisations 
comprised 67 individual universities, 14 companies, 16 research organisations and 
three government bodies. 
Motivations for participation in FP7  
Key motives for participation in FP7 were access to research funding (72%) as well 
as the development of new or improved relationships or networks (55%), the desire 
to address specific scientific or technical questions or issues (54%), and to develop 
and extend internal knowledge and capabilities (53%). 
Three-quarters (75%) of respondents indicated that the relevance of both the topics 
and the instruments of FP7 was high or very high for the research they wished to 
conduct. 
Trends in participation in Framework Programmes over time 
The UK has achieved a significant positive increase in participation rates and 
financial returns from FP7 as compared to FP6, and high levels of performance 
within FP7 appear to have been maintained within Horizon 2020 to date. The UK, as 
with other selected comparator countries, is involved in a diminishing proportion of 
the projects over time, but this is due to the fact that the programme increasingly 
consists of smaller and more targeted projects, a change that participants generally 
favour based on the feedback provided on the (larger) FP6 instruments. 
iii 
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UK performance over time also appears to be strong in comparison to the key 
comparator countries of Germany and France. While the UK’s share of participations 
was higher in FP7 and Horizon 2020 than in FP6, both Germany and France have 
seen a slight decrease in their shares across the successive Framework 
Programmes.  
Outputs attributed to FP7 
UK participants were asked to quantify, where applicable, a range of different types 
of output produced by their FP7 project. Across all respondents (i) the opportunity to 
carry out research (96% of responses) and (ii) an improved access to networks 
(87%) were considered key outputs.  
The results show that peer-reviewed journal articles were widely generated (87% of 
projects, 14.7 per project on average). A large proportion of FP7 projects recruited 
personnel specifically for the project (79%), with an average of just more than five 
Full Time Equivalents (FTEs) per project. Scientific exchanges were also very 
prevalent. 
For more commercially oriented outputs across all participants, less than one in five 
(18%) of the respondents’ projects generated one or more new patent applications, 
and just 7% applied for trademarks or registered designs as a result of an FP7 
project. The relatively lower levels of commercially oriented outputs is unsurprising 
due to the focus on basic research in the majority of FP7 projects, and the large 
number of higher education institutions involved. When we look specifically at 
industry respondents, 26% of this category of participant generated a patent 
application and 8% applied for a registered trademark / design. 
UK businesses considered (i) opportunities for prototype development and 
demonstrations / pilots (84% of responses), and (ii) newly-acquired knowledge about 
industrial processes or business parameters (81% of responses) as among the most 
important outputs. 62% of businesses considered that FP7 had met their expectation 
with regards to newly-acquired knowledge about industrial processes or business 
parameters, whilst 24% said that their expectations were exceeded. As regards 
prototype development and demonstrations / pilots, 58% said that FP7 had met their 
expectations, whilst 23% said their expectations were exceeded. 
Outcomes attributed to FP7 
The survey also asked about the extent to which participation in FP7 had resulted in 
positive impacts for their own organisation. The results show a very positive impact 
from FP7 participation. More than 40% of participants reported high impacts in terms 
of increased understanding and knowledge, in both new and existing areas, 
increased scientific capabilities, and improved relationships and networks. More than 
75% reported high or medium impacts in these areas. 
Increased technological capabilities, improved competitive position, improved career 
development for researchers and enhanced reputation also feature as areas where a 
large number (30% or more) of participants reported a high level of impact. 
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More than a third of projects (34%) delivered above participants’ expectations with 
regard to providing opportunities for follow-up research, and almost a quarter (23%) 
delivered above expectations with regard to knowledge spillovers to other sectors or 
research areas. More than 90% of projects delivered at or above expectations in 
terms of improved ability to conduct R&D, provide training and attract staff.   
Whilst the large majority of participants and projects achieved outcomes in line with 
expectations, there were some differences according to the types of outcomes. The 
majority of commercially orientated outcomes met the participants’ expectations. 
Over four in five of the survey respondents reported that expectations in terms of 
development of new products and services, development of new codes and 
standards, access to new markets, and reduced time to market had either been met 
or exceeded. At the same time, businesses reported more frequently than 
universities that outcomes had been delivered below expectations. 
Networking outcomes 
High quality research collaboration is commonly accepted to influence the 
productivity of individual scientists and organisations, as well as the impact of their 
work. FP7 has had a significant impact on the ability of the UK research base to 
conduct collaborative research with non-UK partners who were often reported to be 
world leading in terms of their scientific competences and technology know how, and 
at a scale and scope much greater than other European or international 
programmes. 
The average number of partners in FP7 projects with UK involvement was 13, and 
respondents had worked with on average 4.6 of these organisations before (or 35%). 
This suggests that 65% (on average 8.4 partners per project) were ‘new’ in the sense 
that the UK partner(s) had not previously worked with those organisations. Based on 
the survey responses: 
• An estimated 45,500 new partnerships were formed between UK and non-UK 
FP7 participants (65% of all UK partnerships were new so 24,500 of the 
partnerships were with pre-existing collaborators (35%)). 
• Estimates suggest UK partners expect to work with 32,200 (46%) of their FP7 
partners again in future. 
• An estimated minimum of 7,700 (24%) of these future collaborations will be 
with overseas partners that the UK partner first collaborated with during FP7. 
Employment outcomes 
Survey respondents (n=475) were asked whether their project had (or was likely to 
have) an impact on employment beyond the duration of the project. Whilst almost two 
thirds were unable to provide an answer, in 17% of cases respondents reported an 
increase in employment and in 16% of cases they reported a safeguarding of 
employment. Just two respondents (<1%) reported a decrease in employment as a 
result of their project. Of the respondents answering this question: 
• 64% of universities reported an increase in employment. 
• 57% of research organisations reported an increase in employment. 
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• 31% of industry reported an increase in employment. 
Out of those respondents who reported an increase in employment, a total of 377 
jobs had been created (3.9 FTEs on average within 96 organisations), 595 jobs 
safeguarded (5.6 FTEs on average within 107 organisations). By comparison just 
seven jobs had been lost (1.2 on average across six organisations). 
Commercial Impacts attributed to FP7 
UK participants were asked whether their FP7 project had produced (or was 
expected to produce) commercial benefits for their organisation. Out of all survey 
respondents, over half of respondents (53%) stated that the project would not result 
in any commercial benefit (other than the FP7 funding for their participation in the 
project). A further quarter (25%) were unable to say whether any commercial benefits 
had been realised. In the remaining 22% of cases participants reported that some 
commercial benefit had been achieved. In most of these cases (63%) the commercial 
returns came from the direct use of the project results within the participating 
organisation, but a significant proportion (37%) came from sale or licensing of 
products or intellectual property developed through the project. 
As noted above, universities were the predominant beneficiary of FP7 funding in the 
UK, and this feature has to be considered when discussing commercial impacts 
attributed to FP7. It is also worth noting that much of FP7 was focused on basic 
research. As such, it is not surprising that many participants did not report 
commercial impacts that could be attributed to FP7. 
Industry respondents reported commercial impacts much more frequently. 39% of 
industry respondents reported commercial impacts from the direct use of project 
results, 18% reported commercial impacts from sale or licensing of product, 11% of 
industry respondents reported commercial impacts from sale or licensing of 
intellectual property. 9% of university respondents reported commercial impacts from 
the direct use of project results, 2% reported commercial impacts from sale or 
licensing of product, and 2% of university respondents reported commercial impacts 
from sale or licensing of intellectual property. 
9% of all respondents were able to quantify commercial benefits. On average, 
€937,368 per project was reported. Taking into account average EU funding and 
average project costs, this gave an average net gain of €815,000, and an estimated 
total net gain of around €35 million across the 9% of respondents who detailed 
commercial benefits. 
Impact on additional investments 
FP7 participants were asked to report on whether their project resulted in additional 
investments in new devices or equipment by their organisation, or was expected to 
do so in future. Of the 475 organisations responding to the survey, 109 (23%) 
reported that some investment had been made, of which 38 were able to provide 
some quantification. The remaining respondents indicated either that their project 
had not resulted in any additional investment (57%) or that they did not know (20%). 
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The 38 respondents who were able to quantify the investments reported investments 
of €30.6 million, an average of just over €780,000 per organisation. A wide range of 
organisation types made investments following participation in FP7. 32% of industry 
respondents (39 responses), 24% of research institute respondents (12 responses) 
and 21% of university respondents (63 responses) reported that some investment 
had been made. 
Impact on policy development 
Respondents to the online survey were asked whether their project had, or was 
expected to have, an impact on policy development. Almost 40% stated that their 
project had exerted an impact on policy, in most cases at European level (24%) but 
also at international / global level (11%). Only 4% of participants reported that their 
FP7 project had impacted on policy development at national level. A third of 
respondents (35%) said that their project had not had an impact on policy and a 
further quarter (26%) did not know. 
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Examples of policy impact 
“I was invited to take part in the UK-Japan mission of the BIS Technology Strategy Board. 
The team of five academics and industrialists visited Japanese universities and companies to 
promote UK robotics and scout Japan for collaboration opportunities. The visit resulted in an 
advisory document presented to the TSB in November 2011. The recommendations 
informed a key speech by the Chancellor of the Exchequer, to the Royal Society, which 
informed the £35 million investment in robotics by the Department for BIS, as part of its 
investment in the UK’s “eight great technologies” 
“Influenced EU guidelines for Directives on CO2 storage and Emissions Trading scheme. 
Fed into practice of operators and National implementation of EU directives” 
“Provided evidence to UK policy makers on wheat population performance and potential 
ways that regulations could be modified that resulted in the council decision 2014/150/EU.” 
[decision on the organisation of a temporary experiment providing for certain derogations for 
the marketing of populations of the plant species wheat, barley, oats and maize pursuant] 
Source: ICF online survey of FP7 participants, February 2016 
Additionality of FP7 funding 
FP7 provided substantial added value to existing national and European 
programmes, according to UK participants. Almost all (91%) of the UK participants 
stated that their projects would not have gone ahead without FP7 support. 
This represents roughly 41,000 new partnerships between UK and non-UK 
participants which would not have been established without FP7 funding, and 29,000 
future collaborations with non-UK participants that would have not materialised in the 
absence of FP7 funding. 
The majority (75%) of these additional partnerships created helped UK participants to 
cooperate with world-class organisations, and thereby access scientific and 
technological expertise, know-how and equipment at the forefront of scientific 
discovery and knowledge. 
These networking impacts contribute to an enhanced set of relationships for UK 
organisations, based on the addition of newer and more useful partnerships and the 
cessation of less productive ones. 
Five percent of UK participants felt that their projects would have been able to 
proceed, and achieve similar levels of outputs and impacts, in the absence of FP7 
funding. These projects represented €37.8 million of EU funding or 7.4% of the total 
EU funding secured by survey respondents. This represents a minimum estimate for 
the deadweight effect of the programme.  
Around a third of unsuccessful applicants (34%) undertook similar research activities 
with other funding in absence of EU funding, though this was generally with more 
limited project scale, schedule, scope, partnerships and results than initially planned. 
Only 8% of unsuccessful applicants undertook similar research activities without any 
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change to project scale, schedule, scope, partnership or results. Only half of the 
projects which went ahead after an unsuccessful FP7 bid included non-UK partners. 
Complementarity of FP7 outcomes with other European 
programmes 
The analysis of FP7, EUREKA and COST suggests that whilst there are some 
overlaps in terms of the programme objectives, the activities funded and their results 
and outcomes are largely considered by participants to be complementary, aiming to 
address different objectives.  
FP7 was generally perceived by survey respondents to provide stronger benefits, 
outputs and impacts relating to the implementation of research, improving knowledge 
and skills as well as in accessing research infrastructure or equipment than 
comparator programmes. COST was seen by stakeholders as equally effective or 
more effective in encouraging the mobility of researchers, supporting career 
development and the creation of new networks and partnerships, compared to FP7. 
EUREKA Eurostars tends to fund activities more relevant to industrial application, 
and caters to mainly industrial beneficiaries. Eurostars-1, which ran from 2007-2013, 
was perceived by stakeholders to be more effective in delivering commercial impacts 
than FP7, and a crude comparison of responses to the FP7 participant online survey 
and Eurostars project reports confirms this. However this could not be confirmed 
robustly with the data at hand. 
Complementarity of FP7 with national initiatives 
When comparing the scope for added value of FP7 compared to national initiatives, 
the considerations most frequently raised by respondents were project size and 
networking opportunities. FP7 was largely seen to enable projects with a larger scale 
and wider scope than could be tackled with UK resources and partners alone. In turn, 
national programmes were seen to be more easily accessible and projects funded 
through national schemes were seen to have a lower administrative overhead. 
Stakeholders and survey respondents were largely of the view that FP7 was 
complementary to R&D programmes at the national level. More than half (53%) of 
survey respondents stated that FP7 had supported topics not addressed by national 
programmes. Survey respondents indicated that a lack of available funds (54%), a 
requirement for international collaboration (49%), and the need for a critical mass of 
resources (41%) were the most common reasons they saw for work being supported 
at European level rather than at national level. 
Feedback on FP7 administration and relevance of national 
support services 
From feedback on administrative and reporting procedures, it can be concluded that 
successful FP7 participants were generally satisfied with various aspects of the 
administrative mechanisms and reporting procedures of FP7. 
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The areas of most satisfaction and least dissatisfaction concern (i) the information 
provided to applicants about how to apply, (ii) processes for dissemination and 
exploitation of results, and (iii) evaluation at national and EU level. The greatest 
levels of dissatisfaction were with monitoring and reporting procedures, contract 
negotiation procedures, and mechanisms for payment of the EU’s financial 
contribution to the projects. 
Whilst participants suggested that the European Commission should continue 
simplification efforts, these results from the online survey suggest that successful 
participants were generally satisfied with programme and project management 
processes.  
Unsuccessful applicants were much less positive. They mostly gave negative 
feedback and emphasised that procedures were too complex and time consuming. 
Respondents also referred to the lack of transparency and insufficient guidance and 
feedback by evaluation panels regarding the selection of successful proposal. Some 
felt that the selection process was biased and not entirely based on merit. 
National support services were not used by the majority of stakeholders interviewed 
and survey respondents – the majority of UK participants reported they used effective 
in-house support or experienced partner organisations. Where national contact points 
had been used, their support was useful in understanding FP7, and was deemed 
critical in around 25% of the applications supported. First-time applicants and 
applicants without strong in-house support were most likely to need and appreciate 
help in understanding the programmes themselves, and were likely to need or 
appreciate help with sorting out the project and consortium arrangements. 
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1 Introduction and context 
This section provides a short summary of the study objectives. It also elaborates the 
study context by providing a brief description of the EU and UK research actors and 
activities. 
1.1 Scope and objectives of the study 
ICF Consulting (ICF) was commissioned in 2015 by the Department for Business, 
Innovation and Skills (BIS, now restructured since July 2016 as the Department for 
Business, Energy and Industrial Strategy (BEIS)) to evaluate the added value and 
effects of UK involvement with the Seventh EU Framework Programme for Research 
and Development (FP7), COST and EUREKA. The study also reviewed the UK’s 
participation in the EU Horizon 2020 programme (H2020) up to February 2016. A 
BEIS-managed project steering group oversaw progress of the work and when 
necessary offered additional information, advice and clarification. 
This is the final report of the study. It presents an analysis of the reasons that UK 
researchers provided for using the programmes under investigation, their success in 
securing funding and the perceived benefits from their involvement. 
The study was commissioned in order to inform the UK’s response to the European 
Commission’s interim evaluation of Horizon 2020 and its preparation in due course 
for the ninth Framework Programme.   
The study seeks to provide evidence on the added value and impact of the 
Framework Programme and other European collaborative/non-collaborative activities 
(COST and EUREKA) on UK’s businesses and research base. 
Given the overall objectives, the study followed two main lines of investigation. First, 
a major data collection and analysis exercise was undertaken to evaluate past and 
current UK performance in the Framework Programme. Second, complementary 
fieldwork has been conducted to qualify the performance data collected and 
understand in detail the pathways of participation and motivations of individual 
participation groups. This served to provide an understanding of: 
• current impact and performance; and
• policy options to maximise participation and impacts.
The report sets out conclusions on the main motivations, nature and effects of 
involvement in the Framework Programme. 
The research was commissioned before the UK referendum on 23rd June 2016. In 
this referendum, the UK voted to leave the European Union. The Government has 
made clear it would welcome agreement to continue to collaborate with European 
partners on major science, research and technology initiatives. As set out in the 
future partnership paper, “Collaboration on Science and Innovation”, published on 
6th September 2017, the UK will seek an ambitious Science and Innovation 
Agreement with the EU.  
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1.2 Study context 
This section provides a brief overview of the context for this study, briefly describing 
European research and innovation funding, and then describing in similar terms the 
UK research and innovation system.  
1.2.1 European research and innovation landscape 
The European research and innovation landscape is multi-layered and complex. The 
EU and other European initiatives offer funding and support alongside a variety of 
national funding programmes in individual European countries. Within the EU, some 
key strategies set the policy context for research and innovation funding: 
• European Research Area (ERA) - The ERA was conceptualised as an 
instrument to integrate research resources and capacity across EU member 
states, mirroring the single market. The ERA was introduced to support the 
Lisbon Agenda, which set out the EU’s strategic economic development goals 
(European Council, 2000). The Lisbon Treaty and its amendments established 
research policy as a shared competence between the European Commission 
and the member states, reinforcing the community dimension of research 
policy. 
• Europe 2020 and the Innovation Union - The ERA operates alongside the 
EU’s strategic growth agenda. Europe 2020 and the Innovation Union flagship 
initiative address framework conditions and access to finance to enable 
exploitation of research and innovation in products and services (EC, 2010). 
The Europe 2020 strategy includes specific development targets, including a 
target to spend 3% of the EU’s GDP on R&D by 2020. The Innovation Union, 
announced as one of seven flagship initiatives in the Europe 2020 strategy, is 
intended to improve the framework conditions for research and innovation in 
Europe. 
1.2.1.1 EU Framework Programmes for research and innovation 
The EU’s Framework Programme for research and innovation, Horizon 2020 
(H2020), is the world’s largest multinational programme for research, development 
and innovation with a budget of €75 billion.1 It is the latest in a series of seven-year 
Framework Programmes, succeeding the Seventh Framework Programme for 
Research (FP7), which ran for the period 2007-2013. Activities eligible for support 
from the Framework Programme include, amongst others, collaborative research 
projects covering fundamental research to technology development and large-scale 
demonstration, as well as researcher mobility (through the Marie Skłodowska-Curie 
Actions). Specific instruments aim to support fast-growing SMEs and provide portable 
grants for leading scientists conducting pioneer research (through the European 
Research Council). 
1 https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020 [accessed 26th June 2016]. 
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The main focus of the present study is FP7.2 Compared to the current H2020 
programme, FP7 had a relatively greater focus on fundamental research but, in its 
concluding years, put increasing emphasis on applied research and technological 
development. Whilst many individual funding instruments of the current programme 
already existed in FP7, there is a markedly greater emphasis on strong societal and 
economic impacts alongside excellent research in H2020. 
1.2.1.2 Other European initiatives 
Besides the EU’s Framework Programme, a number of other programmes offer 
support for research and innovation. European Structural and Investment Funds 
(ESIF) are designed to support structural and economic development in less 
developed regions of the EU.3 Structural Funds may be spent on a range of funding 
priorities, including research and innovation. There is an increasing focus on 
coordinating funding between H2020 and ESIF. 
A number of other EU funding programmes support research, development and 
innovation activities indirectly. These include COSME, a programme for small and 
medium-sized enterprises, Erasmus+, which supports student mobility, the Health 
programme and the Connecting Europe Facility. 
COST is a pan-European intergovernmental framework, consisting of 36 Member 
Countries and a Cooperating State.4 COST seeks to strengthen the European 
Research Area (ERA) by building networks of researchers and enabling them to 
jointly develop their own ideas and new initiatives across a number of academic 
domains.  
Between 2007 and 2013, COST was funded by FP7. Over the course of this seven-
year period, COST was allocated an overall budget of €240 million. Under Horizon 
2020, the COST budget has been increased to €300 million to be spent from 2014-
2020, largely drawing from two Horizon 2020 work programmes: 
• Societal Challenge 6: Europe in a changing world – inclusive, innovative and 
reflective societies; and 
• Spreading Excellence and Widening Participation.  
The COST programme mainly supports networking activities such as meetings (e.g. 
travel, subsistence, and local organiser support), conferences and workshops, short-
term scientific exchanges, training schools, as well as publications and dissemination 
activities. Networks established under COST are large partnerships with around 50 
core participants on average (members of management committees), are usually 
highly interdisciplinary and dominated by academic organisations. 
2 https://ec.europa.eu/research/fp7/index_en.cfm [accessed 26th June 2016]. 
3 https://www.gov.uk/european-structural-investment-funds [accessed 26th June 2016]. 
4 The 36 COST Member Countries are: Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, 
Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, 
Lithuania, Luxembourg, Malta, Montenegro, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, 
Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom and the former Yugoslav Republic of 
Macedonia. The Cooperating State is: Israel. 
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Other relevant programmes funded directly by national governments or by a mix of 
national and EU budgets include: 
• EUREKA – EUREKA facilitates market-driven industrial R&D, often at high 
technology readiness (TRL) levels.5 This includes in particular collaborative 
R&D projects (network projects), collaborative R&D projects led by research-
performing SMEs (Eurostars programme), industry-led cluster initiatives and 
capacity building thematic networks (umbrellas).6 EUREKA is mainly funded 
by participating countries directly but Eurostars is co-financed from the EU 
budget. 
• Joint Programming Initiatives (JPIs) – the JPIs aims to pool national research 
efforts to make better use of resources and to tackle European challenges 
more effectively in key areas. Member states agree voluntarily on so-called 
strategic research agendas which they then attempt to implement in joint 
effort.7 
• ERA NET – ERA-NETs are communication, coordination and networking 
actions funded through Horizon 2020 to support the preparation, design and 
implementation of Joint Programme Initiatives.8 
1.2.2 The UK research context 
1.2.2.1 Structure and main actors 
Research and Innovation policy is developed at a UK level by the Department for 
Business, Energy and Industrial Strategy (BEIS). 
The UK’s academic research base is underpinned by a system of funding that 
provides funds to institutions in two streams:  block grant funding and competitive 
funding. Together they comprise the Dual Support system. Institutional block grant 
funding is commonly known as “Quality-Related research funding” (QR). QR is a non-
hypothecated funding stream provided by the Higher Education Funding Councils 
(HEFCs) to universities based primarily on periodic quality assessment exercises. 
QR provides the basic research infrastructure/capacity which underpins a university's 
ability to carry out its own research program and research funded by others. 
Competitive funding awarded by Research Councils, government departments and 
others funds specific projects and programmes. Competitive funding is won by 
individual researchers in peer reviewed competition. The Haldane principle states 
that Government determines the division of funding amongst the Research Councils 
and overall strategic priorities in consultation with the Research Councils, who in turn 
5 There are different technology readiness scales in application. Throughout this report refers to the European 
Commission definition: 
https://en.wikipedia.org/wiki/Technology_readiness_level#European_Commission_definition ; For a more 
comprehensive discussion see EARTO (2014), The TRL scale as a Research & Innovation policy tool. 
http://www.earto.eu/fileadmin/content/03_Publications/The_TRL_Scale_as_a_R_I_Policy_Tool_-
_EARTO_Recommendations_-_Final.pdf  [accessed 26th June 2016]. 
6 Cf. EUREKA website http://www.eurekanetwork.org/ ; European Commission (2014), Final Evaluation of 
Eurostars Joint Programme, http://ec.europa.eu/research/sme-techweb/pdf/ejp_final_report_2014.pdf [accessed 
26th June 2016]. 
7 http://ec.europa.eu/research/era/joint-programming-documents_en.htm [accessed 26th June 2016]. 
8 http://ec.europa.eu/research/era/era-net_en.html  [accessed 26th June 2016]. 
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are advised by senior members of their academic communities, and academic 
experts recommend which projects deserve funding through independent expert peer 
review. 
The Government Office for Science (GO-Science), based within BEIS, plays the lead 
role in improving the quality of science advice to the UK government, alongside 
departmental Chief Scientific Advisers. It is headed by the Government’s Chief 
Scientific Adviser (GCSA) who reports directly to the Prime Minister and the Cabinet. 
The GCSA also co-chairs the independent Prime Minister’s Council for Science and 
Technology (CST), which provides advice to government on cross-cutting science 
and technology issues. 
Innovate UK (formerly the Technology Strategy Board) is the national innovation 
agency, given responsibility by BEIS for developing and delivering a national strategy 
for increasing levels of innovation within businesses.  
To support the links between excellent research and innovation locally, and to help 
build a joint understanding with local areas of the UK’s potential for global 
competitive advantage, the Government has launched Science & Innovation Audits. 
While the role of universities in publicly-funded research is very prominent in the UK, 
it is less so in other EU countries such as Germany, where a more substantial part of 
government-funded research is conducted by non-university institutes and 
universities of applied sciences. Germany, with the largest research & innovation 
system in Europe, counts more than 800 publicly funded research institutions as 
opposed to 29 research institutes funded directly by the UK government.9,10 
1.2.2.2 Trends in the UK researcher population 
Overall growth of the UK’s researcher population has been modest at 8% between 
2007 and 2014, below the overall growth trend in Europe (21%), Germany (22%) and 
the United States (12%). It is interesting to note that between 2007 and 2014, the 
number of researchers in the higher education sector grew by only 5% in the UK (as 
compared to 16% in EU28 and 37% in Germany), whilst the number of researchers 
in the business enterprise sector grew by 17% (as compared to 27% in EU28 and 
14% in Germany).11 
Apart from the total researcher population, looking at the number of PhD graduates 
can provide an understanding of supply in talent and research capacity. In 2012, the 
UK was the second largest producer of PhD graduates in the EU (behind Germany), 
and the fourth largest in the world (behind the US, China and Germany).12 
A further element contributing to the UK’s strong research base is its international 
mobility. A recent report by Elsevier analysed the mobility of UK researchers based 
9 Considering scientific research institutes funded directly by UK government departments or UK Research 
Councils. See Cunningham (2015), Research and Innovation Observatory, Country Report United Kingdom 2014.  
10 Sofka (2015), Research and Innovation Observatory Country Report Germany 2014.  
11 Eurostat Total R&D personnel by sectors of performance, occupation and sex [rd_p_persocc]. 
12 Eurostat Graduation from tertiary education (ISCED 1997) by sex, level and field of education  [hrst_fl_tegrad]. 
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on their publication patterns.13 The report concluded that up to 72% of UK 
researchers who have published in peer-reviewed journals between 1996 and 2012 
have published whilst affiliated to a non-UK institution during this period. The UK had 
a much lower proportion of researchers who remained ‘sedentary’ during this period, 
at 28% compared to Germany (36%), France (37%) and the US (47%). 
During the same time, the UK recorded a total net outflow of researchers of 3.3% 
between 1996-2012 – compared to a net outflow of 2.6% in Germany and a net 
outflow of 1.8% for the US. The most prominent recipient countries of UK researchers 
were the US, Australia, Canada, Germany and Ireland, whilst the most prominent 
countries supplying researchers to the UK were the US, Germany, Australia, France 
and Italy. 
Overall, these figures suggest that the UK’s research base is a critical component of 
Europe’s research capacity. While the UK’s higher education sector remains the 
largest in Europe, growth of the UK’s research base in recent years has been driven 
by the business enterprise sector. The data also show that the UK has a strong 
domestic supply of PhD graduates, however the fact that mobility is an important 
component of researcher careers makes it difficult to ascertain how much new 
graduates contribute to research outputs and the overall research performance of the 
UK. The UK’s researcher population is also much more mobile and reliant on 
international collaboration than that of comparator countries, when measured by 
institutional affiliation and publications in peer reviewed journals.14 
1.2.2.3 Sources of funding for R&D investment 
The most important sources of funding for R&D investment in the UK are the 
business enterprise sector (47% of total expenditure in 2014) and government 
sources (29% of total expenditure in 2014).  
In 2014, the relative investments by the business enterprise sector in the UK were 
below the EU-28 average (55%) and substantially below that of competitor regions 
such as the United States (59%) or South Korea (76%). Slovenia (68%), Germany 
(65%) and Sweden (61%) are the EU member states with the highest proportion of 
business enterprise investment in R&D. Figure 1.1 provides an overview of the 
sources of funding as a share of Gross Expenditure on R&D (GERD), for all EU 
member states and a selection of competitor regions in 2014. 
13 Elsevier (2014), International Comparative Performance of the UK Research Base – 2013. 
14 Ibid. 
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Figure 1.1 Gross Expenditure on R&D by source of funds, EU-28, Norway, 
Switzerland, United States, Japan and South Korea, 2014 or latest 
available year (%) 
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Compared to other EU countries such as Germany (7% in 2014) or France (8% in 
2014), the UK tends to make use of overseas funding sources to a much higher 
extent (19% in 2014). FP7 was also a more important funding source in the UK 
compared to other EU member states. Over the period 2007-2013, FP7 funding 
constituted 3.1% of the UK’s overall R&D investment but made up less than 2% of 
the total in France (1.7%) and Germany (1.4%).15 FP7 was particularly significant for 
the UK’s higher education sector, where it represented 7.2% of total investments in 
HE R&D between 2007 and 2013.16 
Funding for R&D performed in the higher education sector came mainly from Higher 
Education Funding Councils and similar bodies (30%) and from the Research 
Councils (27%). While only 6% came from government directly, 15% originated both 
from the private, non-profit sector (charities) and overseas sources (of which €750 
million came from EU sources).17 
1.2.2.4 Performers of R&D in the UK 
The largest performers of research in the UK are the business enterprise sector and 
the higher education sector – the UK does not have a large presence of research 
organisations, which account for a large proportion of applied and fundamental 
15 Based on Eurostat [rd_e_gerdtot] and CORDA data on EU funding committed to projects during this period. 
16 Based on Eurostat [rd_e_gerdtot] and CORDA data on FP7 funding committed to UK HE during this period. It 
should be noted that other EU sources of R&D funding, such as the European Structural funds, are not included 
in this figure. 
17 Office for National Statistics, research and development expenditure 2007-2014. 
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research in most other EU member states. Figure 1.2 provides a comparison of total 
R&D expenditure between the UK, other EU-28 member states and international 
competitors in 2014. 
Figure 1.2 Gross Expenditure on R&D by sector of performance, EU-28, Norway, 
Switzerland, United States, Japan and South Korea, 2014 or latest 
available year (%) 
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Source: Eurostat (data for Hungary does not cover private non-profit sectors). 
Figure 1.2 shows that in 2014, the largest performers of research in the UK were the 
Business Enterprise (64%) and the Higher Education (HE) (26%) sectors, continuing 
a trend visible throughout recent years. In Germany the government sector is more 
important than in the UK (15% compared to 8% in the UK), demonstrating the 
significance of its public research institutes. However, a large share of R&D 
performed by the HE sector is funded by government. 
1.2.2.5 Investment levels in R&D 
The UK’s research and innovation system is characterised by a relatively low overall 
investment in R&D, compared to other EU member states. From 2007-2014, the UK 
invested on average 1.7% of its GDP in R&D - the UK ranked 11th out of all EU 
member states and below the EU average, behind countries such as Germany (2.7% 
on average) and France (2.2% on average). In terms of total investments in R&D, the 
UK came 3rd behind Germany and France, with a total investment of €265 billion in 
the period 2007-2014.18 
Between 2007 and 2014, annual UK gross expenditure on R&D (GERD) was on 
average €33 billion (around 13% of average EU GERD during this period). The ratio 
18 Eurostat t2020_20. 
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of UK GERD to GDP has remained broadly steady since 2007, oscillating around 
1.7% and peaking at 1.75% in 2009. 
Business enterprise sector R&D 
The business enterprise sector was the largest investor in research and development 
(BERD) between 2007 and 2014, providing 73% of the total investments. From 2007-
2014, annual UK BERD was on average €21 billion, contributing about 13% of overall 
EU BERD. UK’s GERD and BERD tend to be low in international comparison, and 
compared to that of other large EU member states such as France and Germany. 
The UK has seen a steady increase in R&D expenditure by foreign-owned 
businesses – in 2013, this stood at 50%, up from 39% in 2007.19 
In 2014 the business enterprise sector accounted for €24.7 billion of R&D 
investments, 65% of the total R&D expenditure in the UK. The largest product areas 
of investment were pharmaceuticals (€4.8 billion), computer programming and 
information service activities (€3 billion), motor vehicles and parts (€2.9 billion), 
aerospace (€2.1 billion), miscellaneous business activities and testing (€1.7 billion), 
machinery and equipment (€1.2 billion) and telecommunications (€1.2 billion).20 In 
comparison, Germany recorded the largest total business enterprise R&D 
expenditure of all EU member states with €53.6 billion, dominated by its large 
automotive industry (€17.4 billion), machinery and equipment (€5.4 billion), 
aerospace (€3.9 billion) and pharmaceuticals (€4.1 billion).21 
In terms of relative R&D investments by product group since 2007, pharmaceuticals 
has been the dominant area of investment (representing 20% of all investments in 
2014) in the UK, however the relative share accounted for by this product group 
declined over the period (from 25% in 2007). The proportion of investment in 
telecommunications, machinery and equipment, and aerospace also decreased in 
the period 2007-2014. However, there have been strong relative increases over the 
same period in motor vehicles and parts research (rising from 6% to 12%), 
miscellaneous business activities (from 3% to 7%) and in R&D services (from 1% to 
4%). 
Furthermore, UK businesses invest a large share of their overall R&D expenditure in 
service sectors when compared with other major EU countries – in 2014 this 
represented 57% of the overall business enterprise investment in R&D, compared to 
13% in Germany and 46% in France.22 This is largely accounted for by the relatively 
small role of the manufacturing sector in the UK and the larger role of manufacturing 
in Germany. In the UK, manufacturing accounted for around 10% of overall value 
added in the economy in 2014 – compared to 23% in Germany and 11% in France.23 
19 Office for National Statistics, research and development expenditure 2007-2014; Eurostat rd_e_berdfundr2. 
20 Office for National Statistics, business research and development 2014. 
21 Eurostat rd_e_berdfundr2. 
22 Eurostat, Business enterprise R&D expenditure (BERD) by economic activity (NACE Rev. 2) [rd_e_berdindr2]. 
23 World Bank, national accounts data – manufacturing, value added as % of GDP. 
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1.2.2.6 Output and performance of the UK research and innovation system 
Research and innovation performance is measured across a range of metrics such 
as citation impact, intellectual assets, linkages and entrepreneurship, as well as 
commercial and wider economic impacts. 
Research outputs 
Overall, the UK performs very strongly in terms of research output, courtesy of an 
internationally renowned and highly productive higher education sector.  
The UK’s research base is active in all major subject areas, with some change in 
focus noticeable. From 2002 to 2012, there has been an increase in the number of 
peer-reviewed articles published by UK researchers in clinical sciences, health & 
medical sciences and humanities, social sciences and business studies. UK research 
output measured by the number of peer-reviewed articles published decreased 
during the same period in biological sciences, environmental sciences, mathematics, 
physical sciences and engineering.24 Whilst a stronger focus on articles in business 
studies can be observed as well in other countries, Germany and France at the same 
time largely maintained a focus on physical sciences and mathematics. 
In terms of total numbers of citations, articles by UK researchers represented 11.6% 
of global citations in 2012, and 28% of all EU27 articles cited during this year. This 
demonstrates that on aggregate, the quality and importance of UK research was a 
major force within the EU and on a global scale. It is also interesting to note that the 
UK’s citation share rose more quickly than that of all EU member states (a growth of 
1.5% compared to 1.13% for EU27 between 2008 and 2012). 
Furthermore, the UK’s share of the top 1% of the most highly cited articles is high (at 
15.9% in 2012) and rising (up from 15% in 2008). 
The UK’s field-weighted citation impact25 in terms of peer-reviewed publication is 
high in all major research fields and, on an aggregate level, overtook the US during 
the period 2008-2012. The UK’s field-weighted citation impact is particularly high in 
mathematics, physical sciences and engineering. Germany performs comparably 
strong across the board, whilst France has strong impacts in environmental sciences, 
clinical sciences and biological sciences offset by low impact in the health & medical 
sciences, humanities and social sciences fields.26 
In addition, the UK shows strong performance in public-private co-publications, 
pointing to a high level of collaboration between the public sector and industry.27 The 
EU’s Innovation Union Scoreboard placed the UK’s research system well above the 
EU28 average and highlighted in particular the UK strong performance in terms of 
international scientific co-publications – the UK scores almost three times higher than 
the EU28 average in 2015. 
24 Elsevier (2013), International Comparative Performance of the UK Research Base – 2013. 
25 Field weighted citation impact is an indicator accounting for the mean citation impact in a subject area, 
normalised by its expected citation impact according to the type of document, the publication year and the subject 
area. 
26 Elsevier (2013), International Comparative Performance of the UK Research Base – 2013. 
27 Ibid. 
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Innovation outputs 
Innovation outputs provide an approximation of the economic and social impact of 
R&D activities. However, serious challenges exist in measuring the full extent of 
innovations realised through investment in R&D.28 
As seen above, the UK’s business enterprise investment in R&D as a share of GDP 
has been below the EU average throughout recent years. A number of benchmarking 
studies29, as well as the European Commission’s Innovation Union Scoreboard, 
provide an overview of the UK’s strengths and weaknesses as regards its innovation 
outputs. Whilst methodologies and data sources differ, a number of high level 
conclusions have been identified across all recent work.  
The UK scores well in exporting medium and high-tech products and knowledge-
intensive services, the level of collaboration among innovative SMEs, 
entrepreneurship and start-up support, but sees a relatively high share of firms which 
do not engage in innovation activities and a relatively low share of patent applications 
and other intellectual assets. 
Recent work has also identified a strong positive relationship between innovation, 
exporting and business performance – highlighting the critical role of international 
collaboration for the UK’s innovation performance and overall success of UK 
businesses.30 
1.2.2.7 Productivity 
The UK is a highly productive research nation in terms of its publication output and 
impact. The UK represented 13% of the EU’s total investment in R&D, 16% of the 
EU’s researcher population between 2007 and 2012, but accounted for 28% of the 
worldwide citations of Europe’s articles in 2012, and represented 35% of Europe’s 
share in the world’s most highly cited articles in 2012. The UK’s field weighted 
citation impact was 1.61 in 2012, higher than that of the US, Germany, France and 
the EU27 average of 1.28.31 However, the UK lags behind other EU member states 
and global competitors in in terms of firms introducing new products to the market, 
28 Challenges in measuring benefits and impacts of R&D funding programmes include issues of attribution, 
deadweight, additionality and timing problems. For a more detailed discussions of some of these points see e.g. 
European Court of Auditors (2007), Special Report No 9/2007 concerning ‘Evaluating the EU Research and 
Technological Development (RTD) Framework Programmes — could the Commission’s approach be improved?’ 
Underlying theory also often assumes a linear process of technological development and innovation, whilst many 
observable breakthrough are the result of an iterative process and exposed to a complex set of framework 
conditions – hence making attribution of an observed event to a specific funding programme difficult. 
29 E.g. Department for Business, Innovation and Skills (2014), Insights from international benchmarking of the UK 
science and innovation system. BIS Analysis Paper Number 03; World Economic Forum (2013), Global 
Competitiveness Report, 2013-14; BIS (2014) Innovation Report 2014. Innovation, Research and Growth. 
30 BIS (2014), UK Innovation Survey: Highly Innovative Firms and Growth, and Love & Roper (2013), SME 
Innovation, Exporting, and Growth, Enterprise Research Centre. 
31 Normalised against a global average of 1 - Elsevier (2014), International Comparative Performance of the UK 
Research Base – 2013; Cunningham (2015) RIO Country Report United Kingdom 2014; Elsevier & Science 
Europe (2013), Comparative Benchmarking of European and US Research Collaboration and Researcher 
Mobility. 
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and has a limited role in contributing to disruptive technologies in terms of 
patenting.32 
Past research has suggested that relative increases observed in the UK’s research 
productivity have been alongside an increase in the UK’s international research 
collaborations – and may be associated with the UK’s focus on international 
collaboration with higher citation impact.33 
1.2.3 Summary of features of the study context 
This brief review suggests that:  
• The European context is complex and multi-layered, with a wide selection of 
funding programmes catering to different research-performing actors. Within 
EU programmes, there has been an increased focus on economic and societal 
impacts in recent years. 
• The UK has some unique features in comparison with the average EU 
research base profile. This is characterised by relatively low overall 
investments in R&D, a substantially larger role of universities, strong human 
capital, and an associated very high impact on the UK’s research outputs.   
• The role of business-driven research and innovation performance in the UK is 
somewhat smaller than in the EU overall and other large economies such as 
France and Germany. Business led research has some significant strengths, 
for instance in supporting exports of high-tech products, but some persistent 
weaknesses, especially the high proportion of businesses which do not invest 
in research and innovation.  
• The UK also shows a marked difference in terms of its main areas of research, 
when compared to Germany and (less so) with France. 
These aggregate findings provide the context for the results of the study fieldwork, 
presented in sections 3 - 6, as well as the study conclusions. 
  
32 OECD (2015), OECD Science, Technology and Industry Scoreboard 2015, UK country note. 
http://www.oecd.org/sti/UK-CN-EN-Scoreboard.pdf [accessed 20th October 2016].] 
33 Ibid. 
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1.3 Structure of this Report 
The remainder of this report is structured as follows: 
• Section 2 provides an overview of the method of approach for the study. 
• Section 3 describes participation and performance of the UK in the FP7 
programme as well as in successive Framework Programmes (including 
Horizon 2020 up to February 2016). It includes an overview of UK’s 
participation in COST and EUREKA. 
• Section 4 summarises the outputs, outcomes and impacts of FP7 participation 
as reported by UK participants. The section also discusses perceived benefits 
and impacts of participation in COST and EUREKA. 
• Section 5 discusses the complementarity and additionality of EU Framework 
Programmes and other European initiatives. 
• Section 6 presents feedback from UK participants on administration and 
proposals for improvement of the EU Framework Programmes. 
• Section 7 presents the conclusions from the research. 
The report contains the following Annexes: 
• Annex 1: UK performance in FP7 – data tables and detailed analysis; 
• Annex 2: UK performance in Horizon 2020 – first evidence from 2014-16; and 
• Annex 3: Case studies. 
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2 Method of approach 
This section provides a description of the study methodology. This includes a 
description of the programme logic and a description of the primary research 
undertaken. 
2.1 Meeting the study objectives 
The study objectives are summarised below with a description of how these were 
addressed by the method of approach, and the main sources of evidence (Table 2.1).  
Table 2.1 Study objectives and sources of evidence 
Study objectives Key research questions Sources of evidence 
To evaluate the pathways 
and mechanisms that 
affect UK R&D 
communities’ interaction 
with FP7, COST and 
EUREKA. 
■ Barriers and enablers to participation, 
including whether these programmes are 
reaching the right people 
■ UK performance 
analysis / CORDA34 
data, Online 
surveys, interview 
programme, case 
studies, literature 
review 
 ■ Specific decision processes businesses 
go through in deciding whether to 
participate in national or European 
collaborative programmes 
■ Online surveys, 
interview 
programme 
 ■ UK applicant motivations, and whether 
these affected perceptions of barriers & 
benefits 
■ Online surveys, 
case studies, 
literature review 
 ■ Evidence of formal or informal linkages 
following collaboration 
■ Online surveys, 
case studies 
 ■ Preferences for specific instruments and 
the reasons for those preferences 
(including EUREKA and COST) 
■ Online surveys, 
interview 
programme, 
analysis of EUREKA 
programme data, 
literature review 
 ■ Evidence of the impact of national support 
services on applicants 
■ Online surveys 
 ■ Impact of national strategies and 
programmes on applicants behaviour 
■ Online surveys, 
interview 
programme 
 
 
 
 
 
34 CORDA (Common Research Data Warehouse) is the European Commission’s database containing data on 
applicants/proposals and signed grants/beneficiaries of the EU’s Framework Programmes. 
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Study objectives Key research questions Sources of evidence 
To evaluate UK 
performance relating to 
FP7, the first years of 
Horizon 2020, COST and 
EUREKA, and develop a 
range of success 
measures 
■ Success rate of UK applicants for FP7 
funding (incl. comparator countries – all 
member states and associated countries) 
■ Levels of funding awarded  to UK 
participants (incl. comparator countries – 
all member states and associated 
countries) 
■ UK Performance 
analysis / CORDA 
data 
 ■ Volume and type of collaborations arising 
from programme funding 
■ Typology of successfully funded projects 
and unsuccessfully funded projects 
■ UK Performance 
analysis / CORDA 
data 
To evaluate the impacts of 
UK engagement with the 
programmes (principally 
FP7). 
■ Benefits of participation for applicants 
■ Outcomes of collaborations, with respect 
to different types of collaborations, and 
how those compared with what 
participants were expecting – what 
outcomes provided most value? 
■ Impacts arising from research involving 
UK participants 
■ Leveraged additional funding arising from 
successfully funded projects 
■ Assess the additionality of research 
funding 
■ Online surveys, 
interview 
programme, case 
studies, UK 
Performance 
analysis / CORDA 
data 
 ■ Innovation outputs and scientific outputs 
■ Wider economic and social impacts (GVA, 
jobs, exports of services and products) 
■ Frequency of 
outputs and wider 
impacts reported 
through online 
surveys 
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2.2 Intervention Logic – BEIS support to Framework 
Programme participation 
Figure 2.1 (below) sets out a basic intervention logic for BEIS support activities to 
secure greater value to the UK from Framework Programme participation, reflecting 
the general process through which research performance might generate outputs, 
outcomes and longer-term commercial and economic impacts.  
Figure 2.1 Intervention logic – BEIS support to Framework Programme participation 
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2.3 Study methodology 
The study methodology comprised a number of research activities summarised 
below. 
2.3.1 Literature review 
An in-depth literature review of academic research and previous impact assessments 
was conducted to help frame the approach and the design of individual research 
instruments used in the study. The review examined in particular: 
• the main types of outputs, outcomes and impacts from R&D funding 
programmes with a focus on the links between R&D and commercial impacts; 
• the approaches used to estimate the nature and size of these impacts 
(including the comparison of impacts across different groups, such as non-
participants) and the information sources used;  
• the high-level findings on impacts; and 
• the main limitations of these approaches. 
2.3.2 Composition analysis 
A full analysis of the CORDA database relating to the Sixth Framework Programme 
2002-2006 (FP6), the Seventh Framework Programme 2007-2013 (FP7) and Horizon 
202035 proposals, participations in proposals, projects and participations in projects 
was carried out. The analysis was organised into four main components, as 
described in Table 2.2 below – the results of this analysis are presented in Section 3. 
Annex 1 provides data tables of the analysis performed on FP7 programme data.  
Table 2.2 Approach to the data analysis 
Component Performance and impact metrics Strata 
Analysis of demand 
for participation 
(applications) 
■ Total number of UK applicants, average number 
of UK applicants, number of proposals with UK 
applicants, total EU funding requested, average 
EU funding requested 
■ Subject area, Specific 
programmes, calls for 
proposals; Funding 
instrument; 
Applicant/participant 
organisational type; 
Location of 
applicant/participant 
(NUTS)36; Demographics 
such as gender; 
Technology Readiness 
Level (TRL) of calls – 
basic or applied research, 
country level (UK and 
Analysis of projects 
and participants 
■ Total number of UK participants, average 
number of UK participants, number of projects 
with UK participants, total EU funding awarded, 
average EU funding awarded, total cost of 
projects funded, average costs of projects funded 
■ Top collaborative links (i.e. highest number of 
collaborations on aggregate and disaggregated 
level, top collaborating countries) 
 
 
35 Horizon 2020 is a running programme - only proposals and signed grant agreements up to February 2016 were 
included in the analysis. 
36 Nomenclature of Territorial Units for Statistics. NUTS is a hierarchical classification of spatial units used for 
statistical production across the European Union. 
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Component Performance and impact metrics Strata 
Analysis of success 
rates 
■ Success rate by proposals/projects, 
applicants/participants, EU funding 
requested/awarded 
innovation 
leaders/innovation 
followers as per 
Innovation Union 
Scoreboard) 
In addition to unadjusted performance, UK performance was calculated with 
reference to scale factors such as the size of the UK economy, research base, public 
and private investments in R&D in order to illustrate how the UK performs relative to 
other countries. Available data from the COST and EUREKA programmes was also 
assessed using the framework outlined in Table 2.2. 
2.3.3 Online surveys 
Two online surveys were conducted. One survey was directed at UK participants in 
FP7. A second survey was directed at unsuccessful UK applicants to FP7. The online 
survey of FP7 participants investigated the following areas: 
• Basic information on the respondent, covering type of organisation, number of 
proposals and participations, and thematic / research focus; 
• The relevance of RTD framework thematic areas, calls and instruments, and 
the extent to which these align with the capabilities of the respondents; 
• Motives and drivers for participation; 
• Outputs and outcomes realised as a result of participation; 
• The costs and benefits of participation, and the main reasons underlying high / 
low cost benefit ratios; 
• The wider, long-term impacts of FP7 for participants; 
• The extent to which FP7 has helped to broker new partnerships, particularly 
between industry and academia and the extent to which these new 
relationships endure beyond the project activity; and 
• The relative advantages and disadvantages of FP7 over other European 
funding programmes such as EUREKA and COST. 
The online survey of unsuccessful FP7 applicants examined:  
• Whether the planned research was carried out in the absence of FP7 funding, 
and if yes whether and what type of other external funding was used;  
• Whether the projects underwent changes in terms of their content, structure or 
partnership in order to continue in the absence of FP7 funding; and 
• The outcomes realised in the absence of FP7 funding. 
Table 2.3 presents an overview of survey populations and responses.  
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Table 2.3 Overview of survey population and responses 
 FP7 
participants 
FP7 
unsuccessful 
applicants37 
Contact database (individual contacts) 10,269 33,199 
Number of contacts in pilot survey 200 1,000 
Number of valid contacts for main survey 7,573 24,323 
Number of responses 488 735 
Number of valid responses 475 643 
Response rate (%) 6.4% 2.6% 
Confidence interval38 4.39 3.83 
Number of FP7 projects covered 453 - 
EU funding awarded to FP7 projects covered in survey 
responses (€m) 
590 - 
2.3.4 Interview programme 
The study included an interview programme, comprising 46 semi-structured 
interviews with a representative selection of relevant policy leads and programme 
managers in UK government, UK research funding organisations and from relevant 
European programmes.  
This included people in BEIS, Innovate UK, the UK Research Office (UKRO), 
Universities UK and Research Councils UK. Further interviews were carried out at a 
later stage including the COST office, as well as contacts in the UK Research 
Councils and Catapults focussing on specific thematic areas of research. 
Interviews were also undertaken with: 
• businesses who participated in FP7 and in EUREKA/Innovate UK projects; 
and 
• businesses who did not apply for FP7 but participated in EUREKA/Innovate 
UK projects. 
These interviews investigated the motivations and pathways behind non-participation 
of UK firms which could have benefited from participation in the EU Framework 
Programmes and their comparative assessment of different European and national 
funding options (FP7, EUREKA, Innovate UK). 
  
37 Those who incorrectly selected the survey for unsuccessful applicants were redirected to the survey of 
successful participants. 
38 Confidence level of 95%, assuming even split of responses (e.g. 50% yes, 50% no). 
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2.3.5 Case studies to illustrate the reasons for applications to and 
effects of participation in FP7 
A long list of candidate projects was provided by the steering group. Five case 
studies were selected, interviews with participants undertaken and written up. 
Interviews focused on the motivation and the experience of participating in FP7 
projects, and examining the wider outcomes and impacts of these projects.  
The case studies followed a standard reporting template to permit some degree of 
synthesis and aggregation. The case studies were written up based on CORDA 
programme data available and interviews with UK participants in these projects, as 
well as interviews with project coordinators. 
The projects proposed by the Steering Group for the case study work were mainly 
ongoing at the time of the research. Case studies selected comprise a mix of finished 
FP7 projects with impacts reported and ongoing FP7 projects that are close to 
completion and have already produced impacts, or have strong potential for impacts. 
All case studies are presented in Annex 3. 
2.4 Limitations to the work – issues and problems 
encountered 
This section provides an overview of the main issues and problems encountered, and 
how the study mitigated these. 
2.4.1 Data on outputs from FP7 projects 
The study team hoped to conduct an analysis of outputs reported by completed FP7 
projects to the European Commission. However, confidentiality restrictions currently 
in place prevent the European Commission from releasing final reporting data to 
outside parties. As a next best alternative, FP7 participants were asked to report on 
the outputs produced in the online surveys. However the picture is less complete 
than if output data held by the European Commission had been available. 
2.4.2 Contact details of FP7 participants 
Data available to the study team contained only administrative contacts for FP7 
participating organisations. As the online surveys were targeted at individual 
researchers who have either participated in FP7 or unsuccessfully applied to FP7 
funding, this presented a major challenge to the study design. The study team 
mitigated the issue of missing contacts by asking administrative contacts to forward 
the survey questionnaire to relevant principal investigators / lead researchers. During 
the survey analysis, duplicate entries (responses from the same organisation 
covering the same project) were removed. However, uncertainty on the sample 
population of individual researchers who have either participated in FP7 or 
unsuccessfully applied to FP7 funding remained.  
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2.4.3 Contact details of FP7 unsuccessful applicants 
The CORDA data available on FP7 applicants was less structured and less complete 
than the data provided on FP7 project participants. This meant that the study team 
was less certain of the characteristics of the contacts included in the list. Around 27% 
of the contacts of unsuccessful applicants provided were either invalid or not in use 
anymore. Overall, this meant that the contact database compiled and used for the 
online survey of unsuccessful applicants provided only a rough approximation of the 
sampling frame, and should not be taken as a complete and comprehensive 
population of unsuccessful applicants. 
2.4.4 Comparison with COST and EUREKA 
Aggregate statistics of the UK’s participation in COST have been provided by the 
COST Association. Furthermore, disaggregated data was made available by the 
EUREKA secretariat. However given the differences in programme rationale and 
programme implementation, the data provided was in principle not comparable to the 
FP7 participation data provided through CORDA. Furthermore, out of the EUREKA 
programmes Eurostars-1, which ran calls for proposals from 2008-2013, provided the 
most comprehensive picture on project results and impacts, therefore the analysis of 
EUREKA programmes is limited to EUREKA Eurostars-1. 
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3 UK participation and performance in 
EU research programmes 
Section 3.1 presents a summary of the overall levels of participation and funding 
secured by UK organisations and research individuals within FP7. Section 3.2 
provides a comparative analysis of UK performance across successive Framework 
Programmes - FP6, FP7 and Horizon 2020. Both sections are based on analysis of 
the European Commission’s CORDA database. Sections 0 and 3.4 review UK 
performance in COST and EUREKA and factors influencing participation. 
Note: The analysis of FP7 and Horizon 2020 presented here is based on data 
exported from CORDA in September 2015 and February 2016. Both the FP7 data 
and Horizon 2020 data have undergone further updates since the data was 
extracted. 
3.1 UK participation and performance in FP7  
3.1.1 UK participation in FP7 versus key comparator countries 
This section presents a summary of the overall levels of participation and funding 
secured by UK organisations and individual researchers within FP7. Results for the 
UK are compared with the average levels of participation and funding achieved 
across all the EU27 member states (the FP7 average) and with the results for five 
selected countries: Germany, France, Sweden, Denmark and Finland. These 
countries were chosen either because they are classified as Innovation leaders in the 
Innovation Union Scoreboard or because they have a significant importance in FP7. 
Together with the UK, these countries represent half (50%) of the total EU funding 
allocated by FP7.  
More information and full tables on the UK’s performance in FP7 are provided in 
Annex 1. 
3.1.1.1 Overall participation in FP7 by UK organisations 
The UK achieved a very substantial participation in, and funding from, FP7:  
• The UK had the greatest share of applications submitted to FP7, being present 
in almost 53,000 proposals (33% of all proposals), making up 12% of 
participations in proposals, and accounting for 13% of the EU funding 
requests. 
• The UK participated in 10,372 projects (41% of the total). A total of 17,695 UK 
participations (13% of all participations)39 collectively secured funding of some 
€7 billion (15.4% of the total awarded). 
39A total of 2,909 discrete organisations from the UK participated in FP7 (10% of all organisations involved). 
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• The UK achieved the highest level of representation in FP7 projects out of all 
countries and achieved the second greatest share of participations and EU 
funding behind Germany, which had the greatest share in absolute terms. 
Table 3.1 summarises the levels of demand (number of proposals, participations in 
proposals, and the amount of EU funding requested) and actual involvement rates, 
overall and for the UK and selected countries.  
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Table 3.1 Total FP7 applications and grant awards for the UK and other selected 
countries 
 FP7 total 
(all 
countrie
s) 
UK 
total 
in FP7 
UK 
share in 
FP7 
Germa
ny 
share in 
FP7 
France 
share 
in FP7 
Swede
n 
share 
in FP7 
Denmar
k share 
in FP7 
Finland 
share 
in FP7 
Applications         
Proposals 158,609 52,696 33.2% 28.5% 21.4% 9.6% 5.9% 6.1% 
Participations 
in proposals 656,732 80,050 12.2% 11.9% 7.9% 3.1% 1.8% 2.0% 
Funding 
requested (€m) 303,196 38,649 12.7% 12.4% 7.4% 3.7% 2.3% 2.2% 
Awards         
Projects 25,282 10,372 41.0% 34.8% 28.5% 12.2% 8.0% 7.1% 
Participations 
in projects 134,737 17,695 13.1% 13.5% 9.4% 3.4% 2.1% 2.0% 
Funding 
allocated (€m) 45,335 7,002 15.4% 15.8% 11.5% 3.8% 2.4% 1.9% 
Source: ICF CORDA analysis 
3.1.1.2 Rates of success in competitions 
Figure 3.1 below shows three types of success rate to show how the number of 
projects, participations and funding achieved in competitions compares with what 
was bid for and shows these for FP7 overall, for the UK and for selected comparator 
countries. Figure 3.1 shows that the UK achieved higher than average FP7 success 
rates, but was not leading, against these specific measures.  
Overall, the UK performance was strong: the UK project and funding success rates in 
competitions were more than three percentage points higher than the FP7 averages 
(20% versus 16%, and 18% versus 15% respectively), while participation success 
rates for the UK were more than 1.5 percentage points higher than the FP7 average 
for all participating countries. 
However, the UK’s success rates in competitions, compared to what was bid for, 
were below those of the comparator countries in most cases. Compared to the UK: 
• France, Sweden and Denmark achieved a project success rate slightly higher 
than the UK, but the UK outperformed Germany and Finland. 
• Germany, France and Denmark achieved participation success rates higher 
than the UK, but the UK achieved higher success rates than Sweden and 
Finland. 
• Germany and France achieved higher funding success rates than the UK, but 
the UK outperformed Sweden, Denmark and Finland. 
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Figure 3.1 Rates of success in competitions for the UK and other countries  
 
Source: ICF CORDA analysis 
3.1.1.3 Levels of EU funding secured, adjusted for scale factors  
As outlined above, in total the UK secured EU funding of some €7 billion (15.4% of 
the total awarded) in FP7, compared to €7.2 billion secured by Germany and €5.2 
billion secured by France. Smaller comparator countries secured lower nominal 
amounts: Sweden secured €1.7 billion, Denmark secured €1.1 billion and Finland 
€877 million of EU funding. 
Putting this nominal level of EU funding into context is an important performance 
metric for member states, as achieving a share of the available funding that is greater 
than the share of GDP indicates strong relative participation. Similarly, achieving a 
high share of funding having adjusted for other relevant factors such as national R&D 
investment or FTE researchers can also provide a more accurate picture of true 
performance. 
There was a very strong overall performance by the UK in terms of the amount of EU 
funding secured when compared to other EU27 member states, after adjusting for 
GDP, Gross Expenditure on R&D (GERD), Government Expenditure on R&D 
(GOVERD) and the number of FTE researchers.40 
The UK’s funding was above what might have been expected using GDP as a 
variable of normalisation (+16%). The UK was 11th out of the EU27 in terms of the 
amount of EU funding adjusting for the levels of GDP of member states. 
The UK’s funding was substantially above what might have been expected using the 
level of UK GERD as a variable of normalisation (+34%). The UK was 14th out of the 
40 Normalising EU funding won by the above measures tends to make smaller countries perform better, hence 
these results highlight the strong relative performance of the UK. Data used is from Eurostat: Eurostat tec00001, 
Eurostat [rd_e_fundgerd], Eurostat t2020_20, Eurostat [rd_p_persocc]. 
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EU27 in terms of amount of EU funding adjusting for the R&D expenditure by 
government (GERD). 
The UK’s funding was substantially above what might have been expected using the 
level of UK GOVERD as a variable of normalisation (+47%). The UK was 10th out of 
the EU27 in terms of amount of EU funding adjusting for the R&D expenditure by 
government (GOVERD). 
The UK’s funding was above what might have been expected adjusting for the 
number of FTE researchers as a variable of normalisation (+24%). The UK was 7th 
out of the EU27 in terms of the amount of EU funding adjusting for the number of 
FTE researchers. 
In comparison with the selected comparator countries (Figure 3.2), the UK has 
performed very well overall. It is the only country under consideration to have 
achieved a funding share higher than expected when all of GDP, GERD, GOVERD 
and number of FTE researchers have been taken into account41. 
When taking account of GDP size in particular, the Scandinavian countries 
performed best, and the larger western European countries less well. However, the 
UK outperformed Germany and France by some margin on this metric. 
The UK performed particularly well in comparison with other countries when 
considering its FP7 funding factored against its GERD and GOVERD. In both cases 
the UK achieved funding amounts far higher than could have been expected, and 
much higher than each of the five comparator countries. 
The UK’s funding from FP7 factored against the number of FTE researchers 
employed was higher than Germany, France, Denmark and Finland, but below that of 
Sweden. 
41 Ratio of actual to expected FP7 income shares = Share of total EU27 funding between 2007 and 2013/ Share 
of total EU27 GDP/ GERD/ GOVERD between 2007 and 2013. For FTE researchers averages between 2007-
2013 were used. 
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Figure 3.2 FP7 EU funding allocations, factored by key scale metrics 
 
Source: ICF CORDA analysis, Eurostat Eurostat tec00001, Eurostat [rd_e_fundgerd], Eurostat t2020_20, 
Eurostat [rd_p_persocc]. 
3.1.1.4 Participation and funding in FP7 by specific programme 
FP7 was organised into five specific programmes, as follows42: 
• Cooperation – With an initial budget of €32.4 billion, Cooperation was the 
largest FP7 programme, supporting collaborative research projects across 
Europe and other partner countries carried out by transnational consortia of 
industry and academia. 
• Ideas – The Ideas programme was implemented by the European Research 
Council (ERC) and supported "frontier research" on the basis of scientific 
excellence. There was no obligation for cross-border partnerships. The 
programme had an initial budget of €7.5 billion. 
• People – The People programme supported researcher mobility and career 
development, both inside the European Union and internationally. It was 
implemented via a set of Marie Curie actions, providing fellowships and other 
measures to help individual researchers throughout their careers. People had 
an initial budget of €4.75 billion. 
• Capacities – The Capacities programme aimed to strengthen the research 
capacities that Europe needs if it is to become a thriving knowledge-based 
economy, covering areas such as research infrastructures, SME actions, and 
Science in Society. Capacities had an initial budget of €4.1 billion. 
42 https://ec.europa.eu/research/fp7/understanding/fp7inbrief/structure_en.html 
The actual amounts spent can be found in Table A1.3 in Annex 1. Total spent was larger than the initial budget for 
the specific programmes Ideas, People and Euratom. Total spent was smaller than the initial budget for the 
specific programmes Cooperation and Capacities 
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• Euratom – Euratom is the programme for nuclear research and training, 
comprising research, technological development, international cooperation, 
dissemination of technical information, and exploitation activities, and training.  
It was the smallest of the five programmes with an initial budget of €2.7 billion. 
The different types and sizes of projects in the different specific programmes means 
that it is important to look at not only participation levels but also the amounts of 
funding secured in each area. 
3.1.1.4.1 Participation by specific programme 
Within FP7 as a whole (Figure 3.3), the major specific programmes based on 
numbers of participations were Cooperation (by some margin at 66%), followed by 
People (15%), and Capacities (14%).  Ideas and Euratom had relatively small 
numbers of participations (4% and 2% shares respectively). 
The UK profile of participations followed loosely that of FP7 as a whole, with most 
participations coming in the Cooperation programme (56%), followed by People 
(23%), and Capacities (13%), then Ideas (7%) and Euratom (1%). Based on these 
ratios the UK had a relatively high rate of participation in the Ideas and People 
programmes and a relatively low participation in Cooperation, Euratom and (to a 
lesser extent) Capacities. These results indicate that the UK participation profile 
followed the character of its national research and innovation system. UK 
organisations participated strongly in leading edge research (Ideas) and in mobility 
programmes (People) – areas where UK universities are primarily involved – but the 
UK participated relatively less in the more traditional R&D projects conducted under 
the Cooperation and Capacities programme (which have a greater involvement of 
research institutes, industry and public bodies). 
France, Sweden and Denmark followed the average profile in most respects, while 
Germany and Finland participated relatively more in Cooperation and less in most of 
the other areas - reflecting stronger involvement of industry and research institutes 
from these countries in FP7. 
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Figure 3.3 Share of FP7 participations for the UK and selected countries, by specific 
programme 
 
Source: ICF CORDA analysis 
3.1.1.4.2 EU funding by specific programme 
Due to the very different average sizes of the projects within the different FP7 
programmes, the profile of funding by specific programme looked somewhat different 
to the profile of participations (Figure 3.4). Here the Ideas programme (ERC) 
becomes far more prominent, accounting for 17% of the EU FP7 funding (as 
compared to just 4% of the participations). This is because an average Ideas project 
attracted €1.4 million per participation, while the other four programmes provided an 
average of between €173,000 and €324,000 in EU funding per participation. 
Compared to the overall FP7 funding profile, the UK had a relatively very high 
amount of funding from both the Ideas and People programmes, accounting for 24% 
and 16% of UK funding respectively, as compared to 17% and 11% for FP7 as a 
whole. The share of funding received from these two programmes was higher for the 
UK than for any of the comparator countries, a result of the UK’s high specialisation 
in leading edge research and university-based research. The UK share of funding 
from the Capacities programme (at 7%) was close to the FP7 average (8%) and in 
line with most of the comparator countries.   
The corollary to the UK’s relative specialisation in the Ideas and People programmes 
is that the UK secured a relatively smaller share of EU funding from the Cooperation 
programme, which accounted for 52% of the UK’s total EU funding (but between 64% 
and 72% among the comparator countries. The share of the UK’s FP7 funding from 
Euratom participation was also relatively low, and smaller than all comparator 
countries apart from Denmark. 
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Figure 3.4 Share of EU funding for the UK and selected countries, by specific 
programme 
 
Source: ICF CORDA analysis 
3.1.1.4.3 Participation within Cooperation programme priority areas 
Cooperation, being the largest of the FP7 specific programmes, is subdivided into 11 
priority areas, as shown in Figure 3.5. 
The most significant programmes in terms of participation (overall and for the UK) 
were Information and Communication Technologies, Health and Nanosciences, 
Nanotechnologies, Materials and new production Technologies. However, compared 
to the overall FP7 profile, the UK’s participation rates were highest in the Health, 
Socio-economic Sciences and Humanities (SSH), Environment (including climate 
change), Security and Space priority areas. In each case the share of participations 
held by the UK was higher than the share within FP7 as a whole. This was 
particularly so for Health, where the UK participation rate was 33% higher than the 
FP7 rate. 
Conversely, the UK had a relatively low share of its participations within the General 
Activities (Annex IV)43, Energy, and Food, Agriculture & Biotechnology priority areas. 
In each case the UK participation rate was at least 10% lower than would have been 
expected had the UK followed the average profile.  
43 This priority area covers the following activities: dissemination, knowledge transfer and broader engagement, 
coordination of non-Community research programmes and the risk-sharing finance facility. For more information, 
see: http://ec.europa.eu/research/participants/data/ref/fp7/88225/cooperation_annex4_wp_200702_en.pdf  
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Figure 3.5 FP7 and UK participation in Cooperation programme priority areas 
 
Source: ICF CORDA analysis 
The relative share of the EU funding received by the UK in each of the Cooperation 
priority areas followed a broadly similar pattern to the one shown in Figure 3.5 above. 
A small number of differences were noted: 
• While security was an area of relative strength in terms of participations, the 
amount of EU funding received by the UK was below the level that would have 
been expected given the participation rate. This is because UK participants in 
the Security priority area attracted lower amounts of funding per participation 
than in other areas. 
• The opposite situation was found within the Food, Agriculture & Biotechnology 
priority area. This was an area of relative weakness in terms of the UK’s 
participation share, but it accounted for a higher than average share of EU 
funding. This is due to the UK participants attracting larger amounts of funding 
per participation, relative to others, within this particular priority area.  
The relative strengths in areas such as health (Figure 3.5 above) as well as food, 
agriculture & biotechnology (in terms of EU funding won) could to some extent reflect 
the relative importance of these areas to UK’s economy – considering the large share 
of business R&D in pharmaceuticals throughout 2007-2014. Throughout 2007-2014, 
pharmaceuticals was the product group which saw the highest amounts of business 
R&D investment (20% in 2014). 
3.1.1.4.4 Success rates by programme 
Average success rates across all countries varied considerably between specific 
programmes, from a high of 60% in Euratom to a low of 10% in Ideas (success rate 
by applications). In each Specific Programme the UK’s success rates were higher 
than the FP7 average. 
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The UK’s success rates were highest relative to other countries in the People 
programme (23% higher success rate than average across all countries) and above 
the rate achieved by all five of the comparator countries (Figure 3.6). UK success 
rates in Ideas were also very high, being 16% above the overall FP7 success rate, 
and again higher than of all the comparator countries. 
UK applicants did least well in Euratom44 (3% higher success rate than overall 
average), although this level of performance was still strong and higher than that 
achieved by Germany, Sweden and Finland. UK success rates within Cooperation 
were 5% higher than the FP average, but were significantly below those achieved by 
Germany, France, Sweden and Denmark, each of which achieved success rates 15-
24% higher than average. 
Figure 3.6 Participation success rates for the UK and other selected comparator 
countries in FP7, by specific programme 
Source: ICF CORDA analysis 
3.1.2 Participation in FP7 by type of organisation 
3.1.2.1 Participation rates, by type of organisation 
The relative participation of different types of organisation within the FP7 programme 
reflects the nature of the R&D work carried out.  Across the programme as a whole 
and across all countries (Figure 3.7) there was a strong level of involvement from 
Higher and secondary education (HES) establishments, Research organisations 
(REC) and Private commercial (PRC), along with a lesser participation by Public 
Bodies (PUB) and Others (OTH). 
When viewed from a national (UK) perspective, the pattern of participation by 
different types of organisation reflected both the national research and innovation 
system itself, in terms of its constituents and their roles, and their relative 
44 Success rate under Euratom was largely influenced by the continued funding for the Joint European Torus 
(JET) facility located at the Culham Centre for Fusion Energy, a major facility of the European fusion research 
programme;  http://www.ccfe.ac.uk/jet.aspx [accessed 27th June 2016]. 
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engagement with and success within the Framework Programmes. The main 
features of the UK system, as described in Section 1.2 above, are relevant to the 
results reported here. 
HES accounted for more than half (60%) of all UK participations, a much larger share 
than they held in FP7 as a whole (37%) and larger than the share they held within 
any of the comparator countries (HES held between 17% and 51% of the 
participations in the five comparator countries). The dominant presence of the higher 
education sector in the UK’s FP7 participation reflects structural differences between 
the countries. In the UK there are relatively few REC and as such they accounted for 
just 9% of participations in the UK (as opposed to 25% in FP7 overall). REC play a 
more significant role in each of the other countries considered and as such account 
for a larger share of their participations.  
The share of UK participations held by PRC (26%) was below the FP7 average figure 
(30%). However, whilst the relative degree of industry participation was low - most of 
UK’s R&D performing sectors were represented in FP7. Finland was the only 
comparator country in which PRC organisations represented a lower share of 
participations than in the UK.  
PUB accounted for just 3% of UK participations, lower than in FP7 as whole (5%).  
The participation rate of UK PUB was higher than Germany, the same as France but 
below that of Sweden, Denmark and Finland.   
Figure 3.7 Share of participation in the UK and selected comparator countries, by 
organisation type 
 
Source: ICF CORDA analysis 
In the UK, as with most countries, FP7 participation was dominated by a relatively 
small group of key organisations – the top 100 UK organisations (in terms of the 
number of projects involved in) represented just 3% of UK participants but accounted 
for 76% of all EU funding awarded to the UK (or €5.3 billion) and 70% (or 12,397) of 
all UK participants in projects. This group of 100 organisations comprised 67 
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individual universities, 14 companies, 16 research organisations and three 
government bodies. 
In terms of participations, the top 25 UK organisations include 22 universities, the 
Medical Research Council (MRC), the Natural Environment Research Council 
(NERC) and TWI Ltd. 
The UK held by far the largest share out of all HES participations across the FP7 
programme(21%), ahead by a margin of Germany (12%) which held the second 
highest share of overall HEs participations.  
UK industry participants represented 11% of all industry participants in FP7, topped 
only by industry participation from Germany (15% of total). REC from the UK 
represented only 5% of overall REC participation in FP7, clearly behind Germany 
(16%) and France (15%), coming 6th overall out of all participating countries. 
Furthermore, UK participants from the public sector (PUB) represented the largest 
share out of all PUB participations (9%) when compared to selected countries 
(France held 6% and Germany held 6% of all PUB participations across FP7), 
holding the second highest share out of all countries participating in FP7. Figure 3.8 
provides an overview of UK participation by organisation type as proportion of overall 
FP7 participation of the same organisation type, and compared the UK to five 
comparator countries. 
Figure 3.8 Share of overall FP7 participations, by organisations from selected 
countries 
 
Source: ICF CORDA analysis 
3.1.2.1.2 Success rates in competitions, by type of organisation 
Analysis of UK success rates in competitions (Figure 3.9) indicates that all types of 
organisation in the UK with the exception of ‘Others’ (OTH) achieved participation 
success rates higher than the FP7 average. 
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UK HES did the best, achieving success rates 23% higher than the FP7 average. 
While German, Swedish and Danish HES also outperformed the FP average, UK 
HES had the highest success of all the countries considered. 
UK private commercial organisations (PRC) and research organisations (REC) both 
achieved success rates slightly above the FP7 averages (9% above and 8% above 
respectively). While UK PRC did reasonably well against the FP average, PRC in 
four of the five comparator countries performed better, achieving success rates 
between 12% and 20% above the average. UK REC performed well in comparison to 
two of the other countries, outperforming REC in Germany and Sweden. 
Public bodies in the UK also performed better than average but less markedly so with 
a success rate only 4% higher than the FP7 average. Public bodies in Germany did 
less well than the UK; however, the other comparator countries performed much 
better: Sweden’s and Denmark’s PUB success rates were 51% and 41% higher than 
the FP7 average respectively. 
Figure 3.9 Participation success rates for the UK and selected comparator countries, 
by organisation type 
 
Source: ICF CORDA analysis 
3.1.3 Participation by UK industry 
Within FP7 as a whole private commercial organisations (PRC) accounted for almost 
30% of participations, but made up just 26% of participations by the UK (Figure 3.10). 
The UK PRC participation rate was slightly higher than Finland’s (25%), but below 
that of Sweden and Denmark, and below that of Germany and France (34% and 36% 
respectively). 
Industry participation overall was highest in the Capacities programme, and here as 
well as in Euratom, UK industry had a higher involvement rate than average, and 
above that of most comparator countries. However, in both Cooperation (the largest 
programme) and in People, UK industry participation rates were below average (32% 
versus 35% and 6% versus 10% respectively). In both programmes the UK industry 
participation rate was below that of most of the comparator countries. 
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Figure 3.10 Participation rate of private industry (PRC), by specific programme 
 
Source: ICF CORDA analysis 
Figure 3.11
Lower relative participation of industry is likely a result of various factors, such as the 
predominant role of HES in UK’s FP7 participants, the overall lower proportion of 
innovating businesses in the UK compared to other economies of similar size (see 
section 1.2) and the prominence of private/commercial research institutes which are 
classed as PRC participants in some of the comparator countries.  
The UK’s share of industry participation overall was largest in the Capacities 
programme (15%), and lowest in the Ideas programme (3%). Notably, the UK’s share 
of industry participation overall was substantially behind Germany and France in the 
Cooperation programme – the UK accounted for 11% of all FP7 industry participation 
here, whilst Germany accounted for 17% and France for 11%.  provides 
further detail as regards the share of UK industry participation out of all FP7 industry 
participation, and compares it against a selection of countries. 
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Figure 3.11 Share of business participation out of all FP7 business participation, UK 
and selected comparator countries 
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3.1.4 Participation by UK SMEs 
Given the relatively low involvement rate of UK industry compared to other UK 
organisation types, the relative participation rate of UK SMEs in FP7 was quite 
respectable, and only very slightly below the FP7 average - SMEs made up 17% of 
UK participations as compared to 18% within the programme overall (Figure 3.12), 
and UK SMEs made up 12% of all SMEs participated in FP7.45 The UK’s SME 
participation rate was higher than that of Sweden, Denmark and Finland but below 
that of the other comparator countries in Figure 3.12. Differences between the 
countries were relatively small, all being in the range of between 14%-18%. 
SME involvement rates were highest in the Capacities programme, which contains 
SME-specific sub-programmes. Here the UK SME participation rate was highest 
overall, and in relative terms, making up 42% of UK Capacities participations, versus 
34% within the programme as a whole. All of the comparator countries had much 
lower SME participation rates within Capacities, ranging from 25-33%. 
UK SME participation in the Cooperation programme was also reasonably strong, 
being in line with the programme average (19%) and above that of Sweden, 
Denmark and Finland (14-17%). However, UK SME involvement in the People 
45 This compares to an above average number of UK SME which are innovating, when compared to EU28 and 
comparator countries. 60% of small businesses in the UK were innovation active between 2012 and 2014, 
compared to 48% across EU28, 66% in Germany, 55% in France, 54% in Finland and 53% in Sweden – see 
Community Innovation Survey 2014/15, BEIS https://www.gov.uk/government/statistics/uk-innovation-survey-
2015-statistical-annex-and-interactive-report [accessed 7th February 2017] and Eurostat [inn_cis9_type] 
[Innovative enterprises (including enterprises with abandoned/suspended or on-going innovation activities) with 
FTE between 10-249]. 
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programme was lower than average, with SMEs accounting for 3% of the UK 
participations as compared to 6% within that programme overall. All of the 
comparator countries in Figure 3.12 outperformed the UK in terms of relative SME 
involvement in the People programme. 
Figure 3.12 Share of participations accounted for by SMEs, by specific programme  
 
Source: ICF CORDA analysis 
UK SME participation as a proportion of overall SME participation in FP7 is 12% – 
coming second behind Germany’s 14%. UK SMEs were particularly present in the 
Capacities programme (15%), People programme (12%) and Cooperation 
programme (12%) (see Figure 3.13 below). 
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Figure 3.13 SME participation from UK and comparator countries as proportion of 
overall SME participation in FP7 
 
Source: ICF CORDA analysis 
3.1.5 Project coordination rates 
Project coordination rates are a good indicator of the extent to which UK partners 
occupy a leading role within their projects. Overall, the UK had the highest amount of 
coordinator roles out of all participating countries (5,101 coordinators), before 
Germany (3,119) and France (2,664). A large number of UK coordinators have led 
projects in the Marie Curie and European Research Council programmes, which are 
largely dominated by singe beneficiary projects (75% of all UK coordinators were 
coordinating Marie Curie or European Research Council projects), a larger proportion 
than in Germany (50%) and France (61%). 
Figure 3.14 presents the UK coordination rates across specific programmes in FP7 
and compares them to those of other countries. It shows how many projects that one 
country was involved in were coordinated by an organisation from that country. It 
shows that the UK coordinated a larger share of the projects in the Capacities and 
Marie Curie projects it was involved in when compared to other countries, whilst it 
came second behind Germany in the Cooperation programme. Due to the focus on 
single beneficiary projects under the European Research Council,  the UK and 
comparator countries all coordinated a similar share of projects they were involved in 
- slightly above or below 90%. 
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Figure 3.14 Share of UK coordinator roles out of UK projects compared to other 
countries 
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The UK provided the largest share of project coordinators out of all countries for the 
Marie Curie Actions (26.3% of all project coordinators), the European Research 
Council (22.1% of all project coordinators) and the Capacities programme (13.2% of 
all project coordinators). It came second behind Germany in the Cooperation 
programme, where the UK provided 12.8% of all project coordinators compared to 
Germany’s 16.7% (Figure 3.15). 
Figure 3.15 Share of coordinator roles out of all projects 
 
Source: ICF CORDA analysis 
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Within the Capacities programme, UK participants were most prominent in the priority 
area, ‘Research for the benefit of SMEs’, where the UK supplied 18.7% of all 
coordinators, much higher than the share of coordinators represented by Germany 
(9.6%) and France (3.8%). Within the Cooperation programme, UK participants were 
the most prominent in the priority area ‘Socio-economic sciences and humanities’, 
where 19.8% of all project coordinators where affiliated to a UK organisation, 
compared to Germany (15%) and France (8.3%). The UK also provided the highest 
share of coordinators in the priority area Health (17.9%), followed by Germany 
(16.4%) and France (10.4%). 
This section has shown that UK participants in FP7 projects were more often 
involved in lead roles than participants from all other countries – underlining the 
major contributions UK participants made to their projects, compared to participants 
from other countries. 
Taking to one side coordination roles in Marie Curie and European Research Council 
programmes, the UK still provided a large number of coordinators for the other 
elements of FP7 – coming second only behind Germany in the Cooperation 
programme and coming first in the Capacities programme. 
3.1.6 Use of FP7 instruments 
FP7 used eight main types of instrument, as shown in Figure 3.16. Compared to the 
overall profile, UK participants made particular use of Support for Frontier Research 
(ERC) and Marie Curie actions, reflecting the UK’s strong participation in the Ideas 
and People programmes. For both instruments the UK participation rate was higher 
than that of all five comparator countries. In contrast the UK made less use of 
Collaborative Projects and Coordination and Support actions when compared to 
other countries; instruments that were used mainly within the Cooperation and 
Capacities programmes where UK involvement rates were lower. 
Figure 3.16 Share of participations, by type of instrument  
 
Source: ICF CORDA analysis 
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3.2 UK participation in successive Framework Programmes 
(FP6 – FP7 – Horizon 2020) 
This section provides a comparative analysis of UK performance across successive 
Framework Programmes - FP6, FP7 and Horizon 2020 - based on data from 
CORDA. Where relevant, UK performance is also compared to that of other 
countries.  
It is important to note that the Horizon 2020 programme began in 2014 and will 
award grants until 2020. The database used for the analysis covers only Horizon 
2020 grant contracts signed up until 26th February 2016. Data on UK participation in 
Horizon 2020 is thus preliminary and provides only a very early indication of UK 
performance. In addition, structural differences between FP7 and Horizon 2020 mean 
that the extent to which any performance changes can be confidently identified is 
limited. 
3.2.1 Overall statistics 
Table 3.2 presents the number of proposals, participations in proposals, projects, and 
participations in projects, as well as the amount of EU funding allocated to UK 
organisations for FP6, FP7 and Horizon 2020 (to date). A number of trends can be 
seen: 
• The share of proposals with UK participation was higher in FP6 than in later 
programmes, falling from 40% in FP6 to 33% in FP7 to 28% in Horizon 2020 
(to date). This fall is not an indication of diminishing performance but of 
changes to the FP instruments (in particular smaller projects with fewer 
partners and countries involved in each), as well as demand from a growing 
number of countries (new EU member states and new associated countries). 
• The UK saw a larger share of participations in FP7 and Horizon 2020 (to date) 
than in FP6, with Horizon 2020 levels very close to those achieved in FP7 
(12%), a good indicator of growing demand from UK actors for FP funding – 
particularly against the trend of an increasing number of countries being 
funded overall. 
• In absolute terms, the UK secured almost three times as much income from 
FP7 as compared to FP6. However, the percentage share of EU funding 
allocated to UK organisations remained broadly stable over the three 
programmes, rising only slightly from 14% to 15% from FP6 to FP7, and 
remaining stable at that level in Horizon 2020 to date.  
• The share of EU funding requested by UK applicants is unchanged from FP7 
to Horizon 2020 (12.7%) to date, indicating sustained levels of demand for 
funding. Figures for FP6 are not available. 
• The share of projects with UK involvement has decreased over time. While the 
UK was present in 45% of projects in FP6 and 41% in FP7, it is present in only 
36% of projects funded under Horizon 2020 to date. This mainly reflects a 
reduction in the numbers of partners and countries in an average FP project, 
and similar falls can be seen for comparator countries such as Germany and 
France. 
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• The share of UK participations in projects has been growing over time, 
increasing from 11.8 in FP6 to 13.1% in FP7 and 13.4% during Horizon 2020 
to date. To maintain and even increase its share of participations as more 
countries participate indicates a continued very strong performance of the UK 
within the FPs. 
Based on these main indicators we can conclude that the UK has achieved a 
significant positive increase in participation rates and financial returns from FP7 as 
compared to FP6, and that the high levels of performance within FP7 appear to be 
being maintained within Horizon 2020 to date. The UK, as with other selected 
comparator countries, is involved in a diminishing proportion of the projects over 
time, but this is due to the use of smaller and more targeted projects, a change that 
participants generally favour based on the feedback provided on the (large) FP6 
instruments. 
Table 3.2 Overall statistics for the UK  
Indicator FP6 FP7 Horizon 2020 
Total number of proposals 55,957 158,609 75,518 
UK proposals 22,333 52,696 21,297 
UK share of proposals 39.9% 33.2% 28.1% 
Total number of participations in 
proposals 389,737 656,732 258,519 
UK participations in proposals 40,724 80,050 31,176 
UK share of proposal participations 10.4% 12.2% 12.1% 
Total FP budget requested (€m) No information €303,195m €132,281m 
UK requested FP budget No information €38,649m €16,814m 
UK share of requested FP budget No information 12.7% 12.7% 
Total number of projects 10,058 25,282 8,598 
UK projects 4,559 10,372 3,112 
UK share of projects 45.3% 41.0% 36.2% 
Total number of participations in projects 74,400 134,737 35,359 
UK participations in projects 8,791 17,695 4,731 
UK share of project participations 11.8% 13.1% 13.4% 
FP budget (€m) €16,669 m €45,335 m €14,492m 
UK FP allocation €2,370 m €7,002 m €2,172m 
UK share of FP budget 14.2% 15.4% 15.0% 
Source: ICF CORDA analysis 
UK performance over time also appears to be strong in comparison to the key 
comparator countries of Germany and France. While the UK’s share of participations 
was higher in FP7 and Horizon 2020 than in FP6, both Germany and France have 
seen a slight decrease in their shares across the successive Framework 
Programmes.  
In terms of EU funding allocated, the share of the UK increased by 0.8 percentage 
points from FP6 to Horizon 2020, while the share held by Germany fell by 0.3 
percentage points and France by 2.6 percentage points. These data again confirm 
43 
Evaluation of UK involvement with EU research programmes 
the strong continued performance of the UK across successive FPs, overall and in 
relation to key competitor countries. 
3.2.2 EU funding in context 
The UK attracted €2,370 million of EU funding commitments under FP6, €7,002 
million under FP7 and €2,172 million under Horizon 2020 so far.46 This corresponds 
to a share of EU funding allocated to the UK of 14.2%, 15.4% and 15.0% under the 
three programmes respectively. 
Figure 3.17 shows how performance across the three programmes compares when 
seen in relation to the scale factors used in section 3.1.1.3 above, namely the UK’s 
gross domestic product (GDP), gross domestic expenditure on R&D (GERD), 
government expenditure on R&D (GOVERD) and the number of FTE researchers in 
comparison with other EU member states (EU28 for Horizon 2020, EU27 for FP7 and 
EU25 for FP6). 
Under FP6, the UK received a high share of the EU funding when the scale of its 
GOVERD and FTE research base is taken into account, but below the amount that 
might have been expected considering the size of its GDP and GERD. Within FP7, a 
combination of improved performance within the programme (a higher share of the 
funding) and a contracting economy during some of the FP7 programme lifetime 
meant that the UK’s performance relative to GDP was exceptionally high. Stagnating 
domestic R&D expenditure over the period of FP7, relative to other countries, meant 
that the UK’s good performance within the competition translated into very much 
larger than expected returns when factored against GERD and GOVERD.47 
The situation has changed a little under the first years of Horizon 2020. A small fall in 
the share of EU funding allocated to the UK has coincided with strong growth in the 
UK economy and R&D investments, relative to other EU countries.  This has meant 
that EU funding returns, normalised in this way, are not as great under Horizon 2020 
(to date) as they were under FP7. However, in comparison with the UK’s investments 
in R&D and the size of its research base, it still receives a greater than expected 
share of EU funding under Horizon 2020. Ratios above 100% indicate that the UK 
received more funding that can be expected given its economic strength, domestic 
and government expenditure on R&D, as well as the size of its research sector. A 
ratio below 100% means that the UK received less than can be expected given these 
key metrics. Figure 3.17 shows that the UK not only outperforms the EU average, but 
also consistently and considerably outperforms Germany and France when looking at 
how much funding is received from the Framework Programmes compared to the 
size of the economy and the research base.   
46 EU funding is paid out across and beyond the lifetime of an FP7 project, hence the actual EU payments made 
to date for FP7 and Horizon 2020 projects will be below these figures. 
47 Ratio of actual to expected income shares was calculated as follows: Share of total EU funding allocated to EU 
Member States in respective years was divided by share of total EU27 GDP/ GERD/ GOVERD in respective 
years corresponding to run time of Framework Programme investigated. For FTE researchers averages for each 
period were used. Data was sourced from Eurostat, using same sources as in section 3.1.1.3 above. 
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Figure 3.17 Ratio of actual to expected EU funding given key metrics - UK, DE, and 
FR – successive FPs 
 
Source: ICF based on CORDA analysis; *Horizon 2020 figures are subject to change 
3.2.3 Rates of success in competitions 
As shown in Figure 3.18, the UK’s rates of success in competitions in terms of 
projects, participations and funding (compared with what was bid for) have been 
consistently higher than average across all three Framework Programmes.  The UK’s 
success rate in terms of project involvement have been very high, being 25% higher 
than average in FP7 (20% versus 16%) and 36% higher than average in Horizon 
2020 to date (15% versus 11%). Funding success rates have also been consistently 
higher for the UK than the average for all countries, running at 20% above average 
for both FP7 and Horizon 2020. 
While success rates in competitions have been broadly similar for FP6 and FP7, the 
data presented in Figure 3.18 may seem to suggest at first glance that rates have 
fallen sharply under Horizon 2020. This is not necessarily the case, however, as the 
data for Horizon 2020 are subject to change. Funding decisions are still pending on a 
proportion of the submitted proposals and success rates might well be higher than 
indicated here. 
Figure 3.18 Success rates in competitions, overall and UK - successive FPs 
 
Source: ICF CORDA analysis, *Horizon 2020 figures are subject to change 
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When comparing the UK with a wider group of other EU countries, the UK’s relative 
performance was similarly high in FP7 and (as of February 2016) Horizon 2020. In 
both programmes, the UK received the second-most EU funding after Germany. 
While the UK was ranked 5th in terms of success rate by EU funding and 6th in terms 
of success rate by applications in FP7 out of all countries, it currently is ranked 5th 
and 7th (for the same metrics respectively) in Horizon 2020. The associated ratios of 
successful to unsuccessful applications in the three Framework Programmes are 2:7 
for FP6 and FP7 and 1:6 for Horizon 2020 so far. 
3.2.4 Project coordination rates 
As previously discussed, project coordination rates are a good indicator of the extent 
to which UK partners occupy a leading role within their projects. Figure 3.19 presents 
the UK coordination rates across successive Framework Programmes, both in terms 
of the share of all projects coordinated, and the share of projects with UK 
involvement that have a UK coordinator. It shows that UK coordination rates have 
increased steadily over time on both metrics. 
The share of all projects with a UK coordinator increased slightly over time (from 17% 
for FP6 to 21% for Horizon 2020). This suggests that UK organisations are taking the 
lead role in projects in an increasing share of cases, a very positive achievement 
considering the growing number of countries involved over time.  
The share of the UK’s own projects with a UK coordinator increased much greater, 
from 38% in FP6 to 49% in FP7 and 57% in Horizon 2020. However, specific 
patterns of participation by the UK within the FPs, such as a dominant role within the 
basic research (Ideas in FP7) and mobility (People in FP7) parts of the programmes, 
means that the UK will by definition coordinate a relatively high share of the projects 
in which it is involved. That is because within these two programmes where UK 
involvement is strongest, most projects have only a single partner (the coordinator) 
and as such project coordination rates are exceptionally high. 
Figure 3.19 UK project coordination rates – successive FPs 
 
Source: ICF CORDA analysis 
UK coordination rates have been above those of Germany and France across FP7 
and during the early stages of Horizon 2020. The UK coordinated a total of 5,101 
FP7 projects (49% of projects with UK participation), substantially more than either 
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Germany (3,119, 35% of projects with German participation) or France (2,664, 37% 
of projects with French participation). In Horizon 2020, the UK held 1,785 coordinator 
roles out of 3,112 participations so far (57%), a much higher proportion that either 
France (794 out of 1,885, 42%) or Germany (984 out of 2,427, 41%). 
3.2.5 Participation by type of organisation 
Figure 3.20 shows the relative share of UK participations by organisation type in 
comparison to the overall FP profile, for successive FPs. It confirms that the UK 
universities (HES) have had a relatively high participation rate as compared to the FP 
average throughout the past three FPs.  HES have made up between 50% and 60% 
of the UK participations but just 30% - 40% of participations from across all three 
Framework Programme up to February 2016. This is largely due to structural 
differences wherein research organisations (REC) from other countries play a larger 
role in the FPs than is the case for the UK, where fewer such organisations exist. 
Overall involvement by industry (PRC) has increased within the FPs over time, 
increasing from 19% in FP6 to 30% in FP7 to 32% in Horizon 2020. However, 
relative UK industry participation has not kept up with the average levels, from 19% 
in FP6 (the same as the overall FP level) to 26% in FP7 (4% behind the FP level) 
and 25% in Horizon 2020 (7% behind the FP rate). Survey responses don’t provide 
any hints as to possible reasons for this trend, however three aspects which might 
play a role are the dominant role of HES participants in the UK, a lack of awareness 
of FP7 and EU funding opportunities as well as the relatively low number of 
innovating businesses (see section 1.2). 
Involvement of public bodies can only be tracked from FP7 to Horizon 2020, but the 
indications are that UK public bodies have in both cases played a lesser role than is 
typically the case. This indicates that on aggregate, research activities have more 
prominent roles in government bodies and agencies in other countries. 
Figure 3.20 Share of participations by type of organisation, overall and for the UK - 
successive FPs 
 
Source: ICF CORDA analysis 
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The ratio of UK participation rates to FP average participation rates, over time, can 
be used to identify trends more easily in the patterns of participation of UK 
organisation against what is ‘typical’ within the FPs. Figure 3.21 shows that the 
strong involvement by UK HES has been growing steadily in comparison to average 
HES participation rates. Shortfalls in participation by REC (of which there are few in 
the UK) largely account for the high share held by UK HES.  
Relative participation by UK industry shows a declining trend when compared against 
average industry participation across FPs. In Horizon 2020 UK industry involvement 
is to date running at 20% below the overall average. Again, it is difficult to discern 
specific reasons and root causes for this trend from survey responses – a 
combination of differences in how EU Framework Programmes are perceived as well 
as a relative lack of capacity to access the programmes are likely causes. 
Figure 3.21 Ratio of UK to average participation shares, by type of organisation – 
successive FPs 
 
Source: ICF CORDA analysis 
Figure 3.22 compares the ratios of country participation over overall participation of 
HES, PRC and REC across programmes and competitor countries. It shows that 
HES organisations were more prominent in the UK than in Germany or in France, 
where for all three programmes participations were lower than in the overall 
programme profile.  On the other hand, the relative importance of participation of 
PRC and REC organisations was higher in Germany and France than the UK in all 
three programmes. 
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Figure 3.22 Ratio of actual to average participation shares by type of organisation -
UK, DE and FR in successive Framework Programmes 
 
Source: ICF CORDA analysis 
The overall share of UK organisations out of all participations by similar organisations 
is presented in Figure 3.23 below and compared against France and Germany. It can 
be seen that the share of UK HES organisations out of all HES organisations funded 
rose significantly from FP6 to Horizon 2020, from 18% to 23%, representing the 
largest share out of all countries throughout the three framework programmes. At the 
same time, there was a slight decrease in the overall share of industry participation 
held by UK PRC organisations (from 12% to 11%, coming 3rd out of all countries in 
FP6 and FP7, and 4th in Horizon 2020). 
Compared with Germany and France, the UK has held a much higher proportion of 
overall HES participation across the three framework programmes. Germany has 
maintained the largest share of industry participation throughout the three framework 
programmes up to now, whilst France has decreased in its overall share of industry 
participation from 14% in FP6 to 10% in Horizon 2020 up to now. The strong 
presence of German and French research organisations (REC) can also be seen 
when compared to the UK - France has overtaken Germany as the country with the 
highest share of overall REC participation. The UK share of overall REC participation 
has decreased slightly between FP6 and Horizon 2020 up to now, down from 6% to 
5% (coming 5th out of all countries in FP6, as well as 6th in FP7 and in Horizon 2020 
up to now). 
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Figure 3.23 Share of overall participation, by organisation type and country 
 
Source: ICF CORDA analysis 
3.2.5.2 Involvement of SMEs 
As shown in Table 3.3, the relative importance of SMEs both in terms of participation 
and funding received has been consistently lower in the UK than on average. Over 
time, however, the role of SMEs has been given more attention, leading to increases 
in the rate of participation by SMEs. This upward trend can be seen in the UK data as 
well as for the FPs as whole. In terms of relative share of participations, the gap 
between UK and average SME involvement rates is widening, with two clear 
percentage points between the Horizon 2020 participation rate of 20.2% versus the 
UK figure of 18.2%. However, in terms of funding, the UK SME share under Horizon 
2020 (15.4%) is very close to the average (15.8%), indicating that UK SME 
involvement is strengthening in financial terms. 
Table 3.3 Share of UK SME participations and EU funding allocated 
 FP6 FP7 Horizon 
2020 
Share of participations (whole programme) 13.4% 18.1% 20.2% 
Share of participations (UK) 13.3% 17.1% 18.2% 
Share of EU funding received (whole programme) 9.4% 14.0% 15.8% 
Share of EU funding received (UK) 7.6% 12.7% 15.4% 
Source: ICF CORDA analysis 
Relative UK SME participation rates have been at or below those of German and 
French SMEs since the beginning of FP6, with the gap between UK and Germany 
closing from 2% to 0.4% and the gap between UK and France widening from 0% to 
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1% (Figure 3.24). All three countries have seen growth in their SME participation rate 
over time. However, the increases have been largest in France, and smallest in 
Germany. 
Figure 3.24 SME participation rates of UK, DE and FR across successive Framework 
Programmes 
 
Source: ICF CORDA analysis 
Figure 3.25 gives an overview of the UK’s share of overall SME participation across 
successive FPs, and compares it against Germany and France. It can be seen that 
the UK’s overall share remained stable around 12%, whilst the share of overall SME 
participation fell for both Germany and France. The UK had the 2nd highest proportion 
of overall SME participation throughout FP6 and FP7 behind Germany, and to 
February 201648 has the 2nd largest share of SME participation in Horizon 2020 
behind Spain. To February 2016, the UK has the largest share of EU funding 
allocated to SMEs in Horizon 2020, and came 2nd in FP6 and FP7 behind Germany. 
Figure 3.25 Share of overall SME participation in successive FPs 
 
Source: ICF CORDA analysis 
48 The cutoff point for Horizon 2020 data used in the present study. 
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3.2.6 UK participation in Marie Curie actions and European Research 
Council grants 
Marie Curie Actions (from FP6-Horizon 2020 – renamed Marie Skłodowska-Curie 
Actions in Horizon 2020) and European Research Council grants (from FP7-Horizon 
2020) have played a very important role in UK participation in the Framework 
Programmes. These are the two areas where the UK secures its highest relative 
participation rates, and where most of its net gains in terms of EU funding from the 
FPs originate. Table 3.4 shows the numbers and shares of FP6, FP7 and Horizon 
2020 participations accounted for by the Marie Curie actions and the European 
Research Council, both overall and for the UK. 
Marie Curie Actions have become more important over successive FPs, making up 
11% of the participations in FP6, 15% in FP7 and 17% in Horizon 2020 (to date). A 
consistently high share of UK participations have been within this part of the 
programme compared to other elements of the Framework Programmes, with Marie 
Curie Actions accounting for 18%, 23% and 30% of UK participations in FP6, FP7 
and Horizon 2020 respectively. The UK accounted for 19% of all Marie Curie Actions 
participations in FP6, 20% in FP7, and 24% in Horizon 2020. These data indicate 
that the UK’s exceptionally strong performance in Marie Curie Actions is increasing 
across successive FPs, and confirm that the UK continues to be the top destination 
in Europe for researcher training and career development.49 Interviewees confirmed 
the importance of Marie Curie Actions (and the European Research Council) and 
their added value to the UK. The Marie Curie Actions are seen as a particularly 
effective instrument to recruit high potential researchers at the beginning of their 
career – interviewees suggested that in many cases these individual fellows would 
stay in the UK beyond the Marie Curie project and provide substantial added value to 
the UK’s research base. 
The UK has also performed extremely well in relation to European Research Council 
grants. In both FP7 and Horizon 2020 European Research Council grants have made 
up 7% of UK participations as compared to just 4% and 5% respectively within the 
programmes as a whole. In FP7 the UK was awarded 23% of all European Research 
Council participations – an exceptionally high share. The equivalent figure for 
Horizon 2020 to date is slightly lower at 20%, but is still exceptionally high. 
  
49 Whilst Marie Curie Actions funded both researchers leaving and joining the UK, a crude analysis of the 
researcher recruitments and secondments in FP7 Marie Curie Actions suggest that the UK saw a net income of 
researchers through these programmes – with proportionately less researchers leaving the UK than in comparator 
countries. 
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Table 3.4 Number (and share) of Marie Curie actions and European Research 
Council participations, UK and overall 
 FP6 FP7 Horizon 2020 
 UK All UK All UK All 
MCA (n) 1,568 - 4,000 19,565 1,437 6,083 
MCA (%) 17.8% - 22.6% 14.5% 30.4% 17.2% 
ERC (n) - - 1,235 5,462 344 1,703 
ERC (%) - - 7.0% 4.1% 7.3% 4.8% 
Note: Marie Curie Actions (MCA), European Research Council (ERC). There was no ERC in FP6. Source: ICF 
CORDA analysis. 
The European Research Council was seen by interviewees to have a particularly 
strong effect on retaining world class researchers in the UK. Interviewees 
independently highlighted European Research Council funding as useful as it 
provided comparably large budgets and from the start focussed strongly on world 
leading, excellent research. It therefore is seen as a ‘quality label’. Interviewees also 
highlighted that the European Research Council’s bottom-up approach and its lean 
and flexible management are regarded as very positive. Figure 3.26 shows that the 
very high relative participation of the UK in Marie Curie actions and European 
Research Council over time (with participation rates 40% to 80% higher than 
average) is not matched by either Germany or France. Additionally, the UK’s 
relatively strong engagement in Marie Curie actions has grown steadily in relation to 
these two comparator countries. However, the UK’s share of participations accounted 
for by European Research Council relative to the average, while still high, has fallen 
slightly in Horizon 2020 as compared to FP7, while France has maintained their 
share and Germany has increased theirs. 
Figure 3.26 Actual versus average participation rates in Marie Curie actions and ERC 
of UK, DE and FR – successive FPs 
 
Source: ICF based on CORDA analysis. 
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3.2.7 UK participation across successive Cooperation programme 
areas 
The structure of the FPs change from one to the next, as do the balance of priorities 
and expenditure, making it hard to make accurate comparisons across time with 
respect to involvement in the FP7 Cooperation programme priority areas (such as 
Health, Energy, Transport, etc.). However, a reasonable mapping has been 
attempted from FP6 – FP7 - Horizon 2020 areas, as shown in Table 3.5. The table 
lists the corresponding priority areas for FP6, FP7 and Horizon 2020 along each row 
(note some areas did not exist in FP6), and also shows the ratio of the UK share of 
participations in that area to the average share of participations in that area. This 
allows identification of the areas where the UK has had a relatively high and low 
involvement, and changes within this over time. 
Table 3.5 Ratio of UK participation share to overall participation share – FP6 - FP7 
cooperation priority areas – Horizon 2020 mapping 
FP6  FP7  Horizon 2020  
Area Ratio UK 
share to 
average 
share 
Area Ratio UK 
share to 
average 
share 
Area Ratio UK 
share to 
average 
share 
Life sciences, genomics 
and biotechnology for 
health 
123% Health 132% Health, demographic 
change and wellbeing 
124% 
Citizens and governance 
in a knowledge-based 
society 
115% Socio-economic sciences 
and Humanities 
115% Europe in a changing 
world - inclusive, 
innovative and reflective 
Societies 
96% 
Sustainable 
development, global 
change and ecosystems 
87% Environment (including 
Climate Change) 
103% Climate action, 
environment, resource 
efficiency and raw 
materials 
87% 
- - Security 101% Secure societies - 
Protecting freedom and 
security of Europe and 
its citizens 
112% 
Aeronautics and space 111% Space 100% Space 97% 
- - Transport (including 
Aeronautics) 
93% Smart, green and 
integrated transport 
100% 
Information society 
technologies 
96% Information & 
Communication 
Technologies 
95% Information and 
Communication 
Technologies 
99% 
Nanotechnologies and 
nanosciences, 
knowledge-based 
multifunctional materials 
and new production 
processes and devices 
94% Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
91% Nanotechnologies, 
Advanced Materials and 
Production 
106% 
Food quality and safety 105% Food, Agriculture, and 
Biotechnology 
90% Food security, 
sustainable agriculture 
and forestry, marine and 
maritime and inland 
water research 
90% 
- - Energy 80% Secure, clean and 
efficient energy 
88% 
Source: ICF based on CORDA analysis. 
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The ratios are presented graphically in Figure 3.27. The figures shows that the UK 
has maintained a very strong presence in the area of Health across successive FPs, 
with participation shares around 20-30% higher than average within each FP. 
Another area of historical strength has been the Socio-economic sciences and 
Humanities area. Visible UK performance in the corresponding societal challenge in 
Horizon 2020 has been less strong to date, however it has to be noted that with 
Horizon 2020 the Socio-economic sciences and Humanities area has been 
mainstreamed across the whole programme and is only partly represented by a 
distinct societal challenge.50 
Security was a reasonably strong area for the UK under FP7 and has grown in 
importance under Horizon 2020, now standing as the area where the UK has its 
second highest share of overall participations (after Health). Transport and ICT– 
major programmes where the UK has not historically done well – and Nanosciences 
and Nanotechnologies are other areas where UK performance has lifted from FP7 to 
Horizon 2020.  
The UK performed reasonably well in the area of Environment and climate change 
under FP7, but previous and subsequent participation rates are below average. The 
UK also performed reasonably well in Space under FP7, but the UK share has been 
declining since FP6 and, and in Horizon 2020 Space is no longer an area of 
comparative strength. This coincided with BERD for aerospace products decreasing 
in relative terms – from 12% of overall BERD in 2007 to 9% in 2014.51 
Food was an area of relative strength in FP6, but is not an area where the UK has 
performed well since that time. Energy is another area where the UK has not 
performed very strongly over time. 
50 Socio-economic sciences and humanities (SSH) are not fully contained in the Horizon 2020 societal challenge 
‘Europe in a changing world - inclusive, innovative and reflective Societies’. SSH is indeed embedded across the 
whole Horizon 2020 programme, and this performance of the UK in SSH overall should not only be judged on the 
societal challenge ‘Europe in a changing world - inclusive, innovative and reflective Societies’. 
51 The study did not investigate in detail to what extent relative strengths in FP thematic programmes coincided 
with changed national priorities. In a future exercise, it would be interesting to look at whether the decline in some 
areas relates to an increasing focus on these areas as national priorities and/or increasing opportunities for 
collaboration at EU level through mechanisms like JPIs, which in some cases may mean potential participants of 
the EU Framework Programmes make less use of it. 
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Figure 3.27 Ratio of actual to average participation shares for Cooperation areas FP6 
- Horizon 2020 
 
Source: ICF based on CORDA analysis  
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3.3 UK participation in EUREKA and COST 
3.3.1 UK participation in COST 
3.3.1.1 Some principal differences 
COST is a pan-European intergovernmental framework, consisting of 36 Member 
Countries and a Cooperating State52. COST seeks to strengthen the European 
Research Area (ERA) by building networks of researchers and enabling them to 
jointly develop their own ideas and new initiatives across a number of academic 
domains. This is typically achieved through supporting trans-European coordination 
of research activities (referred to as ‘COST Actions’)53. It is important to note that the 
COST funding focusses on supporting networking and coordination, and does not 
fund R&D activities. 
COST actions typically support activities such as meetings (e.g. travel, subsistence, 
local organiser support), providing access to research infrastructure, conferences 
and workshops, short-term scientific exchanges, training schools and publications 
and dissemination activities. As per the above, the COST programme is substantially 
different from the EU Framework Programmes in objectives and types of activities 
supported. Therefore, this section will not attempt to compare UK participation in 
COST like-for-like with that in FP7. First, an average COST action has around 50 
participating organisations, tenfold more than an average FP7 project (with an 
average number of five participants per projects). Second, COST almost exclusively 
supports academic organisations – 87% of participants are academic compared to 
60% in FP7. Participants from 80 different countries participated in COST between 
2007 and 2013, whilst the largest proportion of participants in FP7 was represented 
by the EU15 countries.54 Table 3.6 presents an overview of the top ten participating 
countries in COST between 2007 and 2013. It is noticeable that the UK, as was the 
case for FP7, was the most frequent coordinating country. 
  
52 The 36 COST Member Countries are: Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, 
Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, 
Lithuania, Luxembourg, Malta, Montenegro, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, 
Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom and the former Yugoslav Republic of 
Macedonia. The Cooperating State is: Israel. 
53 COST website http://www.cost.eu/about_cost 
54 Technopolis (2014) COST Impact Assessment. 
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Table 3.6 Top ten participating countries based on country affiliation of Action 
Chairs and Vice Chairs55 
Country Number of 
MC Chairs 
MC Chairs,%  
of all COST 
actions 
Number of 
MC Vice-
Chairs 
MC Vice-
Chairs,%  of all 
COST actions) 
United Kingdom 41 14% 31 11% 
Italy 39 14% 24 9% 
Germany 30 10% 43 15% 
France 27 9% 28 10% 
Netherlands 24 8% 17 6% 
Spain 16 6% 12 4% 
Switzerland 16 6% 11 4% 
Finland 15 5% 7 3% 
Greece 14 5% 9 3% 
Belgium 12 4% 14 5% 
Total (top 10 countries) 234 81% 196 70%  
All Actions 287 100% 280 100% 
Source: Technopolis (2014) COST Impact Assessment 
3.3.1.2 UK demand for COST funding 
UK research interest in participating in COST actions has risen consistently over 
recent years (Figure 3.28). Data provided by the COST office indicates that the 
number of UK-based researchers participating in COST Action proposals has almost 
doubled over the period 2011- 2014.56 More than 1,200 UK researchers applied to 
the COST Open Call collection 2014-1, up by 77% when compared to participation 
rates recorded for the COST Open Call collection 2011-1.57 This increase however 
corresponds by and large with an increase in programme budget and the overall 
number of funded projects throughout the period investigated. When compared to the 
average number of researchers involved in proposals across COST Member 
Countries, it appears that UK-based researchers by far exceeded the average 
number of researchers from other countries for each COST Open Call since 2011 
(see Figure 3.28 below).58 
55 COST Actions are led by Chairs and Vice-Chairs, individual researchers responsible for the coordination and 
implementation of the projects. 
56 Data provided by COST association. 
57 Data provided by COST association. 
58 This is an average of the difference between the number of UK researchers and the average number of 
researchers from COST Member Countries (excluding the UK)  recorded for each call launched between 2011 
and 2014, notably the following Open Call collections: 2011-1, 2011-2, 2012-1, 2012-2, 2013-1, 2013-2 and 2014-
1 (source: analysis from ICF based on data provided by COST association) 
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Figure 3.28 Number of researchers from the UK, EU-28 and all COST countries 
involved in COST proposals, 2011-2014, by COST calls for proposals 
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3.3.1.3 UK participation in COST Actions 
COST member states actively encourage national researchers and engineers to get 
involved in running COST Actions, and COST Actions are generally open to new 
entrants throughout their lifetime. This results in high numbers of countries 
participated in the average COST project, and larger countries participated in a 
significant proportion of COST Actions. 
UK’s participation in COST Actions has grown steadily in absolute terms in recent 
years, from 286 running Actions in 2011 to 369 Actions in 2014 with UK participation 
(+ 30%).59 In real terms, UK’s involvement in COST Actions remained stable, with UK 
researchers accessing almost every COST Actions (99.7%) from 2011-14 and 
thereby representing a dominant proportion of the overall participations in COST 
Actions.6061 
Although stable, the UK’s participation rate was higher than the average participation 
rate of COST Member Countries, with an average difference of nearly 40 percentage 
points over the period 2011-14.62 
Figure 3.29 presents the number of running COST Actions accessed by UK 
participants, and compares these to the amount of COST actions accessed by 
59 Data provided by COST association. 
6060 Data provided by the COST association did not allow disaggregation of UK participants. Therefore it is 
unclear to what extent UK participants in COST were the same or similar across time, and to what extent new 
participants benefitted from COST support. 
61 Data provided by the COST association does not allow disaggregation of success rates. With view of the 
aggregate statistics however it is likely to be very high and not comparable to success rates in FP7, as the COST 
programme takes a very inclusive approach to participation, and participation is organised around individual 
researchers rather than organisations. 
62 Analysis based on data provided by COST association 
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participants from EU-28 countries on average as well as the whole group of COST 
countries on average. It confirms that the UK’s level of involvement was substantially 
above that of the average EU-28 and the overall average of all 36 COST member 
countries for the period in question. 
Figure 3.29 Number of running COST Actions accessed by the UK, EU-28 and Cost 
Member Countries. 2011-14 
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Participation in COST Actions has also enabled UK researchers to access various 
COST Action networking activities, such as: meetings, workshops, Short-Term 
Scientific Missions (STSMs) and Training Schools. Over the period 2011-14, the UK 
participated in more than 9,000 COST Action networking activities. Although UK’s 
participation increased by more than 130% over the whole period, the year-on-year 
change in participation was less pronounced in recent years (+9% between 2013 and 
2014) than previously (+58% between 2011 and 2012; +34% between 2012 and 
2013). 
3.3.1.4 Recent trends 
The amount of COST funding allocated to the UK rose substantially in recent years, 
from €1.2 million in 2011 to €3.8 million in 2014 (+200%).63 A similar trend can be 
observed among the other COST Member Countries, where the average amount of 
COST funding has grown by almost 160% in the period 2011-14.  
Funding allocations were however more significant (in value) in the UK than in the 
other COST Member Countries, averaging about €2.5 million over the four years 
while the average COST funding allocation in the other COST Member Countries 
was about €730,000 over the same period.64  
63 Data available from COST 
64 Data available from COST 
60 
                                            
Evaluation of UK involvement with EU research programmes 
Figure 3.30 COST funding allocations in the UK and average COST Member 
Countries 
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Overall, it is clear that UK researchers represent a dominant proportion of the COST 
programme, in terms of applicants and participating researchers. During the period 
investigated, they outperformed both overall averages for other COST countries and 
averages for EU countries. However a direct comparison to FP7 is not possible, 
given the distinctly different nature of COST implementation. 
Furthermore, the UK has coordinated the highest number of all COST actions, from 
2007-2013, of all countries, although this ‘preference’ for UK coordinators is less 
pronounced then in FP7. 
3.3.2 UK’s participation in EUREKA 
3.3.2.1 Some principal differences 
The EUREKA programme is fundamentally different to the activities funded under 
FP7. EUREKA predominantly facilitates close to market industrial development, and 
supports mainly private commercial organisations, with a specific focus on R&D 
performing SMEs in the EUREKA Eurostars programme. Therefore, this section will 
not attempt to compare UK participation in EUREKA like-for-like with that in FP7.  
3.3.2.2 UK participation in EUREKA programmes 
To date, the UK has been involved in a total of 886 EUREKA projects.65 A majority of 
these projects (72%) were ‘Individual projects’ (projects where public funding (if any) 
comes entirely from the national funding agencies supporting the project) (Figure 
3.32). However, the number of projects funded through Eurostars, which receives 
match-funding from the Horizon 2020 budget, has been more significant in recent 
years (Figure 3.31). As such, in 2014, 37 projects were funded through the Eurostars 
65 ICF calculation based on EUREKA Annual Reports (2013, 2014) 
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framework, representing nearly 70% of all EUREKA projects in which UK was 
involved in the same year. 66 EUREKA projects with UK participation, since the 
inception of EUREKA in 1987, were worth an estimated €937 million.67 
Figure 3.31 UK’s participation to 
EUREKA, 2012-14 
 Figure 3.32 Number of EUREKA 
projects with UK participation to date, 
broken down by project type (1985-2014) 
 
 
 
Source: ICF (adapted from EUREKA Annual Reports) 
3.3.2.3 UK participation in EUREKA Eurostars 
Since its launch in 2008, the Eurostars programme has received 3,548 project 
applications over 10 cut-off deadlines. A budget of €468 million of public funding was 
mobilised for 783 projects that were approved during the six-year duration of the 
programme.  
Eurostars-1, which ran from 2008 to 2013, had a total budget of €400 million, of 
which €400 million were provided by Eurostars Member Countries and €100 million 
from the FP7 budget. For the second wave of the programme (currently supported by 
Horizon 2020), Eurostars-2, the European Union, along with Participating States and 
partner countries, committed €1.14 billion for the funding and operations of the 
programme.  
Table 3.7 presents the UK’s participation in Eurostars-1. UK organisations 
participated 223 times, and received a total of €58.32 million in EUREKA match-
funding, compared to €802 million of EU funding allocated to UK SMEs under FP7. 
  
66 EUREKA Annual Report 2014 
67 EUREKA Annual Report 2013 
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Table 3.7 EUREKA Eurostars-1 – Overview of UK participation and funding 
Project start 
year 
Number of 
participations 
Total project 
costs (million €) 
EUREKA contribution 
(60% of total costs) 
(million €) 
2008 1  €       0.19   €       0.11  
2009 24  €       9.59   €       5.75  
2010 40  €     16.13   €       9.68  
2011 42  €     19.40   €     11.64  
2012 58  €     24.53   €     14.72  
2013 49  €     23.47   €     14.08  
2014 9  €       4.23   €       2.54  
Total 223  €     97.54   €     58.52  
Source: EUREKA secretariat 
3.3.2.4 Technology domains 
Although the number of projects funded in the ICT and industrial sectors has grown 
rapidly in recent years, a majority of EUREKA projects in the UK have been in the 
biotech/medical sector. As depicted in Figure 3.33 below, 35% of all EUREKA 
projects with UK participation between 2010 and 2014 were in the biotech/medical 
sector, followed by the ICT and industrial sectors. A similar picture is presented when 
looking at UK participations in Eurostars-1 (Figure 3.33). ICT (34%) and Biotech 
(26%) were the dominant sectors represented. Energy (8%), 
Manufacturing/Materials/Transport (9%) and agriculture and marine resources (7%) 
follow. 
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Figure 3.33 UK Eurostars-1 participations by technology domain (2007-2013) 
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Other Industrial Technologies Technology For Protecting Man And The Environment
Source: EUREKA Secretariat 
Compared with the study team’s analysis of FP7 projects with UK involvement 
(section 3.1), this suggests that EUREKA covers a more limited number of thematic 
areas and industries – mostly these represent thematic areas with high commercial 
potential, and areas where UK SMEs are particularly competitive. The focus areas of 
activity also roughly correspond with product groups with the highest business R&D 
investment during the same period. 
3.3.2.5 Types of UK participants 
Over the period 2010-14, participating organisations in Eurostars have mostly been 
SMEs, large companies and universities/research institutes. 85% of participations 
represent R&D performing SMEs68 and 8% other SMEs. The remaining 7% of UK 
participations represent larger companies, universities and larger companies. Figure 
3.34 provides a breakdown of UK participations by organisation type. 
This presents a largely different picture than FP7, where universities were the 
dominant participants (60% of all UK FP7 participations represented universities 
(versus 37% for all of FP7), universities received 71% of EU funding allocated to the 
UK respectively (versus 43% for all of FP7). 
68 With minimum of 10% of FTEs dedicated to R&D or minimum of 10% of turnover spent on R&D. 
https://www.eurostars-eureka.eu/sites/default/files/publications/eurostars-sme.pdf [accessed 12th March 2016]. 
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Figure 3.34 UK participation in Eurostars-1 (2007-2013), by type of organisation 
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Source: EUREKA Secretariat 
3.3.2.6 Success rates in Eurostar competitions 
The average UK rate of successful applications across EUREKA Eurostars-1 was 
22%, broadly comparable to the overall success rate achieved by the UK in FP7, and 
above the success rate of FP7 as a whole.  
Assuming that almost all UK Eurostars applicants were private commercial 
undertakings, the average success rates of UK Eurostars applicants by participations 
and funding requested were largely comparable to those of private commercial 
applicants from the UK in FP7 (27% and 23% respectively). It has to be noted 
however that the CORDA data provided did not allow disaggregating for SME 
applicants based in the UK, and therefore a more detailed comparison of success 
rates between FP7 and Eurostars was not possible. 
Table 3.8 presents an overview of UK applicants, proposals and success rates for 
Eurostars cut-off dates between 2008 and 2015.  
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Table 3.8 Eurostars – UK applicants, proposals and success rates 2008-2015 
Call 
year 
No. of 
applicant
s 
No. of 
proposal
s 
Matched 
funding 
(€m) 
=60% of 
total 
costs 
No. of 
participa
nts 
No. of 
funded 
projects 
Matched 
funding 
(€m) 
=60% of 
total 
costs 
Success 
rate 
(participant
s) 
Success 
rate 
(matched 
funding 
requeste
d) 
2008 6 5 €       1.19 2 2 €       0.29 33% 25% 
2009 61 57 €    15.88 20 17 €       5.04 33% 32% 
2010 103 89 €    24.65 31 26 €       7.38 30% 30% 
2011 172 142 €    42.31 31 22 €       9.22 18% 22% 
2012 141 122 €    35.63 29 26 €       7.07 21% 20% 
2013 188 147 €    47.24 40 34 €    12.29 21% 26% 
2014 141 127 €    35.40 42 37 €    10.53 30% 30% 
2015 110 101 €    27.40 15 13 €       4.39 14% 16% 
Total/ 
Average 
922 790 229.7 210 177 56.21 25% 25% 
Total/ 
Average 
2008-
2013 
671 562 166.9 153 127 41.29 26% 26% 
Source: EUREKA secretariat 
3.4 Factors influencing participation 
3.4.1 Motives for participation 
3.4.1.1 Participants 
The reasons why UK organisations and research individuals have become involved 
in FP7 were many and various (Figure 3.35). The primary motive among participants 
was the opportunity to access research funding – 72% of respondents cited this as a 
very important motive. More than half of the participants also considered: the 
development of new or improved relationships or networks (55%); the desire to 
address specific scientific or technical questions or issues (54%), and to develop and 
extend internal knowledge and capabilities (53%) to be very important motives. A 
large minority also rated developing new or improved tools, methods or techniques 
(44%) and tackling problems with an EU or international dimension (41%) as quite or 
very important motives for their participation in FP7. 
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Figure 3.35 Importance of factors as motives for UK participation in FP7 projects 
(n=474) 
 
Source: ICF survey of UK FP7 participants February 2016 
3.4.1.2 Unsuccessful applicants 
The motives for participation did not differ markedly for unsuccessful applicants 
(Figure 3.36) when compared to successful applicants. To access research funding 
was again the most important motive for applying, and was in fact rated as very 
important by a higher proportion of unsuccessful applicants than successful. Notably, 
the development of new or improved relationships or networks was rated as very 
important by a lower proportion of unsuccessful applicants. 
The profiles of respondents in the two groups (successful and unsuccessful 
applicants) were similar: in both cases, over 60% of respondents were 
representatives of academic institutions. SMEs representatives were the second 
most common type of respondents across the two groups, followed by public 
research institutes, large companies, private research institutes and public bodies. 
Therefore, the reasons for differences regarding motives for applications cannot be 
attributed to different respondent profiles across the two groups. 
It is possible to hypothesise that the observable greater focus on simply accessing 
research funding rather than on collaboration and network building contributed to the 
lack of success within the competition, though this is beyond the scope of this 
research. 
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Figure 3.36 Importance of various factors as motives for applying to FP7 funding for 
unsuccessful applicants (n=643) 
 
Source: ICF survey of UK unsuccessful FP7 applicants, February 2016 
3.4.2 Relevance of FP7 research topics and instruments for FP7 
participants69 
The relevance of the research topics and instruments used within FP7 was a major 
factor influencing participants’ ability and willingness to apply. UK participants were 
asked to rate the relevance of FP7 research topics, priority areas and calls for 
research in their own area, and also the relevance of the FP7 project instruments for 
the research they planned to conduct. Three-quarters (75%) of respondents (Figure 
3.37) indicated that the relevance of both the topics and the instruments was high or 
very high for the research they wished to conduct, and most of the remainder 
indicated that they were of medium relevance.  
A small proportion of respondents (6%) rated FP7 research topics as of low or very 
low relevance. When asked to explain, most of these respondents indicated either 
that their area of research was not a priority for FP7 or that the research topics and 
calls were too narrowly prescribed ‘top down’ to be a good fit with the work they 
wished to carry out. Others described the topics as too politically influenced and not 
connected to real world needs or to efficient outcomes. 
A small proportion of respondents (7%) also rated FP7 instruments as of low or very 
low relevance. Here participants highlighted that FP7 encouraged partnerships that 
were often too large, and made it harder for SMEs to participate. Others mentioned 
69 This section covers responses from successful FP7 participants. 
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that the political nature of the FPs mean that its collaborative instruments do not fit 
well with how science is conducted and reported outside of the FPs. 
Figure 3.37 Relevance of FP7 research topics and instruments (n=473) 
 
 
0% 20% 40% 60% 80% 100%
The relevance of FP7 research topics / priority
areas and calls for your research area
The relevance of FP7 project types (e.g. R&D
collaborative projects. Networks of Excellence) for
the research you were planning to conduct.
Percentage of respondents 
Very high High Medium Low Very low
Source: ICF survey of UK FP7 participants February 2016 
As shown in Figure 3.38 and Figure 3.39, relevance was scored the highest by 
universities: over 40% of university respondents believed that relevance of topic and 
instruments was ‘very high’, compared to 20% of companies. 
Figure 3.38 Relevance of FP7 research topics and instruments: universities (n=286) 
0% 20% 40% 60% 80% 100%
The relevance of FP7 research topics / priority
areas and calls for your research area
The relevance of FP7 project types (e.g. R&D
collaborative projects. Networks of Excellence)
for the research you were planning to conduct.
Percentage of respondents 
Very high High Medium Low Very low Did not respond
Source: ICF survey of UK FP7 participants February 2016 
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Figure 3.39 Relevance of FP7 research topics and instruments: companies (n=117) 
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Source: ICF survey of UK FP7 participants February 2016 
3.4.3 Quality of partners involved in FP7 
Given the importance of new relationships and networks as a motive for participants, 
and the important role afforded to international collaboration within the FPs, the 
quality of partnerships is a key factor influencing levels of involvement. 
UK participants were asked to estimate the proportion of their project partners who 
might be considered world class in relation to (i) their scientific / technological 
competences and know-how, and (ii) their equipment, instruments and tools. Most 
UK participants consider the majority of their partners to be world class on both 
counts (Figure 3.40). Three-quarters (75%) of respondents indicated that half or 
more of their partners were world class in terms of their scientific / technological 
competences and know how, while almost two-thirds (64%) indicated that half or 
more of their partners were world class in terms of their equipment, instruments and 
tools. 
These results suggest that, in the eyes of the participants, the vast majority of FP7 
projects are helping UK participants to cooperate with world class organisations, and 
thereby access some of their scientific and technological expertise, know-how and 
equipment.  
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Views on quality of partners  
Case study AMAZE 
The partnership formed mainly on the initiative of the former coordinator at the European 
Space Agency. Around 50% of the consortium had worked together previously, on a bilateral 
and multilateral basis, and the ability of the coordinator to assemble and manage 
international consortia was very helpful in this regard. A number of core partners had been 
involved in unsuccessful proposals to FP7 in the past, including an early version of AMAZE, 
which helped understand better how to balance the consortium for the AMAZE project 
between different application areas with different cost bases, and the complementarity of 
needed technology.  
Case study FLUTCORE 
The research topic required a critical mass of effort and resources which were not available 
in the UK. It was therefore of pivotal importance to go beyond the support and funding 
programmes available at the national level to 
 
• Access contract manufacturers to produce materials 
• Access expertise in virus led particles and other scientific expertise not available within 
UK 
• Combine data and resources 
• Cover different regions of Europe to prepare and conduct a clinical trial 
• Combine IQUR tandem platform with knowledge and IP on specific protein targets which 
can be used to produce vaccines. 
The European partnership provided critical input for the project.  
Case study FORTISSIMO 
The decision to fund Fortissimo through FP7 funding was largely influenced by the project 
coordinator’s extensive experience with EU research Framework Programmes. Another key 
motivating factor was the opportunity to work with leading researchers and industry players 
at European and/or international level. 
Figure 3.40 Proportions of UK participants’ FP7 partners considered to be world 
class (n=452) 
0% 20% 40% 60% 80% 100%
Scientific / technological competences and know
how
Equipment, instruments and tools
Percentage of respondents 
75-100% 50-74% 25-49% 0-24%
 
Source: ICF survey of UK FP7 participants February 2016 
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3.4.4 Roles played by UK participants  
In order to extract maximum value from their involvement it is often (although not 
always) favourable for participants to play a central role across the various stages of 
their projects (definition, implementation, exploitation).  A third (30%) of UK 
participants answering the survey occupied the role of coordinator for their project, 
54% described themselves as partners (i.e. regular participants) and 14% as the 
project developer (i.e. commercial firms assisting in the bidding process and taking 
on administrative management of the project, without taking on the formal 
coordination role). 
UK participants played a very active role across almost all elements of their FP7 
project’s planning, implementation and exploitation (Figure 3.41). More than two-
thirds of survey respondents were involved to a large or very large extent in defining 
the objectives, scope and content of the project, conducting the research, 
disseminating the results of the project, and planning future research. By 
comparison, the participants were less centrally involved in elements such as 
research training and negotiating intellectual property arrangements. 
Figure 3.41 Extent to which UK organisations were involved in specific elements of 
their FP7 projects (n=474) 
 
Source: ICF survey of UK FP7 participants February 2016 
3.4.5 Open innovation 
Open innovation systems are associated with stronger opportunities to access 
research resources, for knowledge sharing and associated knowledge spillovers 
supporting and adding value to the research undertaken. Open innovation also 
provides the opportunity to better understand the market potential and the potential 
for more disruptive innovation.70  
70 Disruptive innovations create new markets and value chains, and eventually replace existing markets and value 
chains.  
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The survey results (Figure 3.42) indicate that the main advantages of FP7 as an 
open innovation system was in the access to resources, with collaboration at EU 
level providing the potential for greater pooling of resources.  Most participants also 
reported good levels of knowledge exchange, with limited intellectual property 
restrictions.  
Around 40% of participants reported that conditions for commercialisation were 
fulfilled to a large or very large extent, in relation to demand for goods and services 
around project outputs, existing markets that could be exploited, and the scope for 
different commercial applications. Less than a quarter of participants, however, 
considered the outputs produced to be of a disruptive nature. 
Figure 3.42 Extent to which projects were undertaken within an open innovation 
framework (n=460) 
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Source: ICF survey of UK FP7 participants February 2016 
3.4.6 Use of support services - participants 
3.4.6.1 Use of UK National Contact Point support services 
National Contact Points (NCPs) provide free support service to applicants to EU 
research funding programmes. NCPs assist applicants with the selection of the most 
suitable funding schemes, administrative and contractual procedures, the application 
process and the building of consortia. They also liaise with the European 
Commission to clarify the scope of the call for proposal topics.  
NCPs cover all the themes in the scope of the FP7 and Horizon 2020 programmes: 
• NCPs hosted by Innovate UK provide support on legal issues across all 
sectors, and advice regarding specific sectors71 and SME-relevant areas of 
the programme. 
• NCPs hosted by UKRO and the Research Councils provide advice on funding 
from the European Research Council and Marie Curie Actions. They also 
provide support in different thematic areas72. 
• The Science and Technology Facilities Council NCP advises on research 
infrastructures. 
• The Medical Research Council NCP supports applicants in the area of health, 
wellbeing and demographic change. 
• The EU Energy Focus NCP provides support in the area of energy. 
• While not part of the NCP network, the Enterprise Europe Network (EEN) 
cooperates with the NCP network in providing targeted support to SMEs. 
UK participants were asked about the use of NCP support services when considering 
and applying to FP7. Of the 475 participants completing the survey, 21% had used 
NCP support services at the proposal stage, 67% had not, and the remainder were 
unsure or did not know whether they had. 
The most widely used services of those provided by NCPs were in helping applicants 
understand FP7 administrative and financial eligibility criteria for applying and rules 
for conducting the project (80% of those that used NCP services). Many applicants 
also sought help with understanding the thematic, scientific and technical focus of the 
call for proposals and funding topics (72%), in order to identify suitable calls and 
topics for their own ideas.  By comparison, applicants were much less likely to look to 
NCPs for help with their proposal or consortium, with only a minority taking up 
assistance around identifying project partners (33%), negotiating budgets or 
contracts (38-45%), or resolving IPR arrangements (33%). 
71 Namely, advanced manufacturing and processing; climate action, environment, resource efficiency and raw 
materials; food security, sustainable agriculture and forestry, marine and inland water research, bioeconomy 
health, wellbeing and demographic change; ICT and future and emerging technologies; nanotechnologies and 
advanced materials; secure societies; space and transport.  
72 Science and society; social science and humanities; inclusive, innovative and reflective societies; widening 
participation among EU Member States; and inclusive, innovative and reflective societies. 
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3.4.6.2 Feedback on NCP support services 
Those who stated that they had used NCP services were then asked to provide 
feedback on the utility of the support they had received. The results are presented in 
Figure 3.43 and reveal a fairly mixed set of feedback. Around two-thirds of 
respondents gave positive feedback (medium-very high ratings) for the helpfulness of 
the support they had received around understanding FP7 – whether on the eligibility 
criteria, rules for applying, calls for proposals or in identifying suitable topics.  
However, in cases where the support provided related to the internal project 
arrangements – agreeing budgets, negotiating IPR, defining the partnership and 
scope of the work – the NCP support was rated by most respondents as either not 
helpful or only helpful to a small extent. 
Figure 3.43 Extent to which different elements of support provided by NCPs at 
proposal stage was helpful to participants  (n=474) 
 
Source: ICF survey of UK FP7 participants February 2016 
Taken together these results suggest that prospective applicants to the FPs are most 
likely to need and appreciate help in understanding the programmes themselves, and 
are less likely to need or appreciate help with sorting out the project and consortium 
arrangements.  
Qualitative feedback provided on the NCP support indicated that a small proportion 
of respondents felt that the support requested was not forthcoming or that the advice 
received was of little use. A much larger proportion attested to the invaluable advice 
and assistance provided by NCPs, in many cases making the difference between 
success and failure at the proposal stage. NCPs were applauded for providing key 
links to EC project officers, critical advice on EC legal and financial rules, awareness 
raising and advice on individual proposals. No qualitative feedback was provided on 
assistance with project and consortium arrangements, which interviewees and survey 
respondents were less likely to request. 
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Of those receiving support from NCPs at proposal stage, 25% indicated that their 
FP7 participation would not have been possible if the NCP support had been 
unavailable. This suggests that the support provided is critical in up to a quarter of 
cases, and helpful though not necessarily vital to success in the remaining cases. 
Participants provided a range of suggestion on improvements that could be made to 
NCP support, primarily involving ensuring more resources are available to allow 
NCPs to widen and extend their current service provision, particularly around briefing 
seminars, warning of upcoming calls, advice on specific proposals, lobbying for UK 
projects to be funded, and outreach. Further feedback on how institutional and 
national support to applicants can be improved is presented in Section 3.4.6.4 below. 
It should be noted that most of the feedback on national support services related to 
experiences with FP7, and that the NCP network resources have been increased for 
Horizon 2020. 
3.4.6.3 Feedback on why NCP support is not taken up 
Participants who had chosen not to use the support offered by the NCPs were asked 
to explain why this was the case. The responses provided have been summarised in 
Figure 3.44 and show that in most cases (61%) the NCP support was considered 
unnecessary, either because effective in-house support was available or preferred, 
because the applicants were already familiar or experienced in FP7 rules and 
procedures, or because other partners took the lead in the proposal preparation 
phase. 
While most UK participants felt they did not need the NCP support services on offer, 
one third (33%) of our respondents indicated that they were unaware of the NCP 
support system and didn’t know what help was on offer or who to contact. This 
implies that there is still further work to be done to ensure that the availability of NCP 
services are more widely and actively notified to prospective participants. 
The remaining respondents indicated that either a lack of time (2%) or a lack of 
confidence in NCP support provision (3%) were the reasons for not taking up the 
support. Overall, there were no noticeable differences between different organisation 
types. 
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Figure 3.44 Reasons why NCP support was not taken up (n=84) 
 
Source: ICF survey of UK FP7 participants February 2016 
3.4.6.4 Use of other (institutional or commercial) support services 
Almost three quarters (71%) of UK participants indicated that, at the proposal stage, 
they had made use of support services offered by their organisation internally or from 
a commercial service provider. Of these, the vast majority (90%) had used internal 
support services, with only 10% employing private (commercial) support services. 
The remaining respondents either had not used any (internal or commercial) support 
(26%) or did not know (3%). 
3.4.6.5 Additional support services needed 
UK participants provided a range of suggestions as to how the support services 
available could be strengthened, as follows:  
• Awareness raising - More information on what help is actually available at 
national level and through the NCP network is required (7%). A further 5% of 
respondents suggested that a greater number of awareness raising and 
training seminars and workshops would be helpful in alerting UK actors to 
opportunities. 
• Advanced warning of calls - More and better information on calls for 
proposals would be useful, in particular targeted advance warning of calls of 
interest (10%). This would require the creation of a registry to enable national 
agencies and NCPs to match upcoming calls to interested UK actors. 
• Partner identification - Improved support around partner searching and 
matching would be helpful, particularly in order to enhance industry / SME 
participation in the programmes (13%). 
• Help with proposal preparation - More and better support with proposal 
preparation and bid writing, including provision of feedback on draft proposals 
and conformity checking services was the most popular suggestion (26% of 
respondents). A further 7% asked for more help and support around the 
application and selection processes in general. 
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• Financial assistance - Improved financial support to applicants and 
participants, either through financial support towards the costs of proposal 
preparation or in terms of contribution to the cost of projects not covered by 
the EU (12%). 
• Guidance on how to succeed - Better advice and guidance based on actual 
successes, provided where possible by those with direct experience of 
programme participation and success (9%). 
Smaller numbers of participants asked for more and better information on the 
financial and administrative rules of the FPs, an area of uncertainty for many 
prospective participants (5%); a need for improved coordination of the UK’s positions, 
strategies and networks, in order to maximise the opportunities presented by the FPs 
(4%); more support to lobby for UK interests and topics, and greater political and 
practical support from the relevant UK government departments and agencies (3%). 
The remaining suggestions covered reduced administration, more credit to those who 
succeed in winning EU funding, improved access to European Commission officers, 
more general advice and tips, support for interviews and project management 
training. 
3.4.7 Use of support services - unsuccessful applicants 
3.4.7.1 Use of national NCP support services 
Of the unsuccessful UK FP7 applicants responding to our survey, 37% had used 
NCP support services, 55% had not used them and 17% did not know. Based on this 
result, unsuccessful applicants were more likely than participants to have used NCP 
support.  This may because the unsuccessful applicants were less experienced, and 
therefore both more likely to need support and also possibly more likely to be 
unsuccessful when applying. 
The services taken up most often by unsuccessful applicants were similar to those 
taken up by participants, focusing on understanding eligibility criteria, rules and 
procedures, and the content of the calls. Similarly, services around intellectual 
property arrangements and contract negotiations with partners were much less 
widely used. 
3.4.7.2 Feedback on national NCP support services 
Those who accessed support from NCPs rated the extent to which the NCPs’ 
assistance had helped them in different aspects of their application to FP7 (Figure 
3.45). The responses reveal that, overall, unsuccessful applicants provide more 
positive ratings to the NCP support received that do the successful applicants, even 
though they did not succeed with their bid. 
Additionally, the results indicate that compared to participants, unsuccessful 
applicants rated support around identifying partners as more helpful, possibly 
because the new partners identified may be of future use or interest. Compared to 
participants, unsuccessful applicants rated the support around understanding the 
scientific / technical focus of the calls as less helpful, indicating perhaps that some 
proposals had been rejected due to a lack of understanding in this area. 
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Figure 3.45 Extent to which different elements of support provided by NCPs were 
helpful to unsuccessful applicants 
 
Source: ICF survey of UK unsuccessful FP7 applicants, February 2016 
Unsuccessful applicants who accessed NCP support were asked whether they 
believed that their FP7 application would have been possible without assistance from 
NCPs. Almost two thirds (65%) thought that they would have been able to apply 
without NCP assistance, while 13% would thought that they would have not been 
able to do so and 21% did not know. Compared to participants, unsuccessful 
applicants rated the support as slightly less vital to their ability to apply. 
3.4.7.3 Use of other (institutional or commercial) support services 
Unsuccessful applicants were asked whether they had made use of any application 
support services offered by their organisation internally or from a commercial service 
provider. Close to three quarters (74%) of unsuccessful applicants had used one of 
these services. Most of these (88%) had made use of internal support, and 
commercial providers had helped the remainder (12%). The responses provided by 
participants were largely similar to those provided by unsuccessful applicants. 
3.4.8 Reasons for preferring EUREKA and COST over FP7 
Apart from the online surveys conducted, the study team spoke to a number of 
businesses who had participated 1) both in FP7 and EUREKA programmes and 2) 
exclusively in EUREKA programmes.  
Businesses interviewed generally considered FP7 to be more ‘difficult’ to apply for, 
and thought EUREKA programmes were better aligned to the requirements of 
industrial research.  
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The following main reasons for preferring alternative funding programmes were 
mentioned by interviewees: 
• Resources needed at FP7 pre-application stage: it was felt that, to be 
successful, applicants need to invest significant resources at a pre-application 
stage in order to create contacts with European Commission staff and obtain a 
good understanding of the EU research agenda. The lack of resources to 
engage in this process was perceived as a barrier to SME participation. 
• Resources needed at FP7 application stage: the application process was 
perceived as particularly burdensome. Complex application procedures 
combined with low success rates represented an important barrier, especially 
for SMEs. Many commercial interviewees outlined that they had used services 
and resources of experienced academic institutions to reduce their costs. 
• Resources needed for administration of FP7 projects: interviewees 
reported that resources for project management, monitoring and reporting 
were too high and not always covered by the project budget, thus causing high 
internal project management overheads. 
• Low success rates, in particular for Horizon 2020: non-applicants reported 
that low success rates, in combination with the issues outlined above, had 
considerably increased the risk of applying for the Framework Programme.  
Overall, stakeholders interviewed perceived Eurostars to be more effective in 
delivering commercial impacts, however the choice of programmes under Horizon 
2020 was considered to be more suited to business participants. Reasons for 
preferring FP7 over EUREKA mentioned by interviewees also related to scale and 
scope of projects, with FP7 perceived to fund mostly complex and large R&D 
projects. 
Reasons for preferring COST over FP7 programmes have not been directly 
investigated through surveys or interviews. However, a previous impact assessment 
of COST73 suggests a couple of possible factors. FP7 generally is perceived by UK 
participants to provide stronger benefits, outputs and impacts relating to the 
implementation of research, improving knowledge and skills as well as in accessing 
research infrastructure or equipment when compared to COST. 
COST applicants noted that cross-border networking was their prime reasons for 
participation, as well as gaining access to research funding and to disseminate 
project results. COST does not fund direct research activities, and is therefore often 
seen as a precursor or preparatory action for European research projects. 
3.5 Conclusions 
UK participation and funding achieved from FP7 has been strong 
In FP7, the UK’s performance has been strong, both in terms of overall participation 
levels and EU funding won. In comparison with the other EU27 member states the 
73 Technopolis (2014), COST impact assessment. 
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UK scored very well in terms of the amount of EU funding secured, both in absolute 
terms and relative terms.  
Taking into account the relatively low investments in R&D, the UK performed very 
strongly in FP7 in terms of its overall participation and funding won. The UK won a 
total of €7 billion in EU funding in FP7 (or 15.4% of overall EU funding awarded in 
FP7), the second highest of all participating countries behind Germany.  
FP7 was a relatively important funding source in the UK compared to other EU 
member states. From 2007-2013, FP7 funding constituted 3.1% of the UK’s overall 
R&D investment but made up less than 2% of total in France (1.7%) and Germany 
(1.4%). FP7 was particularly significant for the UK’s higher education sector, where it 
represented 7.2% of total investments in HE R&D in the period 2007-2013. 
The UK recorded a total of 17,695 FP7 participations within 10,372 projects, 
representing 13.1% of all participations in FP7. A total of 2,909 discrete organisations 
from the UK participated in FP7 (10% of all participating organisations). 
UK participants performed particularly well in securing funding form the Ideas and 
People programmes (funded respectively by Support for Frontier Research and 
Marie Curie instruments). Indeed, the UK success in these two programmes was 
higher than in FP7 as a whole and higher than any of the comparator countries 
considered, both in terms of participation and EU funding allocated. 
Taking into account its relative GDP, and government and business investment in 
research and development (GERD), and the number of FTE researchers: 
• The UK was 11th out of the EU27 in terms of the amount of EU funding 
secured adjusting for the levels of GDP of member states. The UK’s funding 
was 16% above what might have been expected based on GDP.  
• The UK was 14th out of the EU27 in terms of amount of EU funding secured 
adjusting for GERD. The UK’s funding was 34% above what might have been 
expected based on the level of UK GERD. 
• The UK was 7th out of the EU27 in terms of the amount of EU funding 
adjusting for the number of FTE researchers. The UK’s funding was 24% 
above what might have been expected based on the number of FTE 
researchers.   
On all of the above metrics, the UK outperformed other large EU economies such as 
Germany and France. 
UK success rates in competitions were above average 
The average proposal success rate of UK applicants when applying to FP7 was 
22.1% - more than 1.5 percentage points higher than the FP7 average proposal 
success rate for all participating countries (20.5%). 
Project proposals with UK participation had a particularly high success rate in the 
Health theme (24% compared to an average success rate of 14%), Nanosciences, 
Nanotechnologies, New Materials and New Production Technologies (23% compared 
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to an average success rate of 12%), the Environment theme (22% compared to an 
average success rate of 12%) and the European Research Council (13% compared 
to an average success rate of 10%). 
UK participants coordinated by far the largest number of FP7 projects 
UK coordination rates have been above those of Germany and France across FP7 
and during the early stages of Horizon 2020. The UK coordinated a total of 5,101 
FP7 projects (49% of projects with UK participation), substantially more than either 
Germany (3,119, 35% of projects with German participation) or France (2,664, 37% 
of projects with French participation). In Horizon 2020, the UK held 1,785 coordinator 
roles out of 3,112 participations so far (57%), a much higher proportion that either 
France (794 out of 1,885, 42%) or Germany (984 out of 2,427, 41%). 
Whilst the UK showed strong presence in the Ideas and People programmes, it 
coordinated relatively less of the more traditional R&D projects conducted under the 
Cooperation and Capacities programme.74  
The UK continues to provide a significant share of project coordinators in Horizon 
2020. UK coordinators are responsible for 21% of all projects funded so far (1,785 
out of 8,599 projects). 
UK universities received the majority of EU funding under FP7 
Universities represented 60% of all UK participations and received 70% of all funding 
allocated to the UK, a much larger presence than in other EU member states, but 
reflecting the dominant presence of the higher education sector in the UK’s research 
and innovation system, in contrast to other large countries such as Germany and 
France. The relative industry share of UK participations ranked 23th out of all EU27 
member states during FP7 (26% compared to an average of 31%). Within FP7, UK 
had the second lowest relative proportion of EU funding allocated to industry (18% 
compared to an average of 25%). 
As regards the UK's share of overall participations, the UK was in the top five 
countries in terms of total level of FP7 involvement. Notable here were UK 
universities, which represented the largest share of overall FP7 university 
participation (21%), leading before Germany in second place (12%). UK businesses 
represented 11% of overall business participation in FP7, with the UK coming 2nd out 
of all countries (behind Germany and on par with France). SMEs from the UK 
represented 12% of all SME participation in FP7, the 2nd highest proportion behind 
Germany. 
FP7 was dominated by a relatively small group of key organisations – the top 100 UK 
participants in terms of the number of projects won (just 3% of UK participants) 
accounted for 76% of all EU funding awarded to the UK (or €5.3 billion) and 70% (or 
74 It is important to note that coordination roles have different meaning across FP7. A large number of UK 
coordinators have led projects in the Marie Curie and Europe Research Council programmes, which are largely 
dominated by singe beneficiary projects (75% of all UK coordinators), a larger proportion than in Germany (50%) 
and France (61%). However the UK came second in terms of coordination roles behind Germany in the 
Cooperation programme, which is dominated by multi-partner, collaborative projects. 
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12,397) of all UK participations in projects. This compared to a slightly less high 
concentration across FP7 as a whole - the top 3% of FP7 participants overall which 
represented 54% of all participations and 64% of all EU funding awarded. This group 
of 100 organisations comprised 67 individual universities, 14 companies, 16 research 
organisations and three government bodies. 
UK participants played a very active role across almost all elements of their FP7 
project’s planning, implementation and exploitation. More than two-thirds of survey 
respondents were involved to a large or very large extent in defining the objectives, 
scope and content of the project, conducting the research, disseminating the results 
of the project, and planning future research. 
Participants had a variety of reasons to participate in FP7, and the topics and funding 
instruments in FP7 were highly relevant 
Key motives to participate in Framework Programme funding were access to 
research funding (72%) as well as the development of new or improved relationships 
or networks (55%); the desire to address specific scientific or technical questions or 
issues (54%), and to develop and extend internal knowledge and capabilities (53%) 
to be very important motives.  
Three-quarters (75%) of respondents) indicated that the relevance of both the topics 
and the instruments of FP7 were high or very high for the research they wished to 
conduct. 
Whilst the UK share of projects across EU Framework Programmes has decreased, it 
has increased its share of participations and funding – with a particularly strong 
performance in Marie Curie Actions and the European Research Council over time 
A review of trends in the UK performance in the EU Research Framework 
Programmes indicates: 
The share of proposals with UK participation was higher in FP6 than in later 
programmes, falling from 40% in FP6 to 33% in FP7 to 28% in Horizon 2020 (to 
date). This fall is not an indication of diminishing performance but of changes to the 
FP instruments (in particular smaller projects with fewer partners and countries 
involved in each), as well as demand from a growing number of countries. 
The share of projects with UK involvement has decreased over time. While the UK 
was present in 45% of projects in FP6 and 41% in FP7, it is present in only 36% of 
projects funded under Horizon 2020 so far. This mainly reflects a reduction in the 
numbers of partners and countries in an average FP project, and an increase in the 
overall number of projects supported. Similar falls can be seen for comparator 
countries such as Germany and France. 
The share of UK participations out of all participations has been growing over time, 
increasing from 11.8 in FP6 to 13.1% in FP7 and 13.4% during Horizon 2020 so far. 
To maintain and even increase its share of participations as more countries 
participate indicates a continued very strong performance of the UK within the 
Framework Programmes. 
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The UK has achieved a significant positive increase in participation rates and 
financial returns from FP7 as compared to FP6, and high levels of performance 
within FP7 appear to have been maintained within Horizon 2020 to date. UK 
performance over time also appears to be strong in comparison to the key 
comparator countries of Germany and France. 
The UK has consistently had a higher than average share of its participations within 
the Marie Curie Actions, accounting for 18%, 23% and 30% of UK participations in 
FP6, FP7 and Horizon 2020 respectively. This strong performance by the UK is also 
reflected in the fact that the UK accounted for 19% of all Marie Curie Actions 
participations in FP6, 20% in FP7, and 24% in Horizon 2020. These data indicate 
that the UK’s exceptionally strong performance in Marie Curie Actions is increasing 
across successive FPs, and confirm that the UK continues to be the top destination 
in Europe for researcher training and career development.75 
The UK has also performed extremely well in relation to European Research Council 
grants. In both FP7 and Horizon 2020 European Research Council grants have made 
up 7% of UK participations as compared to just 4% and 5% respectively within the 
programmes as a whole. In FP7 the UK was awarded 23% of all European Research 
Council participations – an exceptionally high share. The equivalent figure for 
Horizon 2020 is slightly lower at 20%, but is still exceptionally high. 
The UK participates less in the Cooperation programme. This represented only 56% 
of all UK participations (compared to 66% for all of FP7) and only 52% of the EU 
funding allocated to UK participants (compared to 63% of all FP7 participants). These 
shares were higher in all of the other six comparator countries considered in this 
analysis. A similar picture is presented when looking at UK participation in Horizon 
2020. 
Compared to the overall FP7 profile, the UK’s participation rates in FP7 were highest 
in the Health, Socio-economic Sciences and Humanities, Environment (including 
Climate Change), Security and Space priority areas. In each case the share of 
participations held by the UK was higher than the share within FP7 as a whole. This 
was particularly so for Health, where the UK participation rate was 33% higher than 
the FP7 rate. The relative strengths in areas such as health, as well as food, 
agriculture & biotechnology in terms of EU funding won, to some extent, reflect the 
relatively importance of these areas to UK’s economy – considering that throughout 
2007-2014, pharmaceuticals was the product group which saw the highest amounts 
of business R&D investment (20% in 2014). 
During the first years of Horizon 2020, the picture has changed slightly. Here, the UK 
so far achieved a relatively strong performance in the Societal Challenge 
Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, 
and Biotechnology, but was relatively weaker in the Environment/Climate Change 
area. Performance in the Societal Challenge related to Socio-economic sciences and 
Humanities was also less strong when compared to FP7, however as above this 
75 Whilst Marie Curie Actions funded both researchers leaving and joining the UK, a crude analysis of the 
researcher recruitments and secondments in FP7 Marie Curie Actions suggest that the UK saw a net income of 
researchers through these programmes – with proportionately less researchers leaving the UK than in comparator 
countries. 
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needs to be considered in the context of Socio-economic sciences and Humanities 
being mainstreamed across Horizon 2020. Furthermore, in Horizon 2020 Space is no 
longer an area of comparative strength 
UK’s participation in COST Actions has grown steadily in absolute terms in recent 
years, from 286 running Actions in 2011 to 369 Actions in 2014 with UK participation 
(+30%). However, in real terms, UK’s access to COST Actions remained stable, with 
UK researchers accessing 99.7% of all running COST Actions in each year and 
thereby representing a dominant proportion of the overall participations in COST 
Actions. Furthermore, the UK has coordinated the highest number of all COST 
actions in the period 2007-2013 of all countries although this ‘preference’ for UK 
coordinators is less pronounced than in FP7. Overall, UK researchers are a dominant 
group within the COST programme, in terms of applicants and participating 
researchers. They outperform both overall averages for other COST countries and 
averages for EU countries. However a direct comparison to FP7 is not possible, 
given the distinctly different nature of COST implementation. 
In EUREKA, a majority of UK projects to date (72%) were ‘Individual projects’ 
(projects which are entirely funded by the national funding agencies supporting the 
project). With the introduction of the Eurostars programme, UK companies have 
taken a significant interest in this particular EUREKA funding scheme. From 2007-
2013, UK companies participated 223 times in Eurostars, and received a total of 
€58.32 million in match-funding for this programme, compared to €890 million of EU 
funding allocated to UK SMEs under FP7. These projects covered a more limited 
number of thematic areas and industries – ICT (34%) and Biotech (26%) are the 
dominant sectors represented by UK participation.  This corresponds roughly with 
areas that have seen significant R&D investment from UK businesses in the past 
(see section 1.2 for an overview of business R&D investment in the UK). 
National support services are useful mostly for stakeholders without in-house 
support, however they are not known to a significant number of applicants 
As regards the usefulness and relevance of the support offered by the NCPs, the 
following conclusions can be offered: 
• National support services were not used by the majority of stakeholders 
interviewed and survey respondents – the majority of UK participants use 
effective in-house support or experienced partner organisations. Where 
national contact points have been used, their support has been useful in 
understanding FP7, and was deemed critical in around 25% of the applications 
supported. However more should be done to reach out to these potential 
applicants who could potentially make better use of NCP services. 
• First-time applicants and applicants without strong in-house support are most 
likely to need and appreciate help in understanding the programmes 
themselves, and are likely to need or appreciate help with sorting out the 
project and consortium arrangements. Qualitative feedback provided on the 
NCP support indicated that most respondents considered the advice provided 
by NCPs as valuable. However a small proportion of respondents felt that the 
support requested was not forthcoming or that the advice received was of little 
use, and more focus should be put on actively helping applicants to identify 
suitable project partners. 
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4 UK outputs, outcomes and impacts 
from participation in EU research 
programmes 
This section summarises the main outputs and outcomes resulting from FP7 funded 
projects, reported by researchers. Outputs are understood to be the direct results of 
funded projects, whilst outcomes are understood to be expected mid-term results of 
projects likely to occur after projects have ended. Outputs, outcomes and impacts 
presented here should be understood in context – considering the nature of FP7 as a 
programme focussing on research at lower TRL, and the demographics of UK 
participants in FP7 which consisted of a large group of universities (60% of all UK 
participants), and to a lesser extent of private companies (26% of all UK participants), 
as well as other organisations (14%). Perceived outcomes and impacts of COST and 
EUREKA are also reported in this section. 
4.1 FP7 Outputs, outcomes and impacts 
4.1.1 Research outputs of FP7 
The survey sought to establish the views of the participants on what they considered 
to be the most important types of output, estimate the outputs that were generated 
from projects, and the extent to which these outputs met expectations. 
4.1.1.1 Importance of research outputs 
UK participants were asked to indicate the importance they attach to various types of 
research output.  The opportunity to conduct research on specific issues of interest to 
the researcher and the scope to produce peer-reviewed publications were very 
important to a majority of respondents (Figure 4.1).  
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Figure 4.1 Importance of various types of outputs to UK FP7 participants (n=472) 
 
Source: ICF survey of UK FP7 participants February 2016 
Accessing research networks, acquiring new skills and developing new tools and 
techniques were also quite or very important to more than half of those providing 
feedback. Conversely, more commercially orientated outputs such as generating 
patents, risk sharing and investing in new facilities were of little or no importance for 
the majority of participants.  This is unsurprising as only a minority of FP7 projects 
focussed on close-to-market R&D activities. 
The relative importance of different outputs varies between different organisations. 
University researchers rate (i) the opportunity to carry out research and (ii) improved 
access to networks as key outputs. In comparison, private companies did not rate 
peer-reviewed publications or new skills acquisition as of high importance but instead 
rated (i) opportunities for prototype development and demonstrations / pilots, and (ii) 
newly-acquired knowledge about industrial processes or business parameters as 
among the most important outputs. 
4.1.1.2 Quantification of research outputs 
Participants were asked to quantify, where applicable, the number of a range of 
different types of output produced by their FP7 project.  Peer-reviewed journal 
articles are the most widely generated output (76% of respondents) and most 
numerous (14.7 per project on average), most likely a result of universities 
representing the majority of survey respondents and UK participants in FP7.  
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Other large-scale outputs related to the recruitment and training of specialist 
researchers (68% of participants, with an average of five FTEs per project) and 
scientific exchanges and networking (67% of participants sending their own 
personnel on visits overseas and 57% hosting personnel from other institutions 
abroad). 
Commercially oriented outputs were far fewer in number:  less than one in five (14%) 
of the respondents’ projects made one or more new patent applications, and just 3% 
applied for one or more form of intellectual property right. Again, this is likely a result 
of universities representing the majority of survey respondents and UK participants in 
FP7. Table 4.1 provides an overview of outputs reported by all respondents. 
Industry respondents were more likely to report new patent applications (26% of all 
industry respondents) compared with respondents from universities (11%) and 
applications for intellectual property rights (8%) compared with respondents from 
universities (2%). University respondents were more likely to report articles 
published/accepted for publication in peer-reviewed journals than industry 
respondents (84% compared with 58%, respectively). University respondents were 
also much more likely to report the recruitment of researchers specifically for the 
project compared to respondents from industry (79% compared with 48%, 
respectively).  
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Table 4.1 Quantification of outputs by survey respondents (n=475) (all survey 
respondents) 
 
No. of 
respondent
s reporting 
at least one 
output 
Proportion 
of 
respondent
s reporting 
at least one 
output 
Total 
no. of 
outputs 
reporte
d 
Mean 
no.  of 
outputs 
per 
project 
Largest 
no. of 
outputs 
from a 
single 
project 
Articles published/accepted for 
publication in peer-reviewed 
journals 
361 76% 6,085 14.7 160 
Employees recruited specifically for 
the project? (in Full Time 
Equivalent) 
323 68% 2,110 5.2 192 
Researchers from your 
organisation that have undertaken 
or are undertaking 
research/scientific visits at other UK 
organisations or overseas as part 
of the project? 
320 67% 1,158 2.7 100 
Researchers from other UK 
organisations or from overseas that 
have undertaken or are 
undertaking research/scientific 
visits at your organisation as part of 
the project? 
269 57% 2,190 5.3 350 
New patent applications (‘priority 
filings’) made 
68 14% 165 0.4 12 
Trademark 14 3% 21 0.1 3 
Registered Design 9 2% 11 0.0 3 
Other IPR 13 3% 25 0.1 5 
      
Source: ICF survey of UK FP7 participants February 2016 
4.1.1.3 Extent to which outputs met participants’ expectations 
FP7 participants were asked about the extent to which their FP7 project had 
successfully delivered outputs to their satisfaction.   
In almost all cases outputs were delivered in line with or above expectations (Figure 
4.2), especially the most important outputs sought by participants – improved 
networks, opportunities for research and peer reviewed publications. Almost all of the 
listed outputs were delivered in line with or above expectations in more than 80% of 
cases.  
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Figure 4.2 Extent to which FP7 projects delivered outputs to participants’ 
satisfaction (n=468) 
 
Source: ICF survey of UK FP7 participants February 2016 
Only with respect to the more commercial outputs, such as patent and trademark 
applications, did a sizeable share of respondents (30%) report delivery below 
expectations. This should be understood in context of the demographics of UK 
participants in FP7 which consisted of a large group of universities, and to a lesser 
extent of private companies. 
When comparing how far the FP7 experience differed between university and 
business participants, businesses generally reported outputs below expectations 
more frequently. When comparing responses from businesses to those from 
universities, it can be seen that businesses reported a significantly larger proportion 
of projects delivering below expectation (difference of 10% or more) in the following 
areas: 
• new or improved support tools (including measurement or testing instruments) 
or techniques for scientific/technical research; 
• patents/trademarks granted; 
• peer-reviewed scientific publications; and 
• opportunity for inward / outward mobility of early stage researchers. 
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Figure 4.3 below provides an overview of respondents from universities and 
businesses who indicated that their project delivered below outputs below 
expectations in certain areas.76 
Figure 4.3 How far did FP7 projects deliver outputs below participant expectations 
(universities and businesses) 
 
Source: ICF survey of UK FP7 participants February 2016 
4.1.1.4 Reasons for outputs not meeting participants’ expectations 
Where FP7 projects had delivered outputs below expectations, participants indicated 
that the reasons for this were most commonly attributed (Figure 4.4) to the quality of 
project partnerships, limitations or changes to the scope or content of the project, the 
level of funding available, or limitations in the knowledge or capacity of the 
consortium. These reasons revolve around the project partners and their productivity 
rather than external factors such as levels of demand or lack of availability of skilled 
personnel. There is of course also always the possibility of research failure, i.e. 
projects failing to find the breakthrough or solution that was envisaged at project 
start. 
76 Note: Respondents indicating that a certain type of output was not relevant for their project and non-
respondents are excluded from this analysis. 
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Figure 4.4 Reasons why outputs were delivered below participants’ expectations 
(n=240) 
 
Source: ICF survey of UK FP7 participants February 2016 
4.1.2 Research outcomes of FP7 
4.1.2.1 Importance of outcomes 
The most important outcomes resulting from the research activity and the outputs 
achieved were the opportunity and ability to follow-up research and the improved 
ability to attract and retain staff (Figure 4.5). Commercial outcomes compared with 
these outcomes were relatively less important, reflecting the weight of university 
respondents compared with businesses in the overall response. While all groups 
considered the opportunity for follow-up research to be an important outcome, 
companies rated (i) development of new products, services and/or processes, (ii) 
access to new markets and supply chains (both within and outside of the UK), and 
(iii) reduced time to market for new or improved products or services as among their 
most important outcomes. However, these were rated as relatively unimportant as 
outcomes to universities and research institutes, which instead prioritised 
improvements in internal capabilities, training and research performance. 
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Figure 4.5 Importance of various outcomes to UK participants (n=472) 
 
Source: ICF survey of UK FP7 participants February 2016 
4.1.2.2 Extent to which outcomes met participants’ expectations 
The achievement of outcomes met or exceeded expectations for the vast majority of 
projects. More than a third of projects (34%) delivered above participants’ 
expectations with regard to providing opportunities for follow-up research, and almost 
a quarter (23%) delivered above expectations with regards to knowledge spillovers to 
other sectors or research areas.  More than 90% of projects delivered at or above 
expectations in terms of improved ability to conduct R&D, the training provided and 
the ability to attract staff. 
In terms of achievement of outcomes, industry respondents were more likely than 
university respondent to have achieved (i) newly-acquired knowledge about industrial 
processes or business parameters, (ii) opportunity for sharing risks (e.g. financial and 
technological risks), and (iii) leverage in private and public funding, at or above 
expectations.  
93 
Evaluation of UK involvement with EU research programmes 
Commercially oriented outcomes were more likely to be delivered below 
expectations, with one in five or more of the projects achieving less than expected in 
terms of development of new products and services, development of new codes and 
standards, access to new markets, and reduced time to market. 
Respondents indicated that outcomes were relevant to a varying degree. More than 
half of university respondents indicated that the following outcomes were not relevant 
for their project: access to new markets and supply chains (both within and outside of 
the UK); reduced time to market for new or improved products or services; and 
progress in Technical Readiness Level. On the other hand, improved ability to 
provide training and development of new or improved technical codes or standards 
were highlighted by 43% and 39% of industry respondents respectively as not 
relevant. 
University respondents most frequently indicated the following outcomes to be 
delivered above expectations: opportunity for follow-up research (39% of university 
respondents); improved ability and/or capacity to conduct R&D (22%) and improved 
ability to attract staff (19%). 
Industry respondents most frequently indicated the following outcomes to be 
delivered above expectations: development of new products, services and/or 
processes (20% of all industry respondents), knowledge spillovers that will benefit 
other sectors or research areas (17%), access to new markets and supply chains 
(both within and outside of the UK) (15%) and opportunity for follow-up research 
(15%). 
Impacts reported in case studies 
Case study AMAZE 
The main impact is seen in building pilot scale factories across Europe, which will help to 
demonstrate how individual components can be produced and how their production could be 
scaled up to a commercial level. These will be the first pilot scale facilities for the production 
of large scale components allowing the industrial partners to fully explore the cost benefit of 
additive manufacturing. The project has investigated in detail the production of 15 different 
components covering a wide range of materials, scales and manufacturing processes to 
develop the knowledge required for manufacturing by additive manufacturing. 
Case study FLUTCORE 
The project has enabled IQUR  to leverage funding to use the tandem core technology™ for 
other vaccines and safeguard up to five research staff. For instance, a collaboration with the 
Edward Jenner Institute for Vaccine Research to develop a new malaria vaccine was 
currently being funded through the Innovate UK Biocatalyst programme. 
If the phase I clinical trial is successful, the consortium will enter into a partnership with a 
large pharmaceutical company to carry out late stage clinical trials or sell the generated 
Intellectual Property. 
Source: Case studies, details in Annex 3 
When comparing how far the FP7 experience differed between university and 
business participants, businesses generally reported outcomes below expectations 
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more frequently. When comparing responses from businesses to those from 
universities, it can be seen that businesses reported a significantly larger proportion 
of projects delivering outcomes below expectation (difference of 10% or more) in the 
following areas: 
• improved planning and/or coordination of R&D; 
• improved ability to provide training; 
• development of new or improved technical codes or standards; 
• reduced time to market for new or improved products or services; and 
• opportunity for follow-up research. 
The higher frequency of failure to achieve improved planning and/or coordination of 
R&D might just be the result of limited overall research capacity of the participating 
businesses. However the higher frequency of failure to reduce time-to-market and 
offer follow-up opportunities for business-relevant research points to the general 
features of FP7 catering more strongly to research at lower TRLs. A further review of 
how far Horizon 2020 has succeeded in mitigating these issues should be 
undertaken once a substantial subset of Horizon 2020 projects has been completed. 
Figure 4.6 below provides an overview of respondents from universities and 
businesses who indicated that their project delivered outcomes below expectations in 
certain areas.77 
77 Note: Respondents indicating that a certain type of outcomes was not relevant for their project and non-
respondents are excluded from this analysis. 
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Figure 4.6 Extent to which FP7 projects delivered outcomes below expectations, by 
type of respondent 
 
Source: ICF survey of UK FP7 participants February 2016 
  
96 
Evaluation of UK involvement with EU research programmes 
4.1.3 Impacts of FP7 participation 
This section outlines the main impacts resulting from the research outputs and 
outcomes summarised in the previous section. These impacts relate to the wider 
consequences of the research activity for the funded organisations and the possible 
longer-term impacts on the economy. 
4.1.3.1 Impacts on funded organisations 
4.1.3.1.1 Overview of the impacts for funded organisations from FP7 participation 
The large majority (>75%) of participants report medium to high impacts on their 
organisations in terms of (Figure 4.7): 
• increased understanding and knowledge, in both new and existing areas (91% 
of all respondents indicated medium or high impacts in existing areas, 93 in 
new areas); 
• increased scientific capabilities (83% of all respondents indicated medium or 
high impacts); and 
• improved relationships and networks 80% of all respondents indicated medium 
or high impacts). 
The majority (> 60%) of participants report medium to high impacts on their 
organisations in terms of (Figure 4.7): 
• increased technological capabilities (69% of all respondents); 
• increased mobility and improved career development for researchers (66% 
and 65% respectively);  
• an improved competitive position internationally (69%); and  
• enhanced organisational reputation (68%). 
Differences were again noted in the responses provided by industry from those 
provided by university respondents. Industry respondents were more likely than 
university respondent to assign medium-to-high ratings for (i) improved business 
opportunities, (ii) increased income or market share internationally, (iii) access to new 
markets and/or supply chains, at or above expectations.  Industry respondents were, 
however, less likely to have assigned medium-to-high ratings for (i) improved ability 
or capacity to provide training, (ii) improved ability to attract staff, and (iii) improved 
career development of researchers. 
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Figure 4.7 Positive impacts of FP7 projects on participating organisations (n=470) 
 
Source: ICF survey of UK FP7 participants February 2016 
4.1.3.1.2 Employment effects on participating organisations 
Impacts on employment beyond the duration of the project were difficult for 
participants to identify. In two-thirds of cases (67%) respondents indicated that it was 
not possible to provide an answer. In 17% of cases respondents reported an 
increase in employment and in 16% of cases they reported a safeguarding of 
employment. Just two respondents (<1%) reported a decrease in employment as a 
result of their project. Of those respondents who were able to answer this question: 
• 64% of universities reported an increase in employment; 
• 57% of RIs reported an increase in employment; and 
• 31% of industry reported an increase in employment. 
Respondents report a total of almost 1,000 full-time equivalent jobs being generated 
(377 jobs) or safeguarded (596 jobs) representing approximately 10 jobs per 
organisation across the 96 organisations reporting an impact. Industry respondents 
were slightly more likely than university respondents to be able to answer this 
question (70% versus 62% responding and providing an indication of the impact on 
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employment). However, university respondents were much more likely than industry 
respondents to report an increase in employment (19% versus 12%), suggesting that 
FP7 impacts on employment may be greater in the university (research) sector than 
within industry. 
4.1.3.1.3 Impact on investment by participating organisations 
Almost a quarter of respondents (109, 23%) reported that some investment had been 
or would be made as a result of the research project, of which 38 were able to 
provide some quantification. These organisations indicated a level of investment of 
some €30.6 million, an average of just over €780,000 per organisation. The 
remaining respondents indicated either that their project had not resulted in any 
additional investment (57%) or that they did not know (20%). Industry respondents 
were more likely than university respondents to answer this question (84% versus 
78%) and were also more likely to report that their project had resulted in investment 
in new devices or equipment, or is expected to in the future (32% versus 23%). 
4.1.3.1.4 Commercial benefits for participating organisations 
As noted above in section 3.1, universities were the predominant beneficiary of FP7 
funding in the UK, and this feature has to be considered when discussing commercial 
impacts attributed to FP7. 
UK participants were asked whether their FP7 project had produced (or was 
expected to produce) commercial benefits for their organisation. Just over half of 
respondents (53%) stated that the project would not result in any commercial benefit 
(other than the FP7 funding for their participation in the project). A further quarter 
(25%) were unable to say whether any commercial benefits had been realised. In the 
remaining 22% of cases participants reported that some commercial benefit had 
been achieved. In most of these cases (63%) the commercial returns came from the 
direct use of the project results within the participating organisation, but a significant 
proportion (37%) came from sale or licensing of products or intellectual property 
developed through the project.  
Around 38% of respondents who reported commercial benefits (9% of all 
respondents) were able to quantify these benefits. Based on this information, an 
average additional income of €937,000 was reported. These figures result in an 
average net gain of €815,000, and an estimated total net gain of around €35 million, 
across the 9% of respondents who detailed commercial benefits. 
Industry respondents reported commercial impacts much more frequently across all 
impacts queried. With 39% reporting commercial impacts from the direct use of 
project results, 18% reported them from sale or licensing of product and 11% of 
industry respondents from sale or licensing of intellectual property. Among university 
respondents, 9% reported commercial impacts from the direct use of project results, 
2% experienced commercial impacts from the sale or licensing of product and 2% 
from the sale or licensing of intellectual property. The remaining university 
respondents (61%) reported that the project resulted in no commercial impact other 
than reimbursement of project costs, or that they didn’t know whether the project 
resulted in commercial impacts (27%). Among industry respondents, 31% reported 
that the project resulted in no commercial impact other than reimbursement of project 
costs, while 16% said that they didn’t know whether commercial impacts had 
resulted. 
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4.1.3.1.5 Overall costs and benefits of participation 
Figure 4.8 indicates that the large majority of participants (80%) report that the 
benefits of participation outweighed the costs (with 46% indicating that the benefit to 
cost ratio was very high). A further 13% of participants (roughly one in eight) stated 
that benefits obtained were equal to the costs involved, and just 6% indicated that the 
costs of participation had outweighed the benefits. The balance of costs and benefits 
was most positive for universities / colleges and research organisations, with just 3% 
and 6% respectively reporting that the costs had outweighed the benefits. By 
comparison, private companies and public bodies were more likely to report that the 
costs had outweighed the benefits (14% and 18% respectively). 
Figure 4.8 Costs and benefits of FP7 participation (n=469) 
 
Source: ICF survey of UK FP7 participants February 2016 
Where the costs of participation outweighed the benefits most respondents explained 
that this had reflected their requirement to pay part of the costs (25-50%) and carry 
the high costs of administration and reporting. In a small number of cases problems 
with partners failing to deliver on their part of the work had reduced the benefits 
obtained by the UK partner. In one case, a lack of flexibility had limited the value of 
the results and led to missed commercial opportunities, while in another, elements of 
the project managed by the UK partner had to be cancelled.  
4.1.3.2 Wider impacts from FP7 funded research activity 
4.1.3.2.1 Policy impacts 
FP7 participants were asked whether their project had, or was expected to have, an 
impact on policy development. Whilst a large number of respondents considered 
there was no impact (35%) or did not know (26%), 39% stated that their project had 
exerted an impact on policy, in most cases at European level (24% of projects) but 
also at international / global level (11%). Only 4% of participants reported that their 
FP7 project had impacted on policy development at national level.  
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Examples of policy impact 
“I was invited to take part in the UK-Japan mission of the BIS Technology Strategy Board 
(TSB). The team of five academics and industrialists visited Japanese universities and 
companies to promote UK robotics and scout Japan for collaboration opportunities. The visit 
resulted in an advisory document presented to the TSB in November 2011. The 
recommendations informed a key speech by the Chancellor of the Exchequer, to the Royal 
Society, which informed the £35 million investment in robotics by the Department for BIS, as 
part of its investment in the UK’s “eight great technologies”. 
“Influenced EU guidelines for Directives on CO2 storage and Emissions Trading scheme. 
Fed into practice of operators and National implementation of EU directives” 
“Provided evidence to UK policy makers on wheat population performance and potential 
ways that regulations could be modified that resulted in the council decision 2014/150/EU.” 
[decision on the organisation of a temporary experiment providing for certain derogations for 
the marketing of populations of the plant species wheat, barley, oats and maize pursuant] 
Case study ESS-DACE 
“To a large extent, ESS has achieved its objectives. The goal was to allow people to access 
important social data for free as well as to help policy-makers access important data to 
shape policy and tackle societal challenges. To date, 80,000 people have registered to our 
service. About 3,000 publications cite ESS data and have used it in their work. Moreover, 
many countries have used the data to shape national policy, for instance: Bulgaria has used 
ESS data on immigration.” 
Case study FLUTCORE 
As a result of the FLUTCORE work and that of other EU projects focussing on new influenza 
vaccines the European Medicines Agency (EMA) received further incentive to change the 
legislation required for influenza vaccine licensing since it was no longer fit for purpose.78 
Source: ICF survey of FP7 participants, February 2016, Case Studies, details in Annex 3 
4.1.3.2.2 Impacts on UK networks and relationships 
FP7 projects are being used as a mechanism for fostering both existing and new 
relationships. Respondents indicated that for the sample of projects covered79, the 
average number of partners per project was 13, and respondents had previously 
worked with a third of them (on average 4.6 per project). Approximately two-thirds 
(65%) of the partners were ‘new’ in the sense that the UK partner(s) had not 
previously worked with those organisations, (an average of 8.4 new partners per 
project). Participants also reported that they expected to work again in the future with 
just under half (46%) of their FP7 project partners (an average of 6.0 ‘future’ partners 
per project). These collaborations contribute to an enhanced set of relationships for 
UK organisations, based on the addition of newer and more useful partnerships and 
the cessation of less productive ones. 
78 In particular, the use of hemagglutinin inhibition assay as a release criterion for influenza vaccines has been 
discontinued since none of the new products either require it or would meet these standards. 
79 Projects involving only a single organisation or bilateral partnership, such as ERC projects and many Marie 
Curie projects, are excluded from this analysis. 
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There were close to 70,000 non-UK participations in UK led projects. Using these 
figures to scale up from the estimates provided through the surveys, we could 
estimate that: 
• Some 45,500 new partnerships were created between UK and non-UK FP7 
participants (65% of all UK partnerships were new, with 35%, or 24,500, with 
pre-existing collaborators). 
• UK partners expect to work with an estimated 32,200 (46%) of their non-UK 
FP7 partners again in future. 
• An estimated minimum of 7,700 (24%) of these future collaborations will be 
with overseas partners that the UK partner first collaborated with during FP7. 
There were approximately 7,323 UK participations in projects with at least one other 
UK partner. If the above proportions of new and future partners are used, this gives 
the following estimates as regards partnerships with other UK organisations:  
• 4,760 new partnerships between UK organisations; and 
• 3,369 new UK partners with which UK organisations expect to work with again 
after the FP7 project. 
These estimates are assuming that UK participants overall saw similar proportions of 
new partnerships and intend to continue collaboration with partners at a similar 
frequency as those UK participants who responded to the online survey. 
4.1.3.3 Difficulties associated with FP7 projects 
The survey of FP7 participants investigated difficulties associated with participating in 
FP7. Only 60 participants out of 470 (or 13%) reported one or more difficulties. The 
following issues were the most frequently described: 
Administrative burdens: problems arising from complex project administration were 
reported by 21 out of 60 respondents (35%). Onerous administrative tasks 
sometimes meant that fewer resources were available for research tasks. 
“[Impacts arise from] management time diverted on administration overhead that could have 
been much better utilised in other areas of the business for productive and added value 
purposes.” 
Source: ICF survey of FP7 participants, February 2016 
Project management and coordination: When asked about the specific issues 
encountered, 14 participants (23% of all respondents reporting negative impacts) 
reported issues arising from project management and coordination with partners (see 
box below for some examples). This had consequences for participants’ willingness 
to engage with the same partners for further research. As for administrative burdens, 
in some cases the resources needed for project management and coordination 
detracted from resources for scientific tasks. 
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“A lot of work [was] required […] as partners required extensive training.” 
“Ensuring that we had the right research resource available at the right time whilst balancing 
commercial obligations outside of FP7, proved to be challenging. This was primarily down to 
having unclear objectives and dependencies on other partners.” 
“The coordinator did not fully communicate all reports etc. to the partners that were submitted 
to the EU and she did not offer the partners any chance to edit the reports before they were 
submitted“. 
Source: ICF survey of FP7 participants, February 2016 
Insufficient funding: seven respondents (12% of all respondents reporting negative 
impacts) commented that funding was not sufficient to cover all project costs. In 
some cases, economic risks prevented participants from applying to further projects.   
“The funding mechanism didn't cover 100% of full economic costs, so the return for the 
University was low, in financial terms - we had to argue that the non-monetary reputational 
benefit was sufficient to make it a worthwhile investment, for the institution as a whole.” 
“[I] become nervous about trying to apply again […] because money [was not enough] to 
cover costs”. 
Source: ICF survey of FP7 participants, February 2016 
Other unwanted impacts were created by the limited flexibility regarding project 
structure and delivery and barriers to the commercial exploitation of results. Details 
are provided in Table 4.2. 
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Table 4.2 Difficulties associated with participation in FP7 (n=60 respondents who described unwanted impacts) 
Theme 
Summary of impacts 
reported by survey 
respondents 
Quotes from survey responses 
Number 
of 
responden
ts 
reporting 
unwanted 
impacts 
% of all 
responde
nts 
reporting 
unwanted 
impacts 
Administrative 
burdens 
■ Administrative burdens 
affected some participants, in 
particular SMEs.  
“[Impacts were] largely associated with the administrative burden required to support 
the project. [Our organisation] was already set up to accommodate the administration 
required, but the systems did place burdens on some of the smaller companies 
involved. However, we were very pleased with the level of support from the Project 
Officer and the pragmatic approach to delivering this action taken by the Commission.” 
“Consortium science always carries a large administrative overhead. This dilutes the 
funding for the science.” 
21 35% 
Project management 
and coordination 
■ Participants faced problems 
regarding the relationships with 
some partners and difficulties 
with managing inputs and 
resources.  
“Some relationships between partners did not develop in a positive way, these 
partners may not seek future collaboration.” 
14 23% 
Funding ■ Participants were not able to 
recover all project costs, and in 
some cases they faced 
economic impacts from 
participation. 
“[…] some of the work packages required more person hours than were originally 
budgeted for. This was not necessarily a negative thing, in that the extra time was 
invested in order to increase the number of publications resulting from the project.” 
7 12% 
Flexibility ■ Negative impacts included 
those arising from the limited 
flexibility  
“Very heavy bureaucratic administrative load. Inflexibility of the project in a very fast-
moving field of technical advance.” 
5 8% 
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Theme 
Summary of impacts 
reported by survey 
respondents 
Quotes from survey responses 
Number 
of 
responden
ts 
reporting 
unwanted 
impacts 
% of all 
responde
nts 
reporting 
unwanted 
impacts 
Commercial 
exploitation of results 
■ Participants were affected by 
barriers to the full commercial 
exploitation of results.  
“[The negative impact was my] frustration about commercial exploitation of results. I 
believe the EC has high expectations without providing the infrastructure for realising 
them. We are academics, not merchants. […] Advisory offices [should be created] in 
the EC [to] help us commercialise our products.” 
“The project deliverables to the commission can distract from the core research aims 
of the project, creating unusable results that are only there to fill in demands of a plan 
which was decided on many years ago, based on requirements that are no longer 
relevant or cannot be usefully delivered. The strong demand for large reports to be 
written and the worry that those reports don't exactly match the original plan causes 
difficulties in our business to push research directions into fruitful or commercial 
directions. The reality, is you try something and if it isn't going to work well, or be 
deliverable in the available time, it is better to not waste time on it, but that doesn't fit 
the FP7 approach. If something useful pops up, you want to chase that. In a 
commercial environment, that is based on confidential discussions (potential 
customers present a problem they all face for which a technology might be 
commercially viable).” 
4 7% 
Delays ■ Some respondents reported 
delays to the project. 
“Poor administration by DG Research: delayed payment and start but no time 
allowance for this at the end of the program”. 
3 5% 
Other ■ Other responses included a 
variety of issues, such as 
unclear project objectives and 
difficulties regarding IP 
arrangements. 
“The importance and scale of some deliverables changed; access to software that we 
had hoped to modify changed.” 
“The IP arrangements required by the EU makes industry participation difficult.” 
8 13% 
Total   60  
Source: ICF survey of UK FP7 participants, February 2016; Note: each respondent could describe more than one impact 
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4.2 Outcomes/impacts of participation in EUREKA Eurostars 
In the online survey of FP7 participants, nine respondents out of 488 indicated that 
they had received funding for a EUREKA project. The low number of respondents to 
this subsection of the survey could suggest that there is no significant overlap of 
participants between FP7 and EUREKA programmes – it could also suggest that the 
typical EUREKA participants (R&D performing SMEs) are less likely to participate in 
a survey on FP7 benefits and impacts. 
Seven of these responded to questions on the relative advantages of FP7 and 
EUREKA, all of which indicated that they have participated in a EUREKA Eurostars 
project. In this non-representative sample, FP7 benefits in accessing research 
funding and research facilities, sharing costs/risks associated with R&D and 
innovation projects, developing new or improved commercial products or services 
and accessing complementary expertise that does not exist in the UK are all 
considered to outweigh the corresponding benefits of EUREKA Eurostars. 
Regarding the realised impacts, respondents to the online survey were asked 
whether they believed FP7 was more effective in delivering certain impacts than 
EUREKA projects, or vice versa. Again, the non-representativeness of the 
respondents has to be underlined as only a small number of responses was collected 
to this specific part of the questionnaire (n=7). The majority of respondents believed 
that EUREKA was equally effective or more effective to a ‘small’ or ‘large’ extent than 
FP7 in improving business opportunities, improving the competitive position 
nationally, increasing income or market share nationally and accessing new markets 
or supply chains. These responses to the online survey broadly confirm the views 
and opinions of the semi-structured interviews conducted with UK businesses. 
4.2.1 Impacts reported by UK participants in EUREKA Eurostars 
The EUREKA Secretariat collects information on the project outputs, results and 
impacts of Eurostars projects beyond the project duration. It made available project 
final reports (FiR) and market impact reports (MiR) related to UK participations in the 
Eurostars-1 programme. Whilst a like-for-like comparison is not possible due to 
substantial difference in how data is collected, units of measurements and time 
frames during which data is collected, some general trends can be identified and are 
discussed below. In total, 96 project final reports for UK participants (out of 223 total 
UK participations in Eurostars-1) and 20 market-impact reports were made available. 
4.2.2 Progress in Technology Readiness Level 
EUREKA Eurostars final reports ask participants to rate the technological 
achievements of the funded project. 68 (or 71%) of UK respondents rated the 
achievement as excellent or good, 6 (or 6%) rated them as average, and one 
respondent rated the achievements as poor. 21 respondents (or 22%) did not reply to 
this part of the final reports. 
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4.2.3 Development of new/improved products, processes or services 
Of 96 project final reports analysed, 55 respondents (57%) indicated that their 
Eurostars project has resulted in the development of new or improved products, 
processes or services. 20 respondents (21%) explained that the project has not 
resulted in any progress towards new or improved products, processes or services. 
21 respondents did not answer this question. 
Eurostars participants were also asked whether the commercial project results 
(product/ process/service) were successfully achieved. Of 96 respondents, 63 
answered yes, 11 answered no and 22 did not respond. 
To put feedback from Eurostars participants into context, it is useful to review survey 
responses to similar questions in the FP7 participant survey conducted by the study 
team. In the survey respondents were asked whether projects delivered outputs 
above, in line with or below expectations as regards the development of new 
products, services and/or processes. 16% indicated that the projects had delivered 
above expectations, 66% indicated outputs in line with expectations, and 19% 
indicated outputs below expectations.  
FP7 participants were asked as well how they would rate the outcomes of their FP7 
project as regards reduced time to market. 25% noted that the FP7 project had 
delivered below expectations, whilst 67% noted that the project had delivered 
outcomes in line with expectations. 
4.2.4 Impact on employment 
To put feedback from Eurostars participants into context, it is useful to review survey 
responses to similar questions in the FP7 participant survey. FP7 participants were 
asked whether their project had had an impact on employment beyond the duration 
of the project. In most cases (67%) respondents indicated that it was not possible to 
provide an answer. In 17% of cases respondents reported an increase in 
employment and in 16% of cases they reported a safeguarding of employment. Just 
two respondents (<1%) reported a decrease in employment as a result of their 
project. 
Among these responses, a total of 377 jobs had been created (3.9 FTEs on average 
within 96 organisations) and 595 had been safeguarded (5.6 FTEs on average within 
107 organisations). By comparison, just seven jobs had been lost (1.2 on average 
across six organisations). 
When considering the EUREKA Eurostars market impact reports in turn, it first has to 
be noted that the sample of respondents is much smaller (only 13 individual UK 
businesses submitted market impact reports to the EUREKA secretariat for 
Eurostars-1, covering a total of 20 spinoff products, processes or services – 
representing 6% of all UK participations in EUREKA Eurostars). It is likely that out of 
the 223 UK participations in total, this selection is not representative but rather 
presents a subset of UK businesses which did actually achieve market impacts. 
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The market impact reports suggest that among those businesses submitting a market 
impact report, an average of 5.1 FTEs had been created or were expected to be 
created as a result of Eurostars projects.  
4.2.5 Commercial benefits 
Based on market impact reports for EUREKA Eurostars projects, on average, the 13 
businesses reported additional turnover of €320,960 and expected this to increase to 
an average of €4.8 million within three years. 
By way of context, FP7 participants were asked whether their project had produced 
(or was expected to produce) commercial benefits for their organisation. Just more 
than half of respondents (53%) stated that the project would not result in any 
commercial benefit (other than the FP7 funding for their participation in the project). A 
further quarter (25%) were unable to say whether any commercial benefits had been 
realised. In the remaining 22% of cases participants reported that some commercial 
benefit had been achieved. In most of these cases (63%) the commercial returns 
came from the direct use of the project results within the organisation, but a 
significant proportion (37%) came from sale or licensing of products or intellectual 
property developed through the project. 
4.3 Outcomes/impacts of participation in COST 
As stated in section 3.4.8, COST is seen by stakeholders very much as a 
complementary programme to activities funded under FP7 or currently Horizon 2020. 
Furthermore, the COST office does not collect comprehensive impact and outcome 
data on each COST action, which means there is no reliable secondary data that 
would allow a like for like comparison of outcomes and impacts produced by 
participation in COST. 
A recent impact assessment of COST suggests that the main areas of impact were:80 
• Impact on networking - COST delivers benefits to Action participants by 
providing the means to extend the scope of their networks, improve their 
national and international profiles and their embeddedness in European 
networks. There is a clear increase in the cross-border co-publication activities 
of both the Early Stage Researchers as a group and researchers from the 
New Comer countries after their participation in the COST Actions. It also 
increases their ability to secure other funding. 
• Impacts on capacity building / career perspectives - a large emphasis put on 
the engagement and development of Early Stage Researchers and 
researchers from New Comer countries in the COST Actions. Out of 1,500 
Early Stage Researchers responding to an online survey, almost all (96%) 
indicated some form of improvement to career opportunities or some form of 
career development (97%) as a result of their participation in COST actions. 
80 Technopolis (2014) COST Impact Study and Customer Satisfaction Survey 2014.  
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In the online survey of FP7 participants, 50 respondents out of 488 indicated that 
they had received funding through COST. 32 of these responded to questions on the 
relative advantages of FP7 and COST. The picture here is clearer than when 
comparing EUREKA with FP7, which is partially due to the higher number of 
responses collected.  
Figure 4.9 presents an overview of responses as regards the relative benefits of 
participating in FP7 or COST. More than half (or 15) of respondents were of the view 
that the benefits of FP7 outweighed those of COST to a large or small extent as 
regards accessing research funding, to share the costs/risks associated with a R&D 
and innovation project, to access capabilities that do not exist in the UK and to 
develop new or improved methods. 
The benefits of participating in COST outweigh those of FP7 most frequently as 
regards:  
• access to research infrastructure / facilities that do not exist in the UK (14 
respondents feel that COST benefits outweigh those of FP7 to a large or small 
extent); and  
• facilitating researcher mobility (14 respondents respectively). 
These results are roughly in line with the evidence presented by previous COST 
impact assessment studies. 
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Figure 4.9 Online survey – comparison of benefits of FP7 / COST participation 
(n=32) 
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To access research funding
To address specific scientific or technical questions, problems or issues
To access research facilities / infrastructure that do not exist in the UK
To share the costs / risks associated with R&D and innovation project
To develop new or improved commercial products or services
To access capabilities that do not exist in the UK (complementary expertise)
To create new or improved facilities or infrastructure
To develop and extend internal knowledge and capabilities
To tackle problems that have a European or an international dimension
To provide training (e.g. for PhD students or early stage postdocs)
To facilitate the mobility of researchers
To develop new or improved tools, methods or techniques
To develop new or improved regulations or policies
To improve the coordination of research
To develop new or improved relationships or networks
Other (please specify)
Number of respondents
FP7 benefits outweigh those of COST to a large extent FP7 benefits outweigh those of COST to a small extent
Benefits of FP7 and  COST  are similar COST  benefits outweigh those of FP7 to a small extent
COST benefits  outweigh those of FP7 to a large extent Not applicable
Did not respond
Source: ICF survey of UK FP7 participants February 2016 
The box below presents some of the relative advantages of COST actions over FP7, 
according to some survey respondents. 
Views on relative benefits of COST over FP7 
“COST involves much less bureaucracy in the running of projects, and (in my experience) 
involves much larger numbers of researchers/institutions, and hence is much better at 
fostering the formation of networks.” 
“COST Actions provide opportunities for sharing and generating new knowledge across 
disciplines.  These networks can include scholars of different ages, and including early 
career scholars.  There are significant opportunities for networking and relationship building, 
especially in discrete or emerging subject areas.” 
“COST is not ‘better’ than FP7. They serve different objectives. [COST] is a good way of 
getting networking funds that could then result in projects with the funding to do research” 
Source: ICF survey of UK FP7 participants February 2016 
When asked to compare the realised outputs of COST and FP7 projects, more than 
half (or more than 15) respondents were of the view that FP7 was more effective in 
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producing 1) new skills and experience at organisational level, 2) opportunities for 
research around specific scientific/technical issues and 3) new or improved support 
tools or techniques for scientific research, 4) peer reviewed publications, and 5) new 
or improved facilities/equipment or infrastructure. FP7 was seen to be less effective 
than COST in providing opportunities for inward/outward mobility of early stage 
researchers (22 out of 32 responses). Figure 4.10 presents an overview of responses 
with regard to the effectiveness of outputs. 
Figure 4.10 Online survey – Effectiveness of producing certain outputs in FP7/COST 
(n=32) 
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FP7 was more effective  to a large extent FP7 was more effective  to a small extent
Outputs of FP7 and COST are similar COST was more effective  to a small extent
COST was more effective  to a large extent Did not respond
Source: ICF survey of UK FP7 participants February 2016 
The box below provides some further insight into whether COST is considered more 
effective in delivering outputs on mobility and networking, according to some survey 
respondents.  
111 
Evaluation of UK involvement with EU research programmes 
 
Views on effectiveness of outputs (COST and FP7) 
“COST is a much more flexible approach to research. FP7 projects are tied to a research 
project that cannot change as the research itself evolves“ 
“[COST] is best used to develop a long term FP7 project by capacity/network building” 
“COST has a wider network and more opportunities for mobility and training, but does not 
fund research.” 
Source: ICF survey of UK FP7 participants February 2016 
 
Figure 4.11 presents survey responses as regards the relative effectiveness of FP7 
and COST to provide certain outcomes.  
FP7 was considered more effective than COST in delivering mid-term outcomes, 
specifically: 
• an improved ability and/or capacity to conduct R&D; 
• an improved ability to attract staff; and  
• the development of new products, services and/or processes. 
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Figure 4.11 Online survey – comparison of realised outcomes in FP7/COST (n=32) 
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Access to new markets and supply chains (both within and outside of
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Progress in Technical Readiness Level
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Knowledge spillovers that will benefit other sectors or research areas
Opportunity for follow-up research
Number of respondents
FP7 was more effective  to a large extent FP7 was more effective  to a small extent
Outputs of FP7 and COST are similar COST was more effective  to a small extent
COST was more effective  to a large extent Did not respond
Source: ICF survey of UK FP7 participants February 2016 
The impacts that respondents felt FP7 delivered more effectively were: improved 
planning and coordination of R&D, increased understanding and knowledge in new 
and existing areas, increased technological and scientific capabilities, improved 
access to infrastructure and equipment and access to new markets or supply chains. 
Respondents considered COST to be equally effective or more effective than FP7 in 
improving the ability to attract staff and in improving relationships or networks. Figure 
4.12 presents an overview of survey responses as regards the relative effectiveness 
of FP7 and COST to deliver certain long term impacts. Apart from the results 
highlighted above, it can also be seen that there is a considerable proportion of 
indifference (FP7 and COST are considered to be equally effective) for some of the 
impacts suggested. This could be interpreted as a consequence of the differences in 
programme objectives and activities above.  
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Figure 4.12 Online survey – comparison of realised impacts in FP7/COST (n=32) 
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Access to new markets and/or supply chains
Enhanced reputation and image
Increased environmental benefits
Increased social benefits from interactions, communications and exchanges
Number of respondents
FP7 was more effective  to a large extent FP7 was more effective  to a small extent Impacts of FP7 and COST are similar
COST was more effective  to a small extent COST was more effective  to a large extent Did not respond
Source: ICF survey of UK FP7 participants February 2016 
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4.4 Conclusions 
Overall, FP7 met the expectations of participants from both universities and 
businesses with widely varying needs, delivering results across a large portfolio of 
outputs, outcomes and impacts. In the minority of cases where the programme failed 
to deliver, there was some evidence that the programme delivered results for 
businesses to a slightly lesser extent. This is probably not surprising as FP7 as a 
whole did not score strongly on commercially orientated results – a consequence of 
the programme’s focus on research activities ‘further away from market’ throughout 
most of its lifetime, without significant attention to higher TRL. 
FP7 was successful in producing a variety of outputs, with a relatively 
lesser focus on commercial results 
By large, FP7 was successful in producing a wide range of outputs, with a particular 
focus on peer-reviewed journal articles, but with a relatively lesser focus on 
producing more commercially oriented outputs. 
The results show that peer-reviewed journal articles are the most widely generated 
output (87% of projects) and most numerous (14.7 per project on average). A large 
proportion of FP7 projects recruited personnel specifically for the project (79%), with 
an average of just more than five full time equivalents (FTEs) per project. Scientific 
exchanges were also highly prevalent outputs, with 76% of participants sending their 
own personnel on visits overseas and 65% hosting personnel from other institutions 
abroad. 
For more commercially oriented outputs, less than one in five (18%) of the 
respondents’ projects generated one or more new patent applications, and just 7% 
applied for trademarks or registered designs as a result of an FP7 project; 26% of 
industry respondents generated a patent applicant and 8% of industry respondents 
applied for a registered trademark / design.  Industry respondents were more likely to 
be able to quantify new patent applications or other intellectual property right, whilst 
universities and research institutes were more likely than other respondents to 
quantify the number of peer-reviewed articles. 
Some differences were noted between the different types of participating 
organisation as regards the relative importance of specific outputs. While all 
organisation types rated (i) the opportunity to carry out research and (96% of 
responses) and (ii) an improved access to networks (87%) as key outputs; private 
companies did not rate peer-reviewed publications or new skills acquisition as of high 
importance. Instead (i) opportunities for prototype development and demonstrations / 
pilots (84% of responses), and (ii) newly-acquired knowledge about industrial 
processes or business parameters (81% of responses) were rated as among the 
most important outputs for UK companies participating in FP7. 
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Businesses reported more frequently that outputs had been delivered below 
expectations. When compared to university respondents, businesses reported the 
largest additional dissatisfaction with outputs in the following areas: 
• new or improved support tools (including measurement or testing instruments) 
or techniques for scientific/technical research; 
• patents/trademarks granted; 
• peer-reviewed scientific publications; and 
• opportunity for inward / outward mobility of early stage researchers. 
FP7 produced a range of impacts and outcomes, often delivering above 
participant expectations. More commercially oriented outcomes and 
impacts were more likely to be delivered below expectations. 
Participants were asked whether their project had no impacts, low impacts, medium 
or high impacts in certain areas. 40% or more of FP7 participants report high level 
outcomes in terms of increased understanding and knowledge, in both new and 
existing areas, increased scientific capabilities, and improved relationships and 
networks.  Increased technological capabilities, improved competitive position, 
improved career development for researchers and enhanced reputation also feature 
as areas where a large number (30% or more) of participants reported a high level of 
impact. Increased researcher mobility, improved ability & capacity to conduct 
research, improved business opportunities and improved ability to attract staff  were 
also widely cited areas where projects delivered high impacts (20% or more of 
reported high impacts here). 
More than a third of projects (34%) delivered above participants’ expectations with 
regard to providing opportunities for follow-up research, and almost a quarter (23%) 
delivered above expectations with regards to knowledge spillovers to other sectors or 
research areas.  More than 90% of projects delivered at or above expectations in 
terms of improved ability to conduct R&D, provide training and attract staff.   
More commercially oriented outcomes were more likely to be delivered below 
expectations, with more than one in five of the projects survey respondents reported 
on achieving less than expected in terms of development of new products and 
services, development of new codes and standards, access to new markets, and 
reduced time to market. Nonetheless, the vast majority of participants and projects 
did achieve these outputs in line with expectations. 
Overall, businesses reported more frequently that outcomes had been delivered 
below expectations. When compared to university respondents, businesses reported 
the largest additional dissatisfaction with outcomes in the following areas; 
• improved planning and/or coordination of R&D; 
• improved ability to provide training; 
• development of new or improved technical codes or standards; 
• reduced time to market for new or improved products or services; 
• opportunity for follow-up research; and 
• opportunity for inward / outward mobility of early stage researchers. 
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Around 17% of survey respondents reported an increase in employment 
Survey respondents (n=475) were asked whether their project had had (or was likely 
to have) an impact on employment beyond the duration of the project. In most cases 
(67%) respondents indicated that it was not possible to provide an answer.   
Around 17% of cases respondents reported an increase in employment and in 16% 
of cases they reported a safeguarding of employment.  Just two respondents (<1%) 
reported a decrease in employment as a result of their project. Of those respondents 
• 64% of universities reported an increase in employment; 
• 57% of RIs reported an increase in employment; and 
• 31% of industry reported an increase in employment. 
Of respondents that reported an increase in employment, a total of 377 jobs had 
been created (3.9 FTEs on average within 96 organisations), 595 safeguarded (5.6 
FTEs on average within 107 organisations). By comparison just seven jobs had been 
lost (1.2 on average across six organisations). 
Around 22% of survey respondents reported some commercial Impacts 
UK participants were asked whether their FP7 project had produced (or was 
expected to produce) commercial benefits for their organisation.  Just over half of 
respondents (53%) stated that the project would not result in any commercial benefit 
(other than the FP7 funding for their participation in the project), unsurprisingly so as 
the programme largely focussed on research activities which were not considered 
close-to-market. 
A further quarter (25%) were unable to say whether any commercial benefits had 
been realised.  In the remaining 22% of cases participants reported that some 
commercial benefit had been achieved.  In most of these cases (63%) the 
commercial returns came from the direct use of the project results within the 
participating organisation, but a significant proportion (37%) came from sale or 
licensing of products or intellectual property developed through the project. 
Industry respondents reported commercial impacts much more frequently across all 
impacts queried. 39% of industry respondents reported commercial impacts from the 
direct use of project results, 18% said there were commercial impacts from sale or 
licensing of product, 11% described commercial impacts from sale or licensing of 
intellectual property. Among university respondents, 9% reported commercial impacts 
from the direct use of project results, 2% described commercial impacts from sale or 
licensing of product and 2% experienced commercial impacts from sale or licensing 
of intellectual property. 
38% of respondents who reported commercial benefits (9% of all respondents) were 
able to quantify these benefits. On average, €937,368 per project was reported. 
These figures result in an average net gain of €815,000, and a total net gain of 
around €35 million, across the 9% of all respondents who detailed commercial 
benefits. 
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FP7 formed an estimate of 45,500 new partnerships between UK and 
non-UK participants 
High quality research collaboration is commonly accepted to influence the 
productivity of individual scientists and organisations, as well as the impact of their 
work. FP7 has had a significant impact on the ability of UK research base to conduct 
collaborative research with non-UK partners who were often reported to be world 
leading in terms of their scientific competences and technology know how. 
The average number of partners in FP7 projects with UK involvement was 13.0, and 
respondents had worked with on average 4.6 of these organisations before (or 35%). 
This suggests that 65% (on average 8.4 partners per project) were ‘new’ in the sense 
that the UK partner(s) had not previously worked with those organisations. 
The collaboration within FP7 contributed to the continuing evolution in relationships 
between UK researchers and other non-UK researchers: 
• An estimate of 45,500 new partnerships were formed between UK and non-
UK FP7 participants (65% of all UK partnerships were new so 24,500 of the 
partnerships were with pre-existing collaborators (35%)). 
• UK partners expect to work with approximately 32,200 (46%) of their FP7 
partners again in future. 
• An estimated minimum of 7,700 (24%) of these future collaborations will be 
with overseas partners that the UK partner first collaborated with during FP7. 
Around 23% of survey respondents reported additional investments as a 
result of their project 
Almost a quarter (23%) of survey respondents reported that some investment had 
been made, of which 35% (38 respondents) were able to provide some 
quantification. The remaining respondents indicated either that their project had not 
resulted in any additional investment (57%) or that they did not know (20%). 
The 38 respondents who were able to quantify the investments indicated a level of 
investment of some €30.6 million, an average of just over €780,000 per organisation.  
Industry respondents were more likely than university respondents to answer this 
question (84% versus 78%) and were also more likely to report that their project had 
resulted in investment, or is expected to in the future (32% versus 23%, respectively). 
Impacts on policy development were indicated by 39% of survey 
respondents 
A third of survey respondents (35%) said that their project had not had an impact on 
policy and a further quarter (26%) did not know. The remaining respondents (39%) 
stated that their project had exerted an impact on policy, in most cases at European 
level (24%) but also at international / global level (11%). Only 4% of participants 
reported that their FP7 project had impacted on policy development at national level. 
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These results correspond with the largely cross-national, European character of 
many FP7 projects. 
COST and EUREKA Eurostars focussed largely on different types of 
outputs and outcomes, not allowing a direct comparison with FP7 
The analysis of COST and EUREKA Eurostars data confirmed that both programmes 
serve different objectives than FP7 – illustrated by the outputs and outcomes 
reported for these two programmes. 
Respondents did not consider results of COST projects to be comparable with FP7. 
When asked to compare the effectiveness of FP7 with COST in producing certain 
outcomes, more than half (or 15) of respondents were of the view that the benefits of 
FP7 outweighed those of COST to a large or small extent in terms of accessing 
research funding, to share the costs/risks associated with R&D and innovation 
projects, to access capabilities that do not exist in the UK and to develop new or 
improved methods. COST was most frequently seen as having an impact on 
networking and impacts on career building or career perspectives. 
Perhaps not surprisingly, participants in the EUREKA Eurostars programme reported 
commercial outputs and outcomes more frequently than from FP7, with 57% of 
projects with UK involvement describing the development of new or improved 
products, processes or services and 65% of EUREKA Eurostar UK participants 
reporting that commercial project results were successfully achieved. 
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5 Additionality of the research 
Framework Programme and 
complementarity with other initiatives 
5.1 Additional research activity due to FP7 funding 
This section discusses the additionality of project activity funded by FP7, according to 
survey respondents. The section also includes a review of the complementarity of 
FP7 with EUREKA and COST 
5.1.1 Additionality of project activity 
Almost all (91%) of the UK participants stated that their projects would not have gone 
ahead without FP7 support.81 
A separate analysis was undertaken of the views of UK’s FP7 project coordinators82 
(who might be expected to have clearer view on additionality). A similar share (89%) 
of coordinators considered that their projects would not have gone ahead in the 
absence of FP7 funding. 
Views on additionality of FP7  
Case study FLUTCORE 
The project was considered too "difficult" for most UK grant awarding bodies, and was best 
addressed at the European level. Similar activities were being funded by the US Biomedical 
Advanced Research and Development Authority, which started a large-scale programme in 
2011.  Interviewees considered FLUTCORE and its sister projects funded under FP7 to help 
Europe in staying ahead of global competition […]. 
Respondents who stated that their project would have gone ahead without FP7 
funding were asked to indicate the impact (if any) on the project due to the lack of EU 
funding. In the majority of cases (40 out of 42 responses) an impact was reported: 
most projects would have proceeded with reduced funds (25 out of 42 respondents, 
60% of respondents), would have generated less satisfactory outputs (24 
respondents out of 42, 57%) and would have had lower impacts (22 respondents out 
of 42, 52%). The number of partners involved would have been reduced in around 
half of the cases and one third would have proceeded with less ambitious objectives 
over a longer timescale. 
81 It has to be noted that there is a possible response bias when considering only survey responses from 
organisations that were funded by FP7, and by organisations which applied for FP7 funding (unsuccessful 
applicants) – therefore additionality of FP7 should be considered in its entirety as presented in section 5. 
82 Of the 475 respondents to the survey of participants, 141 (30%) were project coordinators. 
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The separate analysis of Project Coordinators who considered that their project 
would have gone ahead without FP7 funding provided similar views to other 
respondents.83  
Figure 5.1 Impact on projects had FP7 funding not been available – only for 
projects that would still have gone ahead in some form (n=42) 
 
Source: ICF survey of UK FP7 participants February 2016 
Respondents considered a small number of projects (22 out of 452, 5%) to have 
been able to proceed and achieve similar levels of outputs and impacts in the 
absence of FP7 funding. These amounted to €37.8 million or 7.4% of the total EU 
funding secured by survey respondents. This represents a minimum estimate for the 
deadweight effect of the programme. 
When comparing university with industry respondents, both groups indicated with 
similar frequency that their project would not have gone ahead without FP7 funding 
(91% and 89% respectively). Industry respondents were more likely to go ahead with 
fewer partners (75% compared with 43% of university respondents) and with a longer 
timescale than initially planned (58% compared with 38% of university respondents). 
University respondents reported that 14 projects (out of 273) worth €20.6 million, or 
6.8% of the total EU funding secured by university respondents, would have been 
able to go ahead with similar levels of outputs and impacts in the absence of FP7 
funding. Industry respondents reported that four projects (out of 111) worth €3.9 
million, or 2.8% of the total EU funding secured by industry respondents, would have 
been able to go ahead with similar levels of outputs and impacts in the absence of 
FP7 funding. This indicates that for the share of FP7 projects reported on, the 
minimum deadweight was slightly higher for university respondents than their 
industry counterparts. 
83 Only 14 coordinators responded that their project would have gone ahead without FP7 funding. The small size 
of this subset of respondents affects the possibility to provide a solid comparison with the broader group of all 
respondents. 
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5.1.2 Project activity of unsuccessful applicants 
Some 62,000 UK applications to FP7 (78%) were unsuccessful in securing FP7 
funding throughout the programme. Unsuccessful applicants for whom contact details 
were available84 were asked if they had gone ahead with the project (or similar 
research activities). About two thirds of respondents (65%) said they were unable to 
undertake the project while around a third (34%) indicated that they undertook similar 
research activities with other funding, but not necessarily at the same scale or with 
the same outputs as planned under FP7. 
The ability to continue with similar research activity varied between different types of 
applicant. More than a third (37%) of unsuccessful academic participants continued 
with some form of research activity, whilst only 21% of unsuccessful industry 
applicants did so. Of the 220 respondents who were able to undertake similar 
research activity, about two thirds (63%) undertook projects with reduced funds and 
50% had to set longer project timescales (Figure 5.2). Close to a half (48%) took 
forward projects with less ambitious objectives and 43% involved fewer partners. 
Only 24% of unsuccessful applicants who undertook similar research activity did not 
experience any effects to the nature of their project, representing 8% of all 
unsuccessful applicants who responded to the survey. 
Figure 5.2 Effects of unsuccessful application to FP7 on subsequent progression of 
a project 
(n=220 respondents who were able to take their projects forward) 
 
Source: ICF survey of UK unsuccessful FP7 applicants, February 2016 
Note: multiple options could be selected by respondents 
84 A total of 33,199 unique contacts representing a total of 52,383 applications/were identified using a Levenshtein 
fuzzy matching algorithm. As CORDA data for applicants is of varying quality, these numbers only provide a 
rough estimate of the overall population of unsuccessful UK applicants. The survey was sent to 24,323 email 
addresses, from which 643 valid responses were collected.  
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The majority of those who undertook similar research activity obtained funding from 
another agency or programme (133 out of 220, or 60%), while a third (33%) did not 
obtain funding from other agencies/programmes but relied instead on funding from 
their own institution or organisation.85 
The 133 respondents who obtained other agency or programme funding relied 
largely on non-UK R&D grants86 (29%), and funding from UK Research Councils 
(also 29%), as shown in Figure 5.3. 
Figure 5.3 Funding sources used in absence of FP7 support  
(n=133 respondents who obtained other agency or programme funding) 
 
Source: ICF survey of UK unsuccessful FP7 applicants, February 2016 
Notes: multiple options could be selected by respondents. None of the respondents selected EUREKA network 
projects, ERUEKA cluster projects or UK Catapults as alternative sources of funding. 
Unsuccessful FP7 applicants who went ahead with their projects and relied on 
funding from other agencies or programmes were also asked about the types of 
organisations involved in the funded projects and the adequacy of the funding 
obtained to establish and complete their projects. 
Close to 50% of respondents (67 out of 133) respondents indicated partner 
organisations from outside the UK were involved, however the remaining 50% (66 
respondents) indicated that no partner from outside the UK was involved in their 
funded project, or they did not know the answer to this question. Regarding 
organisation types, a majority of respondents (91 of 133, or 68%) involved partners 
from academia, while partnerships with industry were less frequently reported (44 of 
133, or 33%). The remaining respondents stated that neither academia nor industry 
85 The remaining 7% did not respond to the question. Funding from their own organisation included a university’s 
own grant funding or a company’s own R&D budget. 
86 Mostly researcher mobility and collaborative grant funding from other European programmes and national 
sources in other countries. E.g. the German Academic Exchange Service (DAAD) or funding from various national 
research councils in partner countries. 
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were involved in their projects (26 respondents, or 20% of the total) or did not know 
what organisation types were involved (3 respondents, 2%).  
More than a third of respondents (37%) indicated that the funding received was not 
adequate at all, considering the original project objectives, while 70 respondents 
(53%) indicated that the funding received was about right, and 6 respondents (5%) 
said it was more than expected (Figure 5.4). 
Figure 5.4 Adequacy of alternative funding  for project completion in the absence of 
FP7 support 
(n=133 respondents who obtained other agency or programme funding)  
 
Source: ICF survey of UK unsuccessful FP7 applicants, February 2016 
5.2 Complementarity with EUREKA and COST 
Section 5.1 outlined the extent to which FP7 funded activities would have been 
conducted without FP7 funding. The vast majority of projects would not have been 
possible according to survey respondents, underlining the strong added value of 
FP7. 
A review of COST programme objectives and activities suggests that FP7 and COST 
are, to a large extent, complementary programmes. COST Actions are often seen as 
a precursor and provide support to prepare collaborative research which is then often 
funded under the Framework Programme. There is however some overlap in 
benefits, outputs and impacts between COST and the Marie Curie actions (now 
Marie Skłodowska-Curie Actions under Horizon 2020) – particular with the Initial / 
Innovative Training Networks (ITNs). This pattern is also visible when analysing the 
results of the online survey. FP7 generally is perceived by UK participants to provide 
stronger benefits, outputs and impacts relating to the implementation of research, 
improving knowledge and skills as well as in accessing research infrastructure or 
equipment. The picture is less clear as regards the mobility of researchers, support to 
career development and the creation of new networks and partnerships – areas 
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where COST is seen as equally effective or more effective in delivering outputs and 
impacts.  
The programme objectives and structure of EUREKA, in particular the EUREKA 
Eurostars programme, could be interpreted as more comparable to FP7 collaborative 
projects than COST. They fund collaborative R&D. However, they have a much 
clearer focus on industrial application than the majorities of FP7 specific programmes 
and cater to mainly industrial participants. EUREKA Eurostars funds mainly R&D 
performing SMEs, a group which was less prominent in FP7. 
When reviewing the expected and realised benefits and impacts of FP7 and 
EUREKA Eurostars, these differences in programme objectives and target groups 
are confirmed in principle. Eurostars is perceived to be more effective in delivering 
commercial impacts, and a crude comparison of responses to the FP7 participant 
online survey and Eurostars project reports confirms this. 
For the particular sample of EUREKA Eurostars projects with UK participation and at 
least one submitted market impact report (n=20), the average impact on employment 
and average realised impact on turnover is higher than for FP7. However, the data 
does not allow a like for like comparison as reporting times are different, and FP7 
data includes a high number of collaborative projects funded by work programmes 
specifically focussing on basic/fundamental research. 
5.3 Comparative advantages of EU Framework Programme 
and other initiatives 
5.3.1 Strength and weaknesses compared to other European initiatives 
(COST, EUREKA) 
As discussed above COST, EUREKA and FP7 were largely not comparable as the 
programmes set out to meet very different objectives. 
Furthermore, perception of comparative advantages of European programmes 
largely depend on the type of beneficiary interviewed and the intended type of project 
activities. This is exemplified by views on EUREKA. Business interviewees were of 
the view that EUREKA programmes in principle are more focussed on applied 
research than FP7. This was noted as an advantage for business in particular, 
however the new orientation of Horizon 2020 on commercial impacts and innovation 
made this advantage less pronounced when interviewees were asked about the new 
EU Framework Programme.  
5.3.2 Strength and weaknesses compared to national programmes 
UK stakeholders agreed that FP7 programmes and national programmes are 
complementary. Business interviewees confirmed the opinion of interviewees from 
UK government and programme management, in that a conscious effort was made to 
align national R&D support to European programmes, and in particular to FP7. 
As regards the complementarity of EU and national funding, interviewees suggested 
that: 
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• EU RTD Framework Programmes largely complemented national activities in 
the UK. Researchers and businesses in the UK could take national research to 
the EU level and collaborate with EU researchers. 
• Furthermore, the EU RTD Framework Programme was perceived to create 
research at critical scale in some areas which might be too large for individual 
national programmes to tackle, such as in the area of diseases, energy 
technologies or fusion research. 
Weaknesses of the EU RTD Framework Programmes in comparison to UK 
programmes, in particular in comparison to InnovateUK programmes, relate to the 
perceived administrative burden. Although there is no comprehensive research 
available which compares time and effort for UK programmes with the EU RTD 
framework, individual participants estimated that it takes between £40,000 and 
£100,000 to prepare a winning EU RTD framework proposal (collaborative research 
projects). Interviewees conceded however that this reflects the more complex project 
design, with multiple partners across different countries, and the larger amount of 
funding available. 
Some examples of feedback on the relative advantages of national and FP7 funding 
are provided in the box below. 
Views on relative advantages of InnovateUK and FP7 funding 
“Application for UK programmes is much less extensive than EU, but the scope of projects is 
different. FP7 is very attractive – large projects, opportunity making very important contacts 
for the future. “ 
“You get the opportunity to create a good EU network. This is probably not the same for UK 
projects, which are smaller and more local. “ 
“Strengths of FP7 depend on the product stage you focus on. FP7 allows to do 
basic/fundamental research and, at the same time, to have a focus on commercial outputs. It 
allows to better investigate problems that new products are meant to address. Innovate UK 
projects have to be closer to the market.” 
“[T]he level of funding provided with FP7 is a big advantage. EU funding does not require to 
provide match funding. Investment in products is part of the project costs. While Innovate UK 
requires match funding, and this may be a disadvantage. With low margin products, it is 
difficult to find investment in early stages. “ 
“[O]ne of the big weaknesses [of FP7] is bureaucracy and lack of flexibility. It is very difficult 
to obtain an amendment” 
“[W]ith FP7 it is very difficult to obtain technical changes and changes regarding how costs 
are recognised. The process is very slow.” 
“There is probably more momentum in the EU than in the UK when looking at leveraging 
additional funds. InnovateUK/TSB tends to change a lot – different people and different 
systems, always changing. In the EU there is a stronger, large and globally recognised 
network which helps raise additional funding.” 
Source: ICF survey of UK FP7 participants February 2016 
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The FP7 participant survey confirmed most of this feedback collected in semi-structured interviews. Respondents 
who said that FP7 had provided support for research topics / issues that had not been addressed by the UK’s 
national funding programmes were asked why they thought this was the case.  
The results are presented in Figure 5.5 and indicate that lack of available funds 
(54%), a requirement for international collaboration (49%), and the need for a critical 
mass of resources (41%) were the most frequently cited reasons.  Roughly one third 
of the respondents also indicated that the research topics tackled related to 
European or global issues, or required the combination of data across countries. As 
such there is a need for international cooperative effort rather than support through 
an exclusively national programme. 
Figure 5.5 Reasons why UK national programmes have not addressed certain FP7 
research topics / issues (n=252) 
 
Source: ICF survey of UK FP7 participants February 2016 
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5.4 Conclusions 
FP7 provides substantial added value to other national and European 
programmes 
FP7 provided substantial added value to existing national and European 
programmes, according to UK participants. Almost all (91%) of the UK participants 
stated that their projects would not have gone ahead without FP7 support, 
suggesting that EU funding is critical for FP7 projects with UK involvement. 
Around 5% of projects covered in the online survey of UK participants were reported 
to have been able to proceed, achieving similar levels of outputs and impacts, in the 
absence of FP7 funding. These projects amounted to €37.8 million or 7.4% of the 
total EU funding secured by survey respondents. This represents a minimum 
estimate for the deadweight effect of the programme. 
Only 8% of unsuccessful applicants were able to go ahead with their project in 
absence of FP7 funding without major changes or limitations to project activities. 
FP7 was largely complementary to other programmes such as COST and 
EUREKA Eurostars  
The analysis of FP7, EUREKA and COST suggests that whilst there are some 
overlaps in terms of the programme objectives, the activities funded and their results 
and outcomes are largely considered to be complementary, aiming to address 
different objectives.  
FP7 was generally perceived to provide strong benefits, outputs and impacts relating 
to the implementation of research, improving knowledge and skills as well as in 
accessing research infrastructure or equipment. The benefits of FP7 are less clear 
cut in terms of encouraging the mobility of researchers, support to career 
development and the creation of new networks and partnerships – areas where 
COST is seen as equally effective or more so in delivering outputs and impacts.  
EUREKA Eurostars tends to fund activities more relevant to industrial application, 
and cater to mainly industrial beneficiaries. Eurostars-1, which ran from 2007-2013, 
was perceived to be more effective in delivering commercial impacts, and a crude 
comparison of responses to the FP7 participant online survey and Eurostars project 
reports confirms this. However this could not be confirmed robustly with the data at 
hand. 
FP7 addressed issues of critical scale and scope that could not be 
tacked at the national level, but is perceived to have a larger 
administrative overhead than national programmes 
When comparing the scope for added value of FP7 compared to national initiatives, 
differences in project size and extent of networking opportunities were most often 
noted. FP7 was largely seen to address issues of critical scale and scope that could 
not be tackled with UK resources and partners alone. In turn, national programmes 
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are seen to be more easily accessible and projects funded through national schemes 
are considered to have a lower administrative overhead. 
Stakeholders and survey respondents were largely of the view that FP7 was 
complementary to R&D programmes at the national level. More than half (53%) of 
survey respondents stated that FP7 had supported topics not addressed by national 
programmes. Survey respondents indicated that a lack of available funds (54%), a 
requirement for international collaboration (49%), and the need for a critical mass of 
resources (41%) were the most common reasons they saw for work being supported 
at European level rather than at national level. Around 92% of respondents said that 
their project would not have been possible without FP7 support. 
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6 Feedback on administration and 
proposals for improvement  
This section provides direct feedback from respondents on the administrative issues 
and suggested improvements for future calls / programmes under FP7 – it combines 
feedback on FP7 administration and reporting procedures from FP7 participants with 
feedback on the application and evaluation procedure from unsuccessful applicants. 
The section summarises advice from FP7 participants to future participants in EU 
Framework Programmes on how to maximise benefits from future FP projects. 
6.1 Feedback on FP7 administration and reporting from 
participants 
Participants reported generally high levels of satisfaction with various aspects of the 
administrative mechanisms and reporting procedures of FP7 (Figure 6.1). The areas 
of most satisfaction and least dissatisfaction concern (i) the information provided to 
applicants about how to apply, (ii) processes for dissemination and exploitation of 
results, and (iii) evaluation at national and EU level. 
The greatest levels of dissatisfaction were with monitoring and reporting procedures, 
contract negotiation procedures, and mechanisms for payment of the EU’s financial 
contribution to the projects. In these cases 15-20% of participants stated that they 
were dissatisfied or very dissatisfied. This compares to 50-60% of participants who 
stated that they were satisfied or very satisfied with these same elements. As such, 
the feedback suggests a good level of satisfaction with FP administrative and 
reporting procedures. 
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Figure 6.1 Satisfaction with FP7 administration and reporting (n=468) 
 
Source ICF survey of UK FP7 participants February 2016 
6.2 Feedback on FP7 application and evaluation procedures 
from unsuccessful applicants 
Unsuccessful applicants87 were asked to report on their level of satisfaction with the 
following aspects of the FP7 programme: 
• information provided to prospective applicants about how to apply; 
• FP application procedures; and 
• FP proposal evaluation and selection procedures. 
Responses suggest that applicants were mainly dissatisfied with FP7 proposal 
evaluation and selection procedures (Figure 6.2). These responses are likely to be 
conditioned by their experience as unsuccessful applicants. 
87 Based on a survey of unsuccessful applicants to FP7, comprising individual researchers affiliated to a UK 
organisation at the time of application who had never succeeded in winning FP7 funding. In total, 643 
unsuccessful applicants submitted a survey response. Annex 8 provides a breakdown of survey respondents. 
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Figure 6.2 Level of satisfaction of unsuccessful applicants with aspects of the FP7 
programme (n=643) 
 
Source: ICF survey of UK unsuccessful FP7 applicants, February 2016 
Unsuccessful applicants were asked to comment on the administrative procedure to 
apply to FP7. A minority of those who commented (59 of 382, or 14%) provided 
positive feedback, indicating that procedures were generally efficient and clear. Most 
respondents (85%) gave negative feedback and emphasised that procedures were 
too complex and time consuming. Respondents also referred to the lack of 
transparency and insufficient guidance and feedback by evaluation panels regarding 
the selection of successful proposal. Some felt that the selection process was biased 
and not entirely based on merit. 
6.3 Advice from participants to future participants on how to 
maximise benefits from EU Framework Programmes 
Advice provided by FP7 participants to other potential UK participants on how to 
maximise benefits from EU Framework Programmes relates most frequently to the 
choice of partners, the design of the consortium and use of networks. 
The most frequent recommendations were: 
• Maximise benefits from networking: (from 16% of those who provided 
advice) - take advantage of the new networks and collaborations created 
through participation in EU Framework Programmes. Examples of the 
comments provided were as follows: 
“Ensure that [project participants] take full advantage of the opportunities to 
collaborate. We have developed an excellent network which will continue long 
after the project ceases.” 
“In my area of research …, the benefits of the programme can be maximized 
by having a long-term programme of cooperation through international 
networking” 
• Ensure careful budgeting and planning: (13%) - consider all factors that 
might affect delivery and cost recovery. for example: 
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“Avoid dependencies on large scale infrastructure targets with simultaneous 
delivery schedules.” 
“Budget adequately for face-to-face project meetings and translation.” 
• Create a balanced consortium: (12%) - involving a mix of organisation types 
and expertise, for example:  
“Make sure that the consortium is well balanced and that you can see a route 
to commercial involvement for your organisation.” 
“Join the right consortium or build your own. Success is critically dependent on 
the consortium. Different partners have different agenda about why they are 
participating. Particularly commercial organisation whose main role seems to 
be making money from EU projects.” 
• Make sure that project partners are known and trusted: (11%) - choose 
partners carefully. In many cases they recommended consortia with partners 
that were previously known by the applicant:  
“It takes a year to build a consortium… putting together a submission rather 
quickly (say within months) is unrealistic unless partners are building on years 
of collaboration already.” 
“Work with partners you know you can trust, including when they bring in new 
partners they know they can trust.  Working together can be almost impossible 
if none of the partners have worked together before.” 
Further details of advice and examples of good practice are provided in Table 6.1. 
133 
Evaluation of UK involvement with EU research programmes 
 
Table 6.1 Views and opinions from participants to potential participants on how to maximise benefits from EU research 
Framework Programmes 
 (n=285 respondents who provided advice) 
Category of 
advice Recommendations Quotes from survey responses 
Number 
(and% ) of 
responde
nts 
Partners and Networks 
Know your 
partners 
■ Work with partners that are 
previously known and trusted. 
“Make sure your partners are honest, look carefully at their EU-funded track record and make sure 
the team actually work on the project. Overall...avoid if you aren't 100% certain of the pedigree of 
your partners.” 
“Work with people you like […] Our group was fantastic and productive because we all got on.” 
32 (11%) 
Reach a clear 
agreement with 
partners on 
expected project 
results 
■ Set clear agreements for each 
project partner’s role and on 
expected project outputs. 
“Be very clear beforehand about what you are trying to achieve, and consider carefully whether the 
benefits from working collaboratively are outweighed by the rigidities and managerial costs of using 
EU funding.” 
“Be very clear about the overall objectives of the project, your role in delivering it and with 
budgetary arrangements.” 
10 (4%) 
Create a 
balanced 
consortium 
■ Reach the right mix of expertise, 
nationalities and/or organisation 
types.  
■ Optimise the number and mix of 
partners in order to maximise 
efficiencies and project benefits. 
“Take great care when selecting consortium partners that they have all the right knowledge 
required.” 
“Be involved in good consortia that provide a mix of academic, innovation, and industrial partners.” 
“Think about and manage expectations of the commercial and academic partners upfront (e.g. that 
academic partners want to carry out research and write papers).” 
 
 
33 (12%) 
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Category of 
advice Recommendations Quotes from survey responses 
Number 
(and% ) of 
responde
nts 
Use opportunities 
for networking 
and cooperation 
■ Take advantage of networking 
opportunities with other 
organisations, such as supply chain 
actors, other researchers and policy 
makers. 
“Use the programme to build strong partnerships.” 
“Look for additional networking and distribution benefits (new collaborations, markets, sectors, 
etc.).” 
“Concentrate on networking for greater understanding rather than short-term routes to financial 
targets.” 
47 (16%) 
Project Management 
Ensure careful 
budgeting and 
planning 
■ Ensure that resourcing is realistic. 
■ Anticipate administrative burdens 
and high overheads. 
“Be more thoughtful about the number and timing deliverables across work packages when 
planning the project.” 
38 (13%) 
Ensure alignment 
with 
organisation's 
priorities and 
resources 
■ Ensure that project objectives are 
relevant to partner organisation’s 
goals and resources. 
“Ensure planned benefits fit well with the participant's strategic goals.” 
“Ensure project is core to Company strategy.” 
31 (11%) 
Ensure adequate 
resources for 
coordination and 
for administrative 
tasks 
■ Ensure adequate support for 
managing administrative burden 
■ Involve an administrator with 
expertise of dealing with EU funding 
programmes 
“To have good/efficient (and low cost if possible) administration to handle the admin overheads.” 
“Hope that your home institution has a good infrastructure in place to help you comply with all EU 
rules and [regulations] for project development/reporting - this can be a major production (and from 
my understanding, always has been for European funding) - but if that burden can be lessened, the 
funding is certainly worth the effort.” 
 
 
 
 
15 (6%) 
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Category of 
advice Recommendations Quotes from survey responses 
Number 
(and% ) of 
responde
nts 
Ensure good 
project 
management 
capacity 
■ Ensure that the project is managed 
by a competent person. 
■ Hire a project management company 
or a full time expert for project 
management 
■ Involve a manager with expertise of 
dealing with EU funding programmes 
“If the project involves more 7-8 partners, engage a project management company as a full partner 
to support the administration, including proposal development and dissemination activities.” 
“Have a strong well-governed management board. Require quarterly updates if the official update 
cycle is bi-annual.” 
“Insist that the overall project is managed by a competent person or organisation.” 
“If you are going to co-ordinate a multi-million euro project make sure you have a good project 
manager with experience of working with the Commission.” 
13 (5%) 
Be flexible on 
project delivery 
■ Anticipate the need to change 
project delivery arrangements.  
“Be clear what you want to achieve going into a collaboration - but be very flexible and expect 
changes as the project is delivered.” 
4 (1%) 
Keep focussed on 
deliverables 
■ Keep focussed on deliverables 
initially agreed.  
■ Keep some flexibility in delivery. 
“Focus on what it is you want to deliver, do not get too broad in scope.” 
“These projects are complex and distributed, so focus and concentrate your involvement if 
possible, to reduce your risks. Join with the intent to work to deliver on the project itself, not against 
your own agenda. Join with an open mind, and be prepared both to listen and to argue!” 
7 (2%) 
Use external 
support services 
(e.g., NCPs and 
UK Research 
Office) 
■ Get support from NCPs and other 
services 
“Get advice from all possible sources, i.e. UK and other EU national contact points.” 
“Talk to National Contact Points and to Programme Officers about calls.” 
“Work with the national contact point early and often -- they are your best help and highly 
knowledgeable.” 
 
 
4 (1%) 
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Category of 
advice Recommendations Quotes from survey responses 
Number 
(and% ) of 
responde
nts 
Dissemination and Exploitation 
Ensure 
dissemination of 
results 
■ Dissemination of results throughout 
the project is important to maximise 
the value of participation in EU 
Framework Programmes 
“Make software modular and standards compliant, and open source, to promote reuse. Ensure that 
software is available for download throughout the project.” 
“By properly resourcing our dissemination activities and a dedicated champion for this work was 
crucial to promoting the project and increasing the profile of our work. Also networking with our 
colleague and using their contacts to promote the work of the project has been important to raising 
awareness. Also a good working relations with your project officer is important.” 
14 (5%) 
Ensure 
exploitation of 
results 
■ Ensure that there is a clear industry 
need for the new product/process 
developed and to have a clearly 
established ownership of intellectual 
property rights. 
“Have a clear idea of commercial value of expected project outcomes and clear agreement on 
ownership of project results.” 
“It depends on the type of project, but for a project with a strong industrial partner bases, 
technologies should have a clear industry need and with a clear route for [technology readiness 
level] growth and exploitation. Ideally, partner proposals should be vetted by a steering committee 
during the application stage to ensure they are aligned with industry need.” 
“[Undertake an] open discussions on IPR in the early stages of the project. Include a member of 
the consortium whose only role is the dissemination and promotion of the outputs (i.e. not a 
scientific contributor).” 
10 (4%) 
Total   285 (100%) 
Source: ICF survey of UK FP7 participants, February 2016 
Note: each respondent could provide more than one piece of advice  
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6.4 Changes that would enhance UK involvement and 
increase the benefits derived 
The survey sought views from FP7 participants on the changes to EU Framework 
Programmes that could improve UK involvement and the benefits from participation. 
A total of 227 comments were received, which can be grouped along the following 
broad themes. 
6.4.1 Thematic coverage of funding programmes 
Modifications to the thematic scope of forthcoming EU programmes to cover 
additional areas were suggested (from 17% of respondents). There was no 
consensus, however, on which thematic areas or technology readiness levels should 
be covered. For example, some respondents emphasised the need to allow for more 
‘blue sky’ science, while others recommended a focus on later TRLs. The following 
are examples of the comments and recommendations provided: 
“Retain the balance of fundamental research that was allowed in FP7 projects.” 
“[Ensure] more basic grants for blue skies research.” 
“H2020 seems much more technologically focused rather than scientifically focussed 
and this is disappointing. It makes it difficult for some fields to participate in the 
programmes except as a service to other more applied researchers.” 
“Have R&D programmes which covers the whole range of TRLs. It seems that for 
16/17 work programmes have much less calls with lower TRLs.” 
“Focus on later TRLs.” 
6.4.2 Flexibility of programmes 
Forthcoming calls should be less prescriptive regarding the specific topics covered 
and the rules for the creation of consortia. On consortium formation, many suggested 
that future programmes should allow smaller consortia. Some also recommended 
that participation from multiple participants from the same country should not be 
discouraged (12% of respondents). Suggestions included: 
“[I recommend] a larger variety of topics. The calls are quite restrictive. 
“The Framework Programme requires that each project has partners in different 
countries (!!)  These partners typically do not know each other well - the reason that 
they are partnering up is to get the Framework money.” 
“If I was involved in designing programmes I would steer away from between-country 
networks and consortia and put more money into individuals or groups of co-located 
individuals.” 
“More ability to have smaller consortia targeting specific regional or thematic issues, 
so that the transaction costs of working with so many partners are reduced.” 
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6.4.3 Administrative burdens 
Reduce the overall administrative burdens arising from participation in funding 
programmes (10% of respondents) Suggestions on how this could be done included: 
“Focus on output and communication towards the broader scientific and international 
community rather than on internal reports.” 
“Manageable, low impact project monitoring (cf. Innovate UK) would remove the 
need for us to outsource the highly bureaucratic project management requirements.” 
“Streamline six-monthly reporting to focus on hitting milestones, deliverables and 
defining re-worked plans where problems have arisen. “ 
6.4.4 Bidding process 
Introduce changes to the bidding process to address the barriers to participation 
arising from complex application procedures paired with low application rates (8% of 
respondents). Suggestions included the introduction of a simplified two-stage 
application process: 
“I understand our proposal took 300 hours [with] 12% success rate.  Perhaps a mini-
proposal would be helpful-- say 200 words - if successful, candidates would be 
invited to prepare a full proposal. This would cut down on the waste of time for all 
concerned.” 
“Applications are long, costly, and time-consuming with a very poor success rate. 
There should be a way (e.g. Expression of Interest) to have proposals vetted first, 
before going to a full application phase. I can understand why people may be put off 
FP projects as it requires an awful lot of effort for a very low chance of success.”  
“As for UK funding, if two-stage applications are involved, make stage one quick to 
apply for with a low percentage of success […] then work with successful applicants 
to ensure the stage two success rate is very high (80%). Also, promote support by 
external organisations who can write bids for companies, especially where success 
leads to the same company providing a management role whilst the project is live.”   
6.4.5 Summary of other recommendations from participants 
Other recommendations are summarised in Table 6.2. These address perceived 
needs to improve the ease with which potential partners can use the programme to 
support their objectives, especially through changes in funding rules and instruments. 
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Table 6.2 Advice from participants on changes to EU Framework Programmes that would help enhance UK involvement and 
benefits 
(n=227 respondents who provided recommendations) 
Category of 
advice 
Summary of recommendation Quotes from survey responses Number 
(and% ) of 
respondents 
Setting Priorities 
UK influence on the 
EU research agenda 
■ The UK should be more involved in the 
definition of EU research priorities. 
“The UK should be better influencing technical areas for future calls.” 
9 (4%) 
UK research strategy ■ The UK research strategy should be more 
clearly communicated and better aligned to 
EU priorities. 
“Greater communication about how the topics of the EU calls is decided. Who 
decides the calls? Who are our UK representatives to this process? How can we 
submit input to increase the chances that our areas of interest are covered by the 
forthcoming calls?” 
“[There should be] Stronger links to directed UK national programmes and vice-
versa.” 
6 (3%) 
Focussed calls ■ The scope of calls should be clearer and 
more focussed. 
“In Horizon 2020, there has been a great tendency for the calls to be too wide in 
scope. The call descriptions are woolly and vague, comprising too much all-
encompassing jargon, which sometimes makes little sense. I suggest using writers 
who are skilled in getting information across without dilution.” 
2 (1%) 
Information and Support 
Information and 
awareness raising 
■ More and clearer information should be 
available on different aspects of funding 
programmes, including the topics covered 
and potential benefits from participation. 
 
 
 
 
 
 
“More awareness of the schemes and application processes.  I would not have 
known about the MC Career Integration Grant scheme except that a colleague 
mentioned it to me.” 
17 (7%) 
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Category of 
advice 
Summary of recommendation Quotes from survey responses Number 
(and% ) of 
respondents 
UK support ■ The UK should improve its support services 
to identify available opportunities, apply for 
funding and participate in research projects. 
■ Support could be improved, such as: 
support targeted to specific applicants 
(SMEs or large companies) and support to 
different stage of the application and 
participation in research projects. 
“A simplified/shorter versions of the call could be circulated in UK to attract potential 
applicants.” 
“Greater priority should be given to SMEs. Consortia bids that I am aware of tend to 
be dominated by Academia. I do not consider this to be healthy.” 
“Would be good to see conditions improved for large industrial players like ours to 
participate.  Currently most FP7/H2020 funding seems to go towards public 
institutions and universities.  Special incentives are in place for SMEs, but these 
don't help the larger companies.” 
“Possibly better legal support when the FP7 are involving a commercial company 
who are normally much stronger in this aspect in comparison with academic 
institutes.” 
16 (7%) 
Transparency of  
proposal evaluation 
■ There should be more information on how 
evaluation of proposal is undertaken, 
including more feedback from evaluators. 
[The] evaluation process is quite arbitrary and results in many "good" applications 
that are rejected.” 
“I think that there is still a perception among UK researchers that there is a political 
element in granting awards which depends on the "mix" of nationalities involved in 
the grant application. Many people think that a certain mix of "Old" EU member 
states and "Newer" member states stand a better chance of obtaining funding than, 
say, an application entirely constructed by original EU member states. Having been 
involved in judging grant applications last year I suspect that only the best 
applications are considered for funding. The EU needs to be more transparent 
about this aspect and how it features in the final selection process.” 
 
 
8 (4%) 
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Category of 
advice 
Summary of recommendation Quotes from survey responses Number 
(and% ) of 
respondents 
Funding Rules and Instruments 
Funding instruments ■ Funding instruments should be simplified. 
■ Improve support for small organisations 
“Introduce medium sized projects with 3-5 partners to carry out novel collaborative 
research. Very big projects can be unwieldy and difficult to manage.” 
“[Introduce a] "value for money" element - encourage lower budget projects (current 
advice is always to be most ambitious). Jumping from 0 to 1-2 Million in funding is a 
huge step, and especially in theory areas probably more benefit would accrue from 
having twice the number of projects at half the funding level (funding twice the 
number of [Principal Investigators]).” 
6 (3%) 
Ring-fencing ■ Funding in some research / geographic 
areas should be ring-fenced. 
“Ring-fence R&T investment funds for aerospace industry.” 
“Administer all countries in the same as for Israel and Switzerland. That is, each 
country has its own allocation of its own funds. The country may then control its 
involvement, by increasing or decreasing funding to the scheme, according to its 
own priorities. Quality control would still occur via the current mechanism of 
proposal review, but rather than proposals being funded according to only those 
ranked above the "funding line", proposals would also be funded according to the 
available national budget.” 
2 (1%) 
Financial risk ■ Funding programmes should include 
instruments to address financial risks, such 
as risks from currency fluctuations. 
“A mechanism for adjusting payments to non-Euro area participants to reduce 
currency risks.” 
3 (1%) 
Project costing ■ Funding rules should be modified to ensure 
a fuller coverage of costs incurred by 
participants, specifically indirect costs. 
■ Some suggested that UK organisations are 
disadvantaged as compared to international 
competitors who receive more institutional 
funding from their national governments  
“H2020 seems easier with 100% funding but indirect costs are still below what our 
organisations indirect costs really are. The UK could contribute to these costs 
directly?” 
“Rules to take into account the cost of research per country based on the core 
funding provided by governments or local institution, the UK is doing very poorly 
here with no core funding to support project when compared to other EU countries.” 
12 (5%) 
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Category of 
advice 
Summary of recommendation Quotes from survey responses Number 
(and% ) of 
respondents 
Funding for research 
equipment  
■ Programme should provide more funding to 
cover costs of research equipment. 
“[programmes should provide] a higher amount of funds, perhaps aimed to the 
purchase of research equipment.” 
2 (1%) 
Funding for 
networking / 
collaborations 
■ Future programmes should devote more 
funding to promote international 
cooperation. 
“[I recommend] programmes that favour exchange of researchers and development 
of international networks.” 
3 (1%) 
Exploitation 
Funding for follow-on 
research 
■ More funding should be provided by the UK 
to follow-up on previous research projects 
“UK grants [should be provided] as follow up of EU grants to maximise benefits and 
exploitation of results.” 
“Leverage of additional funds from the UK for successful EU proposals.” 
6 (3%) 
IPR rules ■ There should be clearer rules on IPR 
exploitation. 
“IPR ownership from projects needs to be made more open. Commercial research 
organisations can restrict national benefit for their own gain.” 
“EU should vet the exploitation and IPR policies of each partner. Business cases 
are integral to proposals but rarely implemented post contract. EU should penalise 
those who fail to follow-up...but it doesn't or perhaps can't do this within existing 
legal frameworks?” 
2 (1%) 
Source: ICF survey of UK FP7 participants, February 2016 
Note: each respondent could provide more than one recommendation 
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6.5 Conclusions 
FP7 participants were largely satisfied with the administrative 
mechanisms and reporting procedures of the programme. Further 
improvements were suggested in areas of project monitoring, contract 
negotiation and mechanisms for paying out EU contributions to 
beneficiaries 
From feedback on administrative and reporting procedures, it can be concluded that 
FP7 participants were generally satisfied with various aspects of the administrative 
mechanisms and reporting procedures of FP7. 
The areas of most satisfaction and least dissatisfaction concern (i) the information 
provided to applicants about how to apply, (ii) processes for dissemination and 
exploitation of results, and (iii) evaluation at national and EU level. The greatest 
levels of dissatisfaction were with monitoring and reporting procedures, contract 
negotiation procedures, and mechanisms for payment of the EU’s financial 
contribution to the projects. 
Whilst participants suggested that the European Commission should continue 
simplification efforts, the results from the online survey suggest that participants were 
generally satisfied with the programme and project management. Unsuccessful 
applicants were much less positive, as would be expected. They mostly gave 
negative feedback and emphasised that procedures are too complex and time 
consuming. Respondents also referred to the lack of transparency and insufficient 
guidance and feedback by evaluation panels regarding the selection of successful 
proposal. Some felt that the selection process was biased and not entirely based on 
merit. 
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7 Study conclusions 
This section summarises the main conclusions from the analysis, particularly the 
strengths and weaknesses of UK participation in FP7. It covers added value, outputs, 
outcomes and impacts, barriers to participation and the effectiveness and adequacy 
of FP7’s administrative and financial rules. It also offers conclusions on 
complementarity between FP7 and possible alternatives at the European and 
national level. 
7.1 Strengths and weaknesses of the FP7 programme 
Overall, FP7 was seen to be highly relevant by UK participants. 75% of survey 
respondents indicated that both the topics and funding instruments in FP7 were high 
or very high. Key motives for participating in FP7 were access to research funding 
(72%), the development of new or improved relationships or networks (55%), the 
desire to address specific scientific or technical questions or issues (54%), and to 
develop and extend internal knowledge and capabilities (53%). 
Dominant presence of UK in FP7 
Taking into account the relatively low investment in research and development, the 
UK performed very strongly in FP7 in terms of its overall participation and funding 
won. The UK won a total of €7 billion (or 15.4% of EU funding awarded in FP7), the 
second-highest of all participating countries behind Germany. 
Overall, the UK performance in securing research funding was strong: its rate of 
success in competitions measured as the number of UK participants in successful 
project bids was more than 1.5 percentage points higher than the FP7 average for all 
participating countries. If measured by the amount of EU funding applied for and 
received, the UK’s rate of success came 4th out of all EU member states, and 
performed more than three percentage points higher than the EU average (18% 
compared with 15%). However, UK applicants were less successful than those from 
Germany (19%) and France (23%). 
The strong performance of the UK is also reflected in the following: 
UK researchers participated in a third of all proposals and comprised 12% of all 
applicant researchers. EU funding requested by UK applicants represented 13% of 
all requested EU funding. On these three indicators the UK ranked higher than all 
member states that ranked similarly or higher in the Innovation Union Scoreboard. 
Even Germany and France (both of which in 2013 had a higher GDP and a larger 
population than the UK) did not participate in the application process as much as the 
UK. 
UK researchers were participants in no fewer than 41% of all projects and comprised 
13% of all FP7 participants. UK project bids secured 15% of all EU funding. Germany 
scored only slightly higher than the UK, but only in terms of the share of participants 
and funding allocated. No other country participated in the FP7 programme as much 
as the UK apart from Germany. However, the UK scored less strongly than other 
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countries ranked similarly or higher in the Innovation Union Scoreboard in terms of 
the overall success rate of applications. For example, application success rates for 
both France and Belgium were higher than those in the UK. 
EU funding allocated to the UK was also higher than expected after accounting 
for the relative size of the country compared with other EU member states in 
terms of GDP, GERD, GOVERD and number of FTE researchers:  
The UK performed above expectation relative to its GDP, GERD, GOVERD and its 
number of FTE researchers – when comparing the proportion of FP7 funding 
received to the proportion of EU GDP, GERD, GOVERD and FTE researchers. 
Overall, rates of UK participation and EU funding won were higher than the FP7 
average adjusting for its relative size, but these rates were lower than in some 
comparable countries. 
UK participants took a coordinating role in FP7 projects more often than any other 
country 
UK coordination rates have been above those of Germany and France across FP7 
and during the early stages of Horizon 2020. The UK coordinated a total of 5,101 
FP7 projects (49% of projects with UK participation), substantially more than either 
Germany (3,119, 35% of projects with German participation) or France (2,664, 37% 
of projects with French participation). In Horizon 2020, the UK held 57% of 
coordinator roles (1,785 out of 3,112 participations so far), a much higher proportion 
that either France (42%) or Germany (41%). 
The UK was responsible for the highest share of project coordinators out of all 
countries participating in FP7. The UK was responsible for project coordination for 
5,101 FP7 projects (23%), substantially more than Germany (3,119) and France 
(2,664). 
Whilst the UK showed strong presence in the Ideas and People programmes, it 
coordinated relatively less of the more traditional R&D projects conducted under the 
Cooperation and Capacities programme.88 It provided the largest share of project 
coordinators out of all countries in the Capacities programme (13% of all project 
coordinators). It came second behind Germany in the Cooperation programme, 
where the UK provided 13% of all project coordinators compared with Germany’s 
17%. 
Survey respondents reported that they also played a very active role across almost 
all elements of their projects. More than two-thirds of the UK participants were 
involved to a large or very large extent in defining the objectives, scope and content 
of the project, conducting the research, disseminating the results of the project, and 
planning future research. 
88 It is important to note that coordination roles had different meaning across FP7. A large number of UK 
coordinators have led projects in the Marie Curie and Europe Research Council programmes, which are largely 
dominated by singe beneficiary projects (75% of all UK coordinators), a larger proportion than in Germany (50%) 
and France (61%). However the UK came second in terms of coordination roles behind Germany in the 
Cooperation programme, which is dominated by multi-partner, collaborative projects. 
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The UK continues to provide a significant share of project coordinators in Horizon 
2020. UK coordinators are responsible for 21% of all projects funded so far, (1,785 
out of 8,599 projects). 
Strong UK participation in Ideas and People projects, lower participation in 
Cooperation projects 
UK participants performed particularly well in securing funding form the Ideas and 
People programmes (funded respectively by Support for Frontier Research and 
Marie Curie actions). Indeed, the UK success in these two programmes was higher 
than in FP7 as a whole and higher than any of the comparator countries considered, 
both in terms of participation and EU funding allocated.  
The UK has consistently had a higher than average share of its participations within 
the Marie Curie actions, accounting for 23% and 30% of UK participations in FP7 and 
Horizon 2020 respectively. The UK also accounted for 20% of all Marie Curie actions 
participations in FP7 and 24% in Horizon 2020. These data indicate that the UK’s 
exceptionally strong performance in Marie Curie actions is increasing across 
successive FPs, and confirm that the UK continues to be the top destination in 
Europe for researcher training and career development.89 
The UK has also performed extremely well in relation to European Research Council 
grants. In both FP7 and Horizon 2020 European Research Council grants have made 
up 7% of UK participations as compared with just 4% and 5% respectively within the 
programmes as a whole. In FP7 the UK was awarded 23% of all European Research 
Council participations – an exceptionally high share. The equivalent figure for 
Horizon 2020 is slightly lower at 20%, but is still exceptionally high. 
Interviewees confirmed the importance of Marie Curie actions and the European 
Research Council and their added value to the UK. The Marie Curie actions 
programme is seen as a particularly effective instrument to recruit high potential 
researchers at the beginning of their career – interviewees suggested that in many 
cases these individual fellows would stay in the UK beyond the Marie Curie 
fellowship and provide substantial added value to the UK’s research base. 
The European Research Council was seen by interviewees to have a particularly 
strong effect on retaining world class researchers in the UK. Interviewees 
independently highlighted European Research Council funding as useful as it 
provided comparably large budgets and from the start focussed strongly on world 
leading, excellent research. It was therefore seen as a ‘quality label’. Interviewees 
also regarded the European Research Council’s bottom-up approach and its lean 
and flexible management as very positive. 
Conversely, the UK participated less in the Cooperation programme when compared 
to the FP7 participations across all countries. This represented only 56% of all UK 
participations (compared with 66% for all of FP7) and only 52% of the EU funding 
89 Whilst Marie Curie Actions funded both researchers leaving and joining the UK, a crude analysis of the 
researcher recruitments and secondments in FP7 Marie Curie Actions suggests that the UK saw a net income of 
researchers through these programmes – with proportionately less researchers leaving the UK than in comparator 
countries. 
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allocated to UK participants (compared with 63% of all FP7 participants). These 
shares were higher in all of the other six comparator countries. 
Compared with the overall FP7 profile, the UK’s participation rates in FP7 were 
highest in the Health, Socio-economic Sciences and Humanities, Environment 
(including Climate Change), Security and Space priority areas. In each case the 
share of participations held by the UK was higher than the share within FP7 as a 
whole. This was particularly so for Health, where the UK participation rate was 33% 
higher than the FP7 rate. The relative strengths in areas such as health, as well as 
food, agriculture & biotechnology in terms of EU funding won do to some extent 
reflect the relatively importance of these areas to UK’s economy – considering that 
throughout 2007-2014, pharmaceuticals was the product group that experienced the 
highest levels of business R&D investment (20% in 2014). 
During the first years of Horizon 2020, the picture has changed slightly. Here, the UK 
so far achieved a relatively strong performance in the Societal Challenge 
Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, 
and Biotechnology, but performed less strong in the Environment/Climate Change 
area. Performance in the societal challenge related to Socio-economic sciences and 
Humanities was also less strong than with FP7. However, this needs to be 
considered in the context of Socio-economic sciences and Humanities being 
mainstreamed across Horizon 2020. So far, Space has also decreased in relative 
importance in Horizon 2020. 
In summary, these results indicate that the UK performs very well in leading edge 
research (Ideas) and in mobility programmes (People) – areas where UK universities 
are primarily involved - but that the UK participates less, in relative terms, in more 
traditional R&D projects conducted under the Cooperation and Capacities 
programme (which have a greater involvement of research institutes, industry and 
public bodies). The thematic areas where the UK performed well reflect to some 
extent areas that have seen large R&D investments (e.g. pharmaceuticals and 
biotechnology). 
Strong presence of higher education institutions, and relatively less participation of 
industry compared to other European countries 
The UK’s participation in FP7 reflects a very substantial engagement in the 
programme by higher or secondary education (HES) organisations. They accounted 
for 60% of all UK participations and received 70% of all funding allocated to the UK. 
In comparison, for the programme overall HES organisations represented only 37% 
of FP7 participations and 43% of the funding. In none of the six other comparator 
countries were HES organisations as important.  
In contrast, UK private commercial organisations (PRC) had a lower presence in the 
programme compared with the EU overall. The UK industry share of UK participation 
in FP7 ranked 23th out of all EU27 member states during FP7 (26% compared to an 
average of 31%).  
Of the comparator countries, only in Finland did PRC organisations represent a lower 
share of participation than in the UK. In all the selected countries (including Finland), 
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PRC organisations represented a higher share of the EU funding allocated to the 
country than in the UK.  
As regards the UK's shares of overall participations, UK universities were again 
particularly notable, representing the largest share of overall FP7 university 
participation (21%), ahead of Germany (12%). UK businesses represented 11% of 
overall business participation in FP7 (third place). 
Presence of UK SMEs is similar to that of FP7 as a whole, with a particular strength 
in Capacities projects and a lower presence in People projects 
For the EU27, SMEs represented 18% of all FP7 participants and received 14% of all 
EU funding. In the UK, the importance of SMEs was only very slightly smaller: SMEs 
represented 17% of all UK participants and received 13% of the EU funding allocated 
to the UK. 
In terms of shares of overall SME participation in FP7, SMEs from the UK 
represented 12%, the second highest proportion behind Germany. The UK’s SME 
participation in Horizon 2020 so far is slightly above its level of UK engagement in 
FP7. 
7.2 Outputs, outcomes and impacts 
UK participants cited the access to new networks and partnerships, opportunities to 
conduct research on specific issues and the development of new tools and 
techniques as important outputs – these were the main reasons for participating in 
FP7, especially for universities. By contrast companies participating in FP7 rated the 
opportunities for prototype development and demonstrations / pilots, and gaining 
newly-acquired knowledge about industrial processes or business parameters as 
important outputs as the main reasons for participating. 
Peer-reviewed journal articles were widely reported as the key type of project output 
(87% of projects, 14.7 per project on average). A large proportion of FP7 projects 
recruited personnel specifically for the project (79%), with an average of just more 
than five Full Time Equivalents (FTEs) per project. Scientific exchanges were also 
very prevalent. 
More commercially oriented outputs were less prevalent across UK participants, 
unsurprising due to the focus on basic research in the majority of FP7 projects. Less 
than one in five (18%) of the respondents’ projects generated one or more new 
patent applications, and 7% applied for trademarks or registered designs as a result 
of an FP7 project. Around 26% of industry participants generated a patent application 
and 8% applied for a registered trademark / design. 
The most important outcomes for UK participants were the opportunity for follow-up 
research, and the improved ability to attract and retain staff. Companies rated (i) 
development of new products, services and/or processes, (ii) access to new markets 
and supply chains (both within and outside of the UK), and (iii) reduced time to 
market for new or improved products or services as among their most important 
outcomes. 
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7.2.1 Realised outcomes/impacts 
Over three quarters of participants report medium or high impacts in terms of: 
• increased understanding and knowledge, in both new and existing areas; 
• increased scientific and technological capabilities; 
• improved relationships and networks; 
• improved competitive position, and enhanced reputation; and 
• increased mobility and improved career development for researchers. 
40% or more of FP7 participants report high level outcomes in terms of increased 
understanding and knowledge, in both new and existing areas, increased scientific 
capabilities, and improved relationships and networks.  Increased technological 
capabilities, improved competitive position, improved career development for 
researchers and enhanced reputation also feature as areas where a large number 
(30% or more) of participants reported a high level of impact. 
Overall, businesses reported more frequently than universities that outcomes had 
been delivered below expectations. 
FP7 had a significant impact on forming new networks and partnerships 
FP7 played a key role in building new networks - approximately two-thirds (65%) of 
project partners were ‘new’ in the sense that the UK partner(s) had not previously 
worked with those organisations. This equates to an average of 8.4 new partners per 
FP7 project. Participants also reported that they expected to work again in the future 
with 46% of their FP7 project partners, which equates to a figure of 6.0 ‘future’ 
partners per project on average. This networking impact contributes to an enhanced 
set of relationships for UK organisations, based on the addition of newer and more 
useful partnerships and the cessation of less productive ones. 
The collaboration within FP7 contributed to the continuing evolution in relationships 
between UK researchers and other non-UK researchers: 
• An estimate of 45,500 new partnerships were formed between UK and non-
UK FP7 participants (65% of all UK partnerships were new so 24,500 of the 
partnerships were with pre-existing collaborators (35%)). 
• UK partners expect to work with approximately 32,200 (46%) of their FP7 
partners again in future. 
• An estimated minimum of 7,700 (24%) of these future collaborations will be 
with overseas partners that the UK partner first collaborated with during FP7. 
The impact of FP7 on creating new networks and accessing critical resources and 
knowledge outside of the UK was also highlighted in the five case studies, and 
therefore was the most widely-cited impact across all parts of the research 
programme (see Annex 3 for details). 
Around 17% of survey respondents reported an increase in employment 
Around 17% of respondents reported an increase in employment and 16% reported a 
safeguarding of employment. Just two respondents (<1%) reported a decrease in 
employment as a result of their project. These survey respondents reported that 3.9 
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FTEs on average had been created and 5.6 FTEs on average had been 
safeguarded. 
Around 22% of survey respondents reported some commercial Impacts 
As would be expected with a programme largely focussed on research activities 
which were not considered “close-to-market”, and in line with only 26% of participants 
coming from industry, only 22% of all respondents reported that some commercial 
benefit had been achieved. In most of these cases the commercial returns came from 
the direct use of the project results within the organisation or from sale or licensing of 
products or intellectual property developed through the project. 
Industry respondents reported commercial impacts much more frequently across all 
impacts queried. 39% of industry respondents reported commercial impacts from the 
direct use of project results, 18% said there were commercial impacts from sale or 
licensing of product, 11% described commercial impacts from sale or licensing of 
intellectual property. Among university respondents, 9% reported commercial impacts 
from the direct use of project results, 2% described commercial impacts from sale or 
licensing of product and 2% experienced commercial impacts from sale or licensing 
of intellectual property. 
Around 9% of all respondents were able to quantify commercial benefits, indicating 
an average net gain of €815,000, and an estimated total net gain of around €35 
million across their projects. 
Around half of all respondents (53%) stated that the project would not result in any 
commercial benefit (other than the FP7 funding for their participation in the project). 
Around 23% of survey respondents reported additional investments as a result of 
their project 
Nearly a quarter of respondents (23%) reported that some investment had been 
made as result of participation in the project, of which 38 (or 8% of all responses) 
were able to provide some quantification. These 38 attested to investments totalling 
some €30.5 million, an average of just over €780,000 per organisation. 
Impacts on policy development were indicated by 39% of survey respondents 
Around 39% of survey respondents stated that their project had exerted an impact on 
policy, in most cases at the European level (24% of projects) but also at international 
/ global level (11%). Only 4% of participants reported that their FP7 project had 
impacted on policy development at the national level. 
7.3 Added value of FP7 for UK researchers 
FP7 represented a significant funding source for the UK research community 
FP7 was a relatively more important funding source for the UK compared with other 
EU member states. Between 2007 and 2013, FP7 funding constituted 3.1% of the 
UK’s overall R&D investment. By comparison, FP7 made up 1.4% of R&D investment 
in Germany and 1.7% in France. FP7 was particularly significant for the UK’s higher 
education sector, where it represented 7.2% of investment in R&D in 2007-2013. 
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Vast majority of the activities funded would not have been possible without FP7 
Almost all (91%) of the UK participants stated that their projects would not have gone 
ahead without FP7 support. 
This represents roughly 41,000 new partnerships between UK and non-UK 
participants which would not have been established without FP7 funding, and 29,000 
future collaborations with non-UK participants that would have not materialised in the 
absence of FP7 funding. 
Without FP7 funding, around 5% of funded projects would have been possible with 
similar levels of outputs and impacts  
Around 5% of projects covered in the online survey of UK participants (22 out of 452) 
are considered to have been able to proceed achieving similar levels of outputs and 
impacts, in the absence of FP7 funding. These projects represented €37.8 million of 
EU funding or 7.4% of the total EU funding secured by survey respondents. This 
represents a minimum estimate for the deadweight effect of the programme.  
Only 8% of unsuccessful applicants were able to go ahead with their project in 
absence of FP7 funding without major changes or limitations to project activities. 
Funding and thematic areas in FP7 were highly relevant for UK stakeholders 
Three-quarters (75%) of participants answering the online survey indicated that the 
relevance of both the topics and the instruments were high or very high for the 
research they wished to conduct, suggesting that the type and thematic areas of 
funding offered by FP7 were of high relevance. 
Benefits outweighed costs for the majority of projects 
Responses to the online survey reveal very high levels of performance for FP7 
projects, with 80% of participants reporting that the benefits outweighed the costs 
(and 46% indicating that the benefit to cost ratio was very high). A further 13% of 
participants stated that benefits obtained were equal to the costs involved, and just 
6% indicated that the costs of participation had outweighed the benefits. 
FP7 enabled UK participants to collaborate with world leading partners 
According to survey respondents, the vast majority of FP7 projects are helping UK 
participants to cooperate with world-class organisations, and thereby access some of 
their scientific and technological expertise, know-how and equipment. Three-quarters 
(75%) of respondents considered that half or more of their partners were world class 
in terms of their scientific / technological competences and know-how, while almost 
two-thirds (64%) considered that half or more of their partners were world class in 
terms of their equipment, instruments and tools. 
For example, interviewees from areas related to the FP7 Health programme, such as 
biotechnology and medical research, highlighted its added value, because it 
provides: 
• access to specialist manufacturers; 
• access to scientific expertise and technical knowledge not available within UK; 
• access to particular combinations of data and resources; 
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• access to different regions of Europe to prepare and conduct a clinical trial; 
and 
• finance for clinical trials out of scope for most UK funding bodies. 
FP7 was perceived to be largely complementary to national programmes 
In the view of stakeholders, EU RTD Framework Programmes are largely 
complementary to research activities in the UK. Researchers and businesses in the 
UK can take national research to the EU level and collaborate with EU researchers.  
The EU RTD Framework Programme was perceived to create research at critical 
scale in some areas which might be too large for individual national programmes to 
tackle, such as in the area of diseases, energy technologies or fusion research. 
7.4 The role of national support services 
National support services, such as the network of national contact points, are an 
important support mechanism for specific groups of applicants that do not have in-
house expertise available. Applicants from larger institutions, such as large 
companies and universities, tend to use in-house support that offers a more in-depth 
assistance throughout the proposal preparation and project management lifecycle. 
For those FP7 participants who used the national contact points, their support was 
critical in 25% of cases. Unsuccessful applicants who were supported by NCPs 
reported in 13% of cases that their FP7 application would have not been possible 
without assistance from NCPs. 
First-time applicants and applicants without strong in-house support are most likely to 
need and appreciate help in understanding the programmes themselves, and are 
likely to need or appreciate help with sorting out the project and consortium 
arrangements. Qualitative feedback provided on the NCP support indicated that most 
respondents considered the advice provided by NCPs as valuable, however a small 
proportion of respondents felt that the support requested was not forthcoming or that 
the advice received was of little use, and more focus should be put on actively 
helping applicants to identify suitable project partners. 
7.5 Barriers to participation for businesses 
Businesses who had experience both with FP7 and EUREKA programmes 
highlighted the following reasons for choosing EUREKA programmes over FP7 or 
Horizon 2020 funding: 
Resources needed at a pre-application stage: it was felt that, to be successful, 
applicants need to invest significant resources at a pre-application stage in order to 
create contacts with European Commission staff and obtain a good understanding of 
the EU research agenda. The lack of resources to engage in this process was 
perceived as a barrier to SME participation. 
Resources needed at application stage: the application process was perceived as 
particularly burdensome. Complex application procedures combined with low 
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success rates represented an important barrier, especially for SMEs. Many 
commercial interviewees outlined that they had used services and resources of 
experienced academic institutions, to reduce their costs. 
Resources needed for administration: interviewees reported that resources for 
project management, monitoring and reporting are too high and not always covered 
by the project budget, thus causing high internal project management overheads. 
Low success rates, in particular for Horizon 2020: non-applicants reported that 
low success rates, in combination with the issues outlined above, have considerably 
increased the risk of applying for the Framework Programme.  
7.6 Analysis of COST 
The review of COST programme objectives and activities suggests that FP7 and 
COST are to a large extent, complementary programmes, but serve different 
objectives. COST actions are often seen as a precursor and provide support to 
prepare collaborative research which is then often funded under FP7. At the same 
time, COST actions are often used to help disseminate and promote project results of 
concluded research projects.  
FP7 is generally perceived by UK participants to provide stronger benefits, outputs 
and impacts relating to the implementation of research, improving knowledge and 
skills as well as in accessing research infrastructure or equipment. The picture is less 
clear as regards the mobility of researchers, support to career development and the 
creation of new networks and partnerships – areas where COST is seen as equally 
effective or more effective in delivering outputs and impacts. The COST office does 
not collect comprehensive data on results and impacts for each COST action, 
therefore a disaggregated analysis was not possible. 
For COST, the nature of the programme is such that UK participated in 98% of all 
actions. Hence there is no specific thematic focus reflected in the UK’s participation 
in COST. 
These results are broadly in line with the evidence presented by previous COST 
impact assessment studies.90 COST in its current form provides for a bottom-up 
networking instrument, which is unique in the European funding landscape.  
For the current Framework Programme Horizon 2020, stakeholders perceive COST 
to provide a bottom up networking instrument that is otherwise missing in the funding 
landscape. 
7.7 Analysis of EUREKA Eurostars-1 
The programme objectives and structure of EUREKA, in particular the EUREKA 
Eurostars-1 programme, are to some extent comparable to FP7 collaborative 
projects, in that they support collaborative R&D. However, they have a much clearer 
90 E.g. Technopolis (2014), COST impact assessment. 
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focus on industrial application than the majority of FP7 specific programmes and 
cater to mainly industrial participants. EUREKA Eurostars-1 funded mainly R&D 
performing SMEs, a group that was underrepresented in FP7. Therefore a direct like-
for-like comparison between EUREKA Eurostars-1 and FP7 was not possible. 
UK’s participation in EUREKA Eurostars-1 reflected the thematic strengths that were 
also visible in FP7. ICT (34%) and Biotech (26%) were the dominant sectors. Energy 
(8%), Manufacturing/Materials/Transport (9%) and agriculture and marine resources 
(7%) follow. 
Overall, stakeholders interviewed perceived Eurostars to be more effective in 
delivering commercial impacts. However the project reports reviewed suggest that 
Eurostars-1 projects reported smaller amounts on average than FP7 participants, if 
and when commercial impacts occurred. It was not possible to ascertain whether this 
was a result of different project size or differences in elapsed time during which 
commercial impacts could have occurred. 
EUREKA programmes provide specific added value and benefits for international, 
industry driven research – and are largely complementary to FP7 and other initiatives 
within the European funding landscape. 
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Annex 1 UK performance in FP7 
A1.1 Methodology employed in undertaking the analysis 
This section presents an analysis of UK ‘performance’ in FP7. It is based on CORDA 
data provided by BEIS in September 2015, relating to all applicants, proposals, 
participants and projects for FP7.  
Data was imported in the statistical software Stata. Stata was then used to produce 
the summary tables presented below. The analysis below complements data 
presented above in section 3. 
A1.1.1 Data used 
The data used include:  
• a list of all UK participants in FP7 projects; 
• a list of all participants in FP7 projects;  
• a list of all FP7 projects; and 
• a list of all proposals and applicants to FP7, including all (80,050) UK 
applicants in FP7 proposals91; 
The analysis of UK participants takes into account the 25,282 FP7 projects for which 
participants’ details were available. 18 FP7 projects are therefore excluded from the 
analysis of participants, as no participant data was available on these projects. 
A1.1.2 Definitions used 
The following definitions were used in this section. These definitions correspond with 
those used for similar studies. 
• Participations – individual participations in projects. The same organisation 
can have multiple project participations across different projects. 
• Participants – Number of discrete participations across a priority area, specific 
programme, country or FP7 overall, i.e. the number of organisation linked to a 
discrete (unique) participant ID. 
• FP7 Specific programme - The Specific Programmes constitute the five major 
building blocks of FP7: Cooperation, Ideas, People, Capacities, Nuclear 
Research. 
• FP7 priority areas / individual programmes – each specific programme 
includes a number of activity areas, these are described as priority areas or 
individual FP7 programmes – in detail these are presented in Table A1.1 
below.  
91 The 80,050 UK applicants identified in proposals include eight applicants for which the country was wrongly 
reported. Five of these applicants were not successful. It is not possible to determine whether the other three 
applicants were successful (the applicants dataset does not contain information on project ID so it is not possible 
to know nor does the participants dataset contain information on proposal ID).  
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Table A1.1 FP7 specific programmes and individual programmes/priority areas 
FP7 specific 
programme FP7 programme/priority area 
FP7 Cooperation Health 
FP7 Cooperation Food, Agriculture, and Biotechnology 
FP7 Cooperation Information & Communication Technologies 
FP7 Cooperation Nanosciences, Nanotechnologies, Materials and new Production Technologies 
FP7 Cooperation Energy 
FP7 Cooperation Environment (including Climate Change) 
FP7 Cooperation Transport (including Aeronautics) 
FP7 Cooperation Socio-economic sciences and Humanities 
FP7 Cooperation Space 
FP7 Cooperation Security 
FP7 Cooperation General Activities (Annex IV) 
FP7 Cooperation Joint Technology Initiatives (Annex IV-SP1) 
FP7 Ideas European Research Council 
FP7 People Marie-Curie Actions 
FP7 Capacities Research Infrastructures 
FP7 Capacities Research for the benefit of SMEs 
FP7 Capacities Regions of Knowledge 
FP7 Capacities Research Potential 
FP7 Capacities Science in Society 
FP7 Capacities Coherent development of research policies 
FP7 Capacities Activities of International Cooperation 
Euratom indirect actions  Nuclear Fission and Radiation Protection 
Euratom indirect actions Fusion Energy 
A1.2 Summary of analysis 
This section presents a short summary of the preliminary UK performance analysis in 
FP7. The key metrics of UK performance are summarises in bullet points below. 
• Importance of the UK within the FP7. The UK was present in no less than 
41% of all FP7 projects (10,372 out of 25,282). UK participations represented 
13% of the total applications to FP7 (17,695 out of 134,737). UK organisations 
scored even better in terms of funding: they managed to receive 15% of the 
total EU funding allocated to FP7 (€7,002m out of €45,335m). 
• Organisation type. Higher or secondary education (HES) organisations had a 
much larger importance in the UK than across all countries involved in FP7. In 
the UK, HES organisations represented 60% of all participations (versus 37% 
for FP7) and received 71% of EU funding (versus 43% for FP7). On the other 
hand, Private commercial organisations (PRC) and Research organisations 
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(REC) had a less important role in the UK than across all countries involved in 
FP7.  
• Business participations. Business participations represented 30.3% of all 
FP7 participations and received 25% of all EU funding across all participating 
countries. As mentioned above, PRC organisations had a less important role 
in the UK: they represented only 25.9% of all UK participations and received 
only 18% of the EU funding allocated to the UK.  
• SME participations. SME participations represented 18% of all FP7 
participations and received 14% of all EU funding. In the UK, this proportion 
was slightly smaller: SME represented 17% of all UK participations and 
received 13% of the EU funding allocated to the UK. 
• Specific programmes. In terms of the number of UK projects and UK 
participations, the specific programmes Cooperation and People were the 
most significant while in terms of the amount of EU funding allocated to UK 
organisations, the Cooperation and Ideas were most significant. However, 
when looking at shares of the FP7 totals, it appears that the UK performed 
particularly strongly in the specific programme People. The specific 
programme with the weakest performance was Euratom. 
• Success rates. Overall, UK performance in terms of success rates for FP7 
has been strong: the UK success rate by number of applications was more 
than 1.5 percentage points higher than the FP7 average for all participating 
countries (22.1% versus 20.5%), while the success rates by number of 
projects and by the amount of EU funding allocated were more than three 
percentage points higher than the FP7 averages (respectively 19.7% versus 
15.9% and 18.1% versus 15.0%).  
• Comparison with other innovation leaders and followers. Using the rank 
of individual countries in the Innovation Union Scoreboard ranking as a 
contextualising metric and comparing the UK to other countries classed either 
as innovation leaders or innovation followers, the UK was the second country 
to receive the most EU funding after Germany. However, the UK did not rank 
as well in terms of success rate by EU funding (5th after France, the 
Netherlands, Germany and Belgium) and in terms of success rate by 
applications (6th after the Netherlands, France, Belgium, Germany and 
Denmark).   
• Coordination levels. UK partners occupied the role of project coordinator in 
49% of the projects in which UK participants were involved, meaning UK 
participants were in a coordinating role for 29% of all UK FP7 participations. 
This is a much higher proportion than the overall FP7 coordinator-to-
participant ratio (18.8%). 
• Collaboration within FP7 projects. There were more than one UK partner in 
37% of the projects in which the UK was involved. In volume terms, the 
greatest number and share of collaborations took place with partners in 
Germany, followed by France, Italy and Spain. When looking at the ratio of 
each country’s share of all participations in UK projects to their overall share of 
FP7 participations, the most active ‘Member State’ collaboration partners were 
the Netherlands, Denmark, Sweden and Ireland. 
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A1.3 Detailed analysis 
This section presents a detailed analysis of UK performance in FP7. 
A1.3.1 Overall participation in FP7 by UK organisations 
The overall statistics on UK participation in FP7 are as follows: 
Demand: The total number of UK applications was 80,050 out of a total of 656,732 
for the whole of FP7. UK’s applications therefore constituted 12.1% of the total 
number of applications in FP7. UK organisations were involved in 52,696 proposals, 
out of a total of 158,609 proposals for the whole of FP7. UK organisations were 
therefore involved in 33.2% of all FP7 proposals. UK organisations requested a total 
of €38.6 billion in EU funding out of a total EU requested of €303.2 billion. UK 
organisations therefore requested 12.7% of all EU funding.  
Projects: UK organisations were involved in 10,372 projects, out of a total of 25,282 
projects for which participants details were available. UK organisations were 
therefore involved in 41.0% of all FP7 projects included in the analysis. 
Participations: The total number of UK participations was 17,695, out of a total of 
134,737 for the whole of FP7. UK’s participations therefore constituted 13.1% of the 
total number of participations in FP7. 
Organisations: A total of 2,909 discrete organisations from the UK participated in 
FP7, out of 28,985 participants (all countries). UK organisations therefore constituted 
10.0% of all organisations involved in FP7. 
Funding: UK organisations were allocated a total of €7.002 billion in EU funding92, 
out of a total EU allocation of €45.335 billion93. UK organisations therefore received 
15.4% of all EU funding. 
Table A1.2 provides a summary of success rates by proposals, by applications, and 
by funding for the UK and the whole of FP7. Overall, the UK had higher success 
rates than the FP7 average.  
  
92 The amounts of EU funding allocated was unknown for four UK organisations and have therefore been 
excluded from the totals. 
93 The amounts of EU funding allocated was unknown for 49 organisations and have therefore been excluded 
from the totals. 
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Table A1.2 Summary of success rates 
Success rates UK FP7 
By proposals  
(no. of projects / no. of proposals) 19.7% 15.9% 
By applications 
(no. of participants / no. of applicants) 22.1% 20.5% 
By funding 
(amount of EU funding allocated / amount of EU funding requested) 18.1% 15.0% 
A1.3.2 UK Participation in FP7 by specific programme and priority area 
Table A1.3 provides a breakdown of key statistics on UK participation in FP7 
(projects, participations, organisations and EU funding) by specific programme and 
priority area.  
Regarding the specific programmes Cooperation, Capacities and Euratom, the share 
of FP7 projects in which the UK were involved was significantly higher than average. 
However, for these three programmes, the share of participations, organisations and 
EU funding received were roughly in line or below the UK averages for the entire FP7 
programme. 
On the contrary, regarding the specific programmes Ideas and People, the share of 
FP7 projects in which the UK was involved in was lower than average. However, for 
these two programmes, the share of participations and EU funding received was 
higher than the UK averages for the entire FP7 programme. 
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Table A1.3 Number of projects, participations and organisations, and EU funding for UK and total FP7, by specific programme and priority 
area  
Specific 
programme 
FP7 programme/priority area 
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FP7 
Cooperation 
Health 756 1,008 75% 1,692 11,348 15% 358 3,466 10% 808 4,792 17% 
Food, Agriculture, and 
Biotechnology 
375 516 73% 804 7,926 10% 288 3,260 9% 241 1,851 13% 
Information & Communication 
Technologies 
1,354 2,328 58% 2,423 22,701 11% 671 6,552 10% 916 7,875 12% 
Nanosciences, 
Nanotechnologies, Materials 
and new Production 
Technologies 
493 804 61% 1,062 10,304 10% 429 4,616 9% 352 3,237 11% 
Energy 186 374 50% 395 4,401 9% 206 2,288 9% 144 1,851 8% 
Environment (including Climate 
Change) 
360 494 73% 835 7,173 12% 274 2,979 9% 238 1,719 14% 
Transport (including 
Aeronautics) 433 701 62% 936 8,907 11% 333 3,329 10% 260 2,269 11% 
Socio-economic sciences and 
Humanities 
212 253 84% 361 2,782 13% 113 1,212 9% 94 580 16% 
Space 158 267 59% 299 2,641 11% 109 1,089 10% 96 713 13% 
Security 217 319 68% 448 3,950 11% 221 1,885 12% 157 1,332 12% 
General Activities (Annex IV) 7 26 27% 8 183 4% 8 132 6% 4 313 1% 
Joint Technology Initiatives 
(Annex IV-SP1) 
266 783 34% 693 6,198 11% 272 2,499 11% 340 2,184 16% 
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Specific 
programme 
FP7 programme/priority area 
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Sub-total: FP7 Cooperation 4,817 7,873 61% 9,956 88,514 11% 3,282 33,307 10% 3,650 28,716 13% 
FP7 Ideas European Research Council 1,072 4,539 24% 1,235 5,462 23% 90 765 12% 1,715 7,710 22% 
FP7 People Marie-Curie Actions 3,328 10,705 31% 4,000 19,565 20% 355 3,547 10% 1,086 4,778 23% 
FP7 
Capacities 
Research Infrastructures 267 341 78% 627 5,276 12% 146 1,657 9% 273 1,528 18% 
Research for the benefit of 
SMEs 609 1,029 59% 1,358 9,165 15% 743 5,587 13% 189 1,250 15% 
Regions of Knowledge 25 84 30% 66 1,007 7% 58 870 7% 9 127 7% 
Research Potential 5 206 2% 5 307 2% 4 228 2% 6 378 2% 
Science in Society 123 183 67% 205 1,835 11% 117 1,105 11% 35 288 12% 
Coherent development of 
research policies 
8 27 30% 19 131 15% 19 115 17% 2 28 6% 
Activities of International 
Cooperation 29 157 18% 35 1,400 3% 20 668 3% 5 173 3% 
Sub-total: FP7 Capacities 1,066 2,027 53% 2,315 19,121 12% 1,107 10,230 11% 519 3,773 14% 
Euratom 
indirect 
actions  
Nuclear Fission and Radiation 
Protection 86 134 64% 181 2,008 9% 52 525 10% 31 353 9% 
Fusion Energy 3 4 75% 8 67 12% 8 58 14% 1 5 20% 
Sub-total: Euratom 89 138 64% 189 2,075 9% 60 583 10% 32 358 9% 
TOTAL 10,372 25,282 41% 17,695 134,737 13% 4,894 48,432 10% 7,002 45,335 15% 
NB: Subtotals for discrete organisations do not add up as the same organisation can participate in several programmes/priority areas.  
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Table A1.4 explores further the results presented in Table A1.3 by looking at the 
importance of the UK in FP7 in terms of projects, participations, organisations and 
EU funding, by type of organisations. It appears that compared to the average UK 
organisation, UK businesses (PRC) represented a smaller share of FP7 projects with 
UK involvement, a smaller share of UK participations in FP7 and a smaller share of 
total EU funding allocated to UK.  
UK businesses were involved in the highest share of projects in the Capacities 
programme. Higher or secondary education organisations were involved in the most 
number of projects in the Cooperation programme, and represented 28.7% of all 
HES organisations in the Ideas specific programme. HES organisations from the UK 
were allocated 32% out of the total EU budget allocated to all HES organisations in 
FP7. 
Table A1.4 Share of UK in FP7 (projects, participations, organisations and EU 
funding), by specific programme and type of organisations 
Share of FP7 
projects with UK 
involvement 
Capaciti
es 
Cooperati
on Euratom Ideas People Total 
Higher or secondary 
education organisations 
(HES) 
34.6% 49.7% 46.6% 29.4% 37.9% 40.3% 
Private commercial 
organisations (PRC) 43.4% 33.0% 38.0% 3.0% 20.9% 33.1% 
Research organisations 
(REC) 16.7% 11.8% 18.6% 5.9% 6.8% 10.6% 
Public bodies (PUB) 15.4% 20.3% 12.2% 21.4% 15.0% 18.7% 
Other (OTH) 13.9% 12.7% 7.1% 0.0% 3.9% 12.1% 
Total 52.6% 61.2% 64.5% 23.6% 31.1% 41.0% 
 
Share of UK 
participations in all 
FP7 
Capaciti
es 
Cooperati
on Euratom Ideas People Total 
Higher or secondary 
education organisations 
(HES) 
16.2% 18.3% 14.6% 28.7% 27.5% 21.2% 
Private commercial 
organisations (PRC) 15.5% 10.1% 11.7% 2.9% 12.5% 11.2% 
Research organisations 
(REC) 6.5% 4.3% 4.2% 5.6% 5.4% 4.8% 
Public bodies (PUB) 6.4% 9.0% 6.5% 20.0% 12.2% 8.6% 
Other (OTH) 7.0% 8.7% 5.9% 0.0% 2.7% 7.7% 
Total 12.1% 11.2% 9.1% 22.6% 20.4% 13.1% 
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Share of FP7 
projects with UK 
involvement 
Capaciti
es 
Cooperati
on Euratom Ideas People Total 
Share of UK 
organisations in all 
FP7 
Capaciti
es 
Cooperati
on Euratom Ideas People Total 
Higher or secondary 
education organisations 
(HES) 
9.5% 6.7% 14.3% 14.6% 10.7% 6.2% 
Private commercial 
organisations (PRC) 13.8% 11.2% 10.2% 5.7% 13.5% 11.8% 
Research organisations 
(REC) 5.4% 5.1% 5.9% 6.9% 4.4% 5.0% 
Public bodies (PUB) 5.4% 7.5% 6.3% 23.1% 5.1% 7.1% 
Other (OTH) 8.6% 10.6% 5.3% 0.0% 5.2% 9.2% 
Total 11.0% 9.7% 10.1% 11.8% 10.0% 10.0% 
 
Share of total EU 
funding allocated 
to UK  
Capaciti
es 
Cooperati
on Euratom Ideas People Total 
Higher or secondary 
education organisations 
(HES) 
16.6% 22.1% 15.9% 28.4% 32.0% 25.2% 
Private commercial 
organisations (PRC) 20.7% 9.9% 15.4% 3.0% 14.3% 11.3% 
Research organisations 
(REC) 6.2% 4.4% 4.1% 5.5% 4.6% 4.8% 
Public bodies (PUB) 14.1% 13.3% 9.2% 14.4% 5.0% 12.2% 
Other (OTH) 5.5% 5.9% 2.8% 0.0% 2.9% 5.5% 
Total 13.8% 12.7% 9.1% 22.2% 22.7% 15.4% 
Table A1.5 provides a breakdown of the share of UK participations by project start 
year. The share of UK participations remained fairly constant throughout time for the 
specific programmes Cooperation, Ideas, Euratom and Capacities. On the other 
hand, the UK saw an improvement in its share of participations for People (from 5% 
in 2007 to 30% in 2014). 
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Table A1.5 Share of UK participations in FP7, by specific programme/priority area and 
by project start year 
Specific 
programme 
FP7 programme/priority area 
20
07
 
20
08
 
20
09
 
20
10
 
20
11
 
20
12
 
20
13
 
20
14
* 
FP7 
Cooperation 
Health  15% 14% 15% 16% 15% 14% 18% 
Food, Agriculture, and 
Biotechnology  10% 9% 10% 11% 11% 9% 10% 
Information & Communication 
Technologies 8% 10% 10% 10% 11% 11% 12% 11% 
Nanosciences, 
Nanotechnologies, Materials and 
new Production Technologies 
 9% 11% 9% 11% 10% 11% 9% 
Energy 0% 10% 8% 9% 9% 8% 9% 8% 
Environment (including Climate 
Change) 0% 13% 10% 10% 13% 13% 12% 12% 
Transport (including Aeronautics) 10% 9% 11% 10% 13% 10% 11% 4% 
Socio-economic sciences and 
Humanities 18% 15% 13% 10% 13% 14% 12% 12% 
Space 0% 10% 8% 11% 8% 13% 13% 20% 
Security  9% 11% 11% 11% 11% 13% 12% 
General Activities (Annex IV) 0% 7% 4% 0% 7% 0%   
Joint Technology Initiatives 
(Annex IV-SP1)   13% 9% 12% 13% 10% 10% 
Sub-total: FP7 Cooperation 9% 11% 11% 11% 12% 11% 12% 12% 
FP7 Ideas European Research Council  18% 19% 21% 24% 24% 26% 21% 
FP7 People Marie-Curie Actions 5% 19% 19% 20% 17% 19% 21% 30% 
FP7 
Capacities 
Research Infrastructures 10% 11% 12% 10% 13% 11% 13% 17% 
Research for the benefit of SMEs 4% 14% 13% 16% 17% 15% 14% 15% 
Regions of Knowledge  1% 6% 9% 7% 8% 10% 0% 
Research Potential  3% 0% 0% 0% 0% 0% 17% 
Science in Society 0% 10% 16% 8% 11% 9% 11% 10% 
Coherent development of 
research policies  0% 6% 12% 0% 43% 21% 17% 
Activities of International 
Cooperation  2% 1% 3% 7% 2% 2% 1% 
Sub-total: FP7 Capacities 9% 11% 11% 12% 14% 13% 12% 13% 
Euratom 
indirect 
actions  
Nuclear Fission and Radiation 
Protection  10% 10% 10% 8% 9% 8% 8% 
Fusion Energy  11% 100%    0%  
Sub-total: Euratom  10% 10% 10% 8% 9% 8% 8% 
Total 8% 12% 12% 12% 13% 13% 14% 16% 
NB: blanks mean there were no participations at the FP7 level for that specific year and that specific 
programme/priority area. 134,607 observations (incl. 17,675 for UK) 
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* All projects started in 2014 or later 
Table A1.6 provides a breakdown of the share of EU funding allocated to UK 
organisations by project start year. Over the years, the UK saw its share of EU 
funding decrease for Euratom (from 14% in 2008 to 3% in 2014). However, it also 
saw some improvements in terms of share of EU funding for Cooperation (from 2% in 
2007 to 13% in 2014), Capacities (from 6% in 2007 to 14% in 2014) and People 
(from 10% in 2007 to 29% in 2014). 
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Table A1.6 Share of total EU funding in FP7 allocated to UK organisations, by specific 
programme/priority area and by project start year 
Specific 
programme 
FP7 programme/priority area 
20
07
 
20
08
 
20
09
 
20
10
 
20
11
 
20
12
 
20
13
 
20
14
* 
FP7 
Cooperation 
Health  16% 19% 18% 18% 16% 14% 23% 
Food, Agriculture, and 
Biotechnology  13% 14% 12% 15% 13% 10% 18% 
Information & Communication 
Technologies 11% 11% 13% 11% 13% 11% 13% 9% 
Nanosciences, 
Nanotechnologies, Materials 
and new Production 
Technologies 
 9% 12% 9% 12% 10% 13% 9% 
Energy 0% 9% 8% 9% 8% 5% 9% 7% 
Environment (including 
Climate Change) 0% 14% 12% 14% 15% 14% 14% 14% 
Transport (including 
Aeronautics) 7% 10% 14% 10% 13% 10% 11% 4% 
Socio-economic sciences and 
Humanities 52% 19% 16% 13% 21% 14% 15% 15% 
Space 0% 8% 12% 10% 13% 14% 15% 28% 
Security  14% 10% 12% 10% 11% 13% 12% 
General Activities (Annex IV) 0% 13% 17% 0% 7% 0%   
Joint Technology Initiatives 
(Annex IV-SP1)   16% 14% 16% 21% 13% 14% 
Sub-total: FP7 Cooperation 2% 14% 19% 12% 14% 13% 13% 13% 
FP7 Ideas European Research Council  19% 19% 21% 22% 24% 26% 20% 
FP7 People Marie-Curie Actions 10% 20% 20% 22% 19% 20% 25% 29% 
FP7 Capacities 
Research Infrastructures 6% 15% 27% 10% 13% 11% 28% 13% 
Research for the benefit of 
SMEs 6% 14% 13% 18% 16% 16% 14% 13% 
Regions of Knowledge  1% 4% 7% 13% 8% 9% 0% 
Research Potential  0% 0% 0% 0% 0% 0% 23% 
Science in Society 0% 14% 18% 9% 12% 8% 13% 12% 
Coherent development of 
research policies  0% 3% 10% 0% 7% 16% 24% 
Activities of International 
Cooperation  4% 1% 2% 4% 2% 3% 1% 
Sub-total: FP7 Capacities 6% 13% 20% 12% 13% 11% 14% 14% 
Euratom indirect 
actions  
Nuclear Fission and Radiation 
Protection  15% 8% 11% 8% 10% 6% 3% 
Fusion Energy  4% 100%    0%  
Sub-total: Euratom  14% 10% 11% 8% 10% 6% 3% 
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Specific 
programme 
FP7 programme/priority area 
20
07
 
20
08
 
20
09
 
20
10
 
20
11
 
20
12
 
20
13
 
20
14
* 
Total 3% 13% 16% 14% 16% 16% 17% 18% 
NB: blanks mean there was no EU funding at the FP7 level for that specific year and that specific 
programme/priority area. 134,607 observations (incl. 17,675 for UK) 
* All projects started in 2014 or later 
A1.3.2.2 By UK organisations 
Participations 
The standard classification of participants in FP7 by organisation type contains five 
main categories. These are: 
• PUB – public bodies 
• REC – research organisations 
• HES – higher or secondary education organisations 
• PRC – private commercial organisations 
• OTH – other 
Table A1.7 compares the breakdown of UK participations by organisation type with 
the breakdown for all FP7 participations. 
The data indicate that UK’s participation profile in terms of participation by different 
types of organisation was different to that of FP7 as a whole. First, HES accounted 
for a significantly larger proportion of UK participations (60%) than that of overall FP7 
(37%). Secondly, PRC and REC from UK accounted for less than the FP7 average 
(26% versus 30% and 9% versus 25% respectively). 
The divergence between the participation of HES and REC comparing UK to the FP7 
average is likely a function of different national research & innovation systems, and 
different institutional landscapes. For instance, in Germany, which has a research & 
innovation system strongly build on research organisations such as Fraunhofer and 
the Helmholtz institutes, the REC category represented 28% of the total German FP7 
participations. In France, the REC category represented 39% of all participations, 
with a strong performance of the Centre National de la Recherche Scientifique 
CNRS).In France in turn, the proportion of the HES category was considerably below 
the FP7 average (17% versus 37%).  
The share of participations accounted for by government bodies (PUB) and other 
types of organisations (OTH) from the UK were roughly in line with FP7 averages. 
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Table A1.7 Breakdown of UK FP7 participations and all FP7 participations, by 
organisation type 
Organisation Type Number (and share) of 
participations – UK 
Number (and share) of 
participations – FP7 overall 
Higher or secondary education 
organisations (HES) 10,662 (60%) 50,239 (37%) 
Private commercial organisations (PRC) 4,577 (26%) 40,834 (30%) 
Research organisations (REC) 1,602 (9%) 33,256 (25%) 
Public bodies (PUB) 530 (3%) 6,193 (5%) 
Other (OTH) 324 (2%) 4,215 (3%) 
Total 17,695 (100%) 134,737 (100%) 
A1.3.2.3 EU Funding 
UK organisations were allocated a total of €7.002 billion in EU funding from FP7, out 
of a total EU allocation of €45.335 billion. UK organisations therefore received 15.4% 
of all EU funding. 
The average volume of EU funding allocated to each UK organisation throughout the 
lifetime of FP7 was €2.406 million. Across FP7 as a whole the average amount of EU 
funding per organisation was around €1.564 million. The average volume of EU 
funding allocated to UK organisations per participation was around €395,700. Again, 
this was higher than the average for FP7 as a whole (around €336,470). 
Table A1.8 shows the total EU funding allocations for UK organisations, by 
organisation type, and compares these to EU allocations as a whole. The data show 
that UK HES were allocated a total of €4.951 billion in EU funding. This represented 
71% of all EU funding to UK organisations, a significantly larger than that obtained by 
HES across FP7 as a whole (43%). For PRC, REC and PUB organisations, the 
respective shares of UK’s total were roughly in line or slightly lower than the shares 
of EU funding obtained across FP7 as a whole. Other UK organisations were 
allocated €59 million. This represented 8% of UK’s total EU funding, significantly 
lower than the share of EU funding received by other organisations across FP7 as a 
whole (27%). 
Again, the proportion of EU funding allocated to PRC and REC organisations was 
much larger in Germany and France than in the UK. The proportion of EU funding 
allocated to HES organisations was substantially larger in the UK (71% versus 38% 
in Germany and 14% in France).  
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Table A1.8 EU funding, by organisation type, allocated to UK and in FP7 in total 
Organisation Type EU funding allocated to UK 
organisations in FP7 (€m) 
Total EU funding allocated in 
FP7 (€m) 
Higher or secondary education 
organisations (HES) 4,951 (71%) 19,678 (43%) 
Private commercial 
organisations (PRC) 1,263 (18%) 11,162 (25%) 
Research organisations (REC) 582 (8%) 12,235 (27%) 
Public bodies (PUB) 146 (2%) 1,193 (3%) 
Other (OTH) 59 (1%) 1,067 (2%) 
Total 7,001 (100%) 45,335 (100%) 
As shown in 0, the share of UK participation and of EU funding allocated to the UK in 
FP7 kept increasing towards the end of the programme for HES and PUB 
organisations. The share of participations for other organisations remained fairly 
constant through time between 2008 and 2014. 
Table A1.9 Share of UK participations in FP7, by organisation type and by project 
start year 
Organisation Type (UK share of 
overall FP7 participations) 2007 2008 2009 2010 2011 2012 2013 2014* 
Higher or secondary education 
organisations (HES) 15% 19% 20% 19% 21% 22% 22% 27% 
Private commercial organisations 
(PRC) 7% 10% 11% 11% 11% 11% 12% 12% 
Research organisations (REC) 5% 5% 5% 5% 5% 5% 4% 5% 
Public bodies (PUB) 3% 7% 7% 8% 9% 10% 10% 10% 
Other (OTH) 0% 9% 9% 5% 10% 7% 7% 8% 
Overall share of FP7 participation 8% 12% 12% 12% 13% 13% 14% 17% 
134,607 observations (incl. 17,675 for UK) 
* All projects started in 2014 or later 
Table A1.10 shows that the share of EU funding allocated to the UK in FP7 kept 
increasing towards the end of the programme for HES and REC organisations. The 
share of funding for other organisations remained fairly constant through time 
between 2008 and 2014. 
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Table A1.10 Share of EU funds allocated to UK participations, by organisation type and 
by project start year 
Organisation Type (UK share of 
overall FP7 participations) 2007 2008 2009 2010 2011 2012 2013 2014* 
Higher or secondary education 
organisations (HES) 23% 22% 24% 23% 25% 26% 27% 28% 
Private commercial organisations 
(PRC) 6% 9% 16% 10% 11% 10% 12% 10% 
Research organisations (REC) 1% 4% 6% 5% 6% 4% 4% 6% 
Public bodies (PUB) 11% 14% 12% 9% 12% 14% 13% 10% 
Other (OTH) 0% 11% 7% 5% 11% 6% 6% 6% 
Overall share of FP7 participation 3% 13% 16% 14% 16% 16% 17% 18% 
134,607 observations (incl. 17,675 for UK) 
* All projects started in 2014 or later 
A1.3.2.4 Business participation 
As illustrated in Table A1.11, the total number of UK PRC participations was 4,577 
out of a total of 40,834 for the whole of FP7, with UK business participations 
representing 11.2% of all business participations in FP7. Business participations 
represented 30.3% of all FP7 participations. The share of UK business participations 
compared to overall UK participations was lower (25.9%). However, UK business 
organisations represented a higher proportion of participations than the average for 
FP7 for the specific programmes Capacities and Euratom. 
Compared to German and French businesses, UK business organisations 
represented a higher proportion of participations for Capacities (48% versus 35% for 
each of Germany and France) but a lower proportion of participations for Cooperation 
(32% versus 40% in Germany and 45% in France).  
Table A1.11 Number of business participations, by specific programme and priority 
area 
Specific 
programme 
FP7 programme/priority area 
UK business 
participations (% of 
total UK 
participations) 
FP7 business 
participation (% of 
total) 
FP7 
Cooperation 
Health 263 (15.5%) 2,203 (19.4%) 
Food, Agriculture, and Biotechnology 170 (21.1%) 2,002 (25.3%) 
Information & Communication 
Technologies 
796 (32.9%) 8,551 (37.7%) 
Nanosciences, Nanotechnologies, 
Materials and new Production 
Technologies 
480 (45.2%) 4,630 (44.9%) 
Energy 182 (46.1%) 1,939 (44.1%) 
Environment (including Climate Change) 146 (17.5%) 1,393 (19.4%) 
Transport (including Aeronautics) 456 (48.7%) 4,396 (49.4%) 
Socio-economic sciences and 10 (2.8%) 135 (4.9%) 
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Specific 
programme FP7 programme/priority area 
UK business 
participations (% of 
total UK 
participations) 
FP7 business 
participation (% of 
total) 
Humanities 
Space 87 (29.1%) 802 (30.4%) 
Security 206 (46.0%) 1,665 (42.2%) 
General Activities (Annex IV) 1 (12.5%) 9 (4.9%) 
Joint Technology Initiatives (Annex IV-
SP1) 
356 (51.4%) 3,352 (54.1%) 
Sub-total: FP7 Cooperation 3,153 (31.7%) 31,077 (35.1%) 
FP7 Ideas European Research Council 2 (0.2%) 70 (1.3%) 
FP7 People Marie-Curie Actions 253 (6.3%) 2,017 (10.3%) 
FP7 Capacities 
Research Infrastructures 62 (9.9%) 434 (8.2%) 
Research for the benefit of SMEs 988 (72.8%) 6,077 (66.3%) 
Regions of Knowledge 17 (25.8%) 307 (30.5%) 
Research Potential 0 (0%) 6 (2.0%) 
Science in Society 30 (14.6%) 182 (9.9%) 
Coherent development of research 
policies 
4 (21.1%) 18 (13.7%) 
Activities of International Cooperation 10 (28.6%) 150 (10.7%) 
Sub-total: FP7 Capacities 1,111 (48.0%) 7,174 (37.5%) 
Euratom 
indirect actions  
Nuclear Fission and Radiation 
Protection 
58 (32%) 496 (24.7%) 
Fusion Energy 0 (0%)) 0 (0%) 
Sub-total: Euratom 58 (30.7%) 496 (23.9%) 
Total 4,577 (25.9%) 40,834 (30.3%) 
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From Table A1.12, it appears that the share of UK business participations in overall 
FP7 business participations improved with time for the specific programmes 
Cooperation and People. However, the UK did not perform as well in other 
programmes, for which the share of participations remained stable or decreased over 
time.  
Table A1.12 Share of UK business participations in overall FP7 business 
participations, by specific programme and by project start year 
Specific programme 2007 2008 2009 2010 2011 2012 2013 2014* 
Cooperation 6% 9% 10% 9% 11% 10% 11% 11% 
Ideas  0% 0% 0% 0% 8% 0% 5% 
People 0% 14% 15% 12% 8% 13% 12% 20% 
Capacities 31% 15% 14% 17% 16% 15% 15% 15% 
Euratom  14% 11% 20% 6% 8% 12% 0% 
Total 7% 10% 11% 11% 11% 11% 12% 12% 
NB: blanks mean there were no participations at the FP7 level for that specific year and that specific programme. 
40,803 observations (incl. 4,574 for UK) 
* All projects started in 2014 or later 
As illustrated in Table A1.13, the total EU funding allocated to UK businesses 
amounted to €1,263 million out of a total of €11,162 million allocated to businesses in 
all of FP7. EU funding to businesses represented 24.6% of all FP7 allocated EU 
funding. In the UK, the share of EU funding received by PRC was lower (18.0%). 
However, UK business organisations were allocated a higher proportion of EU 
funding than the average for FP7 for the specific programmes Capacities and 
Euratom. These results are consistent with the findings from Table A1.11. 
German and French organisations were allocated a higher proportion of EU funding 
than UK businesses (27% for each of Germany and France versus 18% for the UK). 
The proportion of businesses in Capacities and Euratom projects was larger in the 
UK than in Germany or France. However, the proportion of businesses in 
Cooperation and People projects was smaller in the UK than in Germany or France. 
Table A1.13 EU funding to businesses, by specific programme 
Specific programme 
UK business - EU funding 
allocations (€m) (% of total UK 
allocated EU funding) 
Total EU funding allocations to 
business (€m) (% of total 
allocated EU funding) 
Cooperation 913 (25.0%) 9,230 (32.1%) 
Ideas 2 (0.1%) 79 (1%)  
People 72 (6.6%) 502 (10.5%) 
Capacities 266 (51.3%) 1,288 (34.1%) 
Euratom 10 (29.6%) 63 (17.5%)  
Total 1,263 (18.0%) 11,162 (24.6%) 
NB: 40,803 observations (incl. 4,574 for UK) 
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Table A1.14 shows the evolution of the share of EU funding allocated to UK 
businesses in overall EU funding to businesses. Results are broken down by specific 
programme. There are no clearly identifiable patterns. 
Table A1.14 Share of EU funding allocated to UK businesses in overall EU funding to 
businesses, by specific programme and by project start year 
Specific programme 2007 2008 2009 2010 2011 2012 2013 2014* 
Cooperation 6% 8% 11% 9% 10% 10% 11% 10% 
Ideas  0% 0% 0% 0% 11% 0% 4% 
People 0% 18% 15% 12% 8% 13% 15% 24% 
Capacities 26% 14% 41% 18% 16% 15% 22% 14% 
Euratom  37% 9% 21% 6% 16% 16% 0% 
Total 6% 9% 16% 10% 11% 10% 12% 10% 
NB: blanks mean there was no EU funding at the FP7 level for that specific year and that specific programme. 
40,803 observations (incl. 4,574 for UK) 
* All projects started in 2014 or later 
A1.3.2.5 SME participation 
As illustrated in Table A1.15, the total number of UK SME participations was 3,034 
out of a total of 24,336 for the whole of FP7, with UK SME participations representing 
12.4% of all SME participations in FP7. SME participations represented 18% of all 
FP7 participations. The share of UK SME participations was slightly lower (17.1%). 
However, UK SME organisations represented a higher proportion of participations 
than the average for FP7 for the specific programmes Capacities and Cooperation.  
Table A1.15 Number of SME participations, by specific programme 
Specific programme UK SME participations (% of 
total UK participations) 
FP7 SME participation (% of 
total) 
Cooperation 1,918 (19.3%) 16,582 (18.7%) 
Ideas 2 (0.2%) 29 (0.5%) 
People 136 (3.4%) 1,106 (5.7%) 
Capacities 967 (41.8%) 6,496 (34%) 
Euratom 11 (5.8%) 123 (5.9%) 
Total 3,034 (17.1%) 24,336 (18.1%) 
As illustrated in Table A1.16, the total EU funding allocated to UK SMEs amounted to 
€890 million out of a total of €6,367 million allocated to SMEs in all of FP7. EU 
funding to SMEs represented 14% of all FP7 allocated EU funding to SMEs. UK SME 
organisations were allocated a higher proportion of EU funding than the average for 
FP7 for the specific programmes Capacities (50.6% versus 34.5%). These results are 
consistent with the findings from Table A1.15. 
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Table A1.16 EU funding to SME, by specific programme 
Specific programme 
UK SMEs - EU funding 
allocations (€m) (% of total UK 
allocated EU funding) 
Total EU funding allocations to 
SMEs (€m) (% of total allocated 
EU funding) 
Cooperation 587 (16.1%) 4,752 (16.5%) 
Ideas 0.15 (0.01%) 21 (0.3%) 
People 39 (3.6%) 274 (5.7%) 
Capacities 262 (50.6%) 1,300 (34.5%) 
Euratom 1.7 (5.1%) 19 (5.3%) 
Total 890 (12.7%) 6,367 (14%) 
A1.3.2.6 Innovation Union Scoreboard  
Table A1.17 provides a summary of success rates by EU funding and by applications 
for all countries classified as Innovation leaders or Innovation followers in the 
Innovation Union Scoreboard (2013)(IUS).94 The table is sorted by the final column, 
so the countries listed towards to the top of the table are those where the share of 
EU27 funding was the highest. 
The UK was the second country to receive the most EU funding after Germany. 
However, the UK was ranked 5th in terms of success rate by EU funding (after 
France, the Netherlands, Germany and Belgium) and 6th in terms of success rate by 
applications (after the Netherlands, France, Belgium, Germany and Denmark). 
Table A1.17 Success rate by EU funding and by applications, share of EU27 funding, 
by innovation leader and innovation follower countries 
Member State IUS category 
Success rate by 
EU funding 
Success rate by 
applications 
Share of EU 
funding totals 
under FP7, 
allocated to EU27 
Germany Innovation leader  19.1% 23.4% 17.7% 
United 
Kingdom Innovation follower 
18.1% 22.1% 17.3% 
France Innovation follower 23.1% 24.6% 12.9% 
Netherlands Innovation follower 20.2% 24.8% 8.4% 
Belgium Innovation follower 18.6% 23.6% 4.5% 
Sweden Innovation leader  15.5% 22.0% 4.3% 
Austria Innovation follower 16.4% 21.7% 2.9% 
Denmark Innovation leader  15.6% 23.1% 2.7% 
Finland Innovation leader  13.0% 20.5% 2.2% 
Ireland Innovation follower 15.4% 20.5% 1.5% 
Slovenia Innovation follower 9.4% 15.4% 0.4% 
Estonia Innovation follower 14.3% 20.9% 0.2% 
Cyprus Innovation follower 9.3% 14.4% 0.2% 
94 https://ec.europa.eu/growth/industry/innovation/facts-figures/scoreboards_de [accessed 21st November 2016] 
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Member State IUS category 
Success rate by 
EU funding 
Success rate by 
applications 
Share of EU 
funding totals 
under FP7, 
allocated to EU27 
Luxembourg Innovation follower 15.8% 22.1% 0.1% 
A1.3.2.7 By specific programme and thematic priority area 
Table A1.18 shows the number of UK projects and participations, and the volume of 
EU funding allocated, in each of the FP7 specific programmes and priority areas. 
Due to the differing scales of the different programmes/priority areas within FP7 it is 
not possible to draw conclusions on the performance of UK from this table. The 
specific programmes Cooperation and People were the most significant in terms of 
the number of UK projects and UK participations. However, the Cooperation and 
Ideas were the specific programmes for which the UK received the most EU funding.   
Table A1.18 Number of UK projects, participations, and EU funding, by specific 
programme and priority area 
Specific 
programme 
FP7 programme/priority 
area 
Number of projects 
with UK 
involvement 
Number of UK 
participations 
EU funding 
allocated to UK 
organisations (€ 
million) 
FP7 
Cooperation 
Health 756 1,692 808 
Food, Agriculture, and 
Biotechnology 375 804 241 
Information & 
Communication 
Technologies 
1,354 
 
2,423 916 
Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
493 1,062 352 
Energy 186 395 144 
Environment (including 
Climate Change) 
360 835 238 
Transport (including 
Aeronautics) 433 936 260 
Socio-economic sciences 
and Humanities 212 361 94 
Space 158 299 96 
Security 217 448 157 
General Activities (Annex 
IV) 7 8 4 
Joint Technology 
Initiatives (Annex IV-SP1) 266 693 340 
Sub-total: FP7 
Cooperation 4,817 9,956 3,650 
FP7 Ideas European Research 1,072 1,235 1,715 
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Specific 
programme 
FP7 programme/priority 
area 
Number of projects 
with UK 
involvement 
Number of UK 
participations 
EU funding 
allocated to UK 
organisations (€ 
million) 
Council 
FP7 People Marie-Curie Actions 3,328 4,000 1,086 
FP7 
Capacities 
Research Infrastructures 267 627 273 
Research for the benefit of 
SMEs 609 1,358 189 
Regions of Knowledge 25 66 9 
Research Potential 5 5 6 
Science in Society 123 205 35 
Coherent development of 
research policies 
8 19 2 
Activities of International 
Cooperation 29 35 5 
Sub-total: FP7 
Capacities 1,066 2,315 519 
Euratom 
indirect 
actions  
Nuclear Fission and 
Radiation Protection 86 181 31 
Fusion Energy 3 8 1 
Sub-total: Euratom 89 189 32 
Total 10,372 17,695 7,002 
In order to place the raw numbers shown in Table A1.18 in context, projects with UK 
involvement, UK participations and EU funding allocated to UK organisations have 
been expressed as a share of the FP7 totals for each priority area. The results are 
shown in 0, and (+), (=) and (-) have been used to symbolise whether UK has 
performed comparatively strongly or less well in each area, as compared to UK’s 
overall performance in FP795. For example, across FP7 as a whole the UK 
participated in 41% of the projects, so we can say that a project participation rate of 
40% in the research infrastructures area is ‘close to average’ (=) while involvement in 
75% of Health projects is ‘above’ average (+). 
The results indicate that the UK performed particularly strongly in the specific 
programme People. The specific programme with the weakest performance was 
Euratom. In terms of involvements in projects, the UK performed comparably strong 
in all FP7 Cooperation programmes apart from General Activities (Annex IV) and the 
Joint Technology Initiatives. In terms of the numbers of participations and the share 
of total EU funding allocated, the UK performed comparably strong in programmes of 
the European Research Council and the Marie Curie Actions. 
95 (-): difference between UK’s performance in priority area and K’s overall performance <-2% 
(=): difference between UK’s performance in priority area and K’s overall performance [-2%; 2%] 
(+): difference between UK’s performance in priority area and K’s overall performance >2% 
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Table A1.19 UK projects, participations and EU funding, expressed as a share of FP7 
totals, by specific programme and priority area 
Specific 
program
me 
FP7 programme/priority 
area 
Share of total 
number of projects 
Share of total 
number of 
participations 
Share of total EU 
funding 
FP7 
Cooperat
ion 
Health 75% (+) 15% (=) 17% (=) 
Food, Agriculture, and 
Biotechnology 73% (+) 10% (-) 13% (=) 
Information & 
Communication 
Technologies 
58% (+) 11% (=) 12% (-) 
Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
61% (+) 10% (-) 11% (-) 
Energy 50% (+) 9% (-) 8% (-) 
Environment (including 
Climate Change) 73% (+) 12% (=) 14% (=) 
Transport (including 
Aeronautics) 62% (+) 11% (=) 11% (-) 
Socio-economic sciences 
and Humanities 84% (+) 13% (=) 16% (=) 
Space 59% (+) 11% (=) 13% (=) 
Security 68% (+) 11% (=) 12% (-) 
General Activities (Annex 
IV) 27% (-) 4% (-) 1% (-) 
Joint Technology Initiatives 
(Annex IV-SP1) 34% (-) 11% (=) 16% (=) 
Sub-total: FP7 
Cooperation 61% (+) 11% (=) 13% (=) 
FP7 
Ideas 
European Research 
Council 24% (-) 23% (+) 22% (+) 
FP7 
People Marie-Curie Actions 31% (+) 20% (+) 23% (+) 
FP7 
Capacitie
s 
Research Infrastructures 78% (+) 12% (=) 18% (+) 
Research for the benefit of 
SMEs 59% (+) 15% (=) 15% (=) 
Regions of Knowledge 30% (-) 7% (-) 7% (-) 
Research Potential 2% (-) 2% (-) 2% (-) 
Science in Society 67% (+) 11% (=) 12% (-) 
Coherent development of 
research policies 30% (-) 15% (=) 6% (-) 
Activities of International 
Cooperation 18% (-) 3% (-) 3% (-) 
Sub-total: FP7 Capacities 53% (+) 12% (=) 14% (=) 
Euratom 
indirect 
Nuclear Fission and 
Radiation Protection 64% (+) 9% (-) 9% (-) 
179 
 
Evaluation of UK involvement with EU research programmes 
Specific 
program
me 
FP7 programme/priority 
area 
Share of total 
number of projects 
Share of total 
number of 
participations 
Share of total EU 
funding 
actions  Fusion Energy 75% (+) 12% (=) 20% (+) 
Sub-total: Euratom 64% (+) 9% (-) 9% (-) 
Total 41.0% 13.1% 15.4% 
 
Table A1.20 compares the profile of UK participation across the specific programmes 
and the priority areas with the profile of all FP7 participations, and these data are 
then split out for each type of organisation. Ratios are calculated by comparing the 
proportion of UK participations accounted for by a specific programme and priority 
area with the proportion of all participations accounted for by that programme/area. 
As such, percentages greater than 100% indicate that UK participation has been 
higher in this area compared with the overall FP7 profile of the UK. 
The data indicate the UK participation has been higher in the following 
programmes/priority areas: Health (Cooperation), European Research Council 
(Ideas), Marie-Curie Actions (People), Research for the benefit of SMEs and 
Coherent development of research policies (Capacities). 
Table A1.20 Comparison of profile of UK FP7 participations, by specific programme 
and priority area (overall and then by organisation type) 
Specific 
program
me 
FP7 programme/priority 
area 
Overall 
ratio 
HES PRC REC PUB 
Other 
(OTH) 
FP7 
Coopera
tion 
Health 114% 102% 107% 136% 92% 79% 
Food, Agriculture, and 
Biotechnology 
77% 69% 76% 129% 140% 128% 
Information & 
Communication 
Technologies 
81% 82% 83% 45% 99% 146% 
Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
78% 82% 92% 69% 40% 143% 
Energy 68% 78% 84% 37% 76% 110% 
Environment (including 
Climate Change) 
89% 83% 94% 146% 123% 108% 
Transport (including 
Aeronautics) 
80% 96% 93% 59% 84% 70% 
Socio-economic 
sciences and Humanities 
99% 85% 66% 113% 68% 47% 
Space 86% 102% 97% 108% 146% 61% 
Security 86% 90% 110% 59% 135% 115% 
General Activities 
(Annex IV) 
33% 118% 99% 74% 23% 145% 
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Specific 
program
me 
FP7 programme/priority 
area 
Overall 
ratio HES PRC REC PUB 
Other 
(OTH) 
Joint Technology 
Initiatives (Annex IV-
SP1) 
85% 84% 95% 83% 246% 184% 
Sub-total: FP7 
Cooperation 86% 86% 91% 89% 105% 113% 
FP7 
Ideas 
European Research 
Council 172% 135% 25% 117% 234% 0% 
FP7 
People Marie-Curie Actions 156% 129% 112% 113% 143% 35% 
FP7 
Capaciti
es 
Research Infrastructures 90% 85% 127% 151% 99% 88% 
Research for the benefit 
of SMEs 113% 89% 145% 188% 132% 89% 
Regions of Knowledge 50% 55% 49% 56% 100% 53% 
Research Potential 12% 13% 0% 16% 0% 0% 
Science in Society 85% 71% 147% 71% 55% 132% 
Coherent development 
of research policies 
110% 88% 198% 358% 112% 163% 
Activities of International 
Cooperation 19% 26% 59% 8% 10% 59% 
Sub-total: FP7 
Capacities 92% 76% 138% 134% 74% 91% 
Euratom 
indirect 
actions  
Nuclear Fission and 
Radiation Protection 69% 68% 104% 87% 76% 77% 
Fusion Energy 91% 79% n/a 83% n/a n/a 
Sub-total: Euratom 69% 69% 104% 87% 76% 77% 
NB: PUB = public bodies, REC = research organisations, HES = higher or secondary education organisations, 
PRC = private commercial organisations and OTH = other 
A1.3.2.8 By type of instrument 
FP7 employed a range of different types of instruments (projects and actions) to 
implement its priorities.96 
Table A1.21 shows the numbers of projects and participations, and the volume of EU 
funding, achieved by UK participations for the main types of instrument covered by 
the FP7 database. As with the specific programmes/priority areas, the various 
instruments were used to a greater or lesser degree across FP7 and so it is not 
96 Research for the Benefit of Specific Groups (BSG-CSO, BSG-SME and BSG-SME-AG) / Collaborative Projects 
(CP, CP-FP, CP-FP-INFSO, CP-FP-INFSO-NET, CP-FP-SICA, CP-IP, CP-IP-INFSO-FET, CP-IP-SICA, CP-
SICA, CP-SICA-INFSO, CP-SOU and CP-TP) / Coordination and Support Actions (CSA-CA, CSA-CA-INFSO-
FET, CSA-ERANET, CSA-ERA-PLUS, CSA-SA, CSA-SA(POC) and CSA-SA-INFSO-FET) / CP-CSA (CP-CSA, 
CP-CSA-INFRA, CP-CSA-INFRA-IP and CP-CSA-INFRA-PP) / Support for Frontier Research (ERC-AG, ERC-
CG, ERC-SG and ERC-SYG) / Support for Training and Career Development of Researchers (MC-CIG,MC-
COFUND, MC-ERG, MC-IAPP, MC-IEF, MC-IIF, MC-IIFR, MC-IOF, MC-IRG, MC-IRSES AND MC-ITN) / Joint 
Technology Initiatives (JTI-CP-ARTEMIS, JTI-CP-ENIAC, JTI-CP-FCH, JTI-CP-IMI, JTI-CS, JTI-CSA-FCH) / 
Networks of Excellence (NoE). 
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possible to draw firm conclusions on the performance of UK from this table. However, 
in terms of numbers alone, UK participation was highest for CPs and MCs. 
Looking at the number of projects, of participations as well as the amount of EU 
funding allocated for European Research Council and Marie Curie - MC, the UK is 
ahead of Germany and France, as well as all other comparator countries.  
Table A1.21 UK projects, participations and EU funding, by type of instrument 
Instrument  
Number of projects 
Number of 
participations 
EU funding (€ million) 
Research for the Benefit of 
Specific Groups (BSG) 
583 1,318 182 
Collaborative Projects (CP) 3,904 8,161 3,117 
Coordination and Support 
Actions (CSA) 
1,008 1,632 233 
CP-CSA 214 565 286 
Support for Frontier Research 
(ERC) 
1,037 1,199 1,710 
Support for Training and Career 
Development of Researchers 
(Marie Curie -MC) 
3,312 3,982 1,085 
Joint Technology Initiatives 
(JTI) 
266 683 340 
Networks of Excellence (NoE) 48 145 50 
Total  10,372 17,695 7,002 
 
In order to place the raw numbers shown in Table A1.22 in context, UK projects, 
participations and EU funding have been expressed as a share of the FP7 totals for 
each type of instrument. The results are shown in Table A1.22, and (-), (=) and (+) 
have been used to symbolise whether the UK has used each type of instrument 
comparatively more frequently or less frequently, as compared to UK’s overall 
performance in FP797. 
Table A1.22 UK projects, participations and EU funding, expressed as a share of FP7 
totals, by type of instrument 
Instrument  Project share Participation 
share 
EU funding 
share 
Research for the Benefit of Specific 
Groups (BSG) 
60.2% (+) 15.0% (=) 15.1% (=) 
Collaborative Projects (CP) 65.7% (+) 11.6% (=) 12.7% (-) 
Coordination and Support Actions 
(CSA) 
39.2% (=) 8.1% (-) 8.1% (-) 
CP-CSA 80.8% (+) 10.9% (-) 15.8% (=) 
97 (-): difference between UK’s performance with instrument and UK’s overall performance <-2% 
(=): difference between UK’s performance with instrument and UK’s overall performance [-2%; 2%] 
(+): difference between UK’s performance with instrument and UK’s overall performance >2% 
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Instrument  Project share Participation 
share 
EU funding 
share 
Support for Frontier Research (ERC) 23.8% (-) 22.9% (+) 22.3% (+) 
Support for Training and Career 
Development of Researchers (Marie 
Curie -MC) 
32.0% (-) 22.1% (+) 22.9% (+) 
Joint Technology Initiatives (JTI) 34.0% (-) 11.2% (=) 15.6% (=) 
Networks of Excellence (NoE) 84.2% (+) 13.0% (=) 16.0% (=) 
Total 41.0% 13.1% 15.4% 
Table A1.23 compares the profile of UK participation across the different types of 
instruments with the profile of all FP7 participations, and these data are then split out 
for each type of organisation. As in Table A1.20 , ratios are calculated by comparing 
the proportion of UK participations accounted for by a specific type of instrument with 
the proportion of all participations accounted for by that instrument. As such, 
percentages greater than 100% indicate that UK participation has been higher with 
this instrument compared with the overall FP7 profile. 
The data indicate the UK participation has been higher for the following instruments: 
BSGs, ERCs and Marie-Curie projects. 
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Table A1.23 Comparison of profile of UK FP7 participations, by type of instrument 
(overall and then by organisation type) 
Instrument  Overall 
ratio HES PRC REC PUB 
Other 
(OTH) 
Research for the Benefit of 
Specific Groups (BSG) 
114% 88% 146% 193% 228% 92% 
Collaborative Projects (CP) 89% 88% 89% 91% 149% 125% 
Coordination and Support 
Actions (CSA) 
62% 64% 97% 76% 49% 85% 
CP-CSA 83% 77% 123% 134% 108% 65% 
Support for Frontier Research 
(ERC) 
174% 136% 31% 121% 234% 0% 
Support for Training and Career 
Development of Researchers 
(Marie Curie -MC) 
169% 137% 118% 121% 280% 147% 
Joint Technology Initiatives 
(JTI) 
85% 84% 95% 83% 246% 184% 
Networks of Excellence (NoE) 99% 90% 81% 95% 173% 0% 
NB: PUB = public bodies, REC = research organisations, HES = higher or secondary education organisations, 
PRC = private commercial organisations and OTH = other 
Table A1.24 shows the profile of involvement of each of the main groups of 
participants in each of the instruments, overall for FP7 and for UK only. For example, 
the UK participants in BSG projects were mainly private commercial organisations 
(76% of the participations). The profile of UK involvement in BSGs shows that most 
of its involvement was through the private sector, with the remaining participation in 
BSGs split between higher or secondary education organisations (14% of the 
participations) and other types of organisations.    
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Table A1.24 Profile of involvement in each type of instrument, split by organisation 
type for all FP7 participants and UK only  
Instrument  HES PRC REC PUB Other (OTH) Total 
BSG UK only 14% 72% 9% 1% 3% 100% 
all FP7  12% 66% 15% 1% 7% 100% 
CP UK only 55% 31% 9% 3% 2% 100% 
all FP7  34% 36% 25% 3% 2% 100% 
CSA UK only 46% 25% 13% 8% 8% 100% 
all FP7  28% 19% 28% 16% 10% 100% 
CP-CSA UK only 56% 11% 25% 6% 2% 100% 
all FP7  38% 9% 43% 7% 4% 100% 
ERC UK only 93% 0% 6% 0% 0% 100% 
all FP7  74% 1% 25% 0% 0% 100% 
MC UK only 87% 6% 6% 1% 0% 100% 
all FP7  66% 11% 22% 1% 0% 100% 
JTI UK only 37% 51% 7% 2% 2% 100% 
all FP7  24% 54% 20% 1% 1% 100% 
NoE UK only 79% 8% 11% 3% 0% 100% 
all FP7  53% 11% 31% 2% 2% 100% 
NB: PUB = public bodies, REC = research organisations, HES = higher or secondary education organisations, 
PRC = private commercial organisations and OTH = other 
A1.3.2.9 Nature of FP7 participation  
Participants in FP7 can occupy the role of project coordinator or are otherwise listed 
simply as one of the participants. Analysis of UK’s FP7 participations reveals that UK 
partners occupied the role of project coordinator in 5,101 cases, or 49% of the 
projects in which UK participants were involved. This means that the UK participants 
were in a coordinating role for 29% of all UK FP7 participations, which was more than 
the FP7 average of 19%. As a comparison, 17% of German participants and 21% of 
French participants were in a coordinating role. 
Table A1.25 presents the number of UK coordinators for each type of instrument and 
the ratio of UK coordinators to participants. The average FP7 coordinator to 
participant ratio for each type of instrument is also shown for comparison. The data 
indicate that UK partners occupied the role of coordinator to a higher degree than 
might have expected within BSG, MC and JTI projects. UK coordination was lower 
than might have expected primarily for the ERC projects.  
The coordinator to participant ratio was higher in France than in the UK or Germany 
for ERC projects (89% in France versus 81% for the UK and Germany). The ratio 
was however much higher in the UK for Marie Curie –MC projects than in France or 
Germany (70% versus 44-57%). 
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Table A1.25 UK coordination levels by type of instrument 
Instrument  
Number of UK 
coordinators 
Coordinator to 
participant 
ratio 
(UK) 
Coordinator to 
participant 
ratio 
(FP7 overall) 
Research for the Benefit of Specific 
Groups (BSG) 
183 13.9% 11.0% 
Collaborative Projects (CP) 782 9.6% 8.5% 
Coordination and Support Actions (CSA) 222 13.6% 12.8% 
CP-CSA 29 5.1% 5.1% 
Support for Frontier Research (ERC) 970 80.9% 83.1% 
Support for Training and Career 
Development of Researchers (Marie 
Curie -MC) 
2,799 70.3% 57.5% 
Joint Technology Initiatives (JTI) 105 15.2% 12.6% 
Networks of Excellence (NoE) 11 7.6% 5.1% 
Total  5,101 28.8% 18.8% 
Patterns of UK coordination by F7 specific programmes and priority areas have also 
been analysed, and are shown in Table A1.26. It reveals a significantly higher than 
expected coordination rate for UK in the specific programme Ideas (70% versus 
55%). The only specific programme for which the coordinator to participant ratio was 
lower than expected was Euratom. 
As a comparison, Germany and France had a smaller coordinator to participant ratio 
for People projects than the UK (44-55% versus 70%), but a higher ratio for Euratom 
projects (11-14% versus 5%).  
Table A1.26 UK coordination levels by specific programme and priority area 
Specific 
programme 
FP7 programme/priority area 
Number of UK 
coordinators 
Coordinator to 
participant ratio 
(UK) 
Coordinator to 
participant ratio 
(FP7 overall) 
FP7 
Cooperation 
Health 180 11% 9% 
Food, Agriculture, and 
Biotechnology 
75 9% 7% 
Information & Communication 
Technologies 
237 10% 10% 
Nanosciences, 
Nanotechnologies, Materials and 
new Production Technologies 
96 9% 8% 
Energy 35 9% 8% 
Environment (including Climate 
Change) 
70 8% 7% 
Transport (including 
Aeronautics) 
81 9% 8% 
Socio-economic sciences and 
Humanities 
50 14% 9% 
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Specific 
programme FP7 programme/priority area 
Number of UK 
coordinators 
Coordinator to 
participant ratio 
(UK) 
Coordinator to 
participant ratio 
(FP7 overall) 
Space 38 13% 10% 
Security 39 9% 8% 
General Activities (Annex IV) 2 25% 14% 
Joint Technology Initiatives 
(Annex IV-SP1) 
105 15% 13% 
Sub-total: FP7 Cooperation 1,008 10% 9% 
FP7 Ideas European Research Council 1,004 81% 83% 
FP7 People Marie-Curie Actions 2,812 70% 55% 
FP7 
Capacities 
Research Infrastructures 41 7% 6% 
Research for the benefit of 
SMEs 
190 14% 11% 
Regions of Knowledge 4 6% 8% 
Research Potential 2 40% 67% 
Science in Society 25 12% 10% 
Coherent development of 
research policies 
2 11% 21% 
Activities of International 
Cooperation 
3 9% 11% 
Sub-total: FP7 Capacities 267 12% 11% 
Euratom 
indirect 
actions  
Nuclear Fission and Radiation 
Protection 
9 5% 7% 
Fusion Energy 1 13% 6% 
Sub-total: Euratom 10 5% 7% 
Total 5,101 29% 19% 
A1.3.2.10 Collaboration within FP7 projects 
Number of participants in UK FP7 projects 
The average number of partners in projects in which UK participated was 8.35, 
higher than the average number of participants in a ‘typical’ FP7 project (n=5.33). 
Collaboration between UK organisations within FP7 projects 
With 17,695 participations across 10,372 projects it is clear that in some cases more 
than one UK partner was involved in the same FP7 project. In fact, there were 3,828 
FP7 projects with more than one UK partner involved (37% of the projects in which 
the UK was involved). The profile of intra-UK collaboration within the 10,372 projects 
is shown in Table A1.27 below. The largest number of UK participants in a single 
FP7 project was 18. 
  
187 
 
Evaluation of UK involvement with EU research programmes 
Table A1.27 Number and share of UK FP7 projects with UK partners 
UK partners Number of FP7 projects Share of FP7 projects 
1 (no intra-UK collaboration) 6,544 63.1% 
2 2,062 19.9% 
3 932 9.0% 
4 410 4.0% 
5 205 2.0% 
6 107 1.0% 
7 50 0.5% 
8 25 0.2% 
9 19 0.2% 
10 8 0.1% 
11 4 0.04% 
12 4 0.04% 
13 1 0.01% 
18 1 0.01% 
Total 10,372 100.0% 
Table A1.28 shows the extent of intra-UK collaboration within each of the FP7 
specific programmes and priority areas. It reveals that there have been high levels 
(more than 50%) of intra-UK collaborations for the following programmes: 
Cooperation, Capacities and Euratom. The level of intra-UK collaborations was lower 
for Ideas (13%) and People (14%). 
Table A1.28 UK projects with intra-UK collaboration, by specific programme and 
priority area 
Specific 
programme 
FP7 
programme/priority 
area 
UK projects 
UK projects 
with more 
than 1 UK 
partner 
Share of 
projects with 
more than 
one UK 
partner 
FP7 
Cooperation 
Health 756 434 57.4% 
Food, Agriculture, and 
Biotechnology 
375 212 56.5% 
Information & 
Communication 
Technologies 
1,354 651 48.1% 
Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
493 282 57.2% 
Energy 186 94 50.5% 
Environment (including 
Climate Change) 
360 217 60.3% 
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Specific 
programme 
FP7 
programme/priority 
area 
UK projects 
UK projects 
with more 
than 1 UK 
partner 
Share of 
projects with 
more than 
one UK 
partner 
Transport (including 
Aeronautics) 
433 235 54.3% 
Socio-economic sciences 
and Humanities 
212 100 47.2% 
Space 158 70 44.3% 
Security 217 126 58.1% 
General Activities (Annex 
IV) 
7 1 14.3% 
Joint Technology Initiatives 
(Annex IV-SP1) 
266 147 55.3% 
Sub-total: FP7 
Cooperation 
4,817 2,569 53.3% 
FP7 Ideas European Research Council 
1,072 137 12.8% 
FP7 People Marie-Curie Actions 3,328 480 14.4% 
FP7 
Capacities 
Research Infrastructures 267 154 57.7% 
Research for the benefit of 
SMEs 
609 367 60.3% 
Regions of Knowledge 25 15 60.0% 
Research Potential 5 0 0.0% 
Science in Society 123 48 39.0% 
Coherent development of 
research policies 
8 6 75.0% 
Activities of International 
Cooperation 
29 5 17.2% 
Sub-total: FP7 Capacities 1,066 595 55.8% 
Euratom 
indirect 
actions  
Nuclear Fission and 
Radiation Protection 
86 45 52.3% 
Fusion Energy 3 2 66.7% 
Sub-total: Euratom 89 47 52.8% 
Total 10,372 3,828 36.9% 
Table A1.29 shows the extent of intra-UK collaboration for each type of instrument. It 
reveals that there have been high levels of intra-UK collaborations for the following 
instruments: NoE, CP-CSA and BSG. The level of intra-UK collaborations was lower 
for ERC and Marie Curie projects. 
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Table A1.29 UK projects with intra-UK collaboration, by type of instrument 
Instrument 
UK projects 
UK projects 
with more than 
1 UK partner 
Share of 
projects with 
more than one 
UK partner 
Research for the Benefit of Specific 
Groups (BSG) 
583 358 61.4% 
Collaborative Projects (CP) 3,904 2173 55.7% 
Coordination and Support Actions 
(CSA) 
1,008 361 35.8% 
CP-CSA 214 141 65.9% 
Support for Frontier Research (ERC) 1,037 136 13.1% 
Support for Training and Career 
Development of Researchers (Marie 
Curie –MC) 
3,312 478 14.4% 
Joint Technology Initiatives (JTI) 266 147 55.3% 
Networks of Excellence (NoE) 
48 34 70.8% 
Total 10,372 3,828 36.9% 
Collaboration with actors from different countries 
There were 68,946 participations by organisations from other countries in UK FP7 
projects, with the partners being drawn from a total of 119 different countries. 
Table A1.30 presents data on the number and share of participations by actors 
from other countries within UK projects. 
In volume terms the greatest number and share of collaborations took place with 
partners in Germany, followed by France, Italy and Spain. However, this reflects 
mainly the high levels of participation in FP7 by these countries as a whole. A 
better indicator of the strength of collaboration between the UK and other countries 
is shown in the final column, which expresses the ratio of each country’s share of 
all participations in UK projects to their overall share of FP7 participations. Using 
this indicator, the most active ‘Member State’ collaboration partners were the 
Netherlands, Denmark, Sweden and Ireland. 
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Table A1.30 UK collaboration with actors from different countries  
 Country  
Participation
s in 
UK projects 
Share of all 
other 
participations 
in 
UK projects 
Ratio of participation 
in UK projects to 
overall level of FP7 
participation 
O
ld
 E
U
 m
em
be
r s
ta
te
s 
(E
U
15
)-U
K
 
Austria 1,956 2.8% 107.9% 
Belgium 3,351 4.9% 119.0% 
Denmark   1,733 2.5% 121.6% 
Finland 1,641 2.4% 117.4% 
France 7,413 10.8% 114.0% 
Germany  11,085 16.1% 118.8% 
Greece 2,177 3.2% 114.1% 
Ireland 1,216 1.8% 121.2% 
Italy 6,963 10.1% 114.1% 
Luxembourg 154 0.2% 119.4% 
Netherlands 5,166 7.5% 122.4% 
Portugal 1,306 1.9% 107.9% 
Spain 6,304 9.1% 109.4% 
Sweden 2,829 4.1% 121.5% 
N
ew
 E
U
 m
em
be
rs
 S
ta
te
s 
(E
U
12
) 
Bulgaria 420 0.6% 116.1% 
Cyprus 282 0.4% 119.0% 
Czech Republic 864 1.3% 119.0% 
Estonia 307 0.4% 109.5% 
Hungary 893 1.3% 108.4% 
Latvia 164 0.2% 96.2% 
Lithuania 250 0.4% 116.0% 
Malta 101 0.1% 101.7% 
Poland 1,308 1.9% 115.5% 
Romania 606 0.9% 111.3% 
Slovakia 295 0.4% 118.4% 
Slovenia 548 0.8% 115.9% 
Th
ird
 c
ou
nt
rie
s 
Europe (other) 5,078 7.4% 113.9% 
Americas 994 1.4% 130.2% 
Africa 728 1.1% 116.3% 
Asia 2,605 3.8% 98.6% 
Oceania 209 0.3% 157.1% 
Collaboration between different types of organisation 
The partners in the UK FP7 projects breakdown by organisation type as shown in the 
final column of Table A1.31. For comparison, the table also re-shows the breakdown 
of all FP7 participations and all UK participations by organisation type. 
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The UK has a considerably higher HES participation than UK partners (60% versus 
32%) and slightly lower participation by other activity types. 
Table A1.31 Partners in UK FP7 projects, by organisation type 
Organisation Type  Participations - 
UK 
Participations – 
FP7 overall 
Partners in UK 
projects 
Higher or secondary education 
organisations (HES) 
10,662 (60%) 50,239 (37%) 22,113 (32%) 
Private commercial 
organisations (PRC) 
4,577 (26%) 40,834 (30%) 22,064 (32%) 
Research organisations (REC) 1,602 (9%) 33,256 (25%) 19,045 (28%) 
Public bodies (PUB) 530 (3%) 6,193 (5%) 3,418 (5%) 
Other (OTH) 324 (2%) 4,215 (3%) 2,306 (3%) 
Total  17,695 (100%) 134,737 (100%) 68,946 (100%) 
A1.3.2.11 UK participation in proposals and success rates 
Proposals submitted to FP7 with UK applications 
The number of discrete proposals in which UK applicants were named was 
calculated as 52,696. The CORDA data provided indicates that the total number of 
proposals submitted to FP7 was 158,609, so we can calculate that UK’s application 
rate measured in proposals was 33.2%. This is an indicator of the level of ‘demand’ 
for participation in FP7 by UK organisations. 
Table A1.32 provides a breakdown of the number of discrete proposals over time. 
The share of proposals with UK application was roughly constant through time until 
2013. In 2014, the proportion jumped from around 32% to almost 59%, possibly a 
function of the expected gap in funding opportunities at the EU level during the 
transition from FP7 to Horizon 2020. 
Table A1.32 Number of discrete proposals in which UK applicants are named and 
number of total discrete proposals, by year of call deadline 
 2007 2008 2009 2010 2011 2012 2013 2014 Total 
FP7 25,354 16,389 20,370 19,878 25,739 29,311 21,522 46 158,609 
UK 8,833 5,456 7,105 6,227 8,561 9,566 6,921 27 52,696 
Share of 
UK 34.8% 33.3% 34.9% 31.3% 33.3% 32.6% 32.2% 58.7% 33.2% 
Table A1.33 shows the breakdown of FP7 proposals with UK involvement, by specific 
programme and priority area. In terms of numbers alone, proposals with UK 
application were most numerous in the specific programme Cooperation. However, 
the share of bids with UK involvement was the highest for the following programme: 
Euratom.  
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Table A1.33 Number of proposals with UK involvement, compared to total number of 
FP7 proposals by specific programme and priority area 
Specific 
programme 
FP7 programme/priority area All proposals UK proposals 
Demand – 
share of bids 
with UK 
involvement 
FP7 
Cooperation 
Health 7,107 3,086 43% 
Food, Agriculture, and 
Biotechnology 
3,042 1,767 58% 
Information & Communication 
Technologies 
17,299 9,485 55% 
Nanosciences, Nanotechnologies, 
Materials and new Production 
Technologies 
6,555 2,151 33% 
Energy 2,163 917 42% 
Environment (including Climate 
Change) 
3,396 1,653 49% 
Transport (including Aeronautics) 3,186 1,772 56% 
Socio-economic sciences and 
Humanities 
2,729 1,770 65% 
Space 1,005 535 53% 
Security 1,815 1,143 63% 
General Activities (Annex IV) 73 16 22% 
Joint Technology Initiatives 
(Annex IV-SP1) 
2,948 933 32% 
Sub-total: FP7 Cooperation 51,318 25,228 49% 
FP7 Ideas European Research Council 44,923 8,003 18% 
FP7 People Marie-Curie Actions 50,937 14,812 29% 
FP7 
Capacities 
Research Infrastructures 926 592 64% 
Research for the benefit of SMEs 5,917 3,104 52% 
Regions of Knowledge 458 113 25% 
Research Potential 2,287 44 2% 
Science in Society 873 494 57% 
Coherent development of 
research policies 
56 18 32% 
Activities of International 
Cooperation 
613 121 20% 
Sub-total: FP7 Capacities 11,130 4,486 40% 
Euratom 
indirect 
actions  
Nuclear Fission and Radiation 
Protection 
290 163 56% 
Fusion Energy 11 4 36% 
Sub-total: Euratom 301 167 55% 
Total 158,609 52,696 33% 
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Table A1.34 shows the breakdown of FP7 proposals with UK application, by type of 
instrument, and gives an indication of the relative level of demand for involvement in 
each type. In terms of numbers alone UK’s proposal application rate was highest in 
proposals submitted in relation to NoE and CP-CSA projects. UK application rates 
were lowest in relation to ERCs actions. 
Table A1.34 Proposals with UK involvement, compared to total number of FP7 
proposals by type of instrument 
Type of instrument  All 
proposals 
UK 
proposals 
Demand – share of 
bids with UK 
involvement 
Research for the Benefit of Specific 
Groups (BSG) 
5,747 3,051 53.1% 
Collaborative Projects (CP) 44,138 22,339 50.6% 
Coordination and Support Actions (CSA) 9,632 2,946 30.6% 
CP-CSA 782 511 65.3% 
Support for Frontier Research (ERC) 44,869 7,994 17.8% 
Support for Training and Career 
Development of Researchers (Marie Curie 
-MC) 
50,293 14,774 29.4% 
Joint Technology Initiatives (JTI) 2,948 933 31.6% 
Networks of Excellence (NoE) 200 148 74.0% 
Total 158,609 52,696 33% 
UK applications in proposals submitted to FP7 
There were 80,050 UK applications in FP7 proposals. The data indicates that there 
were a total of 656,732 applications in all of the submitted proposals received under 
FP7, so UK’s share of the applications in proposals is calculated as 12%. This is an 
indicator of the level of ‘demand’ for participation in FP7 by individual applications. 
Table A1.35 provides a breakdown of the number of applications over time. The 
share of UK applications was roughly constant through time until 2013. In 2014, there 
was a slight increase in the proportion of UK applications.  
Table A1.35 Number of UK applications in proposals and total number of 
applications, by year of call deadline 
 2007 2008 2009 2010 2011 2012 2013 2014 Total 
FP7 127,041 76,232 91,657 77,631 100,483 110,785 72,283 620 656,732 
UK 13,886 8,743 10,717 9,485 12,926 14,561 9,628 104 80,050 
Share of 
UK 10.9% 11.5% 11.7% 12.2% 12.9% 13.1% 13.3% 16.8% 12.20% 
 
Table A1.36 and Table A1.37 are similar to Table A1.33 and Table A1.34 but provide 
information on the number of applications instead of the number of proposals. 
Differences between specific programmes and between types of instrument were 
less strongly marked for the number of applications than for the number of proposals.  
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Table A1.36 provides the number of applications by specific programme and priority 
area. In terms of volume, the two specific programmes for which the UK applied were 
Cooperation and People. In terms of the share of UK applications in all FP7 
applications, Ideas and People were the two most significant programmes.   
Table A1.36 UK’s applications in FP7 proposals by specific programme and priority 
area 
Specific 
programme 
FP7 programme/priority area All applications  UK applications  
Demand – share of 
UK applications   
FP7 
Cooperation 
Health 42,152 5,440 13% 
Food, Agriculture, and 
Biotechnology 36,390 3,317 9% 
Information & Communication 
Technologies 136,546 15,250 11% 
Nanosciences, 
Nanotechnologies, Materials 
and new Production 
Technologies 
36,281 3,772 10% 
Energy 18,382 1,701 9% 
Environment (including 
Climate Change) 33,021 3,114 9% 
Transport (including 
Aeronautics) 32,555 3,497 11% 
Socio-economic sciences and 
Humanities 24,928 2,573 10% 
Space 8,356 853 10% 
Security 18,968 2,168 11% 
General Activities (Annex IV) 293 17 6% 
Joint Technology Initiatives 
(Annex IV-SP1) 19,100 2,013 11% 
Sub-total: FP7 Cooperation 406,972 43,715 11% 
FP7 Ideas European Research Council 54,462 8,746 16% 
FP7 People Marie-Curie Actions 110,131 18,267 17% 
FP7 
Capacities 
Research Infrastructures 10,897 1,247 11% 
Research for the benefit of 
SMEs 49,917 6,513 13% 
Regions of Knowledge 4,703 271 6% 
Research Potential 3,259 50 2% 
Science in Society 8,384 763 9% 
Coherent development of 
research policies 372 30 8% 
Activities of International 
Cooperation 4,199 145 3% 
Sub-total: FP7 Capacities 81,731 9,019 11% 
Euratom 
indirect 
Nuclear Fission and Radiation 
Protection 3,356 294 9% 
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Specific 
programme FP7 programme/priority area All applications  UK applications  
Demand – share of 
UK applications   
actions  Fusion Energy 80 9 11% 
Sub-total: Euratom 3,436 303 9% 
Total 656,732 80,050 12% 
 
Table A1.37 provides the number of applications by type of instrument. Almost half of 
UK applications were Collaborative Projects (CP).However, in terms of the share of 
UK applications in all FP7 applications, the most significant instruments were Support 
for Frontier Research (ERC) and Support for Training and Career Development of 
Researchers (Marie Curie -MC). 
Table A1.37 UK’s applications in FP7 proposals, by type of instrument 
Type of instrument  All 
applications 
UK 
applications 
Demand – 
share of UK 
applications 
Research for the Benefit of Specific Groups 
(BSG) 49,115 6,414 13.1% 
Collaborative Projects (CP) 353,351 38,568 10.9% 
Coordination and Support Actions (CSA) 59,874 4,597 7.7% 
CP-CSA 10,673 1,169 11.0% 
Support for Frontier Research (ERC) 54,337 8,736 16.1% 
Support for Training and Career Development 
of Researchers (Marie Curie -MC) 107,618 18,209 16.9% 
Joint Technology Initiatives (JTI) 19,100 2,013 10.5% 
Networks of Excellence (NoE) 2,664 344 12.9% 
Total  656,732 80,050 12% 
Table A1.38  shows the breakdown of UK applications in FP7 proposals by 
organisation type and gives an indication of the relative level of demand for 
involvement by each type.  
The data shows that HES organisations from the UK accounted for the greatest 
proportion (52%) of applications in proposals, followed by PRC organisations (21%). 
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Table A1.38 Number of UK applications, by organisation type 
Organisation Type  Number of UK applications  Share of all UK 
applications  
Higher or secondary education 
organisations (HES) 41,840 52% 
Private commercial 
organisations (PRC) 17,145 21% 
Research organisations (REC) 5,454 7% 
Public bodies (PUB) 1,964 2% 
Other (OTH) 4,911 6% 
N/A 8,736 11% 
Total 80,050 100% 
UK success rates by specific programmes/priority areas 
UK success rates in applying to FP7, by proposals 
UK organisations have participated in 52,696 FP7 proposals and in 10,372 FP7 
projects. This means that UK’s overall project-level success rate was 20%, above the 
average success rate figures for FP7 as a whole (16%). As a comparison, the 
success rates for Germany and France were respectively 20% and 21%. 
Table A1.39 shows the success rates of proposals with UK application and compares 
these to the overall success rates for all proposals submitted to FP7, by specific 
programme and priority area. It shows that UK proposal success rates were above 
the FP7 average in 21 of the 23 priority areas. 
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Table A1.39 UK and FP7 proposal success rates by specific programme and priority 
area 
Specific 
programme 
FP7 programme/priority 
area 
UK 
proposals 
UK 
projects 
Proposal 
success 
rate -UK 
Proposal 
success 
rate – all 
FP7 
Ratio of 
UK 
success 
rates to 
FP7 
success 
rates 
FP7 
Cooperation 
Health 3,086 756 24% 14% 173% 
Food, Agriculture, and 
Biotechnology 1,767 375 21% 17% 125% 
Information & 
Communication 
Technologies 
9,485 1,354 14% 13% 106% 
Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
2,151 493 23% 12% 187% 
Energy 917 186 20% 17% 117% 
Environment (including 
Climate Change) 1,653 360 22% 15% 150% 
Transport (including 
Aeronautics) 1,772 433 24% 22% 111% 
Socio-economic sciences 
and Humanities 1,770 212 12% 9% 129% 
Space 535 158 30% 27% 111% 
Security 1,143 217 19% 18% 108% 
General Activities (Annex 
IV) 16 7 44% 36% 123% 
Joint Technology Initiatives 
(Annex IV-SP1) 933 266 29% 27% 107% 
Sub-total: FP7 
Cooperation 25,228 4,817 19% 15%  124% 
FP7 Ideas European Research Council 8,003 1,072 13% 10% 133% 
FP7 People Marie-Curie Actions 14,812 3,328 22% 21% 107% 
FP7 
Capacities 
Research Infrastructures 592 267 45% 37% 122% 
Research for the benefit of 
SMEs 3,104 609 20% 17% 113% 
Regions of Knowledge 113 25 22% 18% 121% 
Research Potential 44 5 11% 9% 126% 
Science in Society 494 123 25% 21% 119% 
Coherent development of 
research policies 18 8 44% 48% 92% 
Activities of International 
Cooperation 121 29 24% 26% 94% 
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Specific 
programme 
FP7 programme/priority 
area 
UK 
proposals 
UK 
projects 
Proposal 
success 
rate -UK 
Proposal 
success 
rate – all 
FP7 
Ratio of 
UK 
success 
rates to 
FP7 
success 
rates 
Sub-total: FP7 Capacities 4,486 1,066 24%  18% 130% 
Euratom 
indirect 
actions  
Nuclear Fission and 
Radiation Protection 163 86 53% 46% 114% 
Fusion Energy 4 3 75% 36% 206% 
Sub-total: Euratom 167 89 53% 46% 116% 
Total 52,696 10,372 20% 16% 123% 
UK success rates in applying to FP7, by applications 
There were 80,050 UK applicants and 17,695 UK participants in FP7. This means 
that UK’s overall participation-level success rate was 22%, just above the average 
success rate figures for FP7 as a whole (21%). As a comparison, the success rates 
for Germany and France were respectively 23% and 25%. 
Table A1.40 shows the success rates of UK applications and compares these to the 
overall success rates for all applications in FP7, by specific programme and priority 
area. It shows that UK application success rates were above the FP7 average in 16 
of the 23 priority areas. 
Table A1.40 UK and FP7 application success rates by specific programme and 
priority area 
Specific 
programme FP7 programme/priority area 
UK 
applicants 
UK 
participants 
Application 
success 
rate -UK 
Application 
success 
rate – all 
FP7 
Ratio of 
UK 
success 
rates to 
FP7 
success 
rates 
FP7 Cooperation 
Health 5,440 1,692 31% 27% 116% 
Food, Agriculture, and 
Biotechnology 3,317 804 24% 22% 111% 
Information & 
Communication 
Technologies 
15,250 2,423 16% 17% 96% 
Nanosciences, 
Nanotechnologies, Materials 
and new Production 
Technologies 
3,772 1,062 28% 28% 99% 
Energy 1,701 395 23% 24% 97% 
Environment (including 
Climate Change) 3,114 835 27% 22% 123% 
Transport (including 
Aeronautics) 3,497 936 27% 27% 98% 
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Specific 
programme FP7 programme/priority area 
UK 
applicants 
UK 
participants 
Application 
success 
rate -UK 
Application 
success 
rate – all 
FP7 
Ratio of 
UK 
success 
rates to 
FP7 
success 
rates 
Socio-economic sciences 
and Humanities 2,573 361 14% 11% 126% 
Space 853 299 35% 32% 111% 
Security 2,168 448 21% 21% 99% 
General Activities (Annex IV) 17 8 47% 62% 75% 
Joint Technology Initiatives 
(Annex IV-SP1) 2,013 693 34% 32% 106% 
Sub-total: FP7 
Cooperation 43,715 9,956 23% 22% 105% 
FP7 Ideas European Research Council 8,746 1,235 14% 10% 141% 
FP7 People Marie-Curie Actions 18,267 4,000 22% 18% 123% 
FP7 Capacities 
Research Infrastructures 1,247 627 50% 48% 104% 
Research for the benefit of 
SMEs 6,513 1,358 21% 18% 114% 
Regions of Knowledge 271 66 24% 21% 114% 
Research Potential 50 5 10% 9% 106% 
Science in Society 763 205 27% 22% 123% 
Coherent development of 
research policies 30 19 63% 35% 180% 
Activities of International 
Cooperation 145 35 24% 33% 72% 
Sub-total: FP7 Capacities 9,019 2,315 26% 23% 110% 
Euratom indirect 
actions  
Nuclear Fission and 
Radiation Protection 294 181 62% 60% 103% 
Fusion Energy 9 8 89% 84% 106% 
Sub-total: Euratom 303 189 62% 60% 103% 
Total 80,050 17,695 22% 21% 108% 
UK success rates in applying to FP7, by funding 
UK organisations requested €38.649 billion from the EU, and were allocated a total of 
€7.002 billion. This means that UK’s overall project-level success rate was 18%, 
above the average success rate figures for FP7 as a whole (15%). As a comparison, 
the success rates for Germany and France were respectively 19% and 23%. 
Table A1.41 shows the success rates by EU funding for UK proposals and compares 
these to the overall success rates for all proposals submitted to FP7, by specific 
programme and priority area. It shows that UK funding success rates were above the 
FP7 average in 12 of the 22 considered priority areas. 
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Table A1.41 UK and FP7 funding success rates by specific programme and priority 
area98 
Specific 
programme 
FP7 programme/priority area 
UK 
funding 
requested 
(€m) 
UK 
funding 
allocated 
(€m) 
Funding 
success 
rate -UK 
Funding 
success 
rate – all 
FP7 
Ratio of 
UK 
success 
rates to 
FP7 
success 
rates 
FP7 
Cooperatio
n 
Health 4,869 808 17% 14% 117% 
Food, Agriculture, and 
Biotechnology 1,219 241 20% 17% 119% 
Information & Communication 
Technologies 6,341 916 14% 15% 99% 
Nanosciences, 
Nanotechnologies, Materials 
and new Production 
Technologies 
3,340 352 11% 12% 86% 
Energy 823 144 17% 19% 94% 
Environment (including 
Climate Change) 1,287 238 18% 15% 127% 
Transport (including 
Aeronautics) 1,123 260 23% 24% 95% 
Socio-economic sciences and 
Humanities 822 94 11% 10% 121% 
Space 260 96 37% 31% 119% 
Security 837 157 19% 20% 95% 
General Activities (Annex IV) 10 4 46% 260% 18% 
Joint Technology Initiatives 
(Annex IV-SP1) 1,996 340 17% 7% 259% 
Sub-total: FP7 Cooperation 22,926 3,650 16% 14% 114% 
FP7 Ideas European Research Council 13,772 1,715 12% 10% 126% 
FP7 
Capacities 
Research Infrastructures 603 273 45% 31% 147% 
Research for the benefit of 
SMEs 1,014 189 19% 17% 111% 
Regions of Knowledge 39 9 23% 20% 113% 
Research Potential 38 6 17% 9% 192% 
Science in Society 146 35 24% 21% 117% 
Coherent development of 
research policies 3 2 59% 62% 95% 
Activities of International 
Cooperation 21 5 23% 26% 87% 
98 The FP7 PEOPLE programme is excluded from this analysis, as the design of Marie Curie projects and the 
data provided through CORDA by BEIS does not allow constructing meaningful measures of success rate by EU 
funding requested/allocated. 
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Specific 
programme FP7 programme/priority area 
UK 
funding 
requested 
(€m) 
UK 
funding 
allocated 
(€m) 
Funding 
success 
rate -UK 
Funding 
success 
rate – all 
FP7 
Ratio of 
UK 
success 
rates to 
FP7 
success 
rates 
Sub-total: FP7 Capacities 1,864 519 28% 19% 143% 
Euratom 
indirect 
actions  
Nuclear Fission and Radiation 
Protection 78 31 40% 45% 89% 
Fusion Energy 2 1 51% 56% 90% 
Sub-total: Euratom 80 32 41% 46% 89% 
Total 38,649 7,002 18% 15% 118% 
UK success rates by Instrument Type 
UK success rates in applying to FP7, by proposals 
Table A1.42 shows the success rates of proposals with UK application and compares 
these to the overall success rates for all proposals submitted to FP7, by instrument. It 
shows that UK proposal success rates were above the FP7 average in all of the 
types of instruments, with the UK performing particularly well in relation to ERC and 
CP actions.  
Table A1.42 UK and FP7 proposal success rates by type of instrument 
Type of instrument  UK proposals UK projects 
Proposal 
success rate 
-UK 
Proposal 
success rate 
– all FP7 
Ratio of UK 
success 
rates to FP7 
success 
rates 
Research for the Benefit of 
Specific Groups (BSG) 3,051 583 19% 17% 113% 
Collaborative Projects 
(CP) 22,339 3,904 17% 13% 130% 
Coordination and Support 
Actions (CSA) 2,946 1,008 34% 27% 128% 
CP-CSA 511 214 42% 34% 124% 
Support for Frontier 
Research (ERC) 7,994 1,037 13% 10% 134% 
Support for Training and 
Career Development of 
Researchers (Marie Curie 
-MC) 
14,774 3,312 22% 21% 109% 
Joint Technology 
Initiatives (JTI) 933 266 29% 27% 107% 
Networks of Excellence 
(NoE) 148 48 32% 29% 114% 
Total 52,696 10,372 20% 16% 123% 
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UK success rates by Organisation Type 
UK success rates in applying to FP7, by applications 
There were 80,050 UK applications in FP7 proposals and 17,695 UK participations in 
FP7 projects. The UK success rate at the level of participations was therefore 22.1%. 
This is higher than the success rate for FP7 participations overall (20.5%). 
Table A1.43 shows the success rates of UK participations in proposals submitted to 
FP7, by the different organisation types. It suggests that success rates were highest 
amongst participations from REC, PRC and HES (higher than the FP7 success rate), 
while success rates for participations from PUB and Other organisations were below 
the UK and FP7 averages. 
Table A1.43 UK and FP7 application success rates by organisation type 
Organisation Type 
UK 
applications 
in proposals 
UK participations in 
projects 
UK success rates 
FP7 
success 
rate 
Higher or secondary education 
organisations (HES) 
41,840 10,662 25.5% 20.8% 
Private commercial 
organisations (PRC) 
17,145 4,577 26.7% 24.4% 
Research organisations (REC) 5,454 1,602 29.4% 27.3% 
Public bodies (PUB) 1,964 530 17.0% 26.1% 
Other (OTH) 4,911 324 6.6% 8.8% 
N/A 8,736 n/a n/a n/a 
Total 80,050 17,695 22.1% 20.5% 
A1.3.2.12 UK demand for participation in the FP7 
The first two columns of Table A1.44 present data on UK participation rates and 
success rates by specific programme/priority area in FP7, relative to FP7 rates 
overall. These ‘participation ratios’ and ‘success ratios’ have been presented in Table 
A1.20 and Table A1.39. Participation ratio is calculated by comparing the proportion 
of UK participations accounted for by a specific priority area with the proportion of all 
participations accounted for by that area. Success ratio is calculated by comparing 
the UK proposal success rate with the proposal success rate for all FP7. 
Each cell is marked as ‘very low’, ‘low’, ‘average’, ‘high’ or ‘very high’ depending on 
the difference between the UK ratio and the overall average. 
The final column presents the implied level of UK demand for participation in each 
area, set in context to overall demand across all countries. The percentages shown 
are calculated by dividing the UK participation ratio by the UK success ratio. 
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Table A1.44 Levels of UK demand: a comparison between UK’s relative success and 
participation rates in FP7 
Specific 
programme 
FP7 programme/priority 
area 
UK participation 
ratio (ratio of UK to 
FP7 participation 
rates) 
UK success ratio 
(ratio of UK to FP7 
success rate) 
Implied level of UK 
demand for 
participation 
FP7 Cooperation 
Health High - 114% Very high - 173% Low - 66% 
Food, Agriculture, and 
Biotechnology 
Low - 77% High - 125% Low - 62% 
Information & 
Communication 
Technologies 
Low - 81% Average - 106% Low - 76% 
Nanosciences, 
Nanotechnologies, 
Materials and new 
Production Technologies 
Low - 78% Very high - 187% Very low - 42% 
Energy Low - 68% High - 117% Low - 58% 
Environment (including 
Climate Change) 
Low - 89% High - 150% Low - 59% 
Transport (including 
Aeronautics) 
Low - 80% High - 111% Low - 72% 
Socio-economic sciences 
and Humanities 
Average - 99% High - 129% Low - 77% 
Space Low - 86% High - 111% Low - 77% 
Security Low - 86% Average - 108% Low - 80% 
General Activities (Annex 
IV) 
Very low - 33% High - 123% Very low - 27% 
Joint Technology Initiatives 
(Annex IV-SP1) 
Low - 85% Average - 107% Low - 79% 
Sub-total: FP7 
Cooperation 
Low - 86% High - 124% Low - 69% 
FP7 Ideas European Research Council 
Very high - 172% High - 133% High - 129% 
FP7 People Marie-Curie Actions Very high - 156% Average - 107% High - 146% 
FP7 Capacities 
Research Infrastructures Low - 90% High - 122% Low - 74% 
Research for the benefit of 
SMEs 
High - 113% High - 113% Average - 100% 
Regions of Knowledge Low - 50% High - 121% Very low - 41% 
Research Potential Very low - 12% High - 126% Very low - 10% 
Science in Society Low - 85% High - 119% Low - 71% 
Coherent development of 
research policies 
High - 110% Average - 92% High - 120% 
Activities of International 
Cooperation 
Very low - 19% Average - 94% Very low - 20% 
Sub-total: FP7 Capacities 
Average - 92% High - 130% Low - 71% 
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Specific 
programme 
FP7 programme/priority 
area 
UK participation 
ratio (ratio of UK to 
FP7 participation 
rates) 
UK success ratio 
(ratio of UK to FP7 
success rate) 
Implied level of UK 
demand for 
participation 
Euratom indirect 
actions  
Nuclear Fission and 
Radiation Protection 
Low - 69% High - 114% Low - 61% 
Fusion Energy Average - 91% Very high - 206% Very low - 44% 
A1.3.3 UK demand by location 
This section presents an analysis of demand for FP7 funding by UK NUTS 2 region. 
It presents the numbers of applications received from each NUTS2 region across the 
UK. It has to be noted that out of 80,050 UK applications, 6,013 did not include a 
NUTS2 code (7.5% of total number of applications), i.e. the application did not 
include the necessary address information. These applications are excluded from the 
analysis.  Figure A1.1 overleaf presents the geographical distribution of FP7 
applications across the UK. It can be seen that demand for FP7 is roughly in line with 
the presence of research performing organisations and large conurbations. 
Figure A1.1 Applications to FP7 – United Kingdom 
 
Note: The intervals are defined using the ‘Jenks natural breaks optimization’ method, which is the default for Arc 
Map. This is a “data clustering method designed to determine the best arrangement of values into different 
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classes. This is done by seeking to minimize each class’s average deviation from the class mean, while 
maximizing each class’s deviation from the means of the other groups. In other words, the method seeks to 
reduce the variance within classes and maximize the variance between classes.”99 
A1.3.4 UK participation location 
This section presents an analysis of UK participation by NUTS2 region across the 
UK. Figure A1.2 shows that a large proportion of participations (those NUTS2 regions 
with more than 793 project participations) is concentrated in six NUTS2 regions: 
Easter Scotland, Berkshire, Buckinghamshire and Oxfordshire, Surrey, East and 
West Sussex, Gloucestershire, Wiltshire and Bristol/Bath as well as inner London 
(West and East). 
Figure A1.2 FP7 participations – United Kingdom 
 
Note: The intervals are defined using the “Jenks natural breaks optimization” method, which is the default for Arc 
Map. This is a “data clustering method designed to determine the best arrangement of values into different 
classes. This is done by seeking to minimize each class’s average deviation from the class mean, while 
maximizing each class’s deviation from the means of the other groups. In other words, the method seeks to 
reduce the variance within classes and maximize the variance between classes.”100 
99 https://en.wikipedia.org/wiki/Jenks_natural_breaks_optimization  
100 https://en.wikipedia.org/wiki/Jenks_natural_breaks_optimization  
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Annex 2 UK performance in Horizon 
2020 – first evidence from 
2014-16 
This section provides a preliminary analysis of UK performance in Horizon 2020 
between January 2014 and February 2016. 
A summary of the analysis below is presented above in section 3. 
A2.1.1 Summary of analysis 
The overall statistics on UK participation in Horizon 2020 between January 2014 and 
February 2016 are as follows: 
Demand: The total number of UK applications was 31,176 out of a total of 258,519. 
UK’s applications therefore constituted 12.1% of the total number of applications in 
Horizon 2020. UK organisations were involved in 21,297 proposals, out of a total of 
75,519 proposals. UK organisations were therefore involved in 28.1% of all Horizon 
2020 proposals. UK organisations requested a total of €16.814 billion in EU funding 
out of a total EU requested of €132.281 billion. UK organisations therefore requested 
12.7% of all EU funding in Horizon 2020.  
Projects: UK organisations were involved in 3,112 projects, out of a total of 8,598 
projects. UK organisations were therefore involved in 36.2% of Horizon 2020 projects 
included in the analysis. 
Participations: The total number of UK participations was 4,731, out of a total of 
35,359. UK’s participations therefore constituted 13.4% of the total number of 
participations included in the analysis. 
Project coordinator role: The UK so far took up the coordinator role 1,785 times. 
This is the highest number of coordinators in Horizon 2020 out of all countries, 
significantly ahead Spain (1,029), Germany (984) and France (794). 
Organisations: A total of 1,305 discrete organisations from the UK participated in 
Horizon 2020 so far, out of 13,291 participants (all countries). UK organisations 
therefore constituted 9.8% of all organisations involved in projects included in the 
analysis. 
Funding: UK organisations were allocated a total of €2,172 billion in EU funding so 
far, out of a total EU allocation to all participating countries of €14,492 billion so far. 
UK organisations therefore received 15% of all EU funding included in the analysis. 
The total project cost for UK organisations was €2.405 billion, representing 13.3% of 
all Horizon 2020 project costs of €18.046 billion up to February 2016. 
Table A2.1 provides a summary of success rates by proposals, by applications, and 
by funding for the UK and Horizon 2020 for 2014/15. The UK so far has had success 
rates which were higher than the Horizon 2020 average.  
207 
 
Evaluation of UK involvement with EU research programmes 
Table A2.1 Summary of success rates  in Horizon 2020 (2014 - 02/2016) 
Success rates UK All countries 
By proposals  
(no. of projects / no. of proposals) 
14.6% 11.4% 
By applications 
(no. of participants / no. of applicants) 
15.2% 13.7% 
By funding 
(amount of EU funding allocated / amount of EU funding 
requested) 
11.8% 9.86% 
Source: ICF analysis of CORDA data 
A2.1.2 Detailed analysis 
The section below presents some further analysis which complements the analysis 
presented in section 3 above. 
A2.1.2.1 EU funding by pillar and objective 
Table A2.2 provides a breakdown of the funding received by UK organisations in 
Horizon 2020 by pillar and objective, compared to the total funding in the programme, 
between January 2014 and February 2016. In this period, the UK was awarded 
€2.405 billion out of a total of €18.046 billion in EU funding – or 13.3% of all EU 
funding awarded. 
In terms of EU funding as well as in terms of the share of UK funding in the total 
Horizon 2020 programme, the pillars Excellent Science and Societal Challenges 
were the most significant so far. The pillar with the lowest funding values and share 
of UK funding was “Spreading excellence and widening participation”. A large 
difference is noticeable between the share of EU funding awarded to the UK in 
Excellent Science (20%) and the share of EU funding awarded to the UK under 
Industrial Leadership (12%). The pillar Spreading Excellence and Widening 
Participation is focussing on support for countries with less developed research and 
innovation systems, therefore the low share of EU funding awarded to the UK under 
this pillar is an expected result of the pillar’s objectives and structure. 
Table A2.2 EU funding allocated to UK under Horizon 2020 funding, EU funding 
allocated to all countries under Horizon 2020 and share of UK funding, by 
pillar and objective ( 2014 - 02/2016) 
Pillar Objective 
UK funding 
(€ million) 
Total 
funding (€ 
million) 
Share of 
UK funding 
Excellent 
Science 
European Research Council 461 2,274 20% 
Future and Emerging Technologies 70 440 16% 
Marie Sklodowska-Curie actions 376 1,649 22% 
Research infrastructures 67 582 12% 
Subtotal: Excellent Science 974 4,946 20% 
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Pillar Objective 
UK funding 
(€ million) 
Total 
funding (€ 
million) 
Share of 
UK funding 
Industrial 
Leadership 
Industrial Leadership - Cross-theme 15 103 15% 
Information and Communication 
Technologies 
224 1,787 13% 
Nanotechnologies, Advanced Materials 
and Production 
35 261 13% 
Advanced materials 22 215 10% 
Biotechnology 8 93 8% 
Advanced manufacturing and processing 36 442 8% 
Space 28 263 11% 
Access to risk finance101 1 5 14% 
Innovation in SMEs 4 37 10% 
Subtotal: Industrial Leadership 372 3,207 12% 
Societal 
Challenges 
Societal Challenges - Cross-theme 10 42 24% 
Health, demographic change and 
wellbeing 
237 1,291 18% 
Food security, sustainable agriculture 
and forestry, marine and maritime and 
inland water research 
68 622 11% 
Secure, clean and efficient energy 165 1,344 12% 
Smart, green and integrated transport 83 805 10% 
Climate action, environment, resource 
efficiency and raw materials 
83 659 13% 
Europe in a changing world - inclusive, 
innovative and reflective Societies 
37 248 15% 
Secure societies - Protecting freedom 
and security of Europe and its citizens 
63 449 14% 
Subtotal: Societal Challenges 746 5,460 14% 
Spreading 
excellence 
and 
widening 
participation 
Teaming of excellent research 
institutions and low performing RDI 
regions 
1 14 7% 
Twinning of research institutions 6 66 9% 
ERA chairs 0 34 0% 
Transnational networks of National 
Contact Points 
0 2 0% 
Spreading excellence and widening 
participation – cross-theme 
0 0.2 0% 
Subtotal: Spreading excellence and 
widening participation 
7 117 6% 
 
 
101 The CORDA data provided does not include debt and equity products managed by the European Investment 
Bank as part of their InnovFin – EU Finance for Innovators programme. Therefore the number of activities 
reported in CORDA does not account for the majority of Horizon 2020 budget earmarked and already spent under 
the ‘Access to Risk Finance’ heading. 
209 
                                            
 
Evaluation of UK involvement with EU research programmes 
Pillar Objective 
UK funding 
(€ million) 
Total 
funding (€ 
million) 
Share of 
UK funding 
Science 
with and for 
Society 
Science with and for Society - Cross-
theme 
1 6 18% 
Make scientific and technological careers 
attractive for young people 
2 27 8% 
Promote gender equality in research and 
innovation 
1 19 7% 
Integrate society in science and 
innovation 
5 34 15% 
Develop the governance for the 
advancement of responsible research 
and innovation 
2 20 10% 
Subtotal: Science with and for Society 12 106 11% 
Euratom Euratom 32 515 6% 
Cross-
theme 
Cross-theme 28 142 20% 
TOTAL 2,172 14,492 15% 
Source: ICF analysis of CORDA data 
A2.1.2.2 Participations by pillar and objective 
Table A2.3 provides a breakdown of the number of UK participations in Horizon 2020 
by pillar and objective, compared to the total number of participations in the 
programme. Between January 2014 and February 2016, there were 4,731 UK 
participations out of a total of 35,359. UK’s participations therefore constituted 13.4% 
of the total number of participations in Horizon 2020.  
In terms of volume of participations as well as in terms of the share of UK 
participations in the total Horizon 2020 programme, the pillars Excellent Science and 
Societal Challenges were the most significant. A large differential is noticeable 
between the share of UK participations in Excellent Science (20%) and the share of 
UK participations in Industrial Leadership (10%) and Societal Challenges (11%). The 
pillar with the fewest number of participations and the smallest share of UK 
participations was Euratom. 
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Table A2.3 Number of UK participations, total number of Horizon 2020 participations 
and share of UK participations, by pillar and objective ( 2014 - 02/2016) 
Pillar Objective 
Number of 
UK 
participations 
Total number 
of 
participations 
Share of UK 
participations 
Excellent 
Science 
European Research Council 344 1,703 20% 
Future and Emerging 
Technologies 
124 790 16% 
Marie Sklodowska-Curie actions 1,437 6,083 24% 
Research infrastructures 175 1,587 11% 
Subtotal: Excellent Science 2,080 10,163 20% 
Industrial 
Leadership 
Industrial Leadership - Cross-
theme 
22 310 7% 
Information and Communication 
Technologies 
491 4,457 11% 
Nanotechnologies, Advanced 
Materials and Production 
75 640 12% 
Advanced materials 40 445 9% 
Biotechnology 11 149 7% 
Advanced manufacturing and 
processing 
93 1,077 9% 
Space 112 1,040 11% 
Access to risk finance 2 21 10% 
Innovation in SMEs 46 807 6% 
Subtotal: Industrial Leadership 892 8,946 10% 
Societal 
Challenges 
Societal Challenges - Cross-
theme 
8 46 17% 
Health, demographic change and 
wellbeing 
391 2,847 14% 
Food security, sustainable 
agriculture and forestry, marine 
and maritime and inland water 
research 
204 2,041 10% 
Secure, clean and efficient 
energy 
305 3,137 10% 
Smart, green and integrated 
transport 
237 2,128 11% 
Climate action, environment, 
resource efficiency and raw 
materials 
203 2,111 10% 
Europe in a changing world - 
inclusive, innovative and 
reflective Societies 
119 1,123 11% 
Secure societies - Protecting 
freedom and security of Europe 
and its citizens 
161 1,298 12% 
Subtotal: Societal Challenges 1,628 14,731 11% 
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Pillar Objective 
Number of 
UK 
participations 
Total number 
of 
participations 
Share of UK 
participations 
Spreading 
excellence 
and 
widening 
participation 
Spreading excellence and 
widening participation - Cross-
theme 
0 1 0% 
Teaming of excellent research 
institutions and low performing 
RDI regions 
6 133 5% 
Twinning of research institutions 31 263 12% 
ERA chairs 0 14 0% 
Transnational networks of 
National Contact Points 
0 17 0% 
Subtotal: Spreading 
excellence and widening 
participation 
37 428 9% 
Science 
with and for 
Society 
Science with and for Society - 
Cross-theme 
3 15 20% 
Make scientific and technological 
careers attractive for young 
people 
13 149 9% 
Promote gender equality in 
research and innovation 
5 79 6% 
Integrate society in science and 
innovation 
17 154 11% 
Develop the governance for the 
advancement of responsible 
research and innovation 
9 112 8% 
Subtotal: Science with and for 
Society 
47 509 9% 
Euratom Euratom 25 407 6% 
Cross-
theme 
Cross-theme 22 175 13% 
TOTAL 4,731 35,359 13% 
Source: ICF analysis of CORDA data 
Project coordination rates 
Table A2.4 presents an overview of how often the UK has taken on coordinator roles 
in Horizon 2020 so far, split by programme pillar and theme. As a function of the 
large number of UK participations in individual grant instruments under the Excellent 
Science pillar, the number of coordinator roles taken by UK organisations is highest 
under the Excellent Science pillar. In terms of thematic areas funded under Industrial 
Leadership and Societal Challenges, the share of UK coordinators is highest in 
Nanotechnologies, Advanced Materials and Production (13%); Health, Demographic 
Change and Wellbeing (16%); and Inclusive, Innovative and Reflective Societies 
(17%). The UK so far took up the coordinator role 1,785 times. This is the highest 
number of coordinators in Horizon 2020 out of all countries, significantly ahead Spain 
(1,029), Germany (984) and France (794). 
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Table A2.4 Number of project coordinators, UK and total in Horizon 2020 ( 2014 - 
02/2016) 
Pillar Objective 
Number of 
UK project 
coordinators 
Total number 
of 
coordinators 
Share of UK 
coordinators 
Excellent 
Science 
European Research Council 305 1,556 20% 
Future and Emerging Technologies 10 79 13% 
Marie Sklodowska-Curie actions 1,030 3,125 33% 
Research infrastructures 11 100 11% 
Subtotal: Excellent Science 1,356 4,860 28% 
Industrial 
Leadership 
Industrial Leadership - Cross-theme 4 29 14% 
Information and Communication 
Technologies 78 687 11% 
Nanotechnologies, Advanced Materials 
and Production 23 178 13% 
Advanced materials 4 32 13% 
Biotechnology 2 38 5% 
Advanced manufacturing and processing 5 90 6% 
Space 10 169 6% 
Access to risk finance 1 4 25% 
Innovation in SMEs 12 183 7% 
Subtotal: Industrial Leadership 139 1,410 10% 
Societal 
Challenges 
Societal Challenges - Cross-theme 2 2 100% 
Health, demographic change and 
wellbeing 68 420 16% 
Food security, sustainable agriculture 
and forestry, marine and maritime and 
inland water research 
20 245 10% 
Secure, clean and efficient energy 46 472 10% 
Smart, green and integrated transport 59 430 14% 
Climate action, environment, resource 
efficiency and raw materials 36 251 14% 
Europe in a changing world - inclusive, 
innovative and reflective Societies 24 141 17% 
Secure societies - Protecting freedom 
and security of Europe and its citizens 20 146 14% 
Subtotal: Societal Challenges 279 2,107 13% 
Spreading 
excellence 
and 
widening 
participation 
Spreading excellence and widening 
participation - Cross-theme 0 1 0% 
Teaming of excellent research 
institutions and low performing RDI 
regions 
0 31 0% 
Twinning of research institutions 0 66 0% 
ERA chairs 0 14 0% 
Transnational networks of National 
Contact Points 0 1 0% 
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Pillar Objective 
Number of 
UK project 
coordinators 
Total number 
of 
coordinators 
Share of UK 
coordinators 
Subtotal: Spreading excellence and 
widening participation 0 66 0% 
Science 
with and for 
Society 
Science with and for Society - Cross-
theme 1 6 17% 
Make scientific and technological careers 
attractive for young people 1 14 7% 
Promote gender equality in research and 
innovation 0 9 0% 
Integrate society in science and 
innovation 2 10 20% 
Develop the governance for the 
advancement of responsible research 
and innovation 
1 12 8% 
Subtotal: Science with and for Society 5 51 10% 
Euratom Euratom 1 24 4% 
Cross-
theme 
Cross-theme 5 33 15% 
TOTAL 1,785 8,598 21% 
Source: ICF analysis of CORDA data 
A2.1.2.3 Participation of discrete organisations 
Table A2.5 shows that between January 2014 and February 2016, a total of 1,305 
discrete organisations from the UK participated in Horizon 2020, out of 13,291 
discrete participants overall (all countries). In terms of volume as well as in terms of 
the share of UK in the total Horizon 2020 programme, the pillars Excellent Science, 
Industrial Leadership and Societal Challenges were the most significant and saw the 
highest number and share of discrete organisations from the UK. The pillar with the 
fewest number of discrete organisations and the smallest share of UK was Euratom. 
It is interesting to note that the share of discrete UK organisations under the 
Excellent Science pillar is lower than the share of EU funding awarded to UK 
organisations under this pillar. This points to a continued success of a group of high-
performing UK organisations in programmes like the ERC and the Marie Sklodowska 
Curie actions, comparable to the pattern visible in FP7. 
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Table A2.5 Number of discrete UK organisations, total number of Horizon 2020 
discrete organisations and share of UK organisations out of totals, by 
pillar and objective ( 2014 - 02/2016) 
Pillar Objective 
Number of 
discrete UK 
organisations 
Total 
number of 
discrete 
organisations 
Share of UK 
organisations 
out of total 
organisations, 
in% 
Excellent 
Science 
European Research Council 68 480 14% 
Future and Emerging 
Technologies 
64 468 14% 
Marie Sklodowska-Curie actions 215 1,903 11% 
Research infrastructures 80 797 10% 
Subtotal: Excellent Science 281 2,597 11% 
Industrial 
Leadership 
Industrial Leadership - Cross-
theme 
19 260 7% 
Information and Communication 
Technologies 
276 2,561 11% 
Nanotechnologies, Advanced 
Materials and Production 
65 543 12% 
Advanced materials 30 367 8% 
Biotechnology 10 131 8% 
Advanced manufacturing and 
processing 
73 803 9% 
Space 70 705 10% 
Access to risk finance 2 20 10% 
Innovation in SMEs 31 556 6% 
Subtotal: Industrial Leadership 481 5,035 10% 
Societal 
Challenges 
Societal Challenges - Cross-
theme 
8 45 18% 
Health, demographic change and 
wellbeing 
194 1,599 12% 
Food security, sustainable 
agriculture and forestry, marine 
and maritime and inland water 
research 
126 1,324 10% 
Secure, clean and efficient 
energy 
222 2,190 10% 
Smart, green and integrated 
transport 
154 1,432 11% 
Climate action, environment, 
resource efficiency and raw 
materials 
151 1,510 10% 
Europe in a changing world - 
inclusive, innovative and 
reflective Societies 
87 821 11% 
Secure societies - Protecting 
freedom and security of Europe 
and its citizens 
117 943 12% 
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Pillar Objective 
Number of 
discrete UK 
organisations 
Total 
number of 
discrete 
organisations 
Share of UK 
organisations 
out of total 
organisations, 
in% 
Subtotal: Societal Challenges 805 7,923 10% 
Spreading 
excellence 
and 
widening 
participation 
Spreading excellence and 
widening participation - Cross-
theme 
0 1 0% 
Teaming of excellent research 
institutions and low performing 
RDI regions 
5 111 5% 
Twinning of research institutions 24 202 12% 
ERA chairs 0 13 0% 
Transnational networks of 
National Contact Points 
0 17 0% 
Subtotal: Spreading excellence 
and widening participation 
28 308 9% 
Science 
with and for 
Society 
Science with and for Society - 
Cross-theme 
3 15 20% 
Make scientific and technological 
careers attractive for young 
people 
13 139 9% 
Promote gender equality in 
research and innovation 
5 76 7% 
Integrate society in science and 
innovation 
15 146 10% 
Develop the governance for the 
advancement of responsible 
research and innovation 
9 103 9% 
Subtotal: Science with and for 
Society 
37 410 9% 
Euratom Euratom 17 223 8% 
Cross-
theme 
Cross-theme 15 163 9% 
TOTAL 1,305 13,291 10% 
Source: ICF analysis of CORDA data 
Note that subtotals for discrete organisations do not add up as the same organisation can participate in several 
programmes/priority areas. 
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A2.1.2.4 Performance in context 
Table A2.6 lists the EU-28 member states and shows, for each and again covering 
Horizon 2020 projects started up to February 2016, total EU funding received, share 
of EU-28 funding, share of 2014 EU-28 intramural research & development 
expenditure (GERD)102, and the ratio of share of EU-28 funding to share of EU-28 
GERD. The table is sorted by the 4th column (ratio), so the countries listed towards 
the top of the table are those where their share of EU-28 funding allocations were 
greater proportionately than their share of EU-28 GERD. 
In 2014, UK’s contribution towards total EU-28 GERD was 14%. This information can 
be used to normalise the EU funding awarded under Horizon 2020 up to February 
2016. UK’s share of EU funding amongst the EU-28 was 15%. On this basis UK’s 
share of Horizon 2020 between January 2014 and February 2016 was therefore 
higher than what might have been expected, given its level of R&D expenditure 
(+10%).  
UK’s position in the table indicates that it was 18th out of the EU-28 in terms of the 
amount of EU funding realised in comparison with its R&D expenditure.  
Table A2.6 EU funding allocation in Horizon 2020 to EU28 in comparison with GERD ( 
2014 - 02/2016) 
Member State EU funding (€m) 
Share of EU-28 
Funding 
Share of EU-28 
GERD (2014) 
Ratio EU funding 
to GERD 
Cyprus 45 0.3% 0.0% 1055% 
Greece 305 2.3% 0.5% 402% 
Estonia 57 0.4% 0.1% 391% 
Latvia 19 0.1% 0.1% 223% 
Portugal 251 1.9% 0.8% 220% 
Malta 7 0.1% 0.0% 213% 
Romania 59 0.4% 0.2% 200% 
Spain 1,286 9.5% 4.5% 197% 
Ireland 273 2.0% 1.0% 186% 
Slovenia 81 0.6% 0.3% 177% 
Netherlands 1,137 8.4% 4.6% 170% 
Croatia 26 0.2% 0.1% 149% 
Belgium 635 4.7% 3.5% 126% 
Bulgaria 21 0.2% 0.1% 121% 
Luxembourg 37 0.3% 0.2% 117% 
Slovakia 39 0.3% 0.2% 113% 
Hungary 82 0.6% 0.5% 113% 
United Kingdom 2,172 16.0% 13.5% 111% 
Italy 1,177 8.7% 7.3% 111% 
102 Eurostat GERD t2020_20. 
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Member State EU funding (€m) 
Share of EU-28 
Funding 
Share of EU-28 
GERD (2014) 
Ratio EU funding 
to GERD 
Denmark 372 2.7% 2.8% 91% 
Lithuania 16 0.1% 0.1% 85% 
Finland 277 2.0% 2.3% 83% 
Austria 399 2.9% 3.5% 79% 
Poland 136 1.0% 1.4% 69% 
Sweden 464 3.4% 4.8% 67% 
France 1,506 11.1% 17.0% 61% 
Germany 2,574 19.0% 29.3% 61% 
Czech Republic 91 0.7% 1.1% 58% 
Total 13,543 100% 100% 100% 
Source: ICF analysis of CORDA data 
A2.1.2.5 Success rates 
Table A2.7 provides a summary of success rates by EU funding and by applications 
during the first year of Horizon 2020. For comparison, the table lists all countries 
classified as Innovation leaders or Innovation followers in the Innovation Union 
Scoreboard (2015). The table is sorted by the final column, so the countries listed 
towards to the top of the table are those where the share of EU-28 funding was the 
highest. 
As for FP7, the UK was the second country to receive the most EU funding after 
Germany. However, the UK was ranked 5th in terms of success rate by EU funding 
and 7th in terms of success rate by applications. 
Table A2.7 Success rate in Horizon 2020 by EU funding and by applications, share of 
EU-28 funding, by innovation leader and innovation follower countries ( 
2014 - 02/2016) 
Member State IUS category 
Success rate 
by EU funding 
Success rate 
by applications 
Share of EU 
funding totals 
under Horizon 
2020, allocated to 
EU-28 
Germany Innovation leader 14% 16% 18% 
United Kingdom Innovation follower 12% 15% 15% 
France Innovation follower 14% 17% 10% 
Netherlands Innovation follower 12% 16% 8% 
Belgium Innovation follower 14% 16% 4% 
Sweden Innovation leader 10% 14% 3% 
Austria Innovation follower 12% 16% 3% 
Denmark Innovation leader 11% 15% 3% 
Finland Innovation leader 8% 12% 2% 
Ireland Innovation follower 11% 15% 2% 
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Member State IUS category 
Success rate 
by EU funding 
Success rate 
by applications 
Share of EU 
funding totals 
under Horizon 
2020, allocated to 
EU-28 
Slovenia Innovation follower 7% 10% 1% 
Luxembourg Innovation follower 9% 17% 0% 
Source: ICF analysis of CORDA data 
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Annex 3 Case studies 
This section presents the case studies which have been used to support the 
evidence from the online surveys and illustrate a number of aspects investigated, in 
particular the pathways to FP7 participation and the variety and types of impacts 
reported. The projects to be covered were selected by the Steering Group composed 
of BIS, InnovateUK, UKRO and Universities UK. The approach for selecting case 
study projects and writing the case studies up is presented in section 2.3.5. The five 
case studies cover the following research areas: 
• Additive manufacturing 
• Social Sciences 
• Medical research 
• Factories of the Future 
• Robotics and assisted living 
A3.1 AMAZE: Additive Manufacturing Aiming Towards Zero 
Waste & Efficient Production of High-Tech Metal Products 
AMAZE is a unique project set up to design, demonstrate and deliver four streamlined pilot-
scale additive manufacturing factories to produce metal materials, giving European 
manufacturers of additive manufacturing and industrial end-users components a first mover 
advantage. 
A3.1.1 Overview 
Total project costs € 18.2 million 
EU funding  € 10.2 million 
Project coordinator Manufacturing Technology Centre, United Kingdom 
Number of partners involved 29 
Project start date 01/01/2013 
Project end date 30/06/2017 
Type of project CP 
Source: ICF consultation with MTF (project coordinator); CORDIS database 
A3.1.2 Project description 
The project was set up to design, demonstrate and deliver four streamlined pilot-
scale additive manufacturing (AM) factories to produce metal materials, giving 
European manufacturers of additive manufacturing and industrial end-users 
components a first mover advantage. In selected application areas (automotive, 
aeronautics, space, nuclear fusion and tooling), components were defined and their 
manufacturing trialled. The overall objective of the project is to particularly produce 
larger defect-free metallic components up to 2 meter in size. Furthermore, the project 
attempts to: 
• Increase dimensional accuracy of components by 25%; 
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• Increase manufacturing speed tenfold; and 
• Reduce the amount of material loss to less than 5%. 
The project is designed to benefit specifically its industrial participants. These include 
both manufacturers of materials, research service providers and industrial end users.  
A3.1.3 The project consortium 
The project brought together a partnership of eight academic institutions, 19 industry 
partners and one intergovernmental agency. The UK partners were: 
 
• The University of Birmingham’s Interdisciplinary Research Centre on 
Netshape Processing; 
• Swansea University ; 
• Cranfield University; 
• The University of Manchester ; 
• Granta Design; 
• BAE Systems; 
• Short Brothers Plc  (Bombardier Aero); 
• United Kingdom Atomic Energy Authority  (CCFE); 
• Manufacturing Technology Centre (MTC); and 
• Renishaw (previously MTT). 
The consortium was set up to provide a broad background of skills and partner along 
the value chain of technical skills, prototype and process development, information 
and data management, standardisation, component specification and the 
requirements and demand by industrial end users. Most of the academic partners 
specialised in providing equipment for additive manufacturing, whilst industrial 
partners were more experienced in piloting and developing processes and 
components. 
It includes provides a partnership along the technology development and innovation 
value chains of additive manufacturing in a variety of application areas. 
The project is split in so called application pods that work towards end users such as 
BAE, Volvo and Bombardier which have specified components they would like to see 
developed. 
A3.1.4 Pathways to FP7 participation 
The partnership formed mainly on the initiative of the former coordinator at the 
European Space Agency103. Around 50% of the consortium had worked together 
previously, on a bilateral and multilateral basis, and the ability of the coordinator to 
assemble and manage international consortia was very helpful in this regard. A 
number of core partners had been involved in unsuccessful proposals to FP7 in the 
past, including an early version of AMAZE, which helped understand better how to 
balance the consortium for the AMAZE project between different application areas 
103 The role of coordinator was transferred to the MTC during the project lifetime. 
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with different cost bases, and the complementarity of needed technology. For the 
involved service providers such as Granta Design (UK), the partnership offered good 
exposure to potential new customers.  
Industrial end-users were attracted to the project as it offered a unique combination 
of manufacturing technology know-how feeding into high-value component 
development, complementary to existing in house activities.  
FP7 was chosen as it, for one, provided a suitable thematic call for proposals and 
secondly offered the necessary financial support over relatively long timescales 
(AMAZE is running for 4.5 years). The EU funding process was also well known to 
the coordinator and many of the other partners from FP6, which meant that the 
consortium had substantial experience in preparing Framework Programme 
applications. FP7 also allowed for a flexible arrangement regarding the coordinator, 
whilst other funding programmes such as Eurostars would have mandated a specific 
type of coordinating organisation.  
“FP7 allows some development of the work programme as the project progresses 
through amendments (Annexes). These are very important as they allow resource to 
be moved between partners ensuring problems are overcome and bottlenecks 
addressed. However the process of project amendments is rather slow. The funding 
rate for larger partners was rather low (50%) somewhat limiting their participation.”                 
[University of Birmingham] 
A3.1.5 Project outputs and results 
Whilst the project is still ongoing, a number of peer-reviewed articles have been 
published already. Several patent applications have been submitted by UK partners. 
The blue box below summarises other expected project outputs. 
Anticipated project results 
• Information and data collection on composition/process/structure/property relations, 
based on extensive testing of AM samples and standard components, which would 
permit a useful comparison between the different AM techniques; 
• A wider portfolio of certified alloys and the demonstration of new metallic alloys that are 
specifically tailored to AM processes, and give superior properties compared with cast, 
forged or machined parts; 
• Establishment of the “AMAZE Design/Process/Materials Database” – the most 
comprehensive database of its kind in the world, and a marketable deliverable in its own 
right; 
• Commercial software package capable of modelling and predicting AM processing, 
component properties, performance and life-time, as well as tolerance to defects; 
• Maximising the benefits of AM to metal components by exploiting the design freedom 
that it offers, and extensively using free-material and topological optimisation modelling 
in the design phase. This allows component designs that were not achievable 
previously; 
• Development of a complete future supply chain in Europe for certified AM technologies 
and feedstock materials, which has not been achieved to date; 
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• World-wide PCT patents, design rights and copyrights protecting the most promising AM 
innovations, in-situ techniques, post-processing steps, alloy compositions, structures and 
databases; 
• International ISO and ASTM standards for AM materials and processes, co-developed 
between designers, feedstock suppliers, AM producers and industrial end-users in a 
multi-sectoral way. This will naturally lead towards industrial certification, which is 
currently in its infancy; 
• Sustainability assessment of new AM processes and components, based on ISO-guided 
life-cycle analyses, as well as the establishment of new eco-design principles. 
A3.1.6 Impacts of the project 
The project will run until June 2017. However, participants have already reported 
significant positive impacts. 
The main impact is seen in building pilot scale factories across Europe, which will 
help to demonstrate how individual components can be produced and how their 
production could be scaled up to a commercial level. These will be the first pilot scale 
facilities for the production of large scale components allowing the industrial partners 
to fully explore the cost benefit of additive manufacturing. The project has 
investigated in detail the production of 15 different components covering a wide 
range of materials, scales and manufacturing processes to develop the knowledge 
required for manufacturing by AM. 
Furthermore, AMAZE has managed to open up knowledge in a market which has 
formerly been wrapped up in proprietary knowledge, through creating a very 
complementary partnership. The project has enabled to link UK capability in 
aerospace and significant investment in the Manufacturing Technology Centre to be 
linked up with partners across Europe who offer complementary capacity in e.g. 
polymer composites, aerospace-grade titanium and represent potential industrial end 
users. The project has generated substantial interest and is being watched by 
researchers, manufacturers and industrial end users in Europe, China and the US. 
Within the UK, the project had a substantial impact on the SMEs involved. MTT, one 
of the SMEs involved, had been bought by Renishaw. Subsequent to the first results 
of the AMAZE project, their UK-based operations have been significantly scaled up. 
The extent to which this was due to the FP7 partnership is impossible to ascertain, 
however interviewees advised that the AMAZE project helped MTT demonstrating 
their technologies and capabilities. For Granta Design, a company which has grown 
by around 30% over the last five years, the AMAZE project has been key in 
maintaining growth. The project has helped substantially in speeding up the 
development of a process and materials information management solution, one of 
Granta’s main products.  
Furthermore, the process and material information collected throughout the project 
helped both manufacturers and industrial end users to verify their component 
specifications and internal processes for manufacturing large metal components. 
Interviewees agreed that the AMAZE project will thus have a direct impact on income 
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and commercial uptake of additive manufacturing of aerospace components, 
airframe specific components and components in automotive in the short run. 
Interviewees agreed that the project has already resulted in substantial intangible 
benefits. For the academic partners involved, the main intangible benefit is the 
sustained knowledge transfer with industrial end users and complementary research 
groups which have also improved collaboration opportunities for future projects.  
A3.1.7 Future 
A number of partnerships to move components to industry-scale manufacturing and 
application are planned. The consortium has a number of ideas regarding further 
research grants and proposals have been submitted to both UK and EU 
programmes. 
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A3.2 ESS-DACE: The European Social Survey — Data for a 
Changing Europe 
The European Social Survey (ESS) is a cross-national biennial survey that has been 
conducted across Europe for over a decade. The survey measures the attitudes, beliefs and 
behaviour patterns of diverse populations in more than thirty nations. ESS seeks to provide a 
uniquely reliable account of the direction and momentum of attitude change in Europe. 
A3.2.1 Overview 
Total project costs €6.7 million 
EU funding €5.0 million 
Project coordinator City University London, UK 
Number of partners involved 7 
Project start date 1 July 2010 
Project end date 30 June 2014 
Type of project Integrating Activities (IA) 
Source: ICF consultation with City University (project coordinator); CORDIS database 
A3.2.2 Project description 
A3.2.2.1 Key objectives 
Since 2001, the ESS provides data on attitudes, beliefs and behaviour across 30 
participating countries in Europe. To date, seven waves of the survey have been 
undertaken. Key aims of the ESS are: 
1. to produce rigorous trend data at a national and European level about people’s social, 
political and moral values in the context of Europe’s changing institutions; 
2. to achieve and encourage higher standards of rigour in cross-national research in the 
social sciences, specifically, in relation to questionnaire design and piloting, sampling, 
data collection, reduction of bias and the reliability of survey questions; 
3. to bring social indicators into closer focus as a means of monitoring national progress or  
quality of life across European nations; 
4. to facilitate or offer training to European social researchers in comparative quantitative 
measurement and analysis; and 
5. to improve the visibility and outreach of data on social change among key user groups, 
notably: academics, policy-makers and the wider public. 
A3.2.2.2 Funding 
Since its establishment, the ESS project has been funded through various channels, 
notably: 
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1. The European Commission:  funds the design, coordination and overall 
control of the project. Since its establishment, ESS has received funding from 
the Fifth, Sixth and Seventh R&D Framework Programmes administered by the 
Commission.  
2. The European Science Foundation: who initiated the project and funded all of 
its early design and development, now meets the costs of liaison and wider 
academic input into the project. 
3. National funding councils in the participating countries:  cover the costs of 
fieldwork and coordination at a national level. 
A3.2.3 The project consortium 
The consortium consists of seven partner institutions: (1) City University (UK); (2) 
Leibniz Institute for the Social Sciences (Germany); (3) Netherlands Institute for 
Social Research, SCP (The Netherlands); (4) University Pompeu Fabra, UPF 
(Spain); (5) Catholic University of Leuven (Belgium); (6) Norwegian Social Science 
Data Services, NSD (Norway); and (7) University of Ljubljana (Slovenia). Together, 
the seven organisations constitute the Central Coordinating Team (CCT). Each 
partner has pre-specified responsibilities.  
As Project Coordinator, City University has an ‘oversight’ role. It provides overall 
coordination, direction and management of the project. 
“We coordinate ESS which entails a range of activities: (1) overseeing the work 
carried out by each of the other six partner institutions; (2) maintaining/improving the 
ESS website; (3) reviewing and implementing ESS’s sampling strategy; (4) designing 
the survey questionnaire; (5) organising regular training (e.g. training on quantitative 
analysis for researchers; policy training); and (6) building and maintaining the data 
repository.” 
[City University] 
Findings from the consultation with stakeholders do not reveal any particular reasons 
for selecting the aforementioned partners. 
“The network of partners has been stable since the survey was established. There 
was no particular reason for their selection, except that the NSD had already won a 
tender exercise to provide archive services for the project. As regards GESIS, we 
wanted to work with a particular researcher which is why we collaborated with them.” 
[City University] 
A3.2.4 Pathways to FP7 participation  
The decision to bid for FP7 funding was based on past experiences of participation to 
EU R&D Framework Programmes. As such, the consortium first applied for EU 
funding “in 2005,” when the Sixth Framework Programme (FP6) was launched.    
“Our first application for EU funding was in 2005 […]. As a result, our participation to 
FP7 is only a continuation of what we have been doing before.” 
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[City University] 
Findings from the interviews indicate that the requirement to include a cost 
breakdown, as part of the FP7 application, could have acted as a deterrent to FP7 
participation among many prospective applicants.   
“ […]. The different cost categories rendered the application process unnecessarily 
complex – for instance, different cost rates applied, depending on the nature of the 
cost – i.e. direct, indirect, subcontracting and other direct costs.  
[City University] 
It was however remarked that this requirement is no longer in force for Horizon 2020, 
which was regarded as an improvement on FP7. 
With H2020, on the other hand, everything is much clearer – flat rates now apply, 
such that the Commission reimburses 100% of a project’s eligible direct costs and 
25% of its indirect costs.” 
[City University] 
A3.2.5 Impacts of the project  
The evidence gathered indicates that ESS-DACE has delivered significant benefits, 
notably in two main areas: 
• Improving survey methodology: the ESS has set new and improved 
methodological and coordination standards in cross-national survey research. 
These have led to higher quality data outcomes for ESS and, through their 
subsequent adoption by other national and international survey programmes, 
higher standards of measurement in public-oriented surveys and commercial 
survey practice. 
“The survey has had a positive impact on other pan-European surveys which 
have replicated our methodology. Examples are: the Eurofound survey, the 
European Value Survey (EVS).” 
[City University] 
• Influencing the policy-making process and society: the ESS’s high-quality 
biennial social survey datasets and associated dissemination activities have 
facilitated immediate and easy use of ESS data and findings by a wide variety 
of stakeholders.  
“To a large extent, ESS has achieved its objectives. The goal was to allow 
people to access important social data for free as well as to help policy-
makers access important data to shape policy and tackle societal challenges. 
To date, 80,000 people have registered to our service. About 3,000 
publications cite ESS data and have used it in their work. Moreover, many 
countries have used the data to shape national policy, for instance: Bulgaria 
has used ESS data on immigration.” 
[City University] 
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A3.2.6 Future 
In late 2013, the ESS became a European Research Infrastructure Consortium 
(ERIC).104 ESS ERIC, directed by City University, currently has 16 member countries 
and two observer countries. 
ESS ERIC, along with five other research infrastructures, has acquired €8.5 million 
under H2020 to coordinate a new project, entitled “Synergies for Europe's Research 
Infrastructures in the Social Sciences” (SERISS).  
SERISS brings together three research infrastructures in the social sciences: (1) the 
European Social Survey (ESS); (2) the Survey for Health Ageing and Retirement in 
Europe (SHARE); and (3) the Consortium of European Social Science Data Archives 
(CESSDA). Also involved in SERISS are non-ESFRI research infrastructures:105 
Generations and Gender Programme (GGP); European Values Survey (EVS) and 
the WageIndicator Survey. The overarching objective of this project is to support the 
European Union, the European Commission and the member states to tackle these 
challenges with a solid base of socio-economic evidence. 
  
104 A European Research Infrastructure Consortium – ERIC is a full legal entity under European Union law. With a 
membership of at least one EU member states and two EU member states or associated states, it has legal 
personality and full legal capacity recognized in all member states. 
105 Research Infrastructures of pan-European interest (ESFRI) correspond to the long term needs of the 
European research communities and receive specific support through Horizon 2020. 
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A3.3 FLUTCORE: Development of a universal influenza 
vaccine based on tandem core technology 
FLUTCORE aims to develop a powerful new universal influenza vaccine. If successful, this 
will mean the end of annual "flu jabs" and will provide long-term protection against this highly 
variable virus. 
A3.3.1 Overview 
Total project costs € 5.063 million 
EU funding  € 3.873 million 
Project coordinator iQur Ltd., UK 
Number of partners involved 7 
Project start date 01/09/2013 
Project end date 31/03/2017 
Type of project Collaborative Project (CP) 
Source: ICF consultation with iQur Ltd. (project coordinator); CORDIS database 
A3.3.2 Project description 
The influenza virus undergoes fast mutation. This means that current vaccines need 
to be ‘updated’ every year. This is currently done each year on the basis of events in 
the Southern Hemisphere, roughly six months before the onset of winter in Europe. 
Current vaccines are based on two proteins found on the surface of the virus 
(hemagglutinin and neuraminidase), which mutate rapidly. 
The FLUTCORE project aims to develop a new, universal influenza vaccine. This 
would provide coverage against all current and future strains of the virus and greatly 
improve the effectiveness over current vaccines. The approach of the research relies 
on using parts of the influenza virus which do not mutate as fast as the virus’ 
components which form the basis for the current vaccine. The innovative approach 
focusses on the way in which the used proteins are presented to the immune system, 
using so called ‘virus-like particles’106 and a technology called tandem core™.107 This 
would potentially remove the need for annual vaccination and provide long-term 
protection. 
The project is expected to finish with a phase I clinical trial. FLUTCORE is part of a 
cluster of FP7 projects which all work to improve current influenza vaccines.108 
A3.3.3 The project consortium 
London-based IQUR Ltd. are the coordinator of the project and have been 
developing the tandem core™ technology since 2007, after it licensed at the 
University of Leeds. The Department of Biochemical Engineering at University 
106 https://en.wikipedia.org/wiki/Virus-like_particle [accessed 9th March 2016]. 
107 http://www.iqur.com/index.php/the-science/more-in-depth-science/ [accessed 9th March 2016]. 
108 EDUFLUVAC, UNISEC, FLUNIVAC, UNIVAX, FLUTCORE. 
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College London brings in expertise in micro-scale development technology with 
application to the bioprocessing of novel vaccines and therapeutic protein. 
This UK expertise is combined with 3P Biopharmaceuticals from Spain, Contract 
Development and Manufacturing Organization (CDMO) specialized in the 
Development and manufacturing of biopharmaceutical and cell therapy products from 
early stages (Proof of Concepts) up to clinical and commercial. 
Vall d'Hebron University Hospital in Barcelona, Spain, which is widely considered a 
pioneer in the establishment of vaccination programs, supervising the staff 
vaccination and immunization of patients in special circumstances as 
immunosuppression, transplantation, prematurity, international travel and post-
exposure situations. The research group at the hospital has wide experience in 
clinical assays on immunogenicity, efficacy and safety of influenza and other 
vaccines and is coordinating the phase I clinical trial of the FLUTCORE vaccine. 
The Latvian Biomedical Research and Study Centre brought in world-class expertise 
relating to the use of virus-like particles (VLP). The Latvian team is the home of Prof. 
Paul Pumpens, an acknowledged world leading researcher in HBV core virus-like 
particles. Other partners include the Luxembourg Institute of Health and the 
University of Leeds.  
A3.3.4 Pathways to FP7 participation 
The research topic required a critical mass of effort and resources which were not 
available in the UK. It was therefore of pivotal importance to go beyond the support 
and funding programmes available at the national level to 
• Access contract manufacturers to produce materials 
• Access expertise in virus led particles and other scientific expertise not 
available within UK 
• Combine data and resources 
• Cover different regions of Europe to prepare and conduct a clinical trial 
• Combine IQUR tandem platform with knowledge and IP on specific protein 
targets which can be used to produce vaccines. 
The European partnership provided critical input for the project. Interviewees 
confirmed that the project could not have been conducted under any other funding 
programme.  
In particular the inclusion of a large scale clinical trial is out of scope for most UK 
funding bodies. FP7 allowed the project to include a vaccine development from 
inception, through toxicology and clinical testing. One further advantage of FP7 was 
that proprietary IP could be brought into the project without the need for full 
disclosure. In life science research programmes in the UK, this is often a major 
hurdle for the involvement of commercial enterprises in collaborative R&D. 
The project was considered too "difficult" for most UK grant awarding bodies, and 
was best addressed at the European level. Similar activities were being funded by 
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the US Biomedical Advanced Research and Development Authority, which started a 
large-scale programme in 2011.109 Interviewees considered FLUTCORE and its 
sister projects funded under FP7 to help Europe in staying ahead of global 
competition, and compared it in scale and potential impact to any of the projects 
funded by BARDA.  
Initial collaborations existed between the coordinator, Leeds University and 
University College London. The rest of the consortium was put together on the basis 
of a ‘wish list’ and individual recruiting efforts by the coordinator. The partner from 
Luxembourg was identified through a partnership request on the European 
Commission’s CORDIS website. 
Support to bid writing was provided by UCL’s department for European projects 
which provides a similar support as the national contact points and commercial bid 
writing services. This was based on the experience of the coordinator, who advised 
that reporting and project administration can be ‘bureaucratic’ and burdensome, and 
is best left to specialist teams such as UCL’s project managers. 
A3.3.5 Project outputs and results 
The project has developed a working prototype universal influenza vaccine, which 
will be tested in a phase I clinical trial throughout 2016 and 2017. Interviewees 
suggested that a phase I clinical trial is unusual in a sense for vaccines, as they will 
provide a good idea as to whether the vaccine works. However a phase II trial is 
necessary to ascertain its efficacy and exclude placebo effects. 
The manufacturing technology is such that we could apply this to other antigens from 
different diseases that we are working on. For example, malaria and 
cytomegalovirus. The learnings from this project are directly applicable. 
To date, the project outputs can be divided into three areas, all of which are 
prerequisites for a successful conclusion of the project 
• Antigen discovery: The FLUTCORE vaccine uses areas of the influenza 
proteins which do not mutate significantly. However, within these areas there 
are multiple potential targets. Two main proteins have been the focus of this 
work; M2e and HA-stalk. Each antigen is complex and so there are several 
different possible ways in which these targets may be combined. These 
studies are currently underway and a lead candidate VLP will be chosen for 
manufacturing and scale-up within the next three months. 
• Purification: virus-like particles are very complex molecules, being an 
assembly of multiple copies of an equally complex protein. This means that 
their production is far from trivial and the FLUTCORE team has developed a 
method for protein expression and purification which is compatible with 
industrial scale manufacture. A combination of filtration and chromatography is 
used to produce highly pure VLP of good quality. All processes that are 
currently in use are capable of being carried out at industrial scale.  
109 http://novavax.com/page/16/barda-contract [accessed 9th march 2016]. 
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• Characterisation of virus-like particles: virus-like particles are made from 
complexes of tandem core proteins carrying influenza antigens. The assembly 
of these molecules is highly complex and does not always result in the 
formation of properly assembled virus-like particles. The FLUTCORE team 
have now developed a routine method for virus-like particles production and 
analysis suitable for manufacturing a vaccine used in the phase I clinical trial. 
A3.3.6 Impacts of the project 
The project is still ongoing, however it has already resulted in significant impact both 
on participating organisations and beyond.  
Whilst the lead candidate programme for FLUTCORE is obviously influenza, several 
other tandem core based vaccines are also in development at the coordinating 
organisation IQUR for targets such as malaria, Burkholderia and hepatitis A & B. The 
technology is such that a wide variety of targets of different vaccines can be made 
using this platform technology. Furthermore, the lessons learned during the 
development of a universal influenza vaccine will also apply to other tandem core 
based vaccines. 
As a result of the FLUTCORE work and that of other EU projects focussing on new 
influenza vaccines the European Medicines Agency (EMA) received further incentive 
to change the legislation required for influenza vaccine licensing since this was no 
longer fit for purpose.110 
As regards the commercial impact of the project, the project has enabled IQUR to 
leverage funding to use the tandem core technology™ for other vaccines and 
safeguard up to five research staff. For instance, collaboration with the Edward 
Jenner Institute for Vaccine Research to develop a new malaria vaccine was 
currently being funded through the Innovate UK Biocatalyst programme. 
If the phase I clinical trial is successful, the consortium will enter into a partnership 
with a large pharmaceutical company to carry out late stage clinical trials or sell the 
generated Intellectual Property.  
A phase III trial would need approximately 20,000 individuals in the intention to treat 
group. Should this be achieved, then this clearly has implications for both value of the 
product and employment within the EU. 
  
110 In particular, the use of hemagglutinin inhibition assay as a release criterion for influenza vaccines has been 
discontinued since none of the new products either require it or would meet these standards. 
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From a socio-economic standpoint the advantages of a successful universal 
influenza vaccine are manifold and include 
• lower healthcare costs during influenza outbreaks. This is particularly true for 
the elderly population; and 
• increased productivity due to fewer days lost to influenza. 
The value of such a vaccine is considerable. Currently, an annual influenza vaccine 
is approximately €5. However, this is needed annually. Therefore, it would not be 
unreasonable to position the FLUTCORE vaccine as a premium product and charge 
around €50 for coverage lasting at least 3-5 years, although life-long would be the 
ultimate goal. Obviously, such a product would have considerable value with profits, 
and associated taxes, remaining within the EU, a large share of which could be 
commercialised in the UK through the Coordinator IQUR Ltd. 
A3.3.7 Future  
The project is scheduled to run until March 2017. Currently, 3P Pharmaceuticals in 
Spain are preparing the vaccine for the phase I clinical trial, to be launched at the 
end of 2016. 
As regards plans for following up on the project results, the project coordinator 
described these as below. 
We would seek a partner after Phase I [to conduct subsequent clinical trials]. 
However, we fully intend to continue collaborating with our EU partners in several 
other vaccine projects. We have several applications ongoing and will submit further 
ones 
[Project coordinator]. 
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A3.4 FORTISSIMO - Factories of the Future Resources, 
Technology, Infrastructure and Services for Simulation 
and Modelling 
The Fortissimo project was set up to enable European SMEs engaged in manufacturing and 
engineering to become more globally competitive by using simulation services running on a 
High Performance Computing (HPC) cloud infrastructure. Unlike larger companies, SMEs 
often face significant technological hurdles and financial challenges. Fortissimo therefore 
acts as a “one-stop-shop,” where SMEs can easily access simulation services through an 
HPC cloud at an affordable price, such as on a pay-per-use basis. 
A3.4.1 Overview 
Total project costs € 21.7 million 
EU funding  € 16.0 million 
Project coordinator University of Edinburgh, United Kingdom 
Number of partners involved 122 
Project start date July 1st 2013 
Project end date June 30th 2016 
Type of project Collaborative Project (CP) 
Source: ICF consultation with project coordinators and participants; Fortissimo press release (2013), CORDIS 
database 
A3.4.2 Project description 
A3.4.2.1 Key objectives 
High-performance computing (HPC) is the use of super computers and parallel processing 
techniques for solving advanced problems and performing research activities through 
computer modelling, simulation and analysis 
The principal objective of Fortissimo is to enable European manufacturing industries 
to benefit from the efficiency and competitive advantages inherent in the use of 
simulation. Fortissimo seeks to make advanced simulation more easily accessible, 
particularly to SMEs, through the realisation of a “one-stop shop,” also known as the 
‘Marketplace,’ where hardware, expertise, applications, visualisation and tools will be 
easily available and affordable on a pay-per-use basis (see box below). 
To achieve this objective, Fortissimo provides simulation services, which run on a 
cloud infrastructure, by making use of HPC systems and appropriate skills and tools 
available in a distributed, internet-based environment. 
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The Fortissimo Marketplace 
Fortissimo seeks to create a ‘Marketplace’ that brings together all the actors of the HPC 
solution value chain [i.e.  end-users, domain experts, HPC experts, computer centres, 
engineers, Independent Software Vendors (ISVs)] so that “the different skills of the different 
participants in the value chain can be brokered and used by SMEs, especially those in the 
manufacturing sector, whose business can benefit from advanced simulations.” 
The Portal 
The Fortissimo Marketplace portal provides different types of information to SMEs, such as 
the type of services which are being brokered and where they can get the necessary 
expertise and support. SMEs are also able to find ‘success stories’ which should give them a 
clear indication of how their business might benefit from the availability of simulation 
solutions.  
Source: primeurmagazine.com (2015); Fortissimo Marketplace 
A3.4.2.2 Business model 
Fortissimo is coordinated by EPCC at the University of Edinburgh and involves a 
large network of partners. There are 13 core partners in total, including 
supercomputing centres (the HPC cloud service providers) and large private 
companies. Other partnering organisations include: manufacturing companies, 
application developers, domain experts and IT solution providers.  
Fortissimo’s business model is driven by end-user requirements which, in turn, form 
the basis of business-relevant application experiments designed to develop, test and 
demonstrate both the HPC cloud infrastructure and the “marketplace” (also referred 
to as “one-stop pay-per-use shop”). Each experiment typically involves: (1) a core 
partner; (2) a software provider; (3) an expert in engineering; and (4) a small or mid-
cap company (“the problem-holder”).  
20 experiments were launched at the start of Fortissimo, notably in the following 
fields: the simulation of continuous casting and die casting, environmental control 
and urban planning, and aerodynamic design and optimisation. Another 38 
experiments were selected through two open calls in 2013 and 2014 respectively (25 
were selected in the first call; 13 in the second). The UK is involved in five of the 
experiments.  
A3.4.3 The project consortium 
The consortium behind the Fortissimo project was formed by bringing together past 
and new connections.  As the project coordinator, the University of Edinburgh 
reached out to 13 core partners who provide the HPC cloud services. The remaining 
109 partners were selected on the basis of the business challenges they posed and 
skills and expertise they brought to the experiments they were involved in, many 
through the two open calls. 
“[…] you always have a core set of people with whom you have worked with 
before and whom you trust […] so you would seek to work with them at every 
new opportunity. As project coordinator, your task is to reach out to the best 
partners and put together a network that looks compelling to the reviewers” 
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[University of Edinburgh]. 
Of the 122 partners, eight are based in the UK, including: 
• two universities; and 
• six SMEs, each focusing on specialty areas (including environment, 
engineering, building / modelling, algorithms, and seismic analysis). 
As the project coordinator, the University of Edinburgh is responsible for day-to-day 
management, although some of the task activities have been outsourced to a small 
consultancy firm.  
As regards consortium partners, the vast majority are involved in the application 
experiments. Additionally, 13 partners are actively engaged in furthering the “long-
term activity of the project111” which essentially comprises the creation of the 
‘Marketplace.’  
A3.4.4 Pathways to FP7 participation  
The decision to launch Fortissimo through the FP7 ‘Factories of the Future’ 
programme constituted a collective effort among multiple actors with a common 
interest: that of boosting company/industrial competitiveness through the use of HPC 
to deliver new or improved products and services.  
The decision to fund Fortissimo through FP7 funding was largely influenced by the 
project coordinator’s extensive experience with EU research Framework 
Programmes. Another key motivating factor was the opportunity to work with leading 
researchers and industry players at European and/or international level.  
“Our participation goes back a long way – we have participated in EU research 
Framework Programmes since the Fourth Framework Programme (FP4)  – and it’s 
just something that’s grown over time. At any one time, my organisation – which is 
the biggest supercomputing centre in the UK– is leading three or four FP projects 
and is involved as a partner in three or four other projects. […] we are a very 
international organisation and the programmes have allowed us to interact with many 
European organisations.” 
[University of Edinburgh]. 
 
To further interest among new partners, who were mainly solicited through open 
calls, the University of Edinburgh (along with existing core partners) “went to 
enormous lengths to simplify the application process […]” 
A3.4.5 Project outputs and results 
The main contribution of the Fortissimo project lies in the provision of cloud-based 
simulation services to help solve SMEs’ business challenges. As outlined in Table 
A3.1 below, a number of experiments, involving SMEs, have been undertaken to test 
the use of simulation services running on a High Performance Computing cloud 
111 ICF consultation with the University of Edinburgh 
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infrastructure. For the majority of the SMEs involved, benefits mainly include: 
optimised products and services and greater efficiency (especially in the form of time 
and cost savings).  
Table A3.1 Selection of experiments and their results 
Area of application Intended use(s) of cloud-
based HPC 
Key output(s) Realised benefit(s) 
Original experiments: HPC-cloud-based … 
… simulation of light-
aircraft 
aerodynamics 
■ To perform simulations of 
the flow of air over 
aircrafts which are 
sufficiently detailed to 
model real physical 
effects accurately 
■ Cloud-based HPC 
simulations that closely 
model real-world 
behaviour and give 
accurate information on 
how aircrafts would 
behave in flight 
■ Cloud-based HPC 
simulations are 10 times 
cheaper to use 
■ Cloud-based HPC 
simulations give more 
and better data 
■ Considerable savings, 
worth  €270,000, of using 
HPC simulation as 
opposed to in-house 
systems 
… simulation of 
continuous/steel 
casting 
■ To develop an effective, 
automated system for 
ladle-slag monitoring the 
field of continuous 
casting 
■ Dedicated HPC-based 
simulations, followed by 
case experimental 
validation, have provided  
key insights into different 
ladle-emptying 
mechanisms 
■ Development of an 
innovative slag 
monitoring technology 
based on vibrational 
analysis 
■ Better occupational 
safety 
■ Greater productivity of 
steel plants 
■ Significant reduction in 
time to market and 
improved product design 
… design of high-
pressure vessels  
■ To develop a model for 
the simulation of 
composite materials and 
to implement it on an 
HPC system 
■ Development of a 
computer model to 
design composite 
laminates and simulate 
their properties using an 
open-source software 
package, Octave 
■ Reduction in the amount 
of computation time and 
the number of physical 
tests required in the 
design of composite 
laminates 
 
There is evidence that 
parallel computation on 
an HPC system can help 
reduce composite-design 
time by about 30% and 
testing time by about 
10% 
 
 
 
 
…  simulation of 
flange tightening 
■ To simulate and optimise 
the tightening of flanges 
■ Development of a of a 
computer model for 
simulating the tightening 
process and a front-end 
application to control 
simulations in order to 
improve the design of the 
tightening process 
■ Evidence of a 33% time 
saving per flange as 
regards the tightening 
process 
■ Evidence of a saving 
of approximately €180k 
per tightening to the end-
user  
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Area of application Intended use(s) of cloud-
based HPC 
Key output(s) Realised benefit(s) 
… prediction of air 
quality 
■ To demonstrate the use 
of cloud-based-HPC 
services to investigate 
air-quality at the scale of 
cities (this experiment 
used case study used the 
SME’s existing software:  
ADMS-Urban) 
■ ADMS-Urban was 
adapted to run on a 
cloud-based HPC system 
■ The results of the 
simulations were then 
made available via a 
familiar workstation 
environment 
■ If the average percentage 
of use of an internal 
server falls below 40%, a 
pay-on- demand cloud 
service becomes 
economically viable 
compared with the costs 
to acquire and maintain 
that server 
■ Better pricing options to 
customers  
Source: Fortissimo-project.eu 
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A3.4.6 Impacts of the project  
Given that Fortissimo had not yet reached completion at the time of the present 
study, it is difficult to assess its full impacts. Interviewees were however confident 
that Fortissimo will achieve almost all of its objectives, in particular those related to 
promoting cloud-based HPC solutions among SMEs as a means to solving their 
business challenges.  
[…] I think I can say that Fortissimo will certainly achieve its objective of running the 
58 experiments and making the SMEs happy, at least the majority of them. I think the 
most difficult part has been creating the marketplace [...]. So I think we would have 
easily achieved 90% of our objectives by the end. 
[University of Edinburgh]. 
The commercial impacts of the Fortissimo project are uncertain, given that the 
‘Marketplace’ has not been fully developed yet. However, available quantitative 
evidence indicates that investment in HPC infrastructure can have significant positive 
impacts. As such, each dollar invested in HPC is estimated to return, on average, 
$356 in revenue and $38 in profits or cost savings112  
A3.4.7 Future 
The consortium has received an additional €11 million (of which €10 million in EU 
funding) to launch the second phase of Fortissimo – Fortissimo 2.  
Fortissimo 2 kicked off in November 2015. The project focuses on the adoption of 
next-generation ICT advances in the manufacturing domain.  
At the core of Fortissimo 2 are three tranches of ‘application experiments’ 
(approximately 35 in total). An initial set was included in the proposal and two further 
sets will be obtained through open calls for proposals. These experiments will be 
driven by the requirements of first-time users (predominately SMEs) and will bring 
together actors from across the value chain, from cycle providers to domain experts 
via the ‘Fortissimo Marketplace.’ This will enable the development of innovative 
solutions to manufacturing challenges, leading to new and improved design 
processes, products and services. In addition to traditional HPC modelling and 
simulation, Fortissimo 2 will also focus on the application of High Performance Data 
Analytics to the business challenges faced by SMEs. 
 
 
  
112 Fortissimo, 2014. Fortissimo – Enabling Manufacturing SMEs to Benefit from HPC  
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A3.5 SILVER – Supporting Independent Living for the Elderly 
through Robotics 
SILVER is a development program into new robotic-based technologies that could help the 
elderly to continue to live at home even if they have physical or cognitive disabilities. SILVER 
is the first pan-European initiative that searches for new, innovative ways to acquire public 
sector health services by using a Pre-Commercial Procurement (PCP) process designed for 
optimally matching R&D with procurers' needs. 
A3.5.1 Overview 
Total project costs € 4.2 million 
EU funding € 2.6 million 
Project coordinator Innovate UK (formerly Technology Strategy Board),  United Kingdom 
Number of partners involved 13 (of which two are UK-based: Innovate UK and City of Stockport) 
Project start date January 1st 2012  
Project end date August 31st 2016 
Type of project Combined Collaborative Project and Coordination and Support Action (CPCSA) 
Source: ICF consultation with Innovate UK (project coordinator); CORDIS database 
A3.5.2 Project description 
A3.5.2.1 Key objectives 
PCP is the procurement of research and development of new innovative solutions before 
they are commercially available. 
The SILVER project was established in view of developing new robotic technologies 
to assist elderly people in their everyday lives or support their independent living at 
home even if they have physical or cognitive disabilities. The new technologies and 
solutions are sought by using a Pre-Commercial Procurement (PCP) process.   
SILVER has two concrete primary objectives: 
• To establish and execute an agreed PCP process to run a cross-border ‘PCP 
call for tender.’ 
• To use the PCP process in identifying new technologies and services to 
support the independent living of the elderly. 
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A3.5.2.2 Business model 
SILVER is the first European-based PCP initiative that involves multiple countries113. 
The main actors in the process are: 
• ‘Public procurers’ in the participating countries – i.e. Denmark, Finland, the 
Netherlands, Sweden and the United Kingdom – who run / manage the PCP 
call for tender in order to identify precise technologies needed while 
encouraging innovation. In the UK, the designated public procurer is City of 
Stockport. 
• ‘Developers’ – including small-and-medium –sized research enterprises and 
larger research centres – who engage in competitive tendering and, if 
selected, can expect “to receive 100% of the funding required […] to 
undertake the R&D work114.” 
• ‘End-users’ who test first-end products in real-world environments.  
PCP was chosen over traditional procurement routes in order “to get procurement in 
the public sector to be more open to innovation.” Additionally, the PCP’s ‘phased’ 
approach allows “procurers, the public sector and developers to control or balance 
the risks that may be involved in R&D115”. 
  
113 ICF consultation with Innovate UK 
114 ICF consultation with Innovate UK 
115 ICF consultation with Innovate UK 
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A3.5.2.3 Phases of the PCP process 
Figure A3.1 SILVER is based on a three-phased PCP approach. It is currently in the 
third stage of the process. Key stages of the PCP process 
Figure A3.2 below illustrates the different PCP stages. 
Figure A3.2 Key stages of the PCP process 
 
Source: ICF (adapted from ICF stakeholder consultation; the SILVER website) 
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A3.5.3 The project consortium 
A3.5.3.1 Key partners 
The Consortium comprises a total of 13 key partners, including innovation agencies, 
local / national contracting authorities, academic institutions and private research 
companies. In the UK, key partners include: Innovate UK, which coordinates the 
project, and City of Stockport – the national contracting authority. 
Specific work packages assigned to UK partners 
SILVER comprises six work packages, each one having a responsible leader. Work 
Packages 1, 5 and 6 provide a support function to help run the project while the remaining 
Work Packages (2, 3 and 4) interact to generate the PCP call. 
As the project coordinator, Innovate UK leads Work PackagesWP1 project management and 
WP4 administration of the competition and monitoring pilots, with support from the City of 
Stockport. Along with public procurers in the participating countries, the City of Stockport also 
supports WP6 dissemination and exploitation of project results. 
A3.5.3.2 Pathways to FP7 participation  
The decision of launching SILVER through the FP7 ‘Combined Collaborative Project 
and Coordination and Support Action’ programme constituted a collective effort 
among multiple actors with a common interest: that of identifying, trialling and 
adopting innovative healthcare technologies to assist elderly people in their everyday 
lives through a Pre-Commercial Procurement (PCP) process; the latter designed “to 
stimulate innovation by allowing public authorities to identify promising technologies 
early and steer the final development of these technologies towards their own 
specific requirements116.”  
The decision to bid for FP7 funding was largely driven by the project coordinator, 
owing to their experience in the preparation of PCP calls at a local level.   
“[…] Given that we had already implemented PCP in the UK under the Small 
Business Research Initiative (SBRI), we felt we had valuable experience and could 
use it to help others learn about the PCP process and how to run it in practice.”  
[Innovate UK] 
A3.5.3.3 Project outputs and results 
The main contribution of the SILVER project is the LEA (Lean Elderly Assistant) 
robot, developed to enable the elderly to live independently in their own home. LEA is 
the sole product to have met the minimum threshold in Phase 3 of the PCP call and 
therefore selected for real-life testing and commercialisation.  
LEA’s primary function is to assist elderly people in their daily routines and 
housekeeping, for instance, by117: (1) offering support when walking, sitting down 
116 CORDIS, 2016. Helping public authorities drive healthcare R&D forward 
117 CORDIS, 2016. Helping public authorities drive healthcare R&D forward 
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and/or standing up; (2) picking up heavy objects; (3) remembering and recognising 
objects, faces and places, through its cognitive software; and (4) monitoring daily 
routines like eating, sleeping and exercising, through its recognition of actions and 
protocols.  
SILVER healthcare and robotics experts have tested the product and provided the 
contractor, Robot Care Systems118, with detailed feedback on how to improve it 
further. Final tests are due to take place during the spring and summer of 2016 in all 
of the SILVER municipalities (i.e.  Denmark, Finland, the Netherlands, Sweden and 
the United Kingdom).  
A3.5.4 Impacts of the project  
Given that SILVER had not reached completion at the time of the present study and 
the final product has not been commercialised on a wider scale yet, it is difficult to 
assess its full impacts.  
“It is too early to say if SILVER has been successful. The real success will be that the 
contractor commercialises the product fully and sells it in the market and, hopefully, 
the procurers buy it and it helps elderly people at home. Initial signs are looking good 
though.” 
[Innovate UK]  
In spite of prevailing uncertainties, SILVER is expected to deliver important benefits 
to the homecare sector. The promotion of innovative solutions in the sector is 
expected to foster the creation of new markets for assisted-living tools. The 
advanced solutions can in turn achieve significant cost savings, notably through 
increased resource efficiency119.  As such, by 2020, it is expected that new solutions 
implemented in elderly care will allow for 10% more care recipients with the same 
number of care providers / personnel. 
“The project is due to finish at the end of August. It looks like we have a good product 
and something procurers would [...] buy.  Something to bear in mind, though, is that 
the work undertaken by the developers through SILVER is mainly R&D work. So, 
even when the contract finishes in August, the applicant will continue to develop the 
product and commercialise it but probably won’t start selling it until after 2017. The 
goal of the SILVER competition was to launch a new product by 2020. So, it appears 
we are in line with our initial target.” 
[Innovate UK] 
In addition, SILVER is pioneering a new and more cost-effective procurement 
technique – the Pre-Commercial Procurement approach – which can be easily 
transferred. As such, by the completion of the project, a fully documented PCP 
process will be made available. Together with the process, supporting artefacts will 
118 http://www.robotcaresystems.com/  
119 CORDIS, 2016. Helping public authorities drive healthcare R&D forward 
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be provided, including application forms and document templates, which can be used 
by other procurers interested in running a PCP call in the future.  
A3.5.5 Future 
The R&D work stimulated through SILVER is expected to continue, principally by the 
developers themselves. If the LEA robot is commercialised successfully, more 
developers are likely to enter the market and further the work in healthcare robotics.  
The success of SILVER may also influence EU/national policy, especially as regards 
the use of PCP as a means of procuring R&D services. 
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